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Acanthamoeba Molecular Detection
CDC-10471
Test Order
Synonym(s) Free-living ameba, parasite
Performed on Specimens From Human
CDC Points of Contact Alex daSilva
(404) 718-4121
adasilva@cdc.gov
Jennifer Cope
(404) 718-4878
bjt9@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Cerebrospinal fluid (CSF), Tissue
Minimum Volume Required 200 uL
Turnaround Time 21 Days
Interferences & Limitations Formalin fixed specimens are not suitable for molecular studies
Storage & Preservation of
Specimen Prior to Shipping
Storage and preservation is specimen specific
Additional lnformation None
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday – Thursday, overnight to avoid weekend deliveries. Ship specimen 
at room temperature, not on dry ice, as an etiologic agent.
Methodology Conventional PCR, Real Time PCR
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Actinomyces – Anaerobic ID
CDC-10483
Test Order
Synonym(s) Anaerobe ID, Bacterial Identification, Anaerobe
Performed on Specimens From Human, Animal, and Food/Environmental/Medical Devices/Biologics
CDC Points of Contact David Lonsway
(404) 639-2825
Dlonsway@cdc.gov
Kamile Rasheed
(404) 639-3247
jkr1@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Anaerobic bacteria from clinically relevant sources, pure culture isolate in 
suitable anaerobic transport medium (e.g., Chopped Meat Glucose Broth). Prior 
approval from laboratory required for other sample/specimen types.
Minimum Volume Required Not Applicable
Turnaround Time 28 Days
Interferences & Limitations Specimen from respiratory, vaginal, and fecal sources are not acceptable
Storage & Preservation of
Specimen Prior to Shipping
Store anaerobically
Additional lnformation None
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Pure culture isolate in Chopped Meat Glucose broth, thioglycolate broth or 
frozen in TSB plus glycerol
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship specimen Monday -Thursday overnight to avoid weekend deliveries, as an 
etiologic agent.
Frozen specimen should be shipped on dry ice
Specimen stored at room temperature should be shipped at room temperature
Methodology 16s Sequencing, MALDI-TOF, Phenotypic Testing
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Actinomycetes-Aerobic -ID
CDC-10148
Test Order
Synonym(s) Nocardia, Streptomyces
Performed on Specimens From Human and Food/Environmental/Medical Devices/Biologics
CDC Points of Contact John McQuiston
(404) 639-0270
zje8@cdc.gov
Anne Whitney
(404) 639-1374
amw0@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
Please notify laboratory prior to shipment if this is a critical care specimen
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Pure culture isolate on a suitable agar slant medium; consultation required for 
other sample/specimen types
Minimum Volume Required Not Applicable
Turnaround Time 3 Weeks
Interferences & Limitations The 3 week turnaround time applies to all tests unless biochemical and/or 
phenotypic analysis are required, which could take up to 2 months for test 
results.
Storage & Preservation of
Specimen Prior to Shipping
Keep specimen refrigerated if unable to ship immediately
Additional lnformation If available, please provide patient history including if the patient has used a 
catheter and/or if the patient is immunocompromised.
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition
Transport Medium Suitable agar slant medium
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship specimen Monday-Thursday, overnight to avoid weekend deliveries
Methodology Primary culture based on specimen type, 16S sequence based identification, 
MALDI-TOF
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Actinomycetes-Aerobic -ID and AST
CDC-10149
Test Order
Synonym(s) Actinos
Performed on Specimens From Human and Food/Environmental/Medical Devices/Biologics
CDC Points of Contact John McQuiston
(404) 639-0270
zje8@cdc.gov
Anne Whitney
(404) 639-1374
amw0@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
Please notify laboratory prior to shipment if this is a critical care specimen
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Pure culture isolate on a suitable agar slant medium; consultation required for 
other sample/specimen types
Minimum Volume Required Not Applicable
Turnaround Time 3 Weeks
Interferences & Limitations The 3 week turnaround time applies to all tests unless biochemical and/or 
phenotypic analysis are required, which could take up to 2 months for test 
results.
Storage & Preservation of
Specimen Prior to Shipping
Keep specimen refrigerated if unable to ship immediately
Additional lnformation If available, please provide patient history including if the patient has used a 
catheter and/or if the patient is immunocompromised.
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship specimen Monday-Thursday, overnight to avoid weekend deliveries
Methodology AST by broth microdilution, Primary Culture based on specimen type, 16S 
sequence based identification, MALDI-TOF
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Adenovirus Molecular Detection and Typing
CDC-10170
Test Order
Synonym(s) None
Performed on Specimens From Human, Animal, and Food/Environmental/Medical Devices/Biologics
CDC Points of Contact Dean Erdman
(404) 639-3727
dde1@cdc.gov
Shifaq Kamili
(404) 639-2799
sgk5@cdc.gov
Pre-Approval Needed Erdman, Dean, (404) 639-3727, dde1@cdc.gov
Kamili, Shifaq, (404) 639-2799, sgk5@cdc.gov
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Upper or lower respiratory tract specimens, eye swabs, stool, serum, blood or 
plasma, pure culture isolate
Minimum Volume Required 0.25 mL
Turnaround Time 3 Weeks
Interferences & Limitations Use only sterile Dacron or rayon swabs with plastic shafts or if available, flocked 
swabs. Do NOT use calcium alginate swabs or swabs with wooden sticks, as they 
may contain substances that inactivate some viruses and inhibit some molecular 
assays.
Storage & Preservation of
Specimen Prior to Shipping
Refrigerate all specimens promptly after collection. If specimens can be shipped 
to CDC within 72 hours of collection, they should be kept refrigerated at 4°C and 
shipped on gel ice-packs. Freezing should be avoided if possible, as this will 
reduce virus infectivity. Specimens for virus culture should not be frozen at -20°
C. If specimens must be held for >72 hours, they should be promptly frozen 
at -70°C and shipped on dry ice. Liquid specimens should be aliquoted into 
properly labeled, leak-proof, unbreakable screw cap vials. Samples should be 
collected and processed in a manner that prevents cross-contamination between 
specimens, including changing gloves between specimens.
Additional lnformation None
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Swabs may be shipped in commercial viral transport media
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship specimen Monday-Thursday, overnight to avoid weekend deliveries
Frozen specimen should be shipped on dry ice
Refrigerated specimen should be shipped on cold packs
Methodology Polymerase Chain Reaction (PCR), Sequencing
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Alkhurma Identification
CDC-10274
Test Order
Synonym(s) AHFV
Performed on Specimens From Human and Animal
CDC Points of Contact Ute Stroeher
(404) 639-4704
ixy8@cdc.gov
Barbara Knust
(404) 639-1104
bkk0@cdc.gov
Pre-Approval Needed Stroeher, Ute, (404) 639-4704, ixy8@cdc.gov
Knust, Barbara, (404) 639-1104, bkk0@cdc.gov
Supplemental Information
Required
See Supplemental Form
Supplemental Form http://www.cdc.gov/ncezid/dhcpp/vspb/pdf/specimen-submission.pdf
Acceptable Sample/ Specimen 
Type for Testing
Frozen tissue, blood, and serum
Minimum Volume Required 1 mL
Turnaround Time 10 Days
Interferences & Limitations Specimen must remain frozen, warming or freeze thawing reduces sensitivity. 
Heparin may cause interference with the molecular tests and should be avoided.
Storage & Preservation of
Specimen Prior to Shipping
Specimen must be placed in plastic screw capped vials, frozen to -70°C, and kept 
frozen until shipment. See link to supplemental submission form for specific 
information on various specimen types.
Additional lnformation Critical specimens will take less than 4 days to turn around. See link to 
supplemental submission forms for detailed information.
Specimen Labeling Patient name, patient ID #, specimen type, date collected
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday overnight to avoid weekend deliveries. Specimen should 
be shipped frozen on dry ice. See supplemental submission forms for further 
details. Do not ship specimen without prior consultation and approval.
Methodology Molecular Typing, Polymerase Chain Reaction (PCR)
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Alkhurma Serology
CDC-10285
Test Order
Synonym(s) AHFV
Performed on Specimens From Human and Animal
CDC Points of Contact Ute Stroeher
(404) 639-4704
ixy8@cdc.gov
Barbara Knust
(404) 639-1104
bkk0@cdc.gov
Pre-Approval Needed Stroeher, Ute, (404) 639-4704, ixy8@cdc.gov
Knust, Barbara, (404) 639-1104, bkk0@cdc.gov
Supplemental Information
Required
See Supplemental Form
Supplemental Form http://www.cdc.gov/ncezid/dhcpp/vspb/pdf/specimen-submission.pdf
Acceptable Sample/ Specimen 
Type for Testing
Blood and serum
Minimum Volume Required 1 mL
Turnaround Time 10 Days
Interferences & Limitations Specimen must remain frozen; warming or freeze thawing reduces sensitivity
Storage & Preservation of
Specimen Prior to Shipping
Specimen must be kept cold (at or below 4°C). If possible place specimen in 
plastic screw capped vials. See link to supplemental submission form for specific 
information on various specimen types.
Additional lnformation Critical specimens will take less than 4 days to turn around. See link to 
supplemental submission forms for detailed information.
Specimen Labeling Patient name, patient ID #, specimen type, date collected
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday overnight to avoid weekend deliveries. Specimen should 
be shipped on cold packs or dry ice if frozen. See supplemental submission 
forms for further details. Do not ship specimen without prior consultation and 
approval.
Methodology ELISA
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Ameba Identification (Acanthamoeba, Balamuthia, Naegleria)
CDC-10286
Test Order
Synonym(s) Free-living ameba, Acanthamoeba, Balamuthia, Naegleria fowleri
Performed on Specimens From Human, Animal, and Food/Environmental/Medical Devices/Biologics
Pre-Approval Needed None
Supplemental Information
Required
Please provide the following information: history of present illness, exposure 
history, past medical history, treatment history, CSF results, imaging results
If images are available please upload to: www.dpd.cdc.gov/dpdx/
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Fresh, unfixed tissue and Paraffin-embedded and formalin-fixed tissue. 
cerebrospinal fluid (CSF), biopsy specimen, deep corneal scrapings, and ocular 
fluids are also acceptable.
Minimum Volume Required 1 mL
Turnaround Time 3 Days
Interferences & Limitations If the specimen (i.e., CSF or tissue) has been previously frozen or is preserved in 
formalin, CDC will still accept the specimen but the full range of testing 
methodologies might not be available since PCR results would be affected.
Storage & Preservation of
Specimen Prior to Shipping
CSF and fresh, unfixed tissue should be kept at ambient temperatures. Paraffin-
embedded and formalin-fixed tissue should be kept at room temperature. Send 
a few H&E-stained slides and a few (about 6) unstained slides for IHC test, or 
Paraffin-embedded tissue block.
Unfixed deep scraping and biopsy materials for  identification of free-living 
amoeba  are usually very small and may dry if they are not stored in proper fluid 
such as “amoeba saline.” These specimens should be transported to the 
laboratory within 24 hours.
Additional lnformation Include the address of sender and physician contact information with the 
specimen.
Specimen Labeling Provide specimen type, patient name, sex, date of birth, hospital ID, and date of 
collection on label
Transport Medium Care should be taken to pack glass slides securely, as they can be damaged in 
shipment if not packed in a crush-proof container. For deep scraping and biopsy 
materials please transport in ameba saline solution.
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday, overnight. Please contact laboratory prior to shipping 
any specimen and include unit 53 on the outside of package. 
Ship all fresh specimens such as CSF, tissue (e.g., brain, lungs, skin) and all deep 
scraping and biopsy material, contact lens solutions etc. within 24 hours. Fresh, 
unfixed specimens (i.e., CSF and tissue) should be sent at ambient temperature 
by overnight priority mail. Please ship these specimens separately from other 
chilled or frozen samples being shipped. The free-living amebae are heat-loving 
and can be killed by cold temperatures (either refrigeration or freezing).
If specimen has been previously frozen or preserved in formalin, please send 
these specimens by overnight priority mail on ice packs (if tissue is frozen) (do 
NOT ship on dry ice) and ambient temperature if the tissue is fixed in formalin.
Methodology Polymerase Chain Reaction (PCR), Indirect Immunofluorescence (IIF), 
Immunohistochemical (IHC) staining plus microscopy, Microscopy
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Ameba Identification (Acanthamoeba, Balamuthia, Naegleria)
CDC-10286
Test Order
CDC Points of Contact Jennifer Cope
(404) 718-4878
bjt9@cdc.gov
Michael Arrowood
(404) 718-4159
mja0@cdc.gov
For deep scraping and biopsy materials please provide the following information 
to the laboratorians: patient name (first, last and middle initials), age & date of 
birth, sex, date specimen collected, Specimen source (cornea, vitreous fluid), 
specimen type (deep scraping, biopsy, vitreous fluid), suspected infection 
(keratitis, conjunctivitis, endophthalmitis), transport medium used.
Ameba saline, 1X stock:
Sodium chloride (NaCl) 0.120g
Magnesium sulfate (MgSO4.7HOH) 0.004 g
Sodium phosphate, dibasic (Na2HPO4) 0.142g
Potassium phosphate, monobasic  (KH2P O4) 0.136g
Calcium chloride (CaCL2.2HOH) 0.004g
Double distilled water to 1000.0 mL
 If you are calling outside of regular 
business hours, please call the CDC 
Emergency Operations Center (EOC)
(770) 488-7100
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Ameba Serology (Acanthamoeba, Balamuthia, Naegleria)
CDC-10287
Test Order
Synonym(s) Free-living ameba, Acanthamoeba, Balamuthia, Naegleria fowleri
Performed on Specimens From Human
CDC Points of Contact Jennifer Cope
(404) 718-4878
bjt9@cdc.gov
Michael Arrowood
(404) 718-4159
mja0@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
Please provide the following information: history of present illness, exposure 
history, past medical history, treatment history, CSF results, imaging results
If images are available please upload to:  www.cdc.gov/dpdx
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Sera (two specimen taken 2 weeks apart)
Minimum Volume Required 1 mL
Turnaround Time 2 Weeks
Interferences & Limitations None
Storage & Preservation of
Specimen Prior to Shipping
Serum specimens can be collected from the patient in a red-top tube (plain 
vacuum tube with no additive) or a serum-separator tube (tiger top) tube 
(red/gray speckled top with gel in the tube).  Please centrifuge the specimen, 
and if possible, send serum only. If using a plain red-top tube, you must 
separate the serum before shipping and send the serum only.  Should be kept 
refrigerated or frozen.
Additional lnformation Include the address of sender and physician contact information with the 
specimen
Specimen Labeling Provide specimen type, patient name, sex, date of birth, hospital ID, and date of 
collection on label
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday, overnight. Please contact laboratory prior to shipping 
any specimen and include unit 53 on the outside of package
Serum samples should be shipped refrigerated or frozen and packed with cold 
packs
Methodology Indirect Fluorescent Antibody test (IFA)
 If you are calling outside of regular 
business hours, please call the CDC 
Emergency Operations Center (EOC)
(770) 488-7100
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Ameba Special Study
CDC-10288
Test Order
Synonym(s) None
Performed on Specimens From Human, Animal, and Food/Environmental/Medical Devices/Biologics
CDC Points of Contact Jennifer Cope
(404) 718-4878
bjt9@cdc.gov
Micheal Arrowood
(404) 718-4149
mja0@cdc.gov
Pre-Approval Needed Cope, Jennifer, (404) 718-4878, bjt9@cdc.gov
Arrowood, Micheal, (404) 718-4149, mja0@cdc.gov
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
To be determined
Minimum Volume Required To be determined
Turnaround Time  
Interferences & Limitations To be determined
Storage & Preservation of
Specimen Prior to Shipping
To be determined
Additional lnformation To be determined
Specimen Labeling To be determined
Transport Medium To be determined
Shipping Instructions which 
Include Specimen Handling 
Requirements
To be determined
Methodology
 If you are calling outside of regular 
business hours, please call the CDC 
Emergency Operations Center (EOC)
(770) 488-7100
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Amebiasis (Entamoeba histolytica) Enzyme Immunoassay
CDC-10461
Test Order
Synonym(s) Entamoeba histolytica, parasite
Performed on Specimens From Human
CDC Points of Contact Patricia Wilkins
(404) 718-4101
pma1@cdc.gov
Isabel McAuliffe
(404) 718-4100
ibm4@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
Exposure and travel history, include other relevant risk factors; clinical 
symptoms, treatment and relevant lab results.
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Serum and Plasma
Minimum Volume Required 0.5 mL
Turnaround Time 18 Days
Interferences & Limitations Substances known to interfere with immunoassays include: bilirubin, lipids, and 
hemoglobin 
Storage & Preservation of
Specimen Prior to Shipping
No specific requirements
Additional lnformation None
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday – Thursday, overnight to avoid weekend deliveries. Ship specimen 
at room temperature, not on dry ice, as an etiologic agent.
Methodology EIA, ELISA, Antibody Detection
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Anaerobic Bacteria Identification
CDC-10227
Test Order
Synonym(s) Anaerobe ID, Bacterial Identification, Anaerobe
Performed on Specimens From Human, Animal, and Food/Environmental/Medical Devices/Biologics
CDC Points of Contact David Lonsway
(404) 639-2825
Dlonsway@cdc.gov
Kamile Rasheed
(404) 639-3247
jkr1@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Anaerobic bacteria from clinically relevant sources, pure culture isolate in 
suitable anaerobic transport medium (e.g., Chopped Meat Glucose Broth). Prior 
approval from laboratory required for other sample/specimen types.
Minimum Volume Required Not Applicable
Turnaround Time 28 Days
Interferences & Limitations Specimen from respiratory, vaginal, and fecal sources are not acceptable
Storage & Preservation of
Specimen Prior to Shipping
Store anaerobically
Additional lnformation See separate test order for C. difficile
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Pure culture isolate in Chopped Meat Glucose broth, thioglycolate broth or 
frozen in TSB plus glycerol
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship specimen Monday -Thursday overnight to avoid weekend deliveries, as an 
etiologic agent.
Frozen specimen should be shipped on dry ice
Specimen stored at room temperature should be shipped at room temperature
Methodology 16S Sequencing, MALDI-TOF, Phenotypic Testing
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Anaplasma and Ehrlichia Molecular Detection
CDC-10290
Test Order
Synonym(s) Human granulocytic anaplasmosis and Human monocytic ehrlichiosis, HGE
Performed on Specimens From Human
CDC Points of Contact Cecilia Kato
(404) 639-1075
ckato@cdc.gov
Jennifer McQuiston
(404) 639-1075
fzh7@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
Prior approval is required if the following information is not provided:
-Symptom onset date
-Sample collection date
-Type of infection
-Status of illness
Recommended:
-Travel history
-Exposure history
-Therapeutic agents
-Brief clinical history
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Acute samples only, anticoagulated whole blood collected in 
Ethylenediaminetetraacetic acid (EDTA) treated tubes preferred; serum; fresh 
tissue biopsy
Minimum Volume Required 1.0 mL
Turnaround Time 6 Weeks
Interferences & Limitations Hemolysis in whole blood specimen will interfere with results. Multiple freeze 
thaw cycles and sample storage above refrigerated temperatures will interfere 
with proper nucleic acid extraction. If a specimen is drawn at convalescence it 
will reduce the chance of the target organism being present in blood. Avoid 
collection of blood specimen in heparin tubes.
Storage & Preservation of
Specimen Prior to Shipping
Ideally keep specimen at a refrigerated temperature not frozen. If previously 
frozen, then keep specimen frozen.
Additional lnformation The Rickettsial Zoonoses Branch Reference Diagnostic Laboratory aids State 
Laboratories in diagnosis of difficult samples/cases or if specialized tests are 
needed.  Routine diagnostic samples should be sent to your State Laboratory or a 
commercial laboratory.
Specimen Labeling Patient name and date of birth
Transport Medium Ethylenediaminetetraacetic acid (EDTA) blood tubes for blood; tissue in a sample 
collection tube
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday, overnight to avoid weekend deliveries. Specimen should 
be shipped refrigerated on cold packs.
Methodology Real Time Polymerase Chain Reaction (PCR), Sequencing
 
Monday, January 13, 2014 Page 14 of 380Version: 1.1
Anaplasma and Ehrlichia Special Study
CDC-10291
Test Order
Synonym(s) Human granulocytic anaplasmosis and Human monocytic ehrlichiosis, HGE
Performed on Specimens From Human, Animal, and Food/Environmental/Medical Devices/Biologics
CDC Points of Contact Jennifer McQuiston
(404) 639-1075
fzh7@cdc.gov
Cecilia Kato
(404) 639-1075
ckato@cdc.gov
Pre-Approval Needed Kato, Cecilia, (404) 639-1075, ckato@cdc.gov
McQuiston, Jennifer, (404) 639-1075, fzh7@cdc.gov
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
To be determined
Minimum Volume Required To be determined
Turnaround Time  
Interferences & Limitations To be determined
Storage & Preservation of
Specimen Prior to Shipping
To be determined
Additional lnformation To be determined
Specimen Labeling To be determined
Transport Medium To be determined
Shipping Instructions which 
Include Specimen Handling 
Requirements
To be determined
Methodology Molecular detection, Serology, Culture, Immunohistochemistry (IHC), Other
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Anaplasma Serology
CDC-10292
Test Order
Synonym(s) Human granulocytic anaplasmosis
Performed on Specimens From Human
CDC Points of Contact Cecilia Kato
(404) 639-1075
ckato@cdc.gov
Jennifer McQuiston
(404) 639-1075
fzh7@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
Prior approval is required if the following information is not provided:
-Symptom onset date
-Sample collection date
-Type of infection
-Status of illness
Recommended:
-Travel history
-Exposure history
-Therapeutic agents
-Brief clinical history
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Serum
-acute (during active stage of illness)
-convalescent (2-4 weeks after acute stage)
Minimum Volume Required 1.0 mL
Turnaround Time 6 Weeks
Interferences & Limitations Multiple freeze thaw cycles may interfere with antigen binding. Use sterile 
technique to avoid contamination of sample as this may compromise the sample 
and interfere with the ability to get accurate results. Acute and convalescent 
serum is needed for accurate diagnosis and if unable to collect both please 
contact laboratory prior to shipping.
Storage & Preservation of
Specimen Prior to Shipping
Ideally keep specimen at a refrigerated temperature not frozen. If previously 
frozen, then keep specimen frozen.
Additional lnformation The Rickettsial Zoonoses Branch Reference Diagnostic Laboratory aids State 
Laboratories in diagnosis of difficult samples/cases or if specialized tests are 
needed.  Routine diagnostic samples should be sent to your State Laboratory or a 
commercial laboratory.
Specimen Labeling Patient name and date of birth
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday, overnight to avoid weekend deliveries. Specimen should 
be shipped refrigerated on cold packs.
Methodology Indirect Fluorescence Assay (IFA)
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Angiostrongylus cantonensis Molecular Detection
CDC-10472
Test Order
Synonym(s) Angiostrongyliasis, Rat lungworm, parasite
Performed on Specimens From Human, Animal, and Food/Environmental/Medical Devices/Biologics
CDC Points of Contact Alex daSilva
(404) 718-4121
adasilva@cdc.gov
Yvonne Qvarnstrom
(404) 718-4123
bvp2@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Human: Cerebrospinal fluid (CSF); Animal: CSF, Blood, Tissue
Minimum Volume Required 200 uL
Turnaround Time 21 Days
Interferences & Limitations Formalin fixed  specimens are not suitable for molecular studies
Storage & Preservation of
Specimen Prior to Shipping
Storage and preservation is specimen specific
Additional lnformation None
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday – Thursday, overnight to avoid weekend deliveries. Ship specimen 
at room temperature, not on dry ice, as an etiologic agent.
Methodology Conventional PCR, Real Time PCR
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Anthrax Lethal Toxin Neutralization Assay
CDC-10428
Test Order
Synonym(s) Anthrax TNA
Performed on Specimens From Human and Animal
CDC Points of Contact Conrad Quinn
(404) 639-2858
caq7@cdc.gov
Jarad Schiffer
(404) 639-0894
aku3@cdc.gov
Pre-Approval Needed Quinn, Conrad, (404) 639-2858, caq7@cdc.gov
Schiffer, Jarad, (404) 639-0894, aku3@cdc.gov
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Paired acute and convalescent sera
Minimum Volume Required 200 uL
Turnaround Time 2 Weeks
Interferences & Limitations Prefer non-hemolyzed specimen and non-lipemic specimen. If they are 
hemolyzed or lipemic, the specimen will not be tested. Plasma specimen are not 
accepted. Do not store or send specimen in tubes with preservatives or cell 
growth inhibitors.
Storage & Preservation of
Specimen Prior to Shipping
Serum should be separated from whole blood and kept at -80°C
Additional lnformation None
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition including patient ID, date of collection, 
submitter information, and specimen ID number.
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday – Thursday, overnight to avoid weekend deliveries. Contact 
laboratory prior to shipment.  
Ship paired sera together and all frozen specimen should be shipped on dry ice
Methodology Cell Based Serological Assay
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Antimicrobial Susceptibility Testing - Bacterial 
CDC-10223
Test Order
Synonym(s) AST, Sensitivity, MIC testing
Performed on Specimens From Human, Animal, and Food/Environmental/Medical Devices/Biologics
CDC Points of Contact David Lonsway
(404) 639-2825
Dlonsway@cdc.gov
Kamile Rasheed
(404) 639-3247
JRasheed@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
Confirmation of unusual resistance is required before sending specimen for 
testing; please specify antibacterial agent of interest and provide previous 
results and testing method
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Pure culture isolate on suitable agar medium
Minimum Volume Required Not Applicable
Turnaround Time 14 Days
Interferences & Limitations None
Storage & Preservation of
Specimen Prior to Shipping
Keep refrigerated if isolate cannot be shipped immediately. For fastidious 
organisms (e.g. Neisseria meningitidis), store at room temperature.
Additional lnformation None
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Pure culture isolate on suitable agar medium or frozen in TSB plus glycerol
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship specimen Monday-Thursday overnight to avoid weekend deliveries, as an 
etiologic agent.
Refrigerated specimen should be shipped on ice packs
Specimen stored at room temperature should be shipped at room temperature
Methodology Broth Microdilution, Disk Diffusion, Additional Phenotypic Testing, Molecular 
detection of resistance markers
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Arbovirus Isolation and Identification
CDC-10281
Test Order
Synonym(s) Arbo-Isolation
Performed on Specimens From Human
CDC Points of Contact Robert Lanciotti
(970) 221-6440
rsl2@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Serum, cerebrospinal fluid (CSF), and fresh frozen tissue specimen
Minimum Volume Required 0.5 mL
Turnaround Time 2 Weeks
Interferences & Limitations None
Storage & Preservation of
Specimen Prior to Shipping
Specimen should be kept at 4°C or colder
Additional lnformation None
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday, overnight to avoid weekend deliveries 
Frozen specimen should be shipped on dry ice
Ship to:
Centers for Disease Control & Prevention
3156 Rampart Road (CSU Foothills Campus)
Fort Collins, Colorado 80521
Methodology Isolation in cell culture
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Arbovirus Molecular Detection
CDC-10280
Test Order
Synonym(s) Arbo-RT-PCR
Performed on Specimens From Human
CDC Points of Contact Robert Lanciotti
(970) 221-6440
rsl2@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Serum, cerebrospinal fluid (CSF), and fresh frozen tissue specimen
Minimum Volume Required 0.25 mL
Turnaround Time 1 Week
Interferences & Limitations Hemolysis can affect the test results
Storage & Preservation of
Specimen Prior to Shipping
Specimen should be kept at 4°C or colder
Additional lnformation None
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday, overnight to avoid weekend deliveries
Frozen specimen should be shipped on dry ice
Ship to:
Centers for Disease Control & Prevention
3156 Rampart Road (CSU Foothills Campus)
Fort Collins, Colorado 80521
Methodology RT-Polymerase Chain Reaction (PCR)
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Arbovirus Neutralization Antibody
CDC-10283
Test Order
Synonym(s) Arbo-PRNT
Performed on Specimens From Human
CDC Points of Contact Robert Lanciotti
(970) 221-6440
rsl2@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Serum and cerebrospinal fluid (CSF)
Minimum Volume Required 0.5 mL
Turnaround Time 2 Weeks
Interferences & Limitations None
Storage & Preservation of
Specimen Prior to Shipping
Specimen should be kept at 4°C or colder
Additional lnformation None
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday, overnight to avoid weekend deliveries 
Frozen specimen should be shipped on dry ice
Ship to:
Centers for Disease Control & Prevention
3156 Rampart Road (CSU Foothills Campus)
Fort Collins, Colorado 80521
Methodology Plaque reduction neutralization
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Arbovirus Serology
CDC-10282
Test Order
Synonym(s) Arbo-Serology
Performed on Specimens From Human
CDC Points of Contact Robert Lanciotti
(970) 221-6440
rsl2@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Serum and cerebrospinal fluid (CSF)
Minimum Volume Required 0.25 mL
Turnaround Time 1 Week
Interferences & Limitations None
Storage & Preservation of
Specimen Prior to Shipping
Specimen should be kept at 4°C or colder
Additional lnformation None
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday, overnight to avoid weekend deliveries 
Frozen specimen should be shipped on dry ice
Ship to:
Centers for Disease Control & Prevention
3156 Rampart Road (CSU Foothills Campus)
Fort Collins, Colorado 80521
Methodology ELISA, MIA
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Arbovirus Special Study
CDC-10284
Test Order
Synonym(s) None
Performed on Specimens From Human
CDC Points of Contact Robert Lanciotti
(970) 221-6440
rsl2@cdc.gov
Pre-Approval Needed Lanciotti, Robert, (970) 221-6440, rsl2@cdc.gov
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
To be determined
Minimum Volume Required To be determined
Turnaround Time  
Interferences & Limitations To be determined
Storage & Preservation of
Specimen Prior to Shipping
To be determined
Additional lnformation To be determined
Specimen Labeling To be determined
Transport Medium To be determined
Shipping Instructions which 
Include Specimen Handling 
Requirements
To be determined
Methodology
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Arenavirus (New World) - Serology
CDC-10484
Test Order
Synonym(s) Junin virus, Machupo virus, Guanarito virus, Chapare virus, Sabia virus serology
Performed on Specimens From Human and Animal
CDC Points of Contact Ute Stroeher
(404) 639-4704
ixy8@cdc.gov
Barbara Knust
(404) 639-1104
bkk0@cdc.gov
Pre-Approval Needed Stroeher, Ute, (404) 639-4704, ixy8@cdc.gov
Knust, Barbara, (404) 639-1104, bkk0@cdc.gov
Supplemental Information
Required
See Supplemental Form
Supplemental Form http://www.cdc.gov/ncezid/dhcpp/vspb/pdf/specimen-submission.pdf
Acceptable Sample/ Specimen 
Type for Testing
Blood, Serum
Minimum Volume Required 1.0 mL
Turnaround Time 10 Days
Interferences & Limitations None
Storage & Preservation of
Specimen Prior to Shipping
Specimen must be kept cold (at or below 4°C). If possible place specimen in 
plastic screw capped vials. See link to supplemental submission form for specific 
information on various specimen types.
Additional lnformation Critical specimens will take less than 4 days to turn around. See link to 
supplemental submission forms for detailed information.
Specimen Labeling Patient Name, patient ID #, specimen type, date collected
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday overnight to avoid weekend deliveries. Specimen should 
be shipped on cold packs or dry ice if frozen. See supplemental submission 
forms for further details. Do not ship specimen without prior consultation and 
approval.
Methodology ELISA
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Arenavirus (New World) Identification
CDC-10293
Test Order
Synonym(s) New World Arenavirus, South American hemorrhagic fever viruses
Performed on Specimens From Human and Animal
CDC Points of Contact Ute Stroeher
(404) 639-4704
ixy8@cdc.gov
Barbara Knust
(404) 639-1104
bkk0@cdc.gov
Pre-Approval Needed Stroeher, Ute, (404) 639-4704, ixy8@cdc.gov
Knust, Barbara, (404) 639-1104, bkk0@cdc.gov
Supplemental Information
Required
See Supplemental Form
Supplemental Form http://www.cdc.gov/ncezid/dhcpp/vspb/pdf/specimen-submission.pdf
Acceptable Sample/ Specimen 
Type for Testing
Frozen tissue, blood and serum
Minimum Volume Required 1 mL
Turnaround Time 10 Days
Interferences & Limitations Specimen must remain frozen; warming or freeze thawing reduces sensitivity. 
Heparin may cause interference with the molecular tests and should be avoided.
Storage & Preservation of
Specimen Prior to Shipping
Specimen must be placed in plastic screw capped vials, frozen to -70°C, and kept 
frozen until shipment. See link to supplemental submission form for specific 
information on various specimen types.
Additional lnformation Critical specimens will take less than 4 days to turn around. See link to 
supplemental submission forms for detailed information.
Specimen Labeling Patient name, patient ID #, specimen type, date collected
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday overnight to avoid weekend deliveries. Specimen should 
be shipped frozen on dry ice. See supplemental submission forms for further 
details. Do not ship specimen without prior consultation and approval.
Methodology Molecular Typing, Polymerase Chain Reaction (PCR)
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Arenavirus (Old World) Identification
CDC-10294
Test Order
Synonym(s) Old World Arenavirus
Performed on Specimens From Human and Animal
CDC Points of Contact Ute Stroeher
(404) 639-4704
ixy8@cdc.gov
Barbara Knust
(404) 639-1104
bkk0@cdc.gov
Pre-Approval Needed Stroeher, Ute, (404) 639-4704, ixy8@cdc.gov
Knust, Barbara, (404) 639-1104, bkk0@cdc.gov
Supplemental Information
Required
See Supplemental Form
Supplemental Form http://www.cdc.gov/ncezid/dhcpp/vspb/pdf/specimen-submission.pdf
Acceptable Sample/ Specimen 
Type for Testing
Frozen tissue, blood and serum
Minimum Volume Required 1 mL
Turnaround Time 10 Days
Interferences & Limitations Specimen must remain frozen; warming or freeze thawing reduces sensitivity. 
Heparin may cause interference with the molecular tests and should be avoided.
Storage & Preservation of
Specimen Prior to Shipping
Specimen must be placed in plastic screw capped vials, frozen to -70°C, and kept 
frozen until shipment. See link to supplemental submission form for specific 
information on various specimen types.
Additional lnformation Critical specimens will take less than 4 days to turn around. See link to 
supplemental submission forms for detailed information.
Specimen Labeling Patient name, patient ID #, specimen type, date collected
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday overnight to avoid weekend deliveries. Specimen should 
be shipped frozen on dry ice. See supplemental submission forms for further 
details. Do not ship specimen without prior consultation and approval.
Methodology Molecular Typing, Polymerase Chain Reaction (PCR)
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Babesia Molecular Detection
CDC-10473
Test Order
Synonym(s) Babesiosis; Babesia microti; Babesia duncani, parasite
Performed on Specimens From Human
CDC Points of Contact Alex daSilva
(404) 718-4121
adasilva@cdc.gov
Yvonne Qvarnstrom
(404) 718-4123
bvp2@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Blood
Minimum Volume Required 200 uL
Turnaround Time 21 Days
Interferences & Limitations None
Storage & Preservation of
Specimen Prior to Shipping
Collect a 1-5 ml blood sample in Vacutainer® EDTA tubes prior to anti-parasitic 
therapy and ship at 4°C
Additional lnformation None
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday – Thursday, overnight to avoid weekend deliveries. Ship specimen 
at room temperature, not on dry ice, as an etiologic agent.
Methodology Conventional PCR, Real Time PCR
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Babesiosis Indirect Fluorescent Antibody Test
CDC-10456
Test Order
Synonym(s) Babesia microti; Babesia duncani; Babesia divergens, babesiosis, parasite
Performed on Specimens From Human
CDC Points of Contact Patricia Wilkins
(404) 718-4101
pma1@cdc.gov
Isabel McAuliffe
(404) 718-4100
ibm4@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
Exposure and travel history, include other relevant risk factors (ticks, 
transfusion); clinical symptoms, treatment and relevant lab results.
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Serum and plasma
Minimum Volume Required 0.5mL
Turnaround Time 18 Days
Interferences & Limitations Substances known to interfere with immunoassays include: bilirubin, lipids, and 
hemoglobin 
Storage & Preservation of
Specimen Prior to Shipping
No specific requirements
Additional lnformation None
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday – Thursday, overnight to avoid weekend deliveries. Ship specimen 
at room temperature, not on dry ice, as an etiologic agent.
Methodology Indirect Fluorescent Antibody assay, Antibody detection
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Bacillus anthracis Identification, Genotyping, and AST
CDC-10203
Test Order
Synonym(s) Anthrax, Anthrax Gamma phage, Anthrax PCR, Anthrax typing
Performed on Specimens From Human, Animal, and Food/Environmental/Medical Devices/Biologics
CDC Points of Contact Chung Marston
(404) 639-4057
cdk5@cdc.gov
David Lonsway
(404) 639-2825
dul7@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
Select Agent Form 2 required for submission of all confirmed Select Agents.
Supplemental Form http://www.selectagents.gov/TransferForm.html
Acceptable Sample/ Specimen 
Type for Testing
Isolates and clinical specimen found on the website in the Additional Information 
section
Minimum Volume Required Not Applicable
Turnaround Time 1 Week
Interferences & Limitations Depends on specimen, please consult the link to our website in the Additional 
Information section below.
Storage & Preservation of
Specimen Prior to Shipping
Information on storage of acceptable specimen types can be found at link 
provided in the Additional Information section below.
Additional lnformation Turnaround time will vary depending on if an isolate is sent for identification or 
a specimen is sent for isolation. Identification and Susceptibility testing of 
isolates is treated as a priority and may be completed in as early as 2 days, while 
isolation from specimens and subsequent ID and susceptibility may take up to a 
week.
Link to our website: http://www.bt.cdc.gov/agent/anthrax/lab-
testing/recommended_specimens.asp
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition
Transport Medium Dependent on specimen type submitted. Please see website in the Additional 
Information section.
Shipping Instructions which 
Include Specimen Handling 
Requirements
Select agents that have been identified need form 2 approval prior to shipping. 
Form 2 may be found at:  http://www.selectagents.gov/TransferForm.html
Select agents must be shipped Monday through Wednesday to prevent weekend 
arrivals. Please see link in the Supplemental Additional Information section for 
specific specimen shipping instructions.
Methodology Gamma Phage typing, Polymerase Chain Reaction (PCR), Broth Microdilution, 
Capsule Staining, Anthrax toxin detection, MLVA, SNP
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Bacillus anthracis Molecular Detection
CDC-10204
Test Order
Synonym(s) Anthrax PCR
Performed on Specimens From Human, Animal, and Food/Environmental/Medical Devices/Biologics
CDC Points of Contact Alex Hoffmaster
(404) 639-0852
amh9@cdc.gov
Chung Marston
(404) 639-4057
cdk5@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Clinical specimens, see link in Additional Information section. Other specimens 
per consult. Blood specimens should be collected in EDTA or Sodium Citrate 
tubes (not heparin).
Minimum Volume Required 250 uL
Turnaround Time 2 Days
Interferences & Limitations Blood specimens should be collected in EDTA or Sodium Citrate tubes (not 
heparin).
Storage & Preservation of
Specimen Prior to Shipping
For storage of acceptable specimen types are found on the website in the 
Additional Information section.
Additional lnformation See Link: http://www.bt.cdc.gov/agent/anthrax/lab-
testing/recommended_specimens.asp
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition
Transport Medium Dependent on specimen type submitted. Please see link in Additional 
Information section.
Shipping Instructions which 
Include Specimen Handling 
Requirements
Select agents that have been identified need form 2 approval prior to shipping. 
Form 2 can be found at http://www.selectagents.gov/TransferForm.html
Select agents must be shipped Monday through Wednesday to prevent weekend 
arrivals. Please see link in Additional Information section for specific specimen 
shipping instructions
Methodology Polymerase Chain Reaction (PCR)
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Bacillus anthracis rapid AST
CDC-10487
Test Order
Synonym(s) Bacillus anthracis Rapid Antimicrobial Susceptibility Testing
Performed on Specimens From Human, Animal, and Food/Environmental/Medical Devices/Biologics
CDC Points of Contact Linda Weigel
(404) 639-1497
lew9@cdc.gov
David Sue
(404) 639-4027
btx6@cdc.gov
Pre-Approval Needed Weigel, Linda, (404) 639-1497, lew9@cdc.gov
Sue, David, (404) 639-4027, btx6@cdc.gov
Supplemental Information
Required
For isolates from human specimens, prior approval is required. Consult with 
Rapid AST lab for details. 
Select Agent Form 2 required for submission of all confirmed Select Agents. 
Supplemental Form http://www.selectagents.gov/TransferForm.html
Acceptable Sample/ Specimen 
Type for Testing
Isolates on agar plate or slant, consult with Rapid AST Lab for details.
Minimum Volume Required Not Applicable
Turnaround Time 2 Days
Interferences & Limitations Isolates from human specimens may be tested only under Emergency Use 
Authorization.
Storage & Preservation of
Specimen Prior to Shipping
Consult with Rapid AST Lab for details
Additional lnformation Turnaround time can vary depending on age/purity of isolate received
Specimen Labeling Test is subject to CLIA regulations and requires two patient identifiers on the 
specimen container and on the test requisition
Transport Medium Pure culture isolates (only) on sheep blood or Mueller-Hinton agar
Shipping Instructions which 
Include Specimen Handling 
Requirements
Select agents that have been identified need form 2 approval prior to shipping. 
Form 2 may be found at: http://www.selectagents.gov/TransferForm.html
Methodology Modified Broth Microdilution
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Bacillus anthracis Serology
CDC-10196
Test Order
Synonym(s) Anthrax ELISA
Performed on Specimens From Human
CDC Points of Contact Chung Marston
(404) 639-4057
cdk5@cdc.gov
Robyn Stoddard
(404) 639-2053
frd8@cdc.gov
Pre-Approval Needed Stoddard, Robyn, (404) 639-2053, frd8@cdc.gov
Marston, Chung, (404) 639-4057, cdk5@cdc.gov
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Serum (acute and convalescent required)
Minimum Volume Required 100 uL
Turnaround Time 4 Days
Interferences & Limitations Requires acute and convalescent serum for analysis
Storage & Preservation of
Specimen Prior to Shipping
Freeze serum upon collection
Additional lnformation None
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition
Transport Medium Not applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship specimen Monday-Thursday overnight to avoid weekend deliveries
Frozen specimen should be shipped on dry ice
Methodology ELISA
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Bacillus anthracis Study
CDC-10205
Test Order
Synonym(s) None
Performed on Specimens From Human, Animal, and Food/Environmental/Medical Devices/Biologics
CDC Points of Contact Alex Hoffmaster
(404) 639-0852
amh9@cdc.gov
Pre-Approval Needed Hoffmaster, Alex, (404) 639-0852, amh9@cdc.gov
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
To be determined
Minimum Volume Required To be determined
Turnaround Time  
Interferences & Limitations To be determined
Storage & Preservation of
Specimen Prior to Shipping
To be determined
Additional lnformation To be determined
Specimen Labeling To be determined
Transport Medium To be determined
Shipping Instructions which 
Include Specimen Handling 
Requirements
To be determined
Methodology
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Bacillus cereus Detection - Foodborne Outbreak
CDC-10104
Test Order
Synonym(s) None
Performed on Specimens From Human and Food/Environmental/Medical Devices/Biologics
CDC Points of Contact Deborah Talkington
(404) 639-3918
dft1@cdc.gov
Gerardo Gomez
(404) 639-0537
goe4@cdc.gov
Pre-Approval Needed Talkington, Deborah, (404) 639-3918, dft1@cdc.gov
Gomez, Gerardo, (404) 639-0537, goe4@cdc.gov
Supplemental Information
Required
Only specimens from foodborne outbreaks accepted. Consult with EDLB 
contact before sending specimens. Provide preliminary results if available.
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Isolates, food, stool. Only specimens from foodborne outbreaks accepted. 
Consult with  Dr. Talkington before sending specimens.
Minimum Volume Required 25 g (food) and 10g (stool)
Turnaround Time 2 Months
Interferences & Limitations None
Storage & Preservation of
Specimen Prior to Shipping
Food  and stool should be maintained at 4°C
Additional lnformation Direct toxin detection requires food samples
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday, overnight to avoid weekend deliveries. Please notify 
Deborah Talkington (dft1@cdc.gov) and Gerardo Gomez (goe4@cdc.gov) once  
specimens have been shipped to provide the tracking number.
Ship with cold packs in compliance with federal and local guidelines
Methodology Toxin Detection in food, Culture, PCR
 
Monday, January 13, 2014 Page 35 of 380Version: 1.1
Bacillus cereus Genotyping
CDC-10206
Test Order
Synonym(s) Bacillus MLST
Performed on Specimens From Human, Animal, and Food/Environmental/Medical Devices/Biologics
CDC Points of Contact Alex Hoffmaster
(404) 639-0852
amh9@cdc.gov
Jay Gee
(404) 639-4936
xzg4@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Isolates
Minimum Volume Required Not Applicable
Turnaround Time 1 Week
Interferences & Limitations None
Storage & Preservation of
Specimen Prior to Shipping
No Specific Requirements
Additional lnformation Testing can be done on B. cereus and B. thuringiensis
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition
Transport Medium Any medium can be submitted, but preferably agar slants
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship specimen Monday-Thursday overnight to avoid weekend deliveries
Agar slants need to be shipped at room temperature
Methodology Multilocus sequence typing (MLST)
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Bacillus species ID (Not B. anthracis)
CDC-10142
Test Order
Synonym(s) Bacillus Identification
Performed on Specimens From Human and Food/Environmental/Medical Devices/Biologics
CDC Points of Contact John McQuiston
(404) 639-0270
zje8@cdc.gov
Anne Whitney
(404) 639-1374
amw0@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
Please notify laboratory prior to shipment if this is a critical care specimen
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Pure culture isolate on a suitable agar slant medium; consultation required for 
other sample/specimen types
Minimum Volume Required Not Applicable
Turnaround Time 3 Weeks
Interferences & Limitations The 3 week turnaround time applies to all tests unless biochemical and/or 
phenotypic analysis are required, which could take up to 2 months for test 
results.
Storage & Preservation of
Specimen Prior to Shipping
Keep specimen refrigerated if unable to ship immediately
Additional lnformation If available, please provide patient history including if the patient has used a 
catheter and/or if the patient is immunocompromised.
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship specimen Monday-Thursday, overnight to avoid weekend deliveries
Methodology Primary culture based on specimen type, 16S sequence based identification, 
MALDI-TOF
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Bacterial ID from Clinical Specimen (16S rRNA PCR)
CDC-10146
Test Order
Synonym(s) None
Performed on Specimens From Human and Food/Environmental/Medical Devices/Biologics
CDC Points of Contact John McQuiston
(404) 639-0270
zje8@cdc.gov
Anne Whitney
(404) 639-1374
amw0@cdc.gov
Pre-Approval Needed McQuiston, John, (404) 639-0270, zje8@cdc.gov
Whitney, Anne, (404) 639-1374, amw0@cdc.gov
Supplemental Information
Required
Please notify laboratory prior to shipment if this is a critical care specimen
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Primary specimens with prior approval
Minimum Volume Required Not Applicable
Turnaround Time 4 Weeks
Interferences & Limitations The 3 week turnaround time applies to all tests unless biochemical and/or 
phenotypic analysis are required, which could take up to 2 months for test 
results.
Storage & Preservation of
Specimen Prior to Shipping
Keep specimen refrigerated if unable to ship immediately
Additional lnformation If available, please provide patient history including if the patient has used a 
catheter and/or if the patient is immunocompromised.
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship specimen Monday-Thursday, overnight to avoid weekend deliveries
Methodology Primary Culture based on specimen type, MALDI-TOF, 16S sequence based 
identification
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Bacterial ID of Unknown Isolate (Not Strict Anaerobe)
CDC-10145
Test Order
Synonym(s) Bacterial Identification
Performed on Specimens From Human and Food/Environmental/Medical Devices/Biologics
CDC Points of Contact John McQuiston
(404) 639-0270
zje8@cdc.gov
Anne Whitney
(404) 639-1374
amw0@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
Please notify laboratory prior to shipment if this is a critical care specimen
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Pure culture isolate on a suitable agar slant medium; consultation required for 
other sample/specimen types
Minimum Volume Required Not Applicable
Turnaround Time 3 Weeks
Interferences & Limitations The 3 week turnaround time applies to all tests unless biochemical and/or 
phenotypic analysis are required, which could take up to 2 months for test 
results.
Storage & Preservation of
Specimen Prior to Shipping
Keep specimen refrigerated if unable to ship immediately
Additional lnformation If available, please provide patient history including if the patient has used a 
catheter and/or if the patient is immunocompromised.
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship specimen Monday-Thursday overnight to avoid weekend deliveries
Methodology Primary Culture based on specimen type, MALDI-TOF, 16S sequence based 
identification
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Bacterial Select Agent Identification and AST
CDC-10224
Test Order
Synonym(s) BT agent MIC
Performed on Specimens From Human, Animal, and Food/Environmental/Medical Devices/Biologics
CDC Points of Contact David Lonsway
(404) 639-2825
Dlonsway@cdc.gov
Kamile Rasheed
(404) 639-3247
JRasheed@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
Select Agent Form 2 required for submission of all confirmed Select Agents;
Supplemental Form http://www.selectagents.gov/TransferForm.html
Acceptable Sample/ Specimen 
Type for Testing
Pure culture isolates on suitable agar medium
Minimum Volume Required Not Applicable
Turnaround Time 14 Days
Interferences & Limitations None
Storage & Preservation of
Specimen Prior to Shipping
Store isolates at room temperature
Additional lnformation A list of all select agents can be found at: 
http://www.bt.cdc.gov/agent/agentlist.asp
Note: This test order will only test for bacterial select agents
Turnaround time will vary depending on organism sent. Identification and 
susceptibility testing of isolates is treated as a priority and completed as soon as 
possible.
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Pure culture isolate on suitable agar medium or frozen in TSB plus glycerol
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship specimen Monday -Thursday overnight to avoid weekend deliveries
Specimen should be shipped at room temperature as an etiologic agent
Methodology Broth Microdilution, Disk Diffusion, Phenotypic Testing, Molecular detection of 
resistance markers, 16S Sequencing, MALDI-TOF
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Balamuthia Molecular Detection
CDC-10474
Test Order
Synonym(s) Free-living ameba, parasite
Performed on Specimens From Human
CDC Points of Contact Alex daSilva
(404) 718-4121
adasilva@cdc.gov
Jennifer Cope
(404) 718-4878
bjt9@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Cerebrospinal fluid (CSF), Tissue
Minimum Volume Required 200 uL
Turnaround Time 21 Days
Interferences & Limitations Formalin fixed specimens are not suitable for molecular studies
Storage & Preservation of
Specimen Prior to Shipping
Storage and preservation is specimen specific
Additional lnformation None
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday – Thursday, overnight to avoid weekend deliveries. Ship specimen 
at room temperature, not on dry ice, as an etiologic agent.
Methodology Real-time PCR
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Bartonella henselae/B. quintana Indirect Fluorescent Antibody 
(IFA) test
CDC-10486
Test Order
Synonym(s) B. henselae/cat scratch disease, B. quintana/trench fever
Performed on Specimens From Human
CDC Points of Contact Jeannine Peterson
(970) 266-3524
nzp0@cdc.gov
Marty Schriefer
(970) 221-6479
mms7@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
Please provide submitting agency, contact name, address, phone number, 
specimen identifier, patient name, specimen source and type, sex and date of 
birth, date of symptom onset, sample collection date, and clinical information 
including symptoms and type and date of treatment patient has received.
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Serum
Minimum Volume Required 500 uL
Turnaround Time 2 Weeks
Interferences & Limitations Samples with hemolysis, increased lipemia or microbial growth may interfere 
with test results
Storage & Preservation of
Specimen Prior to Shipping
Sera may be stored at 2°-8°C for up to 14 days. If testing is delayed for a longer 
period, serum samples may be frozen.
Additional lnformation Clinical information including symptoms and date of onset must be included; 
specimens without this accompanying information will not be tested.
Specimen Labeling Specimen identifier and patient name
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday, overnight to avoid weekend deliveries. All packages 
must be addressed to:
Centers for Disease Control and Prevention
Bacterial Diseases Branch
Attn: John Young
3156 Rampart Road
Fort Collins, CO 80521
Frozen specimen should be shipped on dry ice
Refrigerated specimen should be shipped on ice packs
Methodology Indirect Fluorescent Antibody (IFA)
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Bartonella Molecular Identification
CDC-10295
Test Order
Synonym(s) Cat scratch fever, B. henselae, Trench fever, B. quintana, Oroya fever, B. 
bacilliformis
Performed on Specimens From Human
CDC Points of Contact Cecilia Kato
(404) 639-1075
ckato@cdc.gov
Jennifer McQuiston
(404) 639-1075
fzh7@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
Prior approval is required if the following information is not provided:
-Symptom onset date
-Sample collection date
-Type of infection
-Status of illness
Recommended:
-Travel history
-Exposure history
-Therapeutic agents
-Brief clinical history
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Acute samples only, anticoagulated whole blood collected in 
Ethylenediaminetetraacetic acid (EDTA) treated tubes preferred; serum; fresh 
tissue biopsy
Minimum Volume Required 1 mL
Turnaround Time 6 Weeks
Interferences & Limitations Hemolysis in whole blood specimen will interfere with results. Multiple freeze 
thaw cycles and sample storage above refrigerated temperatures will interfere 
with proper nucleic acid extraction. If a specimen is drawn at convalescence it 
will reduce the chance of the target organism being present in blood. Avoid 
collection of blood specimen in heparin tubes.
Storage & Preservation of
Specimen Prior to Shipping
Ideally keep specimen at a refrigerated temperature not frozen. If previously 
frozen, then keep specimen frozen.
Additional lnformation The Rickettsial Zoonoses Branch Reference Diagnostic Laboratory aids State 
Laboratories in diagnosis of difficult samples/cases or if specialized tests are 
needed. Routine diagnostic samples should be sent to your State Laboratory or a 
commercial laboratory.
Specimen Labeling Patient name and date of birth
Transport Medium Ethylenediaminetetraacetic acid (EDTA) blood tubes for blood; tissue in a sample 
collection tube
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday - Thursday, overnight to avoid weekend deliveries. Specimen 
should be shipped refrigerated on cold packs.
Methodology Polymerase Chain Reaction (PCR), Sequencing
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Bartonella Special Study
CDC-10297
Test Order
Synonym(s) Cat scratch fever, B. henselae, Trench fever, B. quintana, Oroya fever, B. 
bacilliformis
Performed on Specimens From Human, Animal, and Food/Environmental/Medical Devices/Biologics
CDC Points of Contact Marty Schriefer
(970) 221-6479
mms7@cdc.gov
Jeannine Peterson
(970) 266-3534
nzp0@cdc.gov
Pre-Approval Needed Schriefer, Marty, (970) 221-6479, mms7@cdc.gov
Peterson, Jeannine, (970) 266-3534, nzp0@cdc.gov
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
To be determined
Minimum Volume Required To be determined
Turnaround Time  
Interferences & Limitations To be determined
Storage & Preservation of
Specimen Prior to Shipping
To be determined
Additional lnformation To be determined
Specimen Labeling To be determined
Transport Medium To be determined
Shipping Instructions which 
Include Specimen Handling 
Requirements
To be determined
Methodology Molecular detection, Serology, Culture, Immunohistochemistry (IHC), Other
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Baylisascariasis Immunoblot
CDC-10457
Test Order
Synonym(s) Baylisascariasis, Raccoon roundworm, parasite
Performed on Specimens From Human
CDC Points of Contact Patricia Wilkins
(404) 718-4101
pma1@cdc.gov
Isabel McAuliffe
(404) 718-4100
ibm4@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
Exposure and travel history, include other relevant risk factors (raccoon) 
clinical symptoms, treatment and relevant lab results.
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Serum, plasma; Cerebrospinal fluid (CSF)
Minimum Volume Required 0.5 mL
Turnaround Time 18 Days
Interferences & Limitations Substances known to interfere with immunoassays include: bilirubin, lipids, and 
hemoglobin 
Storage & Preservation of
Specimen Prior to Shipping
No specific requirements
Additional lnformation None
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday – Thursday, overnight to avoid weekend deliveries. Ship specimen 
at room temperature, not on dry ice, as an etiologic agent.
Methodology Immunoblot, Western Blot, Antibody Detection
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Biothreat Agent Testing
CDC-10430
Test Order
Synonym(s) Screening for biothreat agents including, but not limited to: Bacillus anthracis, 
Brucella spp., Burkholderia spp., Francisella tularensis, orthopox viruses, ricin 
toxin, Ricinus communis, and Yersinia pestis.
Performed on Specimens From Human, Animal, and Food/Environmental/Medical Devices/Biologics
CDC Points of Contact Michael Farrell
(404) 639-4923
mqf2@cdc.gov
Brad Bowzard
(404) 639-3626
jbowzard@cdc.gov
Pre-Approval Needed Farrell, Michael, (404) 639-4923, mqf2@cdc.gov
Bowzard, Brad, (404) 639-3626, jbowzard@cdc.gov
Supplemental Information
Required
Please contact Dr. Brad Bowzard at 404 639-3626 or jbowzard@cdc.gov, for 
the required supplemental form and packaging and shipping requirements.
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Environmental swabs, powders, or liquids and clinical specimens, including 
whole blood and serum.
Minimum Volume Required Dependent on Specimen Type
Turnaround Time 1 Day
Interferences & Limitations None
Storage & Preservation of
Specimen Prior to Shipping
Dry swabs or powders can be stored and shipped at room temperature.  For 
storage of liquid/clinical specimens, see link in the Additional Information 
section.
Additional lnformation See Link: http://www.bt.cdc.gov/agent/anthrax/lab-
testing/recommended_specimens.asp
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium None
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday, overnight to avoid weekend deliveries, if possible.  If 
weekend delivery is necessary, please contact laboratory upon shipment.
Methodology Real Time PCR
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Biothreat Study
CDC-10432
Test Order
Synonym(s) None
Performed on Specimens From Human, Animal, and Food/Environmental/Medical Devices/Biologics
CDC Points of Contact Michael Farrell
(404) 639-4923
mqf2@cdc.gov
Brad Bowzard
(404) 639-3626
jbowzard@cdc.gov
Pre-Approval Needed Farrell, Michael, (404) 639-4923, mqf2@cdc.gov
Bowzard, Brad, (404) 639-3626, jbowzard@cdc.gov
Supplemental Information
Required
Please contact Dr. Brad Bowzard at 404 639-3626 or jbowzard@cdc.gov, for 
the required supplemental form and packaging and shipping requirements.
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
To be determined
Minimum Volume Required To be determined
Turnaround Time  
Interferences & Limitations To be determined
Storage & Preservation of
Specimen Prior to Shipping
To be determined
Additional lnformation To be determined
Specimen Labeling To be determined
Transport Medium To be determined
Shipping Instructions which 
Include Specimen Handling 
Requirements
To be determined
Methodology
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Blood Disorders Coagulation Study
CDC-10271
Test Order
Synonym(s) Coag
Performed on Specimens From Human
CDC Points of Contact Anne Rice
(404) 639-4434
amr8@cdc.gov
Pre-Approval Needed Rice, Anne, (404) 639-4434, amr8@cdc.gov
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
To be determined
Minimum Volume Required To be determined
Turnaround Time  
Interferences & Limitations To be determined
Storage & Preservation of
Specimen Prior to Shipping
To be determined
Additional lnformation To be determined
Specimen Labeling To be determined
Transport Medium To be determined
Shipping Instructions which 
Include Specimen Handling 
Requirements
To be determined
Methodology
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Bordetella pertussis Serology
CDC-10166
Test Order
Synonym(s) IgG against pertussis toxin, Pertussis ELISA, whooping cough
Performed on Specimens From Human
CDC Points of Contact Lucia Pawloski
(404) 639-4506
ecz6@cdc.gov
Maria Tondella
(404) 639-1239
mlt5@cdc.gov
Pre-Approval Needed Pawloski, Lucia, (404) 639-4506, ecz6@cdc.gov
Tondella, Maria, (404) 639-1239, mlt5@cdc.gov
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Serum from patients with two or more weeks of cough, but will accept plasma if 
serum is unavailable. Centrifuge the tube of blood at 1100-1300 x g for 
approximately 10 minutes to separate the cells from the serum.
Minimum Volume Required 0.5 mL
Turnaround Time 5 Days
Interferences & Limitations Serum collected from patients with less than 2 weeks of cough are not 
appropriate for this test. Samples should not be used if they have incurred more 
than 5 freeze-thaw cycles. Specimens with unacceptable preservatives such as 
anti-coagulants would invalidate the results. 
In addition, hemolyzed and lipemic specimens are considered suboptimal serum 
specimens for this assay.
Storage & Preservation of
Specimen Prior to Shipping
Serum specimens may be stored refrigerated (2°-8°C) for up to 7 days; If greater 
than 7 days serum must be kept frozen (-20°C or lower). For long-term storage, 
the serum should be frozen (-20°C or colder).
Additional lnformation Please include patient age and duration of cough on specimen submission form
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Note: surveillance studies may label specimens according to protocol
Transport Medium Not applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Serum specimens may be shipped refrigerated (2°-8°C) for up to 7 days. For 
shipments that are in transit for more than 7 days, specimens should be kept 
frozen (-20°C or lower). Sender is responsible for shipping charges and when 
shipping internationally must request CDC's import permit and include this with 
the Air Waybill. Additionally, the Pertussis/Diphtheria Laboratory requests that 
the sender contact the laboratory by email or phone before shipping.
Methodology Enzyme-linked Immunosorbent Assay (ELISA)
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Bordetella species ID/Confirmation of Isolates
CDC-10164
Test Order
Synonym(s) B. pertussis, B. parapertussis, B. holmesii, B. bronchiseptica, whooping cough
Performed on Specimens From Human
CDC Points of Contact Pam Cassiday
(404) 639-1231
pxc1@cdc.gov
Maria Tondella
(404) 639-1239
mlt5@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Pure culture isolates on Regan-Lowe, Bordet-Gengou, charcoal agar or blood 
agar (B. parapertussis, B. holmesii, or B. bronchiseptica only) or cryopreserved 
isolates
Minimum Volume Required Not Applicable
Turnaround Time 2 Weeks
Interferences & Limitations Prior antibiotic treatment will adversely affect results and patients coughing 
more than two weeks will likely not be culture positive.
Storage & Preservation of
Specimen Prior to Shipping
Isolates can be frozen in cryopreservation medium or refrigerated on Regan-
Lowe, Bordet-Gengou, charcoal agar or blood agar (B. parapertussis, B. holmesii, 
or B. bronchiseptica only
Additional lnformation None
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Note: surveillance studies may label specimens according to protocol
Transport Medium Isolates can be frozen in cryopreservation medium or for best results a fresh 
subculture on Regan-Lowe, Bordet-Gengou, charcoal agar or blood agar (B. 
parapertussis, B. holmesii, or B. bronchiseptica only) should be sent refrigerated. 
Calcium alginate and cotton swabs are not acceptable.
Shipping Instructions which 
Include Specimen Handling 
Requirements
Isolates should be shipped refrigerated (2°-8°C) as soon as possible, between 
24-48 hours. Frozen isolates should be sent on dry ice. Sender is responsible for 
shipping charges and when shipping internationally must request CDC's import 
permit and include this with the Air Waybill. Additionally, the 
Pertussis/Diphtheria Laboratory requests that the sender contacts the laboratory 
by email or phone before shipping.
Methodology Culture, Identification
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Bordetella species Isolation and ID
CDC-10163
Test Order
Synonym(s) B. pertussis, B. parapertussis, B. holmesii, B. bronchiseptica, whooping cough
Performed on Specimens From Human
CDC Points of Contact Pam Cassiday
(404) 639-1231
pxc1@cdc.gov
Maria Tondella
(404) 639-1239
mlt5@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Nasopharyngeal (NP) swabs and aspirates; calcium alginate and cotton swabs are 
not acceptable
Minimum Volume Required 0.5 mL aspirate
Turnaround Time 2 Weeks
Interferences & Limitations Prior antibiotic treatment will adversely affect results. Patients coughing more 
than two weeks will likely not be culture positive.
Storage & Preservation of
Specimen Prior to Shipping
Nasopharyngeal (NP) swabs should be collected on Dacron (polyester), rayon or 
nylon. Specimens should be kept refrigerated. Use plastic/glass screw-cap, leak-
proof vials.
Additional lnformation None
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Note: surveillance studies may label specimens according to protocol
Transport Medium Regan-Lowe transport medium is recommended for specimens. Amies Charcoal 
transports are acceptable, but may decrease the probability of isolation.
Shipping Instructions which 
Include Specimen Handling 
Requirements
Swabs in transport or isolates should be shipped refrigerated (2°-8°C) as soon as 
possible, between 24-48 hours. Aspirates can be shipped with ice packs or 
frozen (-20°C or lower). Frozen isolates should be sent on dry ice. Sender is 
responsible for shipping charges and when shipping internationally must request 
CDC's import permit and include this with the Air Waybill. Additionally, the 
Pertussis/Diphtheria Laboratory requests that the sender contacts the laboratory 
by email or phone before shipping.
Methodology Culture
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Bordetella species Molecular Detection
CDC-10165
Test Order
Synonym(s) None
Performed on Specimens From Human
CDC Points of Contact Pam Cassiday
(404) 639-1231
pxc1@cdc.gov
Maria Tondella
(404) 639-1239
mlt5@cdc.gov
Pre-Approval Needed Cassiday, Pam, (404) 639-1231, pxc1@cdc.gov
Tondella, Maria, (404) 639-1239, mlt5@cdc.gov
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Prefer nasopharyngeal aspirate but will also accept nasopharyngeal swab. 
Calcium alginate and cotton swabs are not acceptable.
Minimum Volume Required 0.5 mL
Turnaround Time 5 Days
Interferences & Limitations Prior antibiotic treatment will adversely affect results. Specimens collected from 
patients with more than 4 weeks of cough are not appropriate for this test. 
Samples should not be used if they have incurred more than 2 freeze-thaw 
cycles. Clinical specimens collected subsequent to initiation of antimicrobial 
treatment may not be positive for Bordetella spp. Due to reduction of organisms. 
Whenever possible, specimens collected prior to administration of antimicrobial 
agents should be used to determine infection with Bordetella spp.
Storage & Preservation of
Specimen Prior to Shipping
Specimens should be kept refrigerated or frozen. Use plastic/glass screw-cap, 
leak-proof vials
Additional lnformation None
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Note: surveillance studies may label specimens according to protocol.
Transport Medium Dry swabs in sterile tubes are preferred; if only one swab is collected for both 
culture and PCR, the swabs should be sent in Regan-Lowe transport.
Shipping Instructions which 
Include Specimen Handling 
Requirements
Swabs should be shipped refrigerated (2°-8°C) as soon as possible,  between 
24-48 hours. Aspirates can be shipped with ice packs or frozen (-20°C or lower). 
Sender is responsible for shipping charges and when shipping internationally 
must request CDC's import permit and include this with the Air Waybill. 
Additionally, the Pertussis/Diphtheria Laboratory requests that the sender 
contacts the laboratory by email or phone before shipping.
Methodology Polymerase Chain Reaction (PCR), Real Time Polymerase Chain Reaction (PCR), 
Multi target Polymerase Chain Reaction (PCR)
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Bordetella species Study
CDC-10167
Test Order
Synonym(s) None
Performed on Specimens From Human
CDC Points of Contact Pam Cassiday
(404) 639-1231
pxc1@cdc.gov
Maria Tondella
(404) 639-1239
mlt5@cdc.gov
Pre-Approval Needed Cassiday, Pam, (404) 639-1231, pxc1@cdc.gov
Tondella, Maria, (404) 639-1239, mlt5@cdc.gov
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
To be determined
Minimum Volume Required To be determined
Turnaround Time  
Interferences & Limitations To be determined
Storage & Preservation of
Specimen Prior to Shipping
To be determined
Additional lnformation To be determined
Specimen Labeling To be determined
Transport Medium To be determined
Shipping Instructions which 
Include Specimen Handling 
Requirements
To be determined
Methodology
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Bordetella spp. ID (Not B. pertussis/B. parapertussis)
CDC-10143
Test Order
Synonym(s) Bordetella Identification
Performed on Specimens From Human and Food/Environmental/Medical Devices/Biologics
CDC Points of Contact John McQuiston
(404) 639-0270
zje8@cdc.gov
Anne Whitney
(404) 639-1374
amw0@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
Please notify laboratory prior to shipment if this is a critical care specimen
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Pure culture isolate on a suitable agar slant medium; consultation required for 
other sample/specimen types
Minimum Volume Required Not Applicable
Turnaround Time 3 Weeks
Interferences & Limitations The 3 week turnaround time applies to all tests unless biochemical and/or 
phenotypic analysis are required, which could take up to 2 months for test 
results.
Storage & Preservation of
Specimen Prior to Shipping
Keep specimen refrigerated if unable to ship immediately
Additional lnformation If available, please provide patient history including if the patient has used a 
catheter and/or if the patient is immunocompromised.
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship specimen Monday-Thursday, overnight to avoid weekend deliveries
Methodology Primary Culture based on specimen type, MALDI-TOF, 16S sequence based 
identification
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Borrelia burgdorferi (Lyme Disease) Serology
CDC-10298
Test Order
Synonym(s) Lyme Disease, Borreliosis
Performed on Specimens From Human
CDC Points of Contact Marty Schriefer
(970) 221-6479
mms7@cdc.gov
Jeannine Petersen
(970) 266-3524
nzp0@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
Please include submitting agency, contact name, address, phone number, 
specimen identifier, patient name, specimen source and type, sex and date of 
birth, symptoms of onset, sample collection date, and clinical information 
including type and date of treatment patient has received.
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Serum
Minimum Volume Required 0.5 mL
Turnaround Time 2 Weeks
Interferences & Limitations Hemolyzed samples may interfere with test results
Storage & Preservation of
Specimen Prior to Shipping
Sera may be stored at 2°-8°C for up to 14 days. If testing is delayed for a longer 
period, serum samples may be frozen.
Additional lnformation Two tier testing will be performed. If available, submit any preliminary results. 
Include the date of onset, antibiotic treatment (type of antibiotics and date 
administered), date when the sample was collected, signs and symptoms. 
If testing needs to be performed by another laboratory, i.e. arborvirus, please 
contact laboratory prior to shipping.
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition. Commonly used identifiers are the first and 
last name and date of birth of the patient.
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday, overnight to avoid weekend deliveries. All packages 
must be addressed to:
Centers for Disease Control and Prevention
Bacterial Diseases Branch
Attn: John Young
3156 Rampart Road
Fort Collins, CO 80521
Frozen specimen should be shipped on dry ice
Refrigerated specimen should be shipped on ice packs
Methodology IgG/IgM ELISA, IgG Western Blot, IgM Western Blot
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Borrelia Culture and Identification
CDC-10299
Test Order
Synonym(s) Lyme Disease, Borreliosis, Relapsing fever
Performed on Specimens From Human
CDC Points of Contact Marty Schriefer
(970) 221-6479
mms7@cdc.gov
Jeannine Petersen
(970) 266-3524
nzp0@cdc.gov
Pre-Approval Needed Schriefer, Marty, (970) 221-6479, mms7@cdc.gov
Petersen, Jeannine, (970) 266-3524, nzp0@cdc.gov
Supplemental Information
Required
Please include submitting agency, contact name, address, phone number, 
specimen identifier, patient name, specimen source and type, sex and date of 
birth, symptoms of onset, sample collection date, and clinical information 
including type and date of treatment patient has received.
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Blood, skin biopsy (Erythema Migrans Rash) and others upon consultation (i.e. 
cultures, blood smears for confirmation, spinal fluid, synovial fluid)
Minimum Volume Required 0.5 mL
Turnaround Time 8 Weeks
Interferences & Limitations Antibiotic treatment will minimize growth potential of culture
Storage & Preservation of
Specimen Prior to Shipping
For a skin biopsy, contact laboratory prior to collection and/or shipment for 
specific requirements. Blood may be collected in heparin, citrate or EDTA. All 
specimen should be collected and shipped prior to antibiotic treatment if 
possible.
Additional lnformation Provide any antibiotic treatment information
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition. Commonly used identifiers are the first and 
last name and date of birth of the patient.
Transport Medium Contact laboratory prior to shipping for instructions on skin biopsy's transport 
medium.
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday, overnight to avoid weekend deliveries. All packages 
must be addressed to:
Centers for Disease Control and Prevention
Bacterial Diseases Branch
Attn: John Young
3156 Rampart Road
Fort Collins, CO 80521
Frozen specimen should be shipped on dry ice
Refrigerated specimen should be shipped on ice packs
Methodology Culture, Microscopy Confirmation
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Borrelia hermsii (Tick-borne Relapsing Fever) Serology
CDC-10399
Test Order
Synonym(s) Borreliosis, Recurrent fever, Borrelia
Performed on Specimens From Human
CDC Points of Contact Marty Schriefer
(970) 221-6479
mms7@cdc.gov
Jeannine Petersen
(970) 266-3524
nzp0@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
Please include submitting agency, contact name, address, phone number, 
specimen identifier, patient name, specimen source and type, sex and date of 
birth, symptoms of onset, sample collection date, and clinical information 
including type and date of treatment patient has received.
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Serum
Minimum Volume Required 0.5 mL
Turnaround Time 2 Weeks
Interferences & Limitations Hemolyzed specimen can affect the results
Storage & Preservation of
Specimen Prior to Shipping
Keep specimen either refrigerated or frozen
Additional lnformation Two tier testing will be performed. If available, submit any preliminary results. 
Include the date of onset, antibiotic treatment (type of antibiotics and date 
administered), date when the sample was collected, signs and symptoms. 
If testing needs to be performed by another laboratory, i.e. arborvirus, please 
contact laboratory prior to shipping.
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition. Commonly used identifiers are the first and 
last name and date of birth of the patient.
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday, overnight to avoid weekend deliveries. All packages 
must be addressed to:
Centers for Disease Control and Prevention
Bacterial Diseases Branch
Attn: John Young
3156 Rampart Road
Fort Collins, CO 80521
Frozen specimen should be shipped on dry ice
Refrigerated specimen should be shipped on ice packs
Methodology IgM/IgG ELISA
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Borrelia Special Study
CDC-10300
Test Order
Synonym(s) None
Performed on Specimens From Human
CDC Points of Contact Marty Schriefer
(970) 221-6479
mms7@cdc.gov
Jeannine Petersen
(970) 266-3524
nzp0@cdc.gov
Pre-Approval Needed Schriefer, Marty, (970) 221-6479, mms7@cdc.gov
Petersen, Jeannine, (970) 266-3524, nzp0@cdc.gov
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
To be determined
Minimum Volume Required To be determined
Turnaround Time  
Interferences & Limitations To be determined
Storage & Preservation of
Specimen Prior to Shipping
To be determined
Additional lnformation To be determined
Specimen Labeling To be determined
Transport Medium To be determined
Shipping Instructions which 
Include Specimen Handling 
Requirements
To be determined
Methodology
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Botulinum Toxin Producing Clostridia Subtyping
CDC-10134
Test Order
Synonym(s) Bot, Botulism
Performed on Specimens From Human, Animal, and Food/Environmental/Medical Devices/Biologics
CDC Points of Contact Carolina Luquez (Primary POC)
(404) 639-0896
fry6@cdc.gov
Susan Maslanka (Alternate POC)
(404) 639-0895
sht5@cdc.gov
Pre-Approval Needed Luquez (Primary POC), Carolina, (404) 639-0896, fry6@cdc.gov
Maslanka (Alternate POC), Susan, (404) 639-0895, sht5@cdc.gov
Supplemental Information
Required
APHIS/CDC Form 2 Request to Transfer Select Agents and Toxins is required
Supplemental Form http://www.selectagents.gov/TransferForm.html
Acceptable Sample/ Specimen 
Type for Testing
Isolates
Minimum Volume Required Not Applicable
Turnaround Time 12 Weeks
Interferences & Limitations None
Storage & Preservation of
Specimen Prior to Shipping
No Specific Requirements
Additional lnformation Specify type of subtyping requested in 'Previous Laboratory Results' on back of 
form. APHIS/CDC Form 2 must be approved prior to shipping. Form 2 may be 
found at: http://www.selectagents.gov/TransferForm.html; Please send to POC: 
anticipated arrival date, courier, and tracking number.
Specimen Labeling Not Applicable
Transport Medium Chopped Meat Glucose Starch (CMGS) or Trypticase Peptone Glucose Yeast 
extract  (TPGY) media.
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday, overnight to avoid weekend deliveries
Package must have proper labeling for infectious substance: UN 2814 Infectious 
substance, Category A
Methodology Pulsed field gel electrophoresis (PFGE)
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Botulism Laboratory Confirmation
CDC-10132
Test Order
Synonym(s) Bot, Botulism
Performed on Specimens From Human, Animal, and Food/Environmental/Medical Devices/Biologics
CDC Points of Contact Carolina Luquez (Primary POC)
(404) 639-0896
fry6@cdc.gov
Susan Maslanka (Alternate POC)
(404) 639-0895
sht5@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Foodborne: serum, stool, vomitus, gastric contents, and food
Wound: serum, debrided tissue, swab  from wounds, and stool 
Infant: stool, rectal swabs, and potential sources
Minimum Volume Required See Additional Information
Turnaround Time 12 Weeks
Interferences & Limitations None
Storage & Preservation of
Specimen Prior to Shipping
Maintain specimen at 4°C
Additional lnformation Serum samples must be collected before antitoxin treatment. In addition, for 
non-infant cases, a serum sample must be collected 24 hours after antitoxin 
treatment.
Adult patients: 5 to 15 ml of serum (without anticoagulant); 10 to 20 g of feces  
(if an enema is needed, use sterile non-bacteriostatic water). Infant patients: 
ideally, 10g to 20g of feces should be collected; however, smaller quantities can 
provide confirmatory test results (if an enema is needed, use sterile non-
bacteriostatic water).
Foods should be left in their original containers or placed in sterile unbreakable 
containers. Empty containers with remnants of suspected foods can also be 
recovered and submitted for testing.           
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Packages may arrive on weekends
Ship with on cold packs. Package must have proper labeling for biological 
hazards: UN 3373 biological substance, Category B.
Methodology Mouse Bioassay, ELISA, Mass Spectrometry (MS), Polymerase Chain Reaction (PCR)
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Botulism Special Study
CDC-10133
Test Order
Synonym(s) None
Performed on Specimens From Human, Animal, and Food/Environmental/Medical Devices/Biologics
CDC Points of Contact Carolina Luquez (Primary POC)
(404) 639-0896
fry6@cdc.gov
Susan Maslanka (Alternate POC)
(404) 639-0895
sht5@cdc.gov
Pre-Approval Needed Luquez (Primary POC), Carolina, (404) 639-0896, fry6@cdc.gov
Maslanka (Alternate POC), Susan, (404) 639-0895, sht5@cdc.gov
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
To be determined
Minimum Volume Required To be determined
Turnaround Time  
Interferences & Limitations To be determined
Storage & Preservation of
Specimen Prior to Shipping
To be determined
Additional lnformation To be determined
Specimen Labeling To be determined
Transport Medium To be determined
Shipping Instructions which 
Include Specimen Handling 
Requirements
To be determined
Methodology
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Brucella species Identification, Genotyping, and AST
CDC-10207
Test Order
Synonym(s) Brucellosis
Performed on Specimens From Human, Animal, and Food/Environmental/Medical Devices/Biologics
CDC Points of Contact Rebekah Tiller
(404) 639-4507
eto3@cdc.gov
David Lonsway
(404) 639-2825
dul7@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Blood/serum, tissue, joint fluid, environmental/nonclinical samples and culture 
isolates
Minimum Volume Required Not Applicable
Turnaround Time 3 Weeks
Interferences & Limitations None
Storage & Preservation of
Specimen Prior to Shipping
No Specific Requirements
Additional lnformation Turnaround time will vary depending on if an isolate is sent for identification or 
a specimen is sent for isolation. Identification of isolates generally is completed 
within 1 week and susceptibility testing is completed within 2 weeks, while 
isolation from specimens and subsequent ID may take up to 3 weeks.
For additional information please refer to the ASM sentinel laboratory guide: 
http://www.asm.org/images/pdf/Clinical/Protocols/brucella10-15-04.pdf
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition
Transport Medium Agar slants preferred for shipping isolates
Shipping Instructions which 
Include Specimen Handling 
Requirements
Select agents that have been identified need form 2 approval prior to shipping. 
Form 2 may be found at: http://www.selectagents.gov/TransferForm.html                                                             
Select agents must be shipped Monday through Wednesday to prevent weekend 
arrivals                                                                                                 
Agar slants should be shipped at room temperature and specimens at 4°C.
Methodology Polymerase Chain Reaction (PCR), Biochemicals, Phage Suseptability, Broth Micro 
Dilution, MLVA
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Brucella species Molecular Detection
CDC-10208
Test Order
Synonym(s) Brucella PCR
Performed on Specimens From Human, Animal, and Food/Environmental/Medical Devices/Biologics
CDC Points of Contact Rebekah Tiller
(404) 639-4507
eto3@cdc.gov
Alex Hoffmaster
(404) 639-0852
amh9@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Blood/serum, tissue, joint fluid, environmental/nonclinical samples. Blood 
specimens should be collected in EDTA or Sodium Citrate tubes (not heparin).
Minimum Volume Required 250 uL
Turnaround Time 2 Days
Interferences & Limitations Blood specimens should be collected in EDTA or Sodium Citrate tubes (not 
heparin)
Storage & Preservation of
Specimen Prior to Shipping
No Specific Requirements
Additional lnformation For additional information please refer to the ASM sentinel laboratory guide: 
http://www.asm.org/images/pdf/Clinical/Protocols/brucella10-15-04.pdf
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition
Transport Medium Blood specimens should be transported in EDTA or Sodium Citrate tubes at 4°C
Shipping Instructions which 
Include Specimen Handling 
Requirements
Select agents that have been identified need form 2 approval prior to shipping. 
Form 2 can be found at: http://www.selectagents.gov/TransferForm.html
Select agents must be shipped Monday through Wednesday to prevent weekend 
arrivals.  Specimens should be shipped at 4°C.
Methodology Polymerase Chain Reaction (PCR)
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Brucella species Serology
CDC-10197
Test Order
Synonym(s) BMAT
Performed on Specimens From Human and Animal
CDC Points of Contact Robyn Stoddard
(404) 639-2053
frd8@cdc.gov
Renee Galloway
(404) 639-5461
zul0@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Serum (acute and convalescent preferred)
Minimum Volume Required 100 uL
Turnaround Time 1 Week
Interferences & Limitations Acute and convalescent sera are preferred
No serology available for B. Canis or RB51
May have poor sensitivity for chronic or complicated brucellosis
Storage & Preservation of
Specimen Prior to Shipping
Serum needs to be stored at 4°C
Additional lnformation Acute and convalescent sera are preferred
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition
Transport Medium Not applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship specimen Monday -Thursday overnight to avoid weekend deliveries
Ship serum at 4°C
Methodology Brucella microagglutination test (BMAT)
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Brucella species Study
CDC-10209
Test Order
Synonym(s) None
Performed on Specimens From Human, Animal, and Food/Environmental/Medical Devices/Biologics
CDC Points of Contact Robyn Stoddard
(404) 639-2053
frd8@cdc.gov
Rebekah Tiller
(404) 639-4507
eto3@cdc.gov
Pre-Approval Needed Stodard, Robyn, (404) 639-2053, frd8@cdc.gov
Tiller, Rebekah, (404) 639-4507, eto3@cdc.gov
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
To be determined
Minimum Volume Required To be determined
Turnaround Time  
Interferences & Limitations To be determined
Storage & Preservation of
Specimen Prior to Shipping
To be determined
Additional lnformation To be determined
Specimen Labeling To be determined
Transport Medium To be determined
Shipping Instructions which 
Include Specimen Handling 
Requirements
To be determined
Methodology
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Burkholderia mallei/pseudomallei Identification, Genotyping 
and AST
CDC-10210
Test Order
Synonym(s) Glanders, Melioidosis
Performed on Specimens From Human, Animal, and Food/Environmental/Medical Devices/Biologics
CDC Points of Contact Mindy Elrod
(404) 639-4055
wzg0@cdc.gov
David Lonsway
(404) 639-2825
dul7@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Isolates, clinical specimens (blood, bone marrow, sputum or bronchoscopically 
obtained specimens, abscess material or wound swabs, and urine)
Minimum Volume Required Not Applicable
Turnaround Time 1 Week
Interferences & Limitations None
Storage & Preservation of
Specimen Prior to Shipping
No Specific Requirements
Additional lnformation Turnaround time will vary depending on if an isolate is sent for identification or 
a specimen is sent for isolation. Identification of isolates generally is completed 
within 3 days while isolation from specimens and subsequent ID may take up to 
10 days.
For additional information please refer to the ASM sentinel laboratory guide: 
http://asm.org/images/pdf/Clinical/Protocols/bpseudomallei2008.pdf
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition
Transport Medium Agar slants preferred for isolates
Shipping Instructions which 
Include Specimen Handling 
Requirements
Select agents that have been identified need form 2 approval prior to shipping.  
Form 2 can be found at http://www.selectagents.gov/TransferForm.html; Select 
agents must be shipped Monday through Wednesday to prevent weekend 
arrivals.  Specimens should be shipped at 4°C.
Methodology Polymerase Chain Reaction (PCR), Biochemicals, Broth Micro Dilution, Multilocus 
sequence typing (MLST),  Multiple-Locus Variable number tandem repeat 
Analysis (MLVA)
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Burkholderia mallei/pseudomallei Molecular Detection
CDC-10211
Test Order
Synonym(s) Glanders, Melioidosis
Performed on Specimens From Human, Animal, and Food/Environmental/Medical Devices/Biologics
CDC Points of Contact Jay Gee
(404) 639-4936
xzg4@cdc.gov
Mindy Elrod
(404) 639-4055
wzg0@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Blood, bone marrow, sputum or bronchoscopically obtained specimens, abscess 
material or wound swabs, urine, and serum;  blood specimens should be 
collected in EDTA or Sodium Citrate tubes (not heparin)
Minimum Volume Required 250 uL
Turnaround Time 2 Days
Interferences & Limitations Blood specimens should be collected in EDTA or Sodium Citrate tubes (not 
heparin)
Storage & Preservation of
Specimen Prior to Shipping
No Specific Requirements
Additional lnformation For additional information please refer to the ASM sentinel laboratory guide: 
http://asm.org/images/pdf/Clinical/Protocols/bpseudomallei2008.pdf
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition
Transport Medium Dependent on specimen type
Shipping Instructions which 
Include Specimen Handling 
Requirements
Select agents that have been identified need form 2 approval prior to shipping.  
Form 2 can be found at http://www.selectagents.gov/TransferForm.html; Select 
agents must be shipped Monday through Wednesday to prevent weekend 
arrivals.  Specimens should be shipped at 4°C.  Select agents must be shipped 
Monday through Wednesday to prevent weekend arrivals.  Agar slants should be 
shipped at room temperature and specimens at 4°C.
Methodology Polymerase Chain Reaction (PCR)
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Burkholderia mallei/pseudomallei Study
CDC-10212
Test Order
Synonym(s) None
Performed on Specimens From Human, Animal, and Food/Environmental/Medical Devices/Biologics
CDC Points of Contact Mindy Elrod
(404) 639-4055
wzg0@cdc.gov
Jay Gee
(404) 639-4936
xzg4@cdc.gov
Pre-Approval Needed Elrod, Mindy, (404) 639-4055, wzg0@cdc.gov
Gee, Jay, (404) 639-4936, xzg4@cdc.gov
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
To be determined
Minimum Volume Required To be determined
Turnaround Time  
Interferences & Limitations To be determined
Storage & Preservation of
Specimen Prior to Shipping
To be determined
Additional lnformation To be determined
Specimen Labeling To be determined
Transport Medium To be determined
Shipping Instructions which 
Include Specimen Handling 
Requirements
To be determined
Methodology
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Burkholderia pseudomallei Serology
CDC-10198
Test Order
Synonym(s) Melioidosis
Performed on Specimens From Human and Animal
CDC Points of Contact Alex Hoffmaster
(404) 639-0852
amh9@cdc.gov
Mindy Elrod
(404) 639-4055
wzg0@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Serum (acute and convalescent required)
Minimum Volume Required 100 uL
Turnaround Time 2 Weeks
Interferences & Limitations Acute and convalescent are required.
Storage & Preservation of
Specimen Prior to Shipping
Store serum at 4°C before shipping
Additional lnformation Turnaround time may be shorter depending on risk and need
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship specimen Monday -Thursday overnight to avoid weekend deliveries
Serum should be shipped at 4°C
Methodology IHA-indirect haemagglutantion
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Burkholderia spp. ID (Not B. mallei/B. pseudomallei)
CDC-10144
Test Order
Synonym(s) Burkholderia Identification
Performed on Specimens From Human and Food/Environmental/Medical Devices/Biologics
CDC Points of Contact John McQuiston
(404) 639-0270
zje8@cdc.gov
Anne Whitney
(404) 639-1374
amw0@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
Please notify laboratory prior to shipment if this is a critical care specimen
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Pure culture isolate on a suitable agar slant medium; consultation required for 
other sample/specimen types
Minimum Volume Required Not Applicable
Turnaround Time 3 Weeks
Interferences & Limitations The 3 week turnaround time applies to all tests unless biochemical and/or 
phenotypic analysis are required, which could take up to 2 months for test 
results.
Storage & Preservation of
Specimen Prior to Shipping
Keep specimen refrigerated if unable to ship immediately
Additional lnformation If available, please provide patient history including if the patient has used a 
catheter and/or if the patient is immunocompromised
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship specimen Monday-Thursday, overnight to avoid weekend deliveries
Methodology Primary Culture based on specimen type, MALDI-TOF, 16S sequence based 
identification
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Campylobacter and Helicobacter Study
CDC-10125
Test Order
Synonym(s) Campy, H. pylori
Performed on Specimens From Human, Animal, and Food/Environmental/Medical Devices/Biologics
CDC Points of Contact Collette Fitzgerald
(404) 639-0838
chf3@cdc.gov
Patricia Jones
(404) 639-3334
entericbacteria@cdc.gov
Pre-Approval Needed Fitzgerald, Collette, (404) 639-0838, chf3@cdc.gov
Jones, Patricia, (404) 639-3334, entericbacteria@cdc.gov
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
To be determined
Minimum Volume Required To be determined
Turnaround Time  
Interferences & Limitations To be determined
Storage & Preservation of
Specimen Prior to Shipping
To be determined
Additional lnformation To be determined
Specimen Labeling To be determined
Transport Medium To be determined
Shipping Instructions which 
Include Specimen Handling 
Requirements
To be determined
Methodology
Michael Korth
(404) 639-3334
mqk8@cdc.gov
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Campylobacter species serology  
CDC-10455
Test Order
Synonym(s) Enteric Pathogen
Performed on Specimens From Human
CDC Points of Contact Deborah Talkington
(404) 639-3918
dft1@cdc.gov
Jim Pruckler
(404) 639-3816
jmp3@cdc.gov
Pre-Approval Needed Talkington, Deborah, (404) 639-3918, dft1@cdc.gov
Pruckler, Jim, (404) 639-3816, jmp3@cdc.gov
Supplemental Information
Required
Date of illness onset, date of serum collection, clinical diagnosis (i.e. Guillain–
Barré). 
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Paired serum is preferred. Serum is always preferred but plasma is acceptable. 
Do not pool specimens.
Minimum Volume Required 100 uL (More Preferred)
Turnaround Time 3 Months
Interferences & Limitations None
Storage & Preservation of
Specimen Prior to Shipping
Maintain serum at 4°C (preferred); frozen specimens acceptable
Additional lnformation Paired serum specimens always preferred.
Please send one tube per specimen submission form. Submit multiple forms if 
needed. 
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Separate serum from the clot and ship in a sterile labeled tube with the top 
tightly closed
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday, overnight to avoid weekend deliveries. Please notify 
Deborah Talkington (dft1@cdc.gov) and Jim Pruckler (jmp3@cdc.gov) once  
specimens have been shipped to provide the tracking number.
Ship with cold packs in compliance with federal and local guidelines
Methodology EIA
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Campylobacter, Helicobacter, and Related Organisms 
Identification
CDC-10126
Test Order
Synonym(s) Campy, H. pylori
Performed on Specimens From Human, Animal, and Food/Environmental/Medical Devices/Biologics
CDC Points of Contact Collette Fitzgerald
(404) 639-0838
chf3@cdc.gov
Patricia Jones
(404) 639-3334
entericbacteria@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
Prior approval is not required for human specimens; Please call for approval 
prior to sending other specimen types. Provide any preliminary results 
available. 
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Isolates
Minimum Volume Required Not Applicable
Turnaround Time 4 Weeks
Interferences & Limitations None
Storage & Preservation of
Specimen Prior to Shipping
No Specific Requirements
Additional lnformation Turnaround times for routine isolates may be extended during major foodborne 
outbreak activities or due to limited availability of resources.
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Ship overnight growth on nonselective blood-based slant/stab (preferably not 
TSA); screw cap tubes preferred
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday, overnight to avoid weekend deliveries
Ship with cold packs in compliance with federal and local guidelines
Methodology Phenotypic Identification, Genetic Identification
Michael Korth
(404) 639-3334
mqk8@cdc.gov
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Campylobacter, Helicobacter, and Related Organisms 
Identification and Subtyping
CDC-10127
Test Order
Synonym(s) Campy, H. pylori
Performed on Specimens From Human, Animal, and Food/Environmental/Medical Devices/Biologics
CDC Points of Contact Collette Fitzgerald
(404) 639-0838
chf3@cdc.gov
Patricia Jones
(404) 639-3334
entericbacteria@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
Prior approval is not required for human specimens; Please call for approval 
prior to sending other specimen types. Provide any preliminary results 
available.  
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Isolates
Minimum Volume Required Not Applicable
Turnaround Time 4 Weeks
Interferences & Limitations None
Storage & Preservation of
Specimen Prior to Shipping
No Specific Requirements
Additional lnformation Specify type of subtyping requested in 'Previous Laboratory Results' on back of 
form. Epidemiologic metadata, PulseNet cluster code, and PFGE pattern 
designation requested if available.
Turnaround times for routine isolates may be extended during major foodborne 
outbreak activities due to limited availability of resources.
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Ship overnight growth on nonselective blood-based slant/stab (preferably not 
TSA); screw cap tubes preferred
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday, overnight to avoid weekend deliveries
Ship with cold packs in compliance with federal and local guidelines
Methodology Phenotypic Identification, Genetic Identification, Penner Serotyping, PFGE, AST
Michael Korth
(404) 639-3334
mqk8@cdc.gov
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Chagas Disease Molecular Detection
CDC-10475
Test Order
Synonym(s) Trypanosoma cruzi; American trypanosomiasis, parasite
Performed on Specimens From Human
CDC Points of Contact Alex daSilva
(404) 718-4121
adasilva@cdc.gov
Yvonne Qvarnstrom
(404) 718-4123
bvp2@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Blood
Minimum Volume Required 200 uL
Turnaround Time 21 Days
Interferences & Limitations None
Storage & Preservation of
Specimen Prior to Shipping
Collect a 1-5 ml blood sample in Vacutainer® EDTA tubes prior to anti-parasitic 
therapy and ship at 4°C
Additional lnformation None
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday – Thursday, overnight to avoid weekend deliveries. Ship specimen 
at room temperature, not on dry ice, as an etiologic agent.
Methodology Real-time PCR
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Chagas Disease Serology
CDC-10458
Test Order
Synonym(s) Trypanosoma cruzi; American trypanosomiasis, parasite
Performed on Specimens From Human
CDC Points of Contact Hilda Rivera
(404) 718-4100
igi2@cdc.gov
Frank Steurer
(404) 718-4175
fjs1@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
Exposure and travel history, include other relevant risk factors; clinical 
symptoms, treatment and relevant lab results.
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Serum and plasma
Minimum Volume Required 0.5 mL
Turnaround Time 18 Days
Interferences & Limitations Substances known to interfere with immunoassays include: bilirubin, lipids, and 
hemoglobin 
Storage & Preservation of
Specimen Prior to Shipping
No specific requirements
Additional lnformation None
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday – Thursday, overnight to avoid weekend deliveries. Ship specimen 
at room temperature, not on dry ice, as an etiologic agent.
Methodology Indirect Fluorescent Antibody Assay, EIA, ELISA, Antibody Detection
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Chlamydia trachomatis, Genital - Culture
CDC-10195
Test Order
Synonym(s) Chlamydia isolation
Performed on Specimens From Human
CDC Points of Contact John Papp
(404) 639-3785
jwp6@cdc.gov
Carol Farshy
(404) 639-2870
cef1@cdc.gov
Pre-Approval Needed Papp, John, (404) 639-3785, jwp6@cdc.gov
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Endo-cervical swab, urethral swab, rectal swab, and others determined upon 
consultation
Minimum Volume Required Not Applicable
Turnaround Time 12 Weeks
Interferences & Limitations None
Storage & Preservation of
Specimen Prior to Shipping
All swabs must be frozen at -70°C
Additional lnformation Please provide information on any antibiotics the patient may have been treated 
with
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Prefer specimen to be shipped in M4 transport medium. Additional transport 
medium can be determined upon consultation.
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday – Thursday, overnight to avoid weekend deliveries. Specimen 
should be shipped on dry ice, as an etiologic agent.
Methodology Culture isolation by tissue culture
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Chlamydia trachomatis, Genital - Molecular Detection
CDC-10192
Test Order
Synonym(s) Chlamydia trachomatis (CT) NAATS, Chlamydia
Performed on Specimens From Human
CDC Points of Contact John Papp
(404) 639-3785
jwp6@cdc.gov
Carol Farshy
(404) 639-2870
cef1@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
Please indicate the product or medium used for storage and/or transport.
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Oral pharynx swabs, cervical swabs, vaginal swabs, and rectal swabs collected on 
any commercially available product, and urine
Minimum Volume Required 5 mL (urine)
Turnaround Time 3 Days
Interferences & Limitations Adhere to product insert instructions for swabs
Storage & Preservation of
Specimen Prior to Shipping
Adhere to product insert instructions for swabs
Additional lnformation None
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Adhere to product insert instructions for swabs
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday – Thursday, overnight to avoid weekend deliveries. Specimen 
should be shipped on dry ice if previously frozen, as an etiologic agent.
Methodology Nucleic Acid Amplification Tests (NAATS)
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Chlamydia trachomatis, Genital - Study
CDC-10193
Test Order
Synonym(s) None
Performed on Specimens From Human
CDC Points of Contact John Papp
(404) 639-3785
jwp6@cdc.gov
Carol Farshy
(404) 639-2870
cef1@cdc.gov
Pre-Approval Needed Papp, John, (404) 639-3785, jwp6@cdc.gov
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
To be determined
Minimum Volume Required To be determined
Turnaround Time  
Interferences & Limitations To be determined
Storage & Preservation of
Specimen Prior to Shipping
To be determined
Additional lnformation To be determined
Specimen Labeling To be determined
Transport Medium To be determined
Shipping Instructions which 
Include Specimen Handling 
Requirements
To be determined
Methodology
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Chlamydia trachomatis, LGV - Molecular Detection
CDC-10194
Test Order
Synonym(s) Chlamydia
Performed on Specimens From Human
CDC Points of Contact John Papp
(404) 639-3785
jwp6@cdc.gov
Christi Phillips
(404) 639-2147
div2@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Any exposed anatomic site swab; other specimen types accepted upon 
consultation with laboratory
Minimum Volume Required Not Applicable
Turnaround Time 12 Weeks
Interferences & Limitations None
Storage & Preservation of
Specimen Prior to Shipping
Specimen must be frozen at -20°C
Additional lnformation None
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Nucleic Acid Amplification Test (NAAT) commercial transport medium
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday – Thursday, overnight to avoid weekend deliveries. Specimen 
should be shipped on dry ice, as an etiologic agent.
Methodology PCR
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Chlamydophila pneumoniae Molecular Detection
CDC-10152
Test Order
Synonym(s) Chlamydia pneumoniae, Atypical pneumonia, CAP, Chlamydia
Performed on Specimens From Human
CDC Points of Contact Jonas Winchell
(404) 639-4921
Jwinchell@cdc.gov
Maureen Diaz
(404) 639-4534
mdiaz1@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Nasopharyngeal (NP) and/or Oropharyngeal (OP) swabs, and any lower 
respiratory tract specimen including bronchoalveolar lavage (BAL) and sputum; 
tissue, cerebral spinal fluid, isolates and purified nucleic acid; Others upon 
consultation with laboratory.
Minimum Volume Required Contingent upon specimen type. Please call for consultation
Turnaround Time 7 Days
Interferences & Limitations Do not use cotton swabs with wooden shafts. Specimen should be acquired prior 
to antibiotic treatment. Improper specimen storage and handling may result in 
inconclusive or inaccurate results.
Storage & Preservation of
Specimen Prior to Shipping
Specimens can be kept refrigerated if shipped in less than 72 hours of collection; 
otherwise specimen should be kept frozen. Store swabs in universal transport 
medium.
Additional lnformation None
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Universal transport medium
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday overnight to avoid weekend deliveries
Refrigerated specimen should be sent on ice packs
Frozen specimen should be sent on dry ice
Methodology Real Time PCR
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Chlamydophila psittaci Molecular Detection
CDC-10153
Test Order
Synonym(s) Psittacosis, Parrot fever, Chlamydia psittaci
Performed on Specimens From Human
CDC Points of Contact Jonas Winchell
(404) 639-4921
Jwinchell@cdc.gov
Maureen Diaz
(404) 639-4534
mdiaz1@cdc.gov
Pre-Approval Needed Winchell, Jonas, (404) 639-4921, Jwinchell@cdc.gov
Diaz, Maureen, (404) 639-4534, mdiaz1@cdc.gov
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Nasopharyngeal (NP) and/or Oropharyngeal (OP) swabs, and any lower 
respiratory tract specimen including bronchoalveolar lavage (BAL) and sputum; 
tissue, cerebral spinal fluid , isolates and purified nucleic acid; Others upon 
consultation with laboratory.
Minimum Volume Required Contingent upon specimen type. Please call for consultation
Turnaround Time 7 Days
Interferences & Limitations Do not send fixed tissues. Do not use cotton swabs with wooden shafts. 
Specimen should be acquired prior to antibiotic treatment. Improper specimen 
storage and handling may result in inconclusive or inaccurate results.
Storage & Preservation of
Specimen Prior to Shipping
Blood specimen should be collected in EDTA tubes. Tissues should be kept 
frozen. All other specimens can be kept refrigerated if shipped if less than 72 
hours of collection; otherwise specimen should be kept frozen. Store swabs in 
universal transport medium.
Additional lnformation If specimen is not of human origin please contact Dr. Branson Ritchie at the 
University of Georgia
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Universal transport medium
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday overnight to avoid weekend deliveries
Refrigerated specimen should be sent on ice packs
Frozen specimen should be sent on dry ice
Methodology Real Time PCR
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Chlamydophila psittaci Serology
CDC-10154
Test Order
Synonym(s) Psittacosis, Parrot fever, Chlamydia psittaci
Performed on Specimens From Human
CDC Points of Contact Jonas Winchell
(404) 639-4921
Jwinchell@cdc.gov
Maureen Diaz
(404) 639-4534
mdiaz1@cdc.gov
Pre-Approval Needed Winchell, Jonas, (404) 639-4921, Jwinchell@cdc.gov
Diaz, Maureen, (404) 639-4534, mdiaz1@cdc.gov
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Paired Sera (acute and convalescent)
Minimum Volume Required 2 mL of each serum
Turnaround Time 7 Days
Interferences & Limitations Improper specimen storage and handling may result in inconclusive or 
inaccurate results
Storage & Preservation of
Specimen Prior to Shipping
Specimen should be kept frozen
Additional lnformation None
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday overnight to avoid weekend deliveries
Frozen specimen should be sent on dry ice
Methodology Micro-immunofluoresence (MIF)
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Chlamydophila species Study
CDC-10158
Test Order
Synonym(s) None
Performed on Specimens From Human
CDC Points of Contact Jonas Winchell
(404) 639-4921
Jwinchell@cdc.gov
Maureen Diaz
(404) 639-4534
mdiaz1@cdc.gov
Pre-Approval Needed Winchell, Jonas, (404) 639-4921, Jwinchell@cdc.gov
Diaz, Maureen, (404) 639-4534, mdiaz1@cdc.gov
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
To be determined
Minimum Volume Required To be determined
Turnaround Time  
Interferences & Limitations To be determined
Storage & Preservation of
Specimen Prior to Shipping
To be determined
Additional lnformation To be determined
Specimen Labeling To be determined
Transport Medium To be determined
Shipping Instructions which 
Include Specimen Handling 
Requirements
To be determined
Methodology
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Clinical Microbiology Reference Study
CDC-10231
Test Order
Synonym(s) None
Performed on Specimens From Human, Animal, and Food/Environmental/Medical Devices/Biologics
CDC Points of Contact Kamile Rasheed
(404) 639-3247
JRasheed@cdc.gov
Brandi Limbago
(404) 639-2162
Blimbago@cdc.gov
Pre-Approval Needed Rasheed, Kamile, (404) 639-3247, JRasheed@cdc.gov
Limbago, Brandi, (404) 639-2162, Blimbago@cdc.gov
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
To be determined
Minimum Volume Required To be determined
Turnaround Time  
Interferences & Limitations To be determined
Storage & Preservation of
Specimen Prior to Shipping
To be determined
Additional lnformation To be determined
Specimen Labeling To be determined
Transport Medium To be determined
Shipping Instructions which 
Include Specimen Handling 
Requirements
To be determined
Methodology
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Clostridium difficile Identification
CDC-10228
Test Order
Synonym(s) C. Difficile ID, C. diff
Performed on Specimens From Human and Animal
CDC Points of Contact David Lonsway
(404) 639-2825
Dlonsway@cdc.gov
Kamile Rasheed
(404) 639-3247
jkr1@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Pure culture isolates in suitable anaerobic transport medium (e.g., Chopped Meat 
Glucose Broth)
Minimum Volume Required Not Applicable
Turnaround Time 28 Days
Interferences & Limitations None
Storage & Preservation of
Specimen Prior to Shipping
Store anaerobically
Additional lnformation This test does not include strain typing or characterization
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Pure culture isolate in Chopped Meat Glucose Broth, thioglycolate broth or 
frozen in TSB plus glycerol
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship specimen Monday -Thursday overnight to avoid weekend deliveries, as an 
etiologic agent.
Frozen specimen should be shipped on dry ice
Specimen stored at room temperature should be shipped at room temperature
Methodology Phenotypic Testing, Molecular Testing
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Clostridium difficile Outbreak Strain Typing
CDC-10229
Test Order
Synonym(s) C. Difficile Toxin, C. difficile Characterization
Performed on Specimens From Human, Animal, and Food/Environmental/Medical Devices/Biologics
CDC Points of Contact Kamile Rasheed
(404) 639-3247
JRasheed@cdc.gov
Chris Sieradzki
(404) 639-4899
hwg8@cdc.gov
Pre-Approval Needed Rasheed, Kamile, (404) 639-3247, JRasheed@cdc.gov
Sieradzki, Chris, (404) 639-4899, hwg8@cdc.gov
Supplemental Information
Required
Prior approval and Epidemiologic consultation required.
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Pure culture isolate. Additional specimen types accepted upon consultation with 
laboratory
Minimum Volume Required Not Applicable
Turnaround Time 28 Days
Interferences & Limitations None
Storage & Preservation of
Specimen Prior to Shipping
Store anaerobically
Additional lnformation Not CLIA compliant testing; for epidemiologic purposes only
Specimen Labeling Include date of isolation and unique specimen identifier
Transport Medium Pure culture isolate in Chopped Meat Glucose Broth, thioglycolate broth or 
frozen in TSB plus glycerol
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship specimen Monday -Thursday overnight to avoid weekend deliveries, as an 
etiologic agent.
Frozen specimen should be shipped on dry ice
Specimen stored at room temperature should be shipped at room temperature
Methodology Molecular Strain Typing, Phenotypic Testing
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Clostridium perfringens Detection - Foodborne Outbreak
CDC-10111
Test Order
Synonym(s) C. perfringens
Performed on Specimens From Human and Food/Environmental/Medical Devices/Biologics
CDC Points of Contact Deborah Talkington
(404) 639-3918
dft1@cdc.gov
Gerardo Gomez
(404) 639-0537
goe4@cdc.gov
Pre-Approval Needed Talkington, Deborah, (404) 639-3918, dft1@cdc.gov
Gomez, Gerardo, (404) 639-0537, goe4@cdc.gov
Supplemental Information
Required
Only specimens from foodborne outbreaks accepted. Consult with EDLB 
contact before sending specimens. Provide any preliminary results  available.
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Isolates, stool and food. Only specimens from foodborne outbreaks accepted. 
Consult with  Dr. Talkington before sending specimens.
Minimum Volume Required 10 g (stool) and 25 g (food)
Turnaround Time 2 Months
Interferences & Limitations None
Storage & Preservation of
Specimen Prior to Shipping
Maintain stool and food at 4°C
Additional lnformation Direct toxin detection requires stool specimens
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday, overnight to avoid weekend deliveries. Please notify 
Deborah Talkington (dft1@cdc.gov) and Gerardo Gomez (goe4@cdc.gov) once  
specimens have been shipped to provide the tracking number.
Ship with cold packs  in compliance with federal and local guidelines
Methodology Toxin Detection in Stool, Culture, PCR
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Congo-Crimean Hemorrhagic Fever Identification
CDC-10302
Test Order
Synonym(s) CCHF
Performed on Specimens From Human and Animal
CDC Points of Contact Ute Stroeher
(404) 639-4704
ixy8@cdc.gov
Barbara Knust
(404) 639-1104
bkk0@cdc.gov
Pre-Approval Needed Stroeher, Ute, (404) 639-4704, ixy8@cdc.gov
Knust, Barbara, (404) 639-1104, bkk0@cdc.gov
Supplemental Information
Required
See Supplemental Form
Supplemental Form http://www.cdc.gov/ncezid/dhcpp/vspb/pdf/specimen-submission.pdf
Acceptable Sample/ Specimen 
Type for Testing
Frozen tissue, blood, and serum
Minimum Volume Required 1 mL
Turnaround Time 10 Days
Interferences & Limitations Specimen must remain frozen; warming or freeze thawing reduces sensitivity. 
Heparin may cause interference with the molecular tests and should be avoided.
Storage & Preservation of
Specimen Prior to Shipping
Specimen must be placed in plastic screw capped vials, frozen to -70°C, and kept 
frozen until shipment. See link to supplemental submission form for specific 
information on various specimen types.
Additional lnformation Critical specimens will take less than 4 days to turn around. See link to 
supplemental submission forms for detailed information.
Specimen Labeling Patient name, patient ID #, specimen type, date collected
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday overnight to avoid weekend deliveries. Specimen should 
be shipped frozen on dry ice. See supplemental submission forms for further 
details. Do not ship specimen without prior consultation and approval.
Methodology Molecular Typing, Polymerase Chain Reaction (PCR)
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Congo-Crimean Hemorrhagic Fever Serology
CDC-10303
Test Order
Synonym(s) CCHF
Performed on Specimens From Human and Animal
CDC Points of Contact Ute Stroeher
(404) 639-4704
ixy8@cdc.gov
Barbara Knust
(404) 639-1104
bkk0@cdc.gov
Pre-Approval Needed Stroeher, Ute, (404) 639-4704, ixy8@cdc.gov
Knust, Barbara, (404) 639-1104, bkk0@cdc.gov
Supplemental Information
Required
See Supplemental Form
Supplemental Form http://www.cdc.gov/ncezid/dhcpp/vspb/pdf/specimen-submission.pdf
Acceptable Sample/ Specimen 
Type for Testing
Blood and serum
Minimum Volume Required 1 mL
Turnaround Time 10 Days
Interferences & Limitations Specimen must remain frozen; warming or freeze thawing reduces sensitivity
Storage & Preservation of
Specimen Prior to Shipping
Specimen must be kept cold (at or below 4°C). If possible place specimen in 
plastic screw capped vials. See link to supplemental submission form for specific 
information on various specimen types.
Additional lnformation Critical specimens will take less than 4 days to turn around. See link to 
supplemental submission forms for detailed information.
Specimen Labeling Patient name, patient ID #, specimen type, date collected
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday overnight to avoid weekend deliveries. Specimen should 
be shipped on cold packs or dry ice if frozen. See supplemental submission 
forms for further details. Do not ship specimen without prior consultation and 
approval.
Methodology ELISA
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Cornynebacterium species (Not C. diphtheriae) ID
CDC-10136
Test Order
Synonym(s) Diptheria
Performed on Specimens From Human and Food/Environmental/Medical Devices/Biologics
CDC Points of Contact John McQuiston
(404) 639-0270
zje8@cdc.gov
Anne Whitney
(404) 639-1374
amw0@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
Please notify laboratory prior to shipment if this is a critical care specimen
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Pure culture isolate on a suitable agar slant medium; Consultation required for 
other sample/specimen types
Minimum Volume Required Not Applicable
Turnaround Time 3 Weeks
Interferences & Limitations The 3 week turnaround time applies to all tests unless biochemical and/or 
phenotypic analysis are required, which could take up to 2 months for test 
results.
Storage & Preservation of
Specimen Prior to Shipping
Keep specimen refrigerated if unable to ship immediately
Additional lnformation If available, please provide patient history including if the patient has used a 
catheter and/or if the patient is immunocompromised.
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship specimen Monday-Thursday, overnight to avoid weekend deliveries
Methodology Primary Culture based on specimen type, MALDI-TOF, 16S sequence based 
identification
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Corynebacterium diphtheriae Study
CDC-10172
Test Order
Synonym(s) None
Performed on Specimens From Human
CDC Points of Contact Pam Cassiday
(404) 639-1231
pxc1@cdc.gov
Maria Tondella
(404) 639-1239
mlt5@cdc.gov
Pre-Approval Needed Cassiday, Pam, (404) 639-1231, pxc1@cdc.gov
Tondella, Maria, (404) 639-1239, mlt5@cdc.gov
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
To be determined
Minimum Volume Required To be determined
Turnaround Time  
Interferences & Limitations To be determined
Storage & Preservation of
Specimen Prior to Shipping
To be determined
Additional lnformation To be determined
Specimen Labeling To be determined
Transport Medium To be determined
Shipping Instructions which 
Include Specimen Handling 
Requirements
To be determined
Methodology
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Corynebacterium diphtheriae Toxin - Molecular Detection
CDC-10171
Test Order
Synonym(s) Diphtheria, Real Time PCR
Performed on Specimens From Human
CDC Points of Contact Pam Cassiday
(404) 639-1231
pxc1@cdc.gov
Maria Tondella
(404) 639-1239
mlt5@cdc.gov
Pre-Approval Needed Cassiday, Pam, (404) 639-1231, pxc1@cdc.gov
Tondella, Maria, (404) 639-1239, mlt5@cdc.gov
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Pure culture isolates on a suitable agar slant, extracted DNA, or 
pseudomembrane
Minimum Volume Required 100 uL (DNA)
Turnaround Time 5 Days
Interferences & Limitations Prior antibiotic treatment will adversely affect results. Suboptimal volumes of 
specimens may adversely affect the sensitivity of tests performed therefore it is 
very important to obtain an acceptable volume and a quality specimen. Clinical 
specimens collected subsequent to initiation of antimicrobial treatment may not 
be positive for Corynebacterium species due to reduction of organisms. 
Whenever possible, specimens collected prior to administration of antimicrobial 
agents should be used to determine infection with Corynebacterium species.
Storage & Preservation of
Specimen Prior to Shipping
Specimens should be kept refrigerated or frozen. Use plastic/glass screw-cap, 
leak-proof vials. Pseudo-membrane should be sent in leak-proof container with 
saline, not formalin.
Additional lnformation Diphtheria Antitoxin (DAT) testing should be performed on the patient prior to 
requesting molecular testing from CDC. Corynebacterium PCR testing is not 
currently used for diagnostic purposes for diphtheria and is not considered a 
confirmatory test.
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Note: surveillance studies may label specimens according to protocol
Transport Medium Common transport media such as Amies or Stuart may be used for swabs. 
Isolates should be sent on blood agar slants or TSA. Pseudo-membrane should 
be sent in leak-proof container with saline not formalin.
Shipping Instructions which 
Include Specimen Handling 
Requirements
Once specimens are collected they should be shipped to the laboratory as soon 
as possible, between 24-48 hours. Sender is responsible for shipping charges 
and when shipping internationally must request CDC's import permit and include 
this with the Air Waybill. Additionally, the Pertussis/Diphtheria Laboratory 
requests that the sender contacts the laboratory by email or phone before 
shipping.
Methodology Real Time Polymerase Chain Reaction (PCR)
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Corynebacterium diphtheriae/ulcerans/pseudotuberculosis ID 
and Toxigenicity
CDC-10169
Test Order
Synonym(s) Diphtheria
Performed on Specimens From Human
CDC Points of Contact Pam Cassiday
(404) 639-1231
pxc1@cdc.gov
Maria Tondella
(404) 639-1239
mlt5@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Fresh subculture (24-48 hours old) of a pure culture isolate on a suitable agar 
slant
Minimum Volume Required Not Applicable
Turnaround Time 1 Week
Interferences & Limitations Isolates passed within 24-48 hours are preferred
Storage & Preservation of
Specimen Prior to Shipping
Use plastic/glass screw-cap, leak-proof vials. Isolates can be refrigerated on an 
agar slant or common culture medium or frozen in TSB with glycerol or other 
liquid medium.
Additional lnformation None
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Note: surveillance studies may label specimens according to protocol
Transport Medium Common transport medium such as blood agar, TSA, nutrient agar, 
slants/plates, or frozen
Shipping Instructions which 
Include Specimen Handling 
Requirements
Once specimens are collected they should be shipped to the laboratory as soon 
as possible, between 24-48 hours. Sender is responsible for shipping charges 
and when shipping internationally must request CDC's import permit and include 
this with the Air Waybill. Additionally, the Pertussis/Diphtheria Laboratory 
requests that the sender contacts the laboratory by email or phone before 
shipping.
Methodology Culture, API Coryne, Elek, Polymerase Chain Reaction (PCR)
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Corynebacterium diphtheriae/ulcerans/pseudotuberculosis
Isolation, ID, Toxigenicity
CDC-10168
Test Order
Synonym(s) Diphtheria
Performed on Specimens From Human
CDC Points of Contact Pam Cassiday
(404) 639-1231
pxc1@cdc.gov
Maria Tondella
(404) 639-1239
mlt5@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Throat, nasal and wound swabs, pseudo-membrane, and sputum
Minimum Volume Required 0.5 mL
Turnaround Time 1 Week
Interferences & Limitations Prior antibiotic treatment will adversely affect results. Suboptimal volumes of 
specimens may adversely affect the sensitivity of tests performed therefore it is 
very important to obtain an acceptable volume and a quality specimen. Clinical 
specimens collected subsequent to initiation of antimicrobial treatment may not 
be positive for Corynebacterium species due to reduction of organisms. 
Whenever possible, specimens collected prior to administration of antimicrobial 
agents should be used to determine infection with Corynebacterium species.
Storage & Preservation of
Specimen Prior to Shipping
Use plastic/glass screw-cap, leak-proof vials. Store refrigerated.
Additional lnformation None
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Note: surveillance studies may label specimens according to protocol
Transport Medium Common transport media such as Amies or Stuart may be used for swabs. 
Pseudo-membrane should be sent in leak-proof container with saline not 
formalin.
Shipping Instructions which 
Include Specimen Handling 
Requirements
Once specimens are collected they should be shipped to the laboratory as soon 
as possible, between 24-48 hours. Sender is responsible for shipping charges 
and when shipping internationally must request CDC's import permit and include 
this with the Air Waybill. Additionally, the Pertussis/Diphtheria Laboratory 
requests that the sender contacts the laboratory by email or phone before 
shipping.
Methodology Culture, Polymerase Chain Reaction (PCR), API Coryne, Elek
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Coxiella burnetii Molecular Detection
CDC-10304
Test Order
Synonym(s) Q fever
Performed on Specimens From Human
CDC Points of Contact Cecilia Kato
(404) 639-1075
ckato@cdc.gov
Jennifer McQuiston
(404) 639-1075
fzh7@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
Prior approval is required if the following information is not provided:
-Symptom onset date
-Sample collection date
-Type of infection
-Status of illness
Recommended:
-Travel history
-Exposure history
-Therapeutic agents
-Brief clinical history
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Acute samples only, anticoagulated whole blood collected in 
Ethylenediaminetetraacetic acid (EDTA) treated tubes preferred; serum; fresh 
tissue biopsy
Minimum Volume Required 1.0 mL
Turnaround Time 6 Weeks
Interferences & Limitations Hemolysis in whole blood specimen will interfere with results. Multiple freeze 
thaw cycles and sample storage above refrigerated temperatures will interfere 
with proper nucleic acid extraction. If a specimen is drawn at convalescence it 
will reduce the chance of the target organism being present in blood. Avoid 
collection of blood specimen in heparin tubes.
Storage & Preservation of
Specimen Prior to Shipping
Ideally keep specimen at a refrigerated temperature not frozen. If previously 
frozen, then keep specimen frozen.
Additional lnformation The Rickettsial Zoonoses Branch Reference Diagnostic Laboratory aids State 
Laboratories in diagnosis of difficult samples/cases or if specialized tests are 
needed. Routine diagnostic samples should be sent to your State Laboratory or a 
commercial laboratory.
Specimen Labeling Patient name and date of birth
Transport Medium Ethylenediaminetetraacetic acid (EDTA) blood tubes for blood; tissue in a sample 
collection tube
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday - Thursday, overnight to avoid weekend deliveries. Specimen 
should be shipped refrigerated on cold packs.
Methodology Real Time Polymerase Chain Reaction (PCR), Polymerase Chain Reaction (PCR), 
Sequencing
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Coxiella burnetii Serology
CDC-10305
Test Order
Synonym(s) Q fever
Performed on Specimens From Human
CDC Points of Contact Cecilia Kato
(404) 639-1075
ckato@cdc.gov
Jennifer McQuiston
(404) 639-1075
fzh7@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
Prior approval is required if the following information is not provided:
-Symptom onset date
-Sample collection date
-Type of infection
-Status of illness
Recommended:
-Travel history
-Exposure history
-Therapeutic agents
-Brief clinical history
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Serum
-acute (during active stage of illness)
-convalescent (2-4 weeks after acute stage)
Minimum Volume Required 1.0 mL
Turnaround Time 6 Weeks
Interferences & Limitations Multiple freeze thaw cycles may interfere with antigen binding. Use sterile 
technique to avoid contamination of sample as this may compromise the sample 
and interfere with the ability to get accurate results. Acute and convalescent 
serum is needed for accurate diagnosis and if unable to collect both please 
contact laboratory prior to shipping.
Storage & Preservation of
Specimen Prior to Shipping
Ideally keep specimen at a refrigerated temperature not frozen. If previously 
frozen, then keep specimen frozen.
Additional lnformation The Rickettsial Zoonoses Branch Reference Diagnostic Laboratory aids State 
Laboratories in diagnosis of difficult samples/cases or if specialized tests are 
needed. Routine diagnostic samples should be sent to your State Laboratory or a 
commercial laboratory.
Specimen Labeling Patient name and date of birth
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday - Thursday, overnight to avoid weekend deliveries. Specimen 
should be shipped refrigerated on cold packs.
Methodology Indirect Fluorescence Assay (IFA)
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Coxiella Special Study
CDC-10306
Test Order
Synonym(s) Q fever
Performed on Specimens From Human, Animal, and Food/Environmental/Medical Devices/Biologics
CDC Points of Contact Cecilia Kato
(404) 639-1075
ckato@cdc.gov
Jennifer McQuiston
(404) 639-1075
fzh7@cdc.gov
Pre-Approval Needed Kato, Cecilia, (404) 639-1075, ckato@cdc.gov
McQuiston, Jennifer, (404) 639-1075, fzh7@cdc.gov
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
To be determined
Minimum Volume Required To be determined
Turnaround Time  
Interferences & Limitations To be determined
Storage & Preservation of
Specimen Prior to Shipping
To be determined
Additional lnformation To be determined
Specimen Labeling To be determined
Transport Medium To be determined
Shipping Instructions which 
Include Specimen Handling 
Requirements
To be determined
Methodology
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Cryptosporidium Special Study
CDC-10491
Test Order
Synonym(s) None
Performed on Specimens From None
CDC Points of Contact Alex daSilva
(404) 718-4121
abs8@cdc.gov
Yvonne Qvarnstrom
(404) 718-4123
bvp2@cdc.gov
Pre-Approval Needed daSilva, Alex, (404) 718-4121, abs8@cdc.gov
Qvarnstrom, Yvonne, (404) 718-4123, bvp2@cdc.gov
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
To be determined
Minimum Volume Required To be determined
Turnaround Time  
Interferences & Limitations To be determined
Storage & Preservation of
Specimen Prior to Shipping
To be determined
Additional lnformation To be determined
Specimen Labeling To be determined
Transport Medium To be determined
Shipping Instructions which 
Include Specimen Handling 
Requirements
Methodology
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Cyclospora Molecular Detection
CDC-10477
Test Order
Synonym(s) Cyclospora cayetenensis, parasite
Performed on Specimens From Human, Animal, and Food/Environmental/Medical Devices/Biologics
CDC Points of Contact Alex daSilva
(404) 718-4121
adasilva@cdc.gov
Yvonne Qvarnstrom
(404) 718-4123
bvp2@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Stool (unpreserved or fixed with potassium dichromate); Food
Minimum Volume Required 200 uL
Turnaround Time 21 Days
Interferences & Limitations Formalin and LC-PVA fixed stool specimens are not suitable for molecular 
studies
Storage & Preservation of
Specimen Prior to Shipping
Stool must be collected in absence of preservatives kept and shipped either 
refrigerated (4°C) or frozen (shipped with dry ice). Alternatively stool specimens 
can also be mixed in potassium dichromate 2.5% (1:1 dilution) or in absolute 
ethanol (1:1 dilution) and shipped refrigerated.
Food storage and preservation is specific to the type food being tested
Additional lnformation None
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday – Thursday, overnight to avoid weekend deliveries. Ship stool with ice 
packs or dry ice, as an etiologic agent.
Methodology Conventional PCR
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Cysticercosis Antigen ELISA
CDC-10490
Test Order
Synonym(s) Taenia solium antigen
Performed on Specimens From Human
CDC Points of Contact Patricia Wilkins
(404) 718-4101
pma1@cdc.gov
John Noh
(404) 718-4111
jxn1@cdc.gov
Pre-Approval Needed Wilkins, Patricia, (404) 718-4101, pma1@cdc.gov
Noh, John, (404) 718-4111, jxn1@cdc.gov
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Serum, plasma; Cerebrospinal fluid (CSF)
Minimum Volume Required 0.5 mL
Turnaround Time 21 Days
Interferences & Limitations Substances known to interfere with immunoassays include: bilirubin, lipids, and 
hemoglobin
Storage & Preservation of
Specimen Prior to Shipping
No specific requirements
Additional lnformation None
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday – Thursday, overnight to avoid weekend deliveries. Ship specimen at room 
temperature, not on dry ice, as an etiologic agent.
Methodology ELISA, Antigen Detection
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Cysticercosis Immunoblot
CDC-10459
Test Order
Synonym(s) Neurocysticercosis, Taenia solium, cysitcercus, EITB, LLGP-EITB, parasite
Performed on Specimens From Human
CDC Points of Contact Patricia Wilkins
(404) 718-4101
pma1@cdc.gov
Isabel McAuliffe
(404) 718-4100
ibm4@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
Exposure and travel history, include other relevant risk factors; clinical 
symptoms, treatment and relevant lab results.
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Serum, plasma; Cerebrospinal fluid (CSF)
Minimum Volume Required 0.5 mL
Turnaround Time 15 Days
Interferences & Limitations Substances known to interfere with immunoassays include: bilirubin, lipids, and 
hemoglobin 
Storage & Preservation of
Specimen Prior to Shipping
No specific requirements
Additional lnformation None
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday – Thursday, overnight to avoid weekend deliveries. Ship specimen 
at room temperature, not on dry ice, as an etiologic agent.
Methodology Immunoblot, Western Blot, Antibody Detection
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Cytomegalovirus (CMV) Detection
CDC-10263
Test Order
Synonym(s) CMV
Performed on Specimens From Human
CDC Points of Contact Shelia Dollard
(404) 639-2178
sgd5@cdc.gov
Scott Schmid
(404) 639-0066
dss1@cdc.gov
Pre-Approval Needed Dollard, Shelia, (404) 639-2178, sgd5@cdc.gov
Schmid, Scott, (404) 639-0066, dss1@cdc.gov
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Urine, saliva, and blood
Minimum Volume Required 200 uL
Turnaround Time 1 Week
Interferences & Limitations None
Storage & Preservation of
Specimen Prior to Shipping
Keep specimen either refrigerated or frozen. Blood should be collected in EDTA 
or citrate tubes.
Additional lnformation None
Specimen Labeling Provide a specimen ID. Do not send specimen labeled with patient’s name.
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship overnight Monday–Thursday, with cold packs or dry ice as an etiologic 
agent.
Methodology Polymerase Chain Reaction (PCR)
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Cytomegalovirus (CMV) Serology
CDC-10264
Test Order
Synonym(s) CMV
Performed on Specimens From Human
CDC Points of Contact Sheila Dollard
(404) 639-2178
sgd5@cdc.gov
Scott Schmid
(404) 639-0066
dss1@cdc.gov
Pre-Approval Needed Dollard, Sheila, (404) 639-2178, sgd5@cdc.gov
Schmid, Scott, (404) 639-0066, dss1@cdc.gov
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Serum or plasma
Minimum Volume Required 500 uL
Turnaround Time 1 Week
Interferences & Limitations None
Storage & Preservation of
Specimen Prior to Shipping
Keep specimen either refrigerated or frozen
Additional lnformation None
Specimen Labeling Provide a specimen ID. Do not send specimen labeled with patient’s name.
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship overnight Monday–Thursday, with cold packs or dry ice as an etiologic 
agent.
Methodology IgG antibody detected by EIA, IgM antibody detected by EIA
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Dengue Virus Diagnosis
CDC-10307
Test Order
Synonym(s) Dengue fever, Dengue
Performed on Specimens From Human
Pre-Approval Needed None
Supplemental Information
Required
Dengue case investigation form must be filled out- See supplemental Form
Additional Information on submitting specimen and the Spanish version of 
case investigation form are located at:
http://www.cdc.gov/dengue/clinicalLab/laboratory.html
Supplemental Form http://www.cdc.gov/dengue/resources/dengueCaseReports/DCIF_English.pdf
Acceptable Sample/ Specimen 
Type for Testing
Serum and others upon consultation with laboratory. The blood sample should 
be taken in a red-top or tiger-top tube.
Minimum Volume Required 0.5 mL
Turnaround Time 7 Days
Interferences & Limitations Serological tests can cross react with other Flavivirus, such as West Nile Virus.
Recent vaccinations for Yellow Fever Virus and Japanese Encephalitis Virus, Tick-
borne Encephalitis Virus can cause cross reactive test results. Natural infections 
with St. Louis Encephalitis Virus and West Nile can cause cross reactive results. 
Hemolyzed or contaminated samples are not acceptable for serology testing. 
EDTA will affect PCR and serology results and Nitrate tubes will affect IgM 
results.
Storage & Preservation of
Specimen Prior to Shipping
After blood is allowed to clot, separate serum by centrifugation and keep serum 
refrigerated at 4°C or frozen at -20°C (preferred).
Citrate (collected in yellow top tubes) and heparin plasma (green top tubes) can 
be tested by RT-PCR. Violet-top (with EDTA) is not recommended for RT-PCR 
testing. Violet and or green-top tubes should not be used for serology testing 
(convalescent sample). Please refer to collection devices manufacturer 
instructions for more details.
We recommend freezing the serum immediately after it is separated and to send 
on dry ice. If dry ice is not available, we recommend that the serum is kept 
refrigerated and delivered to the CDC Dengue Branch in cold packs.
Additional lnformation To diagnose dengue, the laboratory requires a serum sample obtained during 
Specimen Labeling Include complete name, age, and sex of patient, home address, date of onset of 
symptoms, date sample was obtained, complete name and mailing address of 
the physician, laboratory, clinic, or hospital
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday, overnight to avoid weekend deliveries
Frozen specimen should be shipped on dry ice
Refrigerated specimen should be shipped on ice packs
        
Ship To:                                                                                
CDC Dengue Branch and Puerto Rico Department of Health
1324 Calle Cañada, San Juan, P. R. 00920-3860
Methodology IgM by ELISA, NS1 Antigen Test, Polymerase Chain Reaction (PCR), Viral isolation, 
IgG seroconversion by ELISA
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Dengue Virus Diagnosis
CDC-10307
Test Order
CDC Points of Contact Elizabeth Hunsperger
(787) 706-2472
enh4@cdc.gov
Jorge Munoz
(787) 706-2460
ckq2@cdc.gov
the acute phase of the infection (DPO=0-5). If this sample is negative, then a 
second convalescent serum sample (that can be taken from day 6 after the onset 
of symptoms) is required to confirm the case. The case is confirmed with 
antibody (IgM or IgG) seroconversion. Informing the patient about the 
importance of returning for a second sample, and providing an appointment for 
a specific day and hour, will increase the probability of obtaining the second 
sample. Samples will be rejected if they are sent without form, form without 
sample, incomplete or illegible form – especially regarding date of onset of 
symptoms, date of sample collection and samples received more than a month 
after onset of illness.
 
Monday, January 13, 2014 Page 106 of 380Version: 1.0
Dengue Virus Special Study
CDC-10308
Test Order
Synonym(s) None
Performed on Specimens From Human
CDC Points of Contact Elizabeth Hunsperger
(787) 706-2472
enh4@cdc.gov
Jorge Munoz
(787) 706-2469
ckq2@cdc.gov
Pre-Approval Needed Hunsperger, Elizabeth, (787) 706-2472, enh4@cdc.gov
Munoz, Jorge, (787) 706-2469, ckq2@cdc.gov
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
To be determined
Minimum Volume Required To be determined
Turnaround Time  
Interferences & Limitations To be determined
Storage & Preservation of
Specimen Prior to Shipping
To be determined
Additional lnformation To be determined
Specimen Labeling To be determined
Transport Medium To be determined
Shipping Instructions which 
Include Specimen Handling 
Requirements
To be determined
Methodology
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Ebola Identification
CDC-10309
Test Order
Synonym(s) None
Performed on Specimens From Human and Animal
CDC Points of Contact Ute Stroeher
(404) 639-4704
ixy8@cdc.gov
Barbara Knust
(404) 639-1104
bkk0@cdc.gov
Pre-Approval Needed Stroeher, Ute, (404) 639-4704, ixy8@cdc.gov
Knust, Barbara, (404) 639-1104, bkk0@cdc.gov
Supplemental Information
Required
See Supplemental Form
Supplemental Form http://www.cdc.gov/ncezid/dhcpp/vspb/pdf/specimen-submission.pdf
Acceptable Sample/ Specimen 
Type for Testing
Frozen tissue, blood, and serum
Minimum Volume Required 1 mL
Turnaround Time 10 Days
Interferences & Limitations Specimen must remain frozen; warming or freeze thawing reduces sensitivity. 
Heparin may cause interference with the molecular tests and should be avoided.
Storage & Preservation of
Specimen Prior to Shipping
Specimen must be placed in plastic screw capped vials, frozen to -70°C, and kept 
frozen until shipment. See link to supplemental submission form for specific 
information on various specimen types.
Additional lnformation Critical specimens will take less than 4 days to turn around. See link to 
supplemental submission forms for detailed information.
Specimen Labeling Patient name, patient ID #, specimen type, date collected
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday overnight to avoid weekend deliveries. Specimen should 
be shipped frozen on dry ice. See supplemental submission forms for further 
details. Do not ship specimen without prior consultation and approval.
Methodology Molecular Typing, Polymerase Chain Reaction (PCR)
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Ebola Serology
CDC-10310
Test Order
Synonym(s) None
Performed on Specimens From Human and Animal
CDC Points of Contact Ute Stroeher
(404) 639-4704
ixy8@cdc.gov
Barbara Knust
(404) 639-1104
bkk0@cdc.gov
Pre-Approval Needed Stroeher, Ute, (404) 639-4704, ixy8@cdc.gov
Knust, Barbara, (404) 639-1104, bkk0@cdc.gov
Supplemental Information
Required
See Supplemental Form
Supplemental Form http://www.cdc.gov/ncezid/dhcpp/vspb/pdf/specimen-submission.pdf
Acceptable Sample/ Specimen 
Type for Testing
Blood and serum
Minimum Volume Required 1 mL
Turnaround Time 10 Days
Interferences & Limitations Specimen must remain frozen; warming or freeze thawing reduces sensitivity.
Storage & Preservation of
Specimen Prior to Shipping
Specimen must be kept cold (at or below 4°C). If possible place specimen in 
plastic screw capped vials. See link to supplemental submission form for specific 
information on various specimen types.
Additional lnformation Critical specimens will take less than 4 days to turn around. See link to 
supplemental submission forms for detailed information.
Specimen Labeling Patient name, patient ID #, specimen type, date collected
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday overnight to avoid weekend deliveries. Specimen should 
be shipped on cold packs or dry ice if frozen. See supplemental submission 
forms for further details. Do not ship specimen without prior consultation and 
approval.
Methodology ELISA
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Echinococcosis Immunoblot
CDC-10460
Test Order
Synonym(s) Hydatid Disease, Echinococcus granulosus, parasite
Performed on Specimens From Human
CDC Points of Contact Patricia Wilkins
(404) 718-4101
pma1@cdc.gov
Isabel McAuliffe
(404) 718-4100
ibm4@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
Exposure and travel history, include other relevant risk factors; clinical 
symptoms, treatment and relevant lab results.
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Serum and plasma
Minimum Volume Required 0.5 mL
Turnaround Time 18 Days
Interferences & Limitations Substances known to interfere with immunoassays include: bilirubin, lipids, and 
hemoglobin 
Storage & Preservation of
Specimen Prior to Shipping
No specific requirements
Additional lnformation None
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday – Thursday, overnight to avoid weekend deliveries. Ship specimen 
at room temperature, not on dry ice, as an etiologic agent.
Methodology Immunoblot, Western Blot, Antibody detection
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Ehrlichia Serology
CDC-10311
Test Order
Synonym(s) Human monocytic ehrlichiosis
Performed on Specimens From Human
CDC Points of Contact Cecilia Kato
(404) 639-1075
ckato@cdc.gov
Jennifer McQuiston
(404) 639-1075
fzh7@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
Prior approval is required if the following information is not provided:
-Symptom onset date
-Sample collection date
-Type of infection
-Status of illness
Recommended:
-Travel history
-Exposure history
-Therapeutic agents
-Brief clinical history
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Serum
-acute (during active stage of illness)
-convalescent (2-4 weeks after acute stage)
Minimum Volume Required 1.0 mL
Turnaround Time 6 Weeks
Interferences & Limitations Multiple freeze thaw cycles may interfere with antigen binding. Use sterile 
technique to avoid contamination of sample as this may compromise the sample 
and interfere with the ability to get accurate results. Acute and convalescent 
serum is needed for accurate diagnosis and if unable to collect both please 
contact laboratory prior to shipping.
Storage & Preservation of
Specimen Prior to Shipping
Ideally keep specimen at a refrigerated temperature not frozen. If previously 
frozen, then keep specimen frozen.
Additional lnformation The Rickettsial Zoonoses Branch Reference Diagnostic Laboratory aids State 
Laboratories in diagnosis of difficult samples/cases or if specialized tests are 
needed. Routine diagnostic samples should be sent to your State Laboratory or a 
commercial laboratory.
Specimen Labeling Patient name and date of birth
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday, overnight to avoid weekend deliveries. Specimen should 
be shipped refrigerated on cold packs.
Methodology Indirect Fluorescence Assay (IFA)
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Entamoeba histolytica/dispar Molecular Detection
CDC-10478
Test Order
Synonym(s) Amebiasis, Entameba histolytica, Entameba dispar, parasite
Performed on Specimens From Human
CDC Points of Contact Alex daSilva
(404) 718-4121
adasilva@cdc.gov
Yvonne Qvarnstrom
(404) 718-4123
bvp2@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Stool (unpreserved)
Minimum Volume Required 200 uL
Turnaround Time 21 Days
Interferences & Limitations Formalin and LC-PVA fixed stool specimens are not suitable for molecular 
studies
Storage & Preservation of
Specimen Prior to Shipping
Stool must be collected in absence of preservatives kept and shipped either 
refrigerated (4°C) or frozen (shipped with dry ice). 
Additional lnformation None
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday – Thursday, overnight to avoid weekend deliveries. Ship stool with ice 
packs or dry ice, as an etiologic agent
Methodology Conventional PCR, Real-Time PCR
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Enteric Isolation - Primary Specimen
CDC-10106
Test Order
Synonym(s) Enteric Pathogen Culture
Performed on Specimens From Human, Animal, and Food/Environmental/Medical Devices/Biologics
CDC Points of Contact Cheryl Bopp
(404) 639-1798
cab4@cdc.gov
Michele Parsons
(404) 639-1965
zcp9@cdc.gov
Pre-Approval Needed Bopp, Cheryl, (404) 639-1798, cab4@cdc.gov
Parsons, Michele, (404) 639-1965, zcp9@cdc.gov
Supplemental Information
Required
Consult with EDLB contact before sending specimens. Targeted organisms 
include: Salmonella, Shigella, Campylobacter, STEC, pathogenic 
Enterobacteriaceae, Listeria, Vibrio, and related foodborne and waterborne 
pathogens. Provide any preliminary results available.
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Specimens that are acceptable will be determined upon consultation. Targeted 
organisms include: Salmonella, Shigella, Campylobacter, STEC, pathogenic 
Enterobacteriaceae, Listeria, Vibrio, and related foodborne and waterborne 
pathogens.
Minimum Volume Required Not Applicable
Turnaround Time 8 Weeks
Interferences & Limitations None
Storage & Preservation of
Specimen Prior to Shipping
Storage and preservation are dependent upon consultation
Additional lnformation None
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Transport medium is dependent upon consultation
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday, overnight to avoid weekend deliveries
Specifics of shipping will depend upon consultation
Methodology Enrichment, Isolation, Phenotypic Identification (Serotyping), PCR testing for 
virulence markers
 
Monday, January 13, 2014 Page 113 of 380Version: 1.0
Enterovirus Detection and Identification
CDC-10312
Test Order
Synonym(s) Enterovirus (EV), coxsackieviruses (CVA) (CVB), Echovirus
Performed on Specimens From Human, Animal, and Food/Environmental/Medical Devices/Biologics
Pre-Approval Needed None
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Specimens include stool, serum, throat or nasal swab, cerebrospinal fluid (CSF), 
vesicle fluid or lesion, rectal, or nasopharyngeal (NP)/oropharyngeal (OP) swabs.  
Fresh or frozen tissues are preferred to Formalin fixed tissues, but will accept 
both.
Minimum Volume Required Not Applicable
Turnaround Time 10 Days
Interferences & Limitations Collecting specimens during the first week of illness is ideal although the virus 
can be shed in stool for several weeks.  A specimen set collected in the second 
week of illness should include a rectal swab or stool sample.
Storage & Preservation of
Specimen Prior to Shipping
Vesicle fluid, rectal, or nasopharyngeal (NP)/oropharyngeal (OP) swabs: 
Use only sterile Dacron or rayon swabs with plastic shafts or if available, flocked 
swabs. Do NOT use calcium alginate swabs or swabs with wooden sticks, as they 
may contain substances that inactivate some viruses and inhibit some molecular 
assays.  Place the swab immediately into a sterile viral containing 2mL of viral 
transport media without antibiotics, if possible.
Stool: Collect in a clean, dry, leak-proof container.
Serum: For each serum specimen, collect whole blood into a serum separator 
tube (marble or tiger top SST). Allow to clot at room temperature for a minimum 
of 30 minutes and centrifuge.
Additional lnformation Minimum volume for cell culture is 0.5-1 mL, for CSF is 60 uL, and for fresh 
frozen tissues is 2 mm^2. 
Stool:  Stool may be collected within 14 days of symptom onset.  Collect 10-20 g 
of stool in a clean, dry, leak-proof container.
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Viral transport medium. If you do not have viral transport media, place the swab 
into a sterile vial without viral transport media.  Aseptically, cut or break 
applicator sticks off near the tip to permit tightening of the cap.  For NP/OP 
swabs, both swabs can be placed in the same vial, if desired.
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday – Thursday, overnight to avoid weekend deliveries. Frozen 
specimen should be shipped on dry ice and refrigerated specimen should be 
shipped on cold packs, as an etiologic agent.
Include the full name, title, complete mailing address, email address, telephone, 
and fax number of the submitter.  This will be the person to whom the final 
report will be mailed to.
Methodology Molecular techniques
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Enterovirus Detection and Identification
CDC-10312
Test Order
CDC Points of Contact Alan Nix
(404) 639-1689
wbn0@cdc.gov
Steve Oberste
(404) 639-5497
mbo2@cdc.gov
Serum:  For each serum specimen, collect (adults and children > 6kg: 5 mL, 
children <6kg: 2 mL) of whole blood into a serum separator tube (marble or tiger 
top SST). A minimum of 1 mL of whole blood is needed for testing of pediatric 
patients. Allow to clot at room temperature for a minimum of 30 minutes and 
centrifuge.
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Environmental Microbiology Study
CDC-10232
Test Order
Synonym(s) None
Performed on Specimens From Food/Environmental/Medical Devices/Biologics
CDC Points of Contact Judith Noble-Wang
(404) 639-2321
cux2@cdc.gov
Heather O'Connell
(404) 639-4864
ftw2@cdc.gov
Pre-Approval Needed Noble-Wang, Judith, (404) 639-2321, cux2@cdc.gov
O'Connell, Heather, (404) 639-4864, ftw2@cdc.gov
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
To be determined
Minimum Volume Required To be determined
Turnaround Time  
Interferences & Limitations To be determined
Storage & Preservation of
Specimen Prior to Shipping
To be determined
Additional lnformation To be determined
Specimen Labeling To be determined
Transport Medium To be determined
Shipping Instructions which 
Include Specimen Handling 
Requirements
To be determined
Methodology
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Epstein Barr Virus (EBV) Detection
CDC-10265
Test Order
Synonym(s) EBV
Performed on Specimens From Human
CDC Points of Contact Scott Schmid
(404) 639-0066
dss1@cdc.gov
Kay Radford
(404) 639-2192
kjr7@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Saliva, cerebrospinal fluid (CSF) or blood
Minimum Volume Required 200 uL
Turnaround Time 1 Week
Interferences & Limitations None
Storage & Preservation of
Specimen Prior to Shipping
Keep specimen either refrigerated or frozen. Blood should be collected in EDTA 
or citrate tubes.
Additional lnformation None
Specimen Labeling Provide a specimen ID. Do not send specimen labeled with patient’s name.
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship overnight Monday–Thursday, with cold packs or dry ice as an etiologic 
agent.
Methodology Polymerase Chain Reaction (PCR)
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Escherichia and Shigella Identification, Serotyping, and 
Virulence Profiling
CDC-10114
Test Order
Synonym(s) None
Performed on Specimens From Human, Animal, and Food/Environmental/Medical Devices/Biologics
CDC Points of Contact Nancy Strockbine
(404) 639-4186
nas6@cdc.gov
Evangeline Sowers
(404) 639-4372
egs1@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
Prior approval is not required for human specimens; Please call for approval 
prior to sending other specimen types.
Provide any preliminary results available
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Isolates
Minimum Volume Required Not Applicable
Turnaround Time 8 Weeks
Interferences & Limitations Virulence and serotype modification genes encoded by mobile genetic elements 
(bacteriophages, plasmids and pathogenicity islands) may be spontaneously lost 
during transit and storage.  Conditions that induce a stress response in the 
bacterium can affect the stability of virulence factors.
Storage & Preservation of
Specimen Prior to Shipping
Store and ship isolates at ambient temperatures not to exceed 35°C or at 4°C. 
Isolates held for more than a month should be frozen. 
Ship in compliance with Federal and local guidelines. Shiga toxin-positive 
bacteria should be shipped as Category A Infectious Substances.
Additional lnformation Specify type of subtyping requested in 'Previous Laboratory Results' on back of 
form. Epidemiologic metadata, PulseNet cluster code, and PFGE pattern 
designation requested if available.
Turnaround times for routine isolates may be extended during major foodborne 
outbreak activities or due to limited availability of resources.
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Ship cultures on nonselective nutrient or similar agar (TSA, HIA, etc.) in tubes 
with leak-proof screw cap closures.  Agar plates are not acceptable.
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday, overnight to avoid weekend deliveries
Ship at ambient temperature in compliance with Federal and local guidelines. 
Shiga toxin-positive bacteria should be shipped as Category  A Infectious 
Substances.
Methodology Phenotypic Identification, Genetic Identification, Serotyping and Virulence 
Profiling, PCR for STEC and other pathotype-specific virulence genes
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Escherichia and Shigella Study
CDC-10115
Test Order
Synonym(s) None
Performed on Specimens From Human, Animal, and Food/Environmental/Medical Devices/Biologics
CDC Points of Contact Nancy Strockbine
(404) 639-4186
nas6@cdc.gov
Evangeline Sowers
(404) 639-4372
egs1@cdc.gov
Pre-Approval Needed Strockbine, Nancy, (404) 639-4186, nas6@cdc.gov
Sowers, Evangeline, (404) 639-4372, egs1@cdc.gov
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
As directed by study protocol
Minimum Volume Required Not Applicable
Turnaround Time  
Interferences & Limitations Virulence and serotype modification genes encoded by mobile genetic elements 
(bacteriophages, plasmids and pathogenicity islands) may be spontaneously lost 
during transit and storage.  Conditions that induce a stress response in the 
bacterium can affect the stability of virulence factors.
Storage & Preservation of
Specimen Prior to Shipping
Ship as directed by study protocol in compliance with Federal and local 
guidelines. Shiga toxin-positive bacteria should be shipped as Category A 
Infectious Substances.
Additional lnformation None
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship overnight growth on nonselective slant/stab such as TSA, HIA, etc.; screw 
cap tubes preferred or as directed by the study protocol.
Methodology
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Escherichia coli (STEC) serology (not serotyping)
CDC-10452
Test Order
Synonym(s) Enteric Pathogen
Performed on Specimens From Human
CDC Points of Contact Deborah Talkington
(404) 639-3918
dft1@cdc.gov
Jim Pruckler
(404) 639-3816
jmp3@cdc.gov
Pre-Approval Needed Talkington, Deborah, (404) 639-3918, dft1@cdc.gov
Pruckler, Jim, (404) 639-3816, jmp3@cdc.gov
Supplemental Information
Required
Date of illness onset, date of serum collection, clinical diagnosis. Indicate if 
patient has HUS and onset date. If patient has undergone plasmaphoresis 
indicate date on submission form. 
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Paired serum is preferred. Serum is always preferred but plasma is acceptable. 
Do not pool specimens.
Minimum Volume Required 100 uL (More Preferred)
Turnaround Time 3 Months
Interferences & Limitations None
Storage & Preservation of
Specimen Prior to Shipping
Maintain serum at 4°C (preferred); frozen specimens acceptable. 
Additional lnformation Paired serum specimens always preferred. 
Please send one tube per specimen submission form. Submit multiple forms if 
needed. 
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Separate serum from the clot and ship in a sterile labeled tube with the top 
tightly closed
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday, overnight to avoid weekend deliveries. Please notify 
Deborah Talkington (dft1@cdc.gov) and Jim Pruckler (jmp3@cdc.gov) once  
specimens have been shipped to provide the tracking number.
Ship with cold packs in compliance with federal and local guidelines
Methodology EIA
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Escherichia coli and Shigella Subtyping
CDC-10116
Test Order
Synonym(s) E. coli Typing, Shigella Typing
Performed on Specimens From Human, Animal, and Food/Environmental/Medical Devices/Biologics
CDC Points of Contact Nancy Strockbine
(404) 639-4186
nas6@cdc.gov
Evangeline Sowers
(404) 639-4372
egs1@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
Isolates should be identified to the species level by the sender.  Provide any 
preliminary results available. Indicate subtyping method(s) requested on 
specimen submission form
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Isolates
Minimum Volume Required Not Applicable
Turnaround Time 8 Weeks
Interferences & Limitations Virulence and serotype modification genes encoded by mobile genetic elements 
(bacteriophages, plasmids and pathogenicity islands) may be spontaneously lost 
during transit and storage.  Conditions that induce a stress response in the 
bacterium can affect the stability of virulence factors and may affect the 
expression of O and H antigens.
Storage & Preservation of
Specimen Prior to Shipping
Store isolates at ambient temperatures not to exceed 35°C or at 4°C.  Isolates 
held for more than a month should be frozen
Additional lnformation Specify type of subtyping requested in 'Previous Laboratory Results' on back of 
form. Epidemiologic metadata, PulseNet cluster code, and PFGE pattern 
designation requested if available.
Turnaround times for routine isolates may be extended during major foodborne 
outbreak activities or due to limited availability of resources.
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Ship cultures on nonselective nutrient or similar agar (TSA, HIA, etc.) in tubes 
with leak-proof screw cap closures.  Agar plates are not acceptable.
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday, overnight to avoid weekend deliveries
Ship at ambient temperature in compliance with Federal and local guidelines. 
Shiga toxin-positive bacteria should be shipped as Category  A Infectious 
Substances.
Methodology Phenotypic Serotyping, Genetic Serotyping, Virulence Profiling, AST, PFGE, MLVA
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Filariasis Bm 14 IgG4 ELISA
CDC-10462
Test Order
Synonym(s) Brugia malayi, Wuchereria bancrofti; Bancroftian filariasis, parasite
Performed on Specimens From Human
CDC Points of Contact Patricia Wilkins
(404) 718-4101
pma1@cdc.gov
Isabel McAuliffe
(404) 718-4100
ibm4@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
Exposure and travel history, include other relevant risk factors; clinical 
symptoms, treatment and relevant lab results.
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Serum or Plasma
Minimum Volume Required 0.5 mL
Turnaround Time 18 Days
Interferences & Limitations Substances known to interfere with immunoassays include: bilirubin, lipids, and 
hemoglobin 
Storage & Preservation of
Specimen Prior to Shipping
No specific requirements
Additional lnformation None
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday – Thursday, overnight to avoid weekend deliveries. Ship specimen 
at room temperature, not on dry ice, as an etiologic agent.
Methodology EIA, ELISA, Antibody Detection
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Francisella tularensis Culture and Identification
CDC-10313
Test Order
Synonym(s) Tularemia
Performed on Specimens From Human and Animal
CDC Points of Contact Jeannine Petersen
(970) 266-3524
nzp0@cdc.gov
Marty Schriefer
(970) 221-6479
mms7@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
Please include submitting agency, contact name, address, phone number, 
specimen identifier, patient name, specimen source and type, sex and date of 
birth, symptoms of onset, sample collection date, and clinical information 
including type and date of treatment patient has received.
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Human: lymph node aspirate, sputum, bronchial/tracheal wash, pleural fluid, 
blood, ulcer swab, biopsy/autopsy specimens (sections of lymph node, lung, 
liver, spleen); Animal: Necropsy specimen (lymph node, lung, liver or spleen)
Minimum Volume Required Not Applicable
Turnaround Time 3 Weeks
Interferences & Limitations Samples for testing by culture should be taken prior to antibiotic treatment
Storage & Preservation of
Specimen Prior to Shipping
Store specimens containing suspected live bacteria at 2°-8°C to maintain 
viability. If processing is delayed, tissue samples can be directly frozen at -70°C. 
Store samples for culture of live bacteria without preservatives (formaldehyde, 
alcohol), at 2°-8°C (not frozen). Anticoagulants such as heparin, citrate and EDTA 
are acceptable because they do not inhibit the viability of bacteria.
Additional lnformation None
Specimen Labeling Specimen identifier and patient name
Transport Medium Respiratory specimens, lymph node aspirates, blood, 
tissue/biopsy/autopsy/necropsy specimens should all be transported at 4°C. 
Swabs must be in a Cary-Blair or Amies medium, not frozen. If tissue 
biopsy/autopsy/necropsy transport is delayed, tissue samples can be directly 
frozen at -70°C.
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday, overnight to avoid weekend deliveries. All packages 
must be addressed to:
Centers for Disease Control and Prevention
Bacterial Diseases Branch
Attn: John Young
3156 Rampart Road
Fort Collins, CO 80521
Frozen specimen should be shipped on dry ice
Refrigerated specimen should be shipped on ice packs
Methodology Culture, Direct Fluorescent Antibody (DFA), Biochemical subtyping
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Francisella tularensis Serology
CDC-10314
Test Order
Synonym(s) Tularemia
Performed on Specimens From Human and Animal
CDC Points of Contact Jeannine Petersen
(970) 266-3524
nzp0@cdc.gov
Marty Schriefer
(970) 221-6479
mms7@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
Please include submitting agency, contact name, address, phone number, 
specimen identifier, patient name, specimen source and type, sex and date of 
birth, symptoms of onset, sample collection date, and clinical information 
including type and date of treatment patient has received.
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Serum
Minimum Volume Required 500 uL
Turnaround Time 2 Weeks
Interferences & Limitations Hemolyzed samples interfere with test results
Storage & Preservation of
Specimen Prior to Shipping
Sera may be stored at 2°-8°C for up to 14 days. If testing is delayed for a longer 
period, serum samples may be frozen.
Additional lnformation None
Specimen Labeling Specimen identifier and patient name
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday, overnight to avoid weekend deliveries. All packages 
must be addressed to:
Centers for Disease Control and Prevention
Bacterial Diseases Branch
Attn: John Young
3156 Rampart Road
Fort Collins, CO 80521
Frozen specimen should be shipped on dry ice
Refrigerated specimen should be shipped on ice packs
Methodology Microagglutination
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Francisella tularensis Special Study
CDC-10315
Test Order
Synonym(s) None
Performed on Specimens From Human and Animal
CDC Points of Contact Jeannine Petersen
(970) 266-3524
nzp0@cdc.gov
Marty Schriefer
(970) 221-6479
mms7@cdc.gov
Pre-Approval Needed Petersen, Jeannine, (970) 266-3524, nzp0@cdc.gov
Schriefer, Marty, (970) 221-6479, mms7@cdc.gov
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
To be determined
Minimum Volume Required To be determined
Turnaround Time  
Interferences & Limitations To be determined
Storage & Preservation of
Specimen Prior to Shipping
To be determined
Additional lnformation To be determined
Specimen Labeling To be determined
Transport Medium To be determined
Shipping Instructions which 
Include Specimen Handling 
Requirements
To be determined
Methodology
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Fungal Identification
CDC-10179
Test Order
Synonym(s) Fungal identification, mold identification, yeast identification
Performed on Specimens From Human, Animal, and Food/Environmental/Medical Devices/Biologics
CDC Points of Contact Mary Brandt
(404) 639-0281
mbb4@cdc.gov
Shawn Lockhart
(404) 639-2569
gyi2@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Pure culture isolate
Minimum Volume Required Not Applicable
Turnaround Time 4 Weeks
Interferences & Limitations None
Storage & Preservation of
Specimen Prior to Shipping
Isolates can be refrigerated or kept at an ambient temperature
Additional lnformation None
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Isolates should be on a suitable agar slant
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday, overnight to avoid weekend deliveries
Specimen should be shipped at ambient temperature
Methodology Phenotypic Testing, DNA Sequencing
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Fungal Serology - Basidiobolus
CDC-10183
Test Order
Synonym(s) Fungal serology; fungal complement fixation; fungal immunodiffusion
Performed on Specimens From Human and Animal
CDC Points of Contact Mary Brandt
(404) 639-0281
mbb4@cdc.gov
Mark Lindsley
(404) 639-4340
mil6@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Serum; CSF. Plasma is not accepted
Minimum Volume Required 0.5 mL
Turnaround Time 2 Weeks
Interferences & Limitations Hemolysis and lipidemia may interfere with the test results
Storage & Preservation of
Specimen Prior to Shipping
Specimens should be kept either refrigerated or frozen
Additional lnformation Serum should be prepared as soon as possible after drawing blood to prevent 
hemolysis
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday, overnight to avoid weekend deliveries
Refrigerated specimen at 4°C should be shipped on cold packs
Frozen specimen should be shipped on dry ice
Methodology Complement Fixation, Immunodiffusion
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Fungal Serology - Histoplasma, Blastomyces, Coccidioides
CDC-10180
Test Order
Synonym(s) Fungal serology, fungal complement fixation, fungal immunodiffusion
Performed on Specimens From Human and Animal
CDC Points of Contact Mary Brandt
(404) 639-0281
mbb4@cdc.gov
Mark Lindsley
(404) 639-4340
mil6@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Serum; CSF. Plasma is not accepted
Minimum Volume Required 0.5 mL
Turnaround Time 4 Weeks
Interferences & Limitations Hemolysis and lipidemia may interfere with the test results
Storage & Preservation of
Specimen Prior to Shipping
Specimens should be kept either refrigerated or frozen
Additional lnformation Serum should be prepared as soon as possible after drawing blood to prevent 
hemolysis
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday, overnight to avoid weekend deliveries
Refrigerated specimen at 4°C should be shipped on cold packs
Frozen specimen should be shipped on dry ice
Methodology Complement Fixation, Immunodiffusion
Shawn Lockhart
(404) 639-2569
gyi2@cdc.gov
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Fungal Serology - Paracoccidioides
CDC-10184
Test Order
Synonym(s) Fungal serology; fungal complement fixation; fungal immunodiffusion
Performed on Specimens From Human and Animal
CDC Points of Contact Mary Brandt
(404) 639-0281
mbb4@cdc.gov
Mark Lindsley
(404) 639-4340
mil6@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Serum; CSF. Plasma is not accepted
Minimum Volume Required 0.5 mL
Turnaround Time 4 Weeks
Interferences & Limitations Hemolysis and lipidemia may interfere with the test results
Storage & Preservation of
Specimen Prior to Shipping
Specimens should be kept either refrigerated or frozen
Additional lnformation Serum should be prepared as soon as possible after drawing blood to prevent 
hemolysis
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday, overnight to avoid weekend deliveries
Refrigerated specimen at 4°C should be shipped on cold packs
Frozen specimen should be shipped on dry ice
Methodology Complement Fixation, Immunodiffusion
Shawn Lockhart
(404) 639-2569
gyi2@cdc.gov
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Fungal Serology - Sporothrix
CDC-10182
Test Order
Synonym(s) Fungal serology, fungal complement fixation, fungal immunodiffusion, latex 
agglutination for Sporothrix
Performed on Specimens From Human and Animal
CDC Points of Contact Mary Brandt
(404) 639-0281
mbb4@cdc.gov
Mark Lindsley
(404) 639-4340
mil6@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Serum; CSF. Plasma is not accepted
Minimum Volume Required 0.5 mL
Turnaround Time 2 Weeks
Interferences & Limitations Hemolysis and lipidemia may interfere with the test results
Storage & Preservation of
Specimen Prior to Shipping
Specimens should be kept either refrigerated or frozen
Additional lnformation Serum should be prepared as soon as possible after drawing blood to prevent 
hemolysis
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday, overnight to avoid weekend deliveries
Refrigerated specimen at 4°C should be shipped on cold packs
Frozen specimen should be shipped on dry ice
Methodology Complement Fixation, Immunodiffusion, Latex Agglutination
Shawn Lockhart
(404) 639-2569
gyi2@cdc.gov
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Fungal Study
CDC-10181
Test Order
Synonym(s) None
Performed on Specimens From Human and Animal
CDC Points of Contact Shawn Lockhart
(404) 639-2569
gyi2@cdc.gov
Mary Brandt
(404) 639-0281
mbb4@cdc.gov
Pre-Approval Needed Lockhart, Shawn, (404) 639-2569, gyi2@cdc.gov
Brandt, Mary, (404) 639-0281, mbb4@cdc.gov
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Not Applicable
Minimum Volume Required Not Applicable
Turnaround Time  
Interferences & Limitations To be determined
Storage & Preservation of
Specimen Prior to Shipping
To be determined
Additional lnformation None
Specimen Labeling To be determined
Transport Medium To be determined
Shipping Instructions which 
Include Specimen Handling 
Requirements
To be determined
Methodology
 
Monday, January 13, 2014 Page 131 of 380Version: 1.0
Gastroenteritis Virus Special Study
CDC-10316
Test Order
Synonym(s) None
Performed on Specimens From Human
CDC Points of Contact Jan Vinje
(404) 639-3721
ahx8@cdc.gov
Nicole Gregoricus
(404) 639-1923
frv6@cdc.gov
Pre-Approval Needed Vinje, Jan, (404) 639-3721, ahx8@cdc.gov
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
To be determined
Minimum Volume Required To be determined
Turnaround Time  
Interferences & Limitations To be determined
Storage & Preservation of
Specimen Prior to Shipping
To be determined
Additional lnformation To be determined
Specimen Labeling To be determined
Transport Medium To be determined
Shipping Instructions which 
Include Specimen Handling 
Requirements
To be determined
Methodology
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Genital Ulcer Disease (Syphilis, Chancroid, Herpes) Molecular 
Detection
CDC-10174
Test Order
Synonym(s) GUD
Performed on Specimens From Human
CDC Points of Contact Cheng Chen
(404) 639-3154
cyc1@cdc.gov
Kai Chi
(404) 639-0694
krc2@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Ulcer swabs, FFPE tissues or frozen tissues, and aspirates from ulcer or buboes
Minimum Volume Required Not Applicable
Turnaround Time 2 Weeks
Interferences & Limitations None
Storage & Preservation of
Specimen Prior to Shipping
FFPE can be kept at room temperature and swabs and other specimens should be 
kept frozen
Additional lnformation None
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Nucleic Acid Amplification Test (NAAT) commercial transport medium, PBS, 
Saline or TRIS buffer
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday – Thursday, overnight to avoid weekend deliveries. Ship FFPE at 
room temperature and frozen specimen should be shipped on dry ice, as an 
etiologic agent.
Methodology PCR
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Gram Negative Bacillus (Non-enteric/Nonfermenter) ID
CDC-10135
Test Order
Synonym(s) GNR, Gram Negative Rod
Performed on Specimens From Human and Food/Environmental/Medical Devices/Biologics
CDC Points of Contact John McQuiston
(404) 639-0270
zje8@cdc.gov
Anne Whitney
(404) 639-1374
amw0@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
Please notify laboratory prior to shipment if this is a critical care specimen
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Pure culture isolate on a suitable agar slant medium; Consultation required for 
other sample/specimen types
Minimum Volume Required Not Applicable
Turnaround Time 3 Weeks
Interferences & Limitations The 3 week turnaround time applies to all tests unless biochemical and/or 
phenotypic analysis are required, which could take up to 2 months for test 
results.
Storage & Preservation of
Specimen Prior to Shipping
Keep specimen refrigerated if unable to ship immediately
Additional lnformation If available, please provide patient history including if the patient has used a 
catheter and/or if the patient is immunocompromised.
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship specimen Monday-Thursday, overnight to avoid weekend deliveries
Methodology Primary Culture based on specimen type, MALDI-TOF, 16S sequence based 
identification
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Gram Negative Coccus (Not GC or meningococcus) ID
CDC-10138
Test Order
Synonym(s) Neisseria Identification, GNC
Performed on Specimens From Human and Food/Environmental/Medical Devices/Biologics
CDC Points of Contact John McQuiston
(404) 639-0270
zje8@cdc.gov
Anne Whitney
(404) 639-1374
amw0@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
Please notify laboratory prior to shipment if this is a critical care specimen
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Pure culture isolate on a suitable agar slant medium; Consultation required for 
other sample/specimen types
Minimum Volume Required Not Applicable
Turnaround Time 3 Weeks
Interferences & Limitations The 3 week turnaround time applies to all tests unless biochemical and/or 
phenotypic analysis are required, which could take up to 2 months for test 
results.
Storage & Preservation of
Specimen Prior to Shipping
Keep specimen refrigerated if unable to ship immediately
Additional lnformation If available, please provide patient history including if the patient has used a 
catheter and/or if the patient is immunocompromised.
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship specimen Monday-Thursday, overnight to avoid weekend deliveries
Methodology Primary Culture based on specimen type, MALDI-TOF, 16S sequence based 
identification
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Gram Positive Bacillus ID
CDC-10137
Test Order
Synonym(s) Gram Positive Rod Identification, GPB, GPR
Performed on Specimens From Human and Food/Environmental/Medical Devices/Biologics
CDC Points of Contact John McQuiston
(404) 639-0270
zje8@cdc.gov
Anne Whitney
(404) 639-1374
amw0@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
Please notify laboratory prior to shipment if this is a critical care specimen
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Pure culture isolate on a suitable agar slant medium; Consultation required for 
other sample/specimen types
Minimum Volume Required Not Applicable
Turnaround Time 3 Weeks
Interferences & Limitations The 3 week turnaround time applies to all tests unless biochemical and/or 
phenotypic analysis are required, which could take up to 2 months for test 
results.
Storage & Preservation of
Specimen Prior to Shipping
Keep specimen refrigerated if unable to ship immediately
Additional lnformation If available, please provide patient history including if the patient has used a 
catheter and/or if the patient is immunocompromised.
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship specimen Monday-Thursday, overnight to avoid weekend deliveries
Methodology Primary Culture based on specimen type, MALDI-TOF, 16S sequence based 
identification
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Haemophilus influenzae Identification and Serotyping
CDC-10221
Test Order
Synonym(s) H. influenzae ID and SAST, H. flu
Performed on Specimens From Human
CDC Points of Contact Xin Wang
(404) 639-5474
gqe8@cdc.gov
Jordan Theodore
(404) 639-0230
ale7@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Pure culture isolate, frozen stock, and primary specimen such as CSF, whole 
blood, serum, and other sterile site specimen types upon consultation
Minimum Volume Required 0.25 mL
Turnaround Time 30 Days
Interferences & Limitations Improperly temperature controlled specimens can give a false negative PCR 
result
Storage & Preservation of
Specimen Prior to Shipping
Keep slants at an ambient temperature. Primary specimens or stocks should be 
kept frozen.
Additional lnformation None
Specimen Labeling Please include either patient name, medical record, hospital or state ID or ABCs 
state ID or accession number
Transport Medium Transport on chocolate agar slants is preferred (plates are not recommended) or 
frozen stock
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday overnight to avoid weekend deliveries
Any frozen specimen should be shipped on dry ice
Methodology Growth, Morphology, Biochemical Testing, Slide Agglutination Serotyping, Real-
time PCR
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Haemophilus influenzae Study
CDC-10222
Test Order
Synonym(s) None
Performed on Specimens From Human
CDC Points of Contact Leonard Mayer
(404) 639-2841
lwm1@cdc.gov
Amanda Cohn
(404) 639-6039
anc0@cdc.gov
Pre-Approval Needed Mayer, Leonard, (404) 639-2841, lwm1@cdc.gov
Cohn, Amanda, (404) 639-6039, anc0@cdc.gov
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
To be determined
Minimum Volume Required To be determined
Turnaround Time  
Interferences & Limitations To be determined
Storage & Preservation of
Specimen Prior to Shipping
To be determined
Additional lnformation To be determined
Specimen Labeling To be determined
Transport Medium To be determined
Shipping Instructions which 
Include Specimen Handling 
Requirements
To be determined
Methodology
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Haemophilus species (Not H. influenzae/H. ducreyi) ID
CDC-10141
Test Order
Synonym(s) None
Performed on Specimens From Human and Food/Environmental/Medical Devices/Biologics
CDC Points of Contact John McQuiston
(404) 639-0270
zje8@cdc.gov
Anne Whitney
(404) 639-1374
amw0@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
Please notify laboratory prior to shipment if this is a critical care specimen
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Pure culture isolate on a suitable agar slant medium; Consultation required for 
other sample/specimen types
Minimum Volume Required Not Applicable
Turnaround Time 3 Weeks
Interferences & Limitations The 3 week turnaround time applies to all tests unless biochemical and/or 
phenotypic analysis are required, which could take up to 2 months for test 
results.
Storage & Preservation of
Specimen Prior to Shipping
Keep specimen refrigerated if unable to ship immediately
Additional lnformation If available, please provide patient history including if the patient has used a 
catheter and/or if the patient is immunocompromised.
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship specimen Monday-Thursday, overnight to avoid weekend deliveries
Methodology Biochemical analysis Primary Culture based on specimen type, MALDI-TOF, 16S 
sequence based identification
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Hantavirus (No. American) Identification
CDC-10319
Test Order
Synonym(s) Hanta, HPS, HFRS
Performed on Specimens From Human and Animal
CDC Points of Contact Ute Stroeher
(404) 639-4704
ixy8@cdc.gov
Barbara Knust
(404) 639-1104
bkk0@cdc.gov
Pre-Approval Needed Stroeher, Ute, (404) 639-4704, ixy8@cdc.gov
Knust, Barbara, (404) 639-1104, bkk0@cdc.gov
Supplemental Information
Required
See Supplemental Form
Supplemental Form http://www.cdc.gov/ncezid/dhcpp/vspb/pdf/specimen-submission.pdf
Acceptable Sample/ Specimen 
Type for Testing
Frozen tissue, blood, and serum
Minimum Volume Required 1 mL
Turnaround Time 10 Days
Interferences & Limitations Specimen must remain frozen; warming or freeze thawing reduces sensitivity. 
Heparin may cause interference with the molecular tests and should be avoided.
Storage & Preservation of
Specimen Prior to Shipping
Specimen must be placed in plastic screw capped vials, frozen to -70°C, and kept 
frozen until shipment. See link to supplemental submission form for specific 
information on various specimen types.
Additional lnformation Critical specimens will take less than 4 days to turn around. See link to 
supplemental submission forms for detailed information.
Specimen Labeling Patient name, patient ID #, specimen type, date collected
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday overnight to avoid weekend deliveries. Specimen should 
be shipped frozen on dry ice. See supplemental submission forms for further 
details. Do not ship specimen without prior consultation and approval.
Methodology Molecular Typing, Polymerase Chain Reaction (PCR)
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Hantavirus (So. American) Identification
CDC-10320
Test Order
Synonym(s) Hanta, HPS, HFRS
Performed on Specimens From Human and Animal
CDC Points of Contact Ute Stroeher
(404) 639-4704
ixy8@cdc.gov
Barbara Knust
(404) 639-1104
bkk0@cdc.gov
Pre-Approval Needed Stroeher, Ute, (404) 639-4704, ixy8@cdc.gov
Knust, Barbara, (404) 639-1104, bkk0@cdc.gov
Supplemental Information
Required
See Supplemental Form
Supplemental Form http://www.cdc.gov/ncezid/dhcpp/vspb/pdf/specimen-submission.pdf
Acceptable Sample/ Specimen 
Type for Testing
Frozen tissue, blood, serum
Minimum Volume Required 1 mL
Turnaround Time 10 Days
Interferences & Limitations Specimen must remain frozen; warming or freeze thawing reduces sensitivity. 
Heparin may cause interference with the molecular tests and should be avoided.
Storage & Preservation of
Specimen Prior to Shipping
Specimen must be placed in plastic screw capped vials, frozen to -70°C, and kept 
frozen until shipment. See link to supplemental submission form for specific 
information on various specimen types.
Additional lnformation Critical specimens will take less than 4 days to turn around. See link to 
supplemental submission forms for detailed information.
Specimen Labeling Patient name, patient ID #, specimen type, date collected
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday overnight to avoid weekend deliveries. Specimen should 
be shipped frozen on dry ice. See supplemental submission forms for further 
details. Do not ship specimen without prior consultation and approval.
Methodology Molecular Testing, Polymerase Chain Reaction (PCR)
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Hantavirus Serology
CDC-10321
Test Order
Synonym(s) Hanta, HPS, HFRS, Hantaan
Performed on Specimens From Human and Animal
CDC Points of Contact Ute Stroeher
(404) 639-4704
ixy8@cdc.gov
Barbara Knust
(404) 639-1104
bkk0@cdc.gov
Pre-Approval Needed Stroeher, Ute, (404) 639-4704, ixy8@cdc.gov
Knust, Barbara, (404) 639-1104, bkk0@cdc.gov
Supplemental Information
Required
See Supplemental Form
Supplemental Form http://www.cdc.gov/ncezid/dhcpp/vspb/pdf/specimen-submission.pdf
Acceptable Sample/ Specimen 
Type for Testing
Blood and serum
Minimum Volume Required 1 mL
Turnaround Time 10 Days
Interferences & Limitations None
Storage & Preservation of
Specimen Prior to Shipping
Specimen must be kept cold (at or below 4°C). If possible place specimen in 
plastic screw capped vials. See link to supplemental submission form for specific 
information on various specimen types.
Additional lnformation Critical specimens will take less than 4 days to turn around. See link to 
supplemental submission forms for detailed information.
Specimen Labeling Patient name, patient ID #, specimen type, date collected
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday overnight to avoid weekend deliveries. Specimen should 
be shipped on cold packs or dry ice if frozen. See supplemental submission 
forms for further details. Do not ship specimen without prior consultation and 
approval.
Methodology ELISA
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Healthcare-associated Outbreak Identification and Typing
CDC-10162
Test Order
Synonym(s) Healthcare Outbreak or Nosocomial Outbreak
Performed on Specimens From Human and Food/Environmental/Medical Devices/Biologics
CDC Points of Contact Heather O'Connell
(404) 639-4864
ftw2@cdc.gov
Judith Noble-Wang
(404) 639-2321
cux2@cdc.gov
Pre-Approval Needed Noble-Wang, Judith, (404) 639-2321, cux2@cdc.gov
O'Connell, Heather, (404) 639-4864, ftw2@cdc.gov
Supplemental Information
Required
Supplemental Line List required contact laboratory for more information
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Pure culture isolates and primary environmental specimen (swabs, wipes, water 
and other fluids, medical devices). In addition, fluids and products used for 
patient care.
Minimum Volume Required Not Applicable
Turnaround Time 8 Weeks
Interferences & Limitations Holding environmental samples at room temperature >1 hour after collection 
may decrease recovery. Neutralization of chlorine residual in potable water is 
necessary during collection.
Storage & Preservation of
Specimen Prior to Shipping
Keep specimen at a refrigerated temperature until ready for shipping
Additional lnformation For most bacteria the turnaround time will be around 3 weeks whereas 
nontuberculosis mycobacteria will take up to 8 weeks. 
Criteria for submission: 
-If healthcare facility will be submitting samples directly to CDC then must 
receive prior approval from State Health Department. Provide State Health 
Department contact information
-State Health Department is investigating a healthcare-associated outbreak
-Consultation with CDC/DHQP Prevention and Response Branch on 
epidemiological investigation. Contact phone number: 404-639-4000
-Prior to submitting samples, CDC Consultation regarding epidemiological 
investigation revealed the potential role of the environment in transmission of 
infections.
Specimen Labeling No patient identifiers. Please include specimen identifiers on Line List
Transport Medium Use an agar slant not a agar plate for isolates
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship isolates at ambient temperatures and ship environmental specimens on 
cold-packs. Ship overnight, Monday through Thursday, for delivery within 24 
hours of collection.
Methodology IgG Antibody detected by EIA
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Helicobacter pylori Special Study
CDC-10117
Test Order
Synonym(s) None
Performed on Specimens From Human, Animal, and Food/Environmental/Medical Devices/Biologics
CDC Points of Contact Karen Rudolph
(907) 729-3454
kmr2@cdc.gov
Pre-Approval Needed Rudolph, Karen, (907) 729-3454, kmr2@cdc.gov
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
To be determined
Minimum Volume Required To be determined
Turnaround Time  
Interferences & Limitations To be determined
Storage & Preservation of
Specimen Prior to Shipping
To be determined
Additional lnformation To be determined
Specimen Labeling To be determined
Transport Medium To be determined
Shipping Instructions which 
Include Specimen Handling 
Requirements
To be determined
Methodology
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Hendra Serology
CDC-10324
Test Order
Synonym(s) None
Performed on Specimens From Human and Animal
CDC Points of Contact Ute Stroeher
(404) 639-4704
ixy8@cdc.gov
Barbara Knust
(404) 639-1104
bkk0@cdc.gov
Pre-Approval Needed Stroeher, Ute, (404) 639-4704, ixy8@cdc.gov
Knust, Barbara, (404) 639-1104, bkk0@cdc.gov
Supplemental Information
Required
See Supplemental Form
Supplemental Form http://www.cdc.gov/ncezid/dhcpp/vspb/pdf/specimen-submission.pdf
Acceptable Sample/ Specimen 
Type for Testing
Blood and serum
Minimum Volume Required 1 mL
Turnaround Time 10 Days
Interferences & Limitations Specimen must remain frozen; warming or freeze thawing reduces sensitivity
Storage & Preservation of
Specimen Prior to Shipping
Specimen must be kept cold (at or below 4°C). If possible place specimen in 
plastic screw capped vials. See link to supplemental submission form for specific 
information on various specimen types.
Additional lnformation Critical specimens will take less than 4 days to turn around. See link to 
supplemental submission forms for detailed information.
Specimen Labeling Patient name, patient ID #, specimen type, date collected
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday overnight to avoid weekend deliveries. Specimen should 
be shipped on cold packs or dry ice if frozen. See supplemental submission 
forms for further details. Do not ship specimen without prior consultation and 
approval.
Methodology ELISA
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Hepatitis A Serology, NAT and Genotyping
CDC-10325
Test Order
Synonym(s) HAV, Hepatitis A virus
Performed on Specimens From Human and Food/Environmental/Medical Devices/Biologics
CDC Points of Contact Jan Drobeniuc
(404) 639-3790
jqd6@cdc.gov
Saleem Kamili
(404) 639-4431
sek6@cdc.gov
Pre-Approval Needed Drobeniuc, Jan, (404) 639-3790, jqd6@cdc.gov
Kamili, Saleem, (404) 639-4431, sek6@cdc.gov
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Serum, plasma, stool
Minimum Volume Required 1.5 mL
Turnaround Time 1 Week
Interferences & Limitations Hemolyzed specimen are not accepted
Storage & Preservation of
Specimen Prior to Shipping
Specimens should be stored frozen
Additional lnformation NAT based assays and genotyping may take up to 3 weeks for turn around time
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship specimen Monday -Thursday overnight to avoid weekend deliveries
Frozen specimen should be shipped on dry ice
Methodology Total anti-HAV by Chemiluminescence, IgM anti-HAV by Chemiluminescence, 
HAV RNA, HAV Genotyping by NAT P2B Sequencing
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Hepatitis B Serology, NAT and Genotyping
CDC-10326
Test Order
Synonym(s) HBV, Hepatitis B virus
Performed on Specimens From Human
CDC Points of Contact Jan Drobeniuc
(404) 639-3790
jqd6@cdc.gov
Saleem Kamili
(404) 639-4431
sek6@cdc.gov
Pre-Approval Needed Drobeniuc, Jan, (404) 639-3790, jqd6@cdc.gov
Kamili, Saleem, (404) 639-4431, sek6@cdc.gov
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Serum, plasma, stool
Minimum Volume Required 2 mL
Turnaround Time 1 Week
Interferences & Limitations Hemolyzed specimen are not accepted
Storage & Preservation of
Specimen Prior to Shipping
Specimens should be stored frozen
Additional lnformation NAT based assays and genotyping may take up to 3 weeks for turn around time
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship specimen Monday -Thursday overnight to avoid weekend deliveries
Frozen specimen should be shipped on dry ice
Methodology HBsAg by EIA, IgM anti-HBc by Chemiluminescence, Total anti-HBc by 
Chemiluminescence, Anti-HBs by Chemiluminescence, HBeAg by 
Chemiluminescence, Anti-Hbe by EIA, HBV DNA by TaqMan IVD, HBV Genotyping 
by NAT S Gene Sequencing
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Hepatitis B Surface Antigen Confirmatory Test
CDC-10451
Test Order
Synonym(s) HBV, Hepatitis B virus
Performed on Specimens From Human
CDC Points of Contact Jan Drobenuic
(404) 639-3790
jqd6@cdc.gov
Saleem Kamili
(404) 639-4431
sek0@cdc.gov
Pre-Approval Needed Drobenuic, Jan, (404) 639-3790, jqd6@cdc.gov
Kamili, Saleem, (404) 639-4431, sek6@cdc.gov
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Serum, Plasma (Serum Preferred)
Minimum Volume Required 300uL
Turnaround Time 10 Days
Interferences & Limitations Do not send whole blood or hemolyzed serum
Storage & Preservation of
Specimen Prior to Shipping
Specimens should be stored frozen at -20°C
Additional lnformation None
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition
Transport Medium None
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship specimen Monday -Thursday overnight to avoid weekend deliveries
Frozen specimen should be shipped on cold packs
Methodology Neutralization
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Hepatitis C Serology, NAT and Genotyping
CDC-10327
Test Order
Synonym(s) HCV, Hepatitis C virus
Performed on Specimens From Human
CDC Points of Contact Jan Drobeniuc
(404) 639-3790
jqd6@cdc.gov
Saleem Kamili
(404) 639-4431
sek6@cdc.gov
Pre-Approval Needed Drobeniuc, Jan, (404) 639-3790, jqd6@cdc.gov
Kamili, Saleem, (404) 639-4431, sek6@cdc.gov
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Plasma and serum
Minimum Volume Required 2 mL
Turnaround Time 1 Week
Interferences & Limitations Hemolyzed specimen are not accepted
Storage & Preservation of
Specimen Prior to Shipping
Specimens should be stored frozen
Additional lnformation NAT based assays and genotyping may take up to 3 weeks for turn around time
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship specimen Monday -Thursday overnight to avoid weekend deliveries
Frozen specimen should be shipped on dry ice
Methodology Anti-HCV by Chemiluminescence, HCV RNA by TaqMan IVD, HCV Genotyping by 
NAT NS5B Gene Sequencing
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Hepatitis D Serology, NAT and Genotyping
CDC-10328
Test Order
Synonym(s) HDV, Hepatitis D virus
Performed on Specimens From Human
CDC Points of Contact Jan Drobeniuc
(404) 639-3790
jqd6@cdc.gov
Saleem Kamili
(404) 639-4431
sek6@cdc.gov
Pre-Approval Needed Drobeniuc, Jan, (404) 639-3790, jqd6@cdc.gov
Kamili, Saleem, (404) 639-4431, sek6@cdc.gov
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Plasma and serum
Minimum Volume Required 2 mL
Turnaround Time 2 Weeks
Interferences & Limitations Hemolyzed specimen are not accepted
Storage & Preservation of
Specimen Prior to Shipping
Specimens should be stored frozen
Additional lnformation NAT based assays and genotyping may take up to 3 weeks for turn around time
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship specimen Monday -Thursday overnight to avoid weekend deliveries
Frozen specimen should be shipped on dry ice
Methodology Total anti-HDV by EIA, HDV RNA by Real Time qRT-PCR, HDV Genotyping by 
direct sequence analysis
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Hepatitis E Serology, NAT and Genotyping
CDC-10329
Test Order
Synonym(s) HEV, Hepatitis E virus
Performed on Specimens From Human and Food/Environmental/Medical Devices/Biologics
CDC Points of Contact Jan Drobeniuc
(404) 639-3790
jqd6@cdc.gov
Saleem Kamili
(404) 639-4431
sek6@cdc.gov
Pre-Approval Needed Drobeniuc, Jan, (404) 639-3790, jqd6@cdc.gov
Kamili, Saleem, (404) 639-4431, sek6@cdc.gov
Supplemental Information
Required
See Supplemental Form
Supplemental Form http://www.cdc.gov/hepatitis/HEV/LabTestingRequests.htm
Acceptable Sample/ Specimen 
Type for Testing
Serum, plasma, and stool
Minimum Volume Required 2 mL
Turnaround Time 2 Weeks
Interferences & Limitations Hemolyzed specimen are not accepted
Storage & Preservation of
Specimen Prior to Shipping
Specimens should be stored frozen
Additional lnformation NAT based assays and genotyping may take up to 3 weeks for turn around time
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship specimen Monday -Thursday overnight to avoid weekend deliveries
Frozen specimen should be shipped on dry ice
Methodology IgM anti-HEV by EIA, IgG anti-HEV by EIA, HEV RNA by Real Time qRT-PCR, HEV 
Genotyping by direct sequence analysis
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Hepatitis Outbreak Investigation
CDC-10330
Test Order
Synonym(s) HAV, HBV, HCV, HDV, HEV, Hepatitis A virus, Hepatitis B virus, Hepatitis C virus, 
Hepatitis D virus, Hepatitis E virus
Performed on Specimens From Human, Animal, and Food/Environmental/Medical Devices/Biologics
CDC Points of Contact Jan Drobeniuc
(404) 639-3790
jqd6@cdc.gov
Saleem Kamili
(404) 639-4431
sek6@cdc.gov
Pre-Approval Needed Drobeniuc, Jan, (404) 639-3790, jqd6@cdc.gov
Kamili, Saleem, (404) 639-4431, sek6@cdc.gov
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Not Applicable
Minimum Volume Required Not Applicable
Turnaround Time  
Interferences & Limitations None
Storage & Preservation of
Specimen Prior to Shipping
No Specific Requirements
Additional lnformation None
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
None
Methodology
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Hepatitis Special Study
CDC-10331
Test Order
Synonym(s) None
Performed on Specimens From Human, Animal, and Food/Environmental/Medical Devices/Biologics
CDC Points of Contact Jan Drobeniuc
(404) 639-3790
jqd6@cdc.gov
Saleem Kamili
(404) 639-4431
sek6@cdc.gov
Pre-Approval Needed Drobeniuc, Jan, (404) 639-3790, jqd6@cdc.gov
Kamili, Saleem, (404) 639-4431, sek6@cdc.gov
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
To be determined
Minimum Volume Required To be determined
Turnaround Time  
Interferences & Limitations To be determined
Storage & Preservation of
Specimen Prior to Shipping
To be determined
Additional lnformation To be determined
Specimen Labeling To be determined
Transport Medium To be determined
Shipping Instructions which 
Include Specimen Handling 
Requirements
None
Methodology
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Herpes Simplex Virus 1 Detection
CDC-10258
Test Order
Synonym(s) Oral herpes
Performed on Specimens From Human
CDC Points of Contact Scott Schmid
(404) 639-0066
dss1@cdc.gov
Kay Radford
(404) 639-2192
kjr7@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Skin lesion, cerebrospinal fluid (CSF) or saliva
Minimum Volume Required 200 uL (saliva)
Turnaround Time 2 Days
Interferences & Limitations None
Storage & Preservation of
Specimen Prior to Shipping
Skin lesions should be kept dry and saliva can be kept either refrigerated or 
frozen.
Additional lnformation None
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship specimen Monday-Thursday, overnight on cold packs or dry ice. Skin 
lesions should be shipped dry. Ship as an etiologic agent.
See standard shipping instructions for biologic agent
Methodology Polymerase Chain Reaction (PCR)
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Herpes Simplex Virus 1 Serology
CDC-10259
Test Order
Synonym(s) Oral herpes
Performed on Specimens From Human
CDC Points of Contact Scott Schmid
(404) 639-0066
dss1@cdc.gov
Kay Radford
(404) 639-2192
kjr7@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Serum, plasma, or cerebrospinal fluid (CSF)
Minimum Volume Required 200 uL
Turnaround Time 2 Days
Interferences & Limitations None
Storage & Preservation of
Specimen Prior to Shipping
Keep specimen either refrigerated or frozen.
Additional lnformation None
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship overnight Monday–Thursday, with cold packs or dry ice as an etiologic 
agent.
Methodology IgG antibody detected by EIA
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Herpes Simplex Virus 2 Detection
CDC-10260
Test Order
Synonym(s) Genital herpes
Performed on Specimens From None
CDC Points of Contact Scott Schmid
(404) 639-0066
dss1@cdc.gov
Kay Radford
(404) 639-2192
kjr7@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Skin lesion, cerebrospinal fluid (CSF) or saliva
Minimum Volume Required 200 uL (saliva)
Turnaround Time 2 Days
Interferences & Limitations None
Storage & Preservation of
Specimen Prior to Shipping
Keep specimen either refrigerated or frozen. Skin lesions should be kept dry.
Additional lnformation None
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship specimen Monday-Thursday, overnight on cold packs or dry ice. Skin 
lesions should be shipped dry. Ship as an etiologic agent.
Methodology Polymerase Chain Reaction (PCR)
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Herpes Simplex Virus 2 Serology
CDC-10261
Test Order
Synonym(s) Genital herpes
Performed on Specimens From Human
CDC Points of Contact Scott Schmid
(404) 639-0066
dss1@cdc.gov
Kay Radford
(404) 639-2192
kjr7@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Serum, plasma, or cerebrospinal fluid (CSF)
Minimum Volume Required 200 uL
Turnaround Time 2 Days
Interferences & Limitations None
Storage & Preservation of
Specimen Prior to Shipping
Keep specimen either refrigerated or frozen
Additional lnformation None
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship overnight Monday–Thursday, with cold packs or dry ice as an etiologic 
agent.
Methodology IgG antibody detected by EIA
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Herpesvirus Encephalitis Panel
CDC-10262
Test Order
Synonym(s) None
Performed on Specimens From Human
CDC Points of Contact Scott Schmid
(404) 639-0066
dss1@cdc.gov
Kay Radford
(404) 639-2192
kjr7@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Cerebrospinal fluid (CSF), saliva, whole blood, or skin lesions
Minimum Volume Required 200 uL
Turnaround Time 2 Days
Interferences & Limitations None
Storage & Preservation of
Specimen Prior to Shipping
Keep specimen either refrigerated or frozen. Blood should be collected in EDTA 
or citrate tubes. Skin lesions should be kept dry.
Additional lnformation None
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship overnight Monday –Thursday, with cold packs or dry ice as an etiologic 
agent.
Methodology Polymerase Chain Reaction (PCR) for VZV, Polymerase Chain Reaction (PCR) for 
HSV1, Polymerase Chain Reaction (PCR) for HSV2, Polymerase Chain Reaction 
(PCR) for EBV, Polymerase Chain Reaction (PCR) for HHV6
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Herpesvirus Special Study
CDC-10270
Test Order
Synonym(s) None
Performed on Specimens From Human
CDC Points of Contact Scott Schmid
(404) 639-0066
dss1@cdc.gov
Pre-Approval Needed Schmid, Scott, (404) 639-0066, dss1@cdc.gov
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
To be determined
Minimum Volume Required Not Applicable
Turnaround Time  
Interferences & Limitations To be determined
Storage & Preservation of
Specimen Prior to Shipping
To be determined
Additional lnformation To be determined
Specimen Labeling To be determined
Transport Medium To be determined
Shipping Instructions which 
Include Specimen Handling 
Requirements
To be determined
Methodology
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HIV antigen/antibody Combo
CDC-10485
Test Order
Synonym(s) None
Performed on Specimens From Human
CDC Points of Contact Timothy Granade
(404) 639-3850
txg1@cdc.gov
Michele Owen
(404) 639-1046
smo2@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Serum or Plasma
Minimum Volume Required 1mL
Turnaround Time 21 Days
Interferences & Limitations Do not heat inactivate specimens
Storage & Preservation of
Specimen Prior to Shipping
2 days at ambient temperature; 7 days at 2-8°C.  Specimens should be stored 
at -20°C for long-term storage and should not have more than 4 freeze/thaw 
cycles.
Additional lnformation None
Specimen Labeling Specimens and accompanying submission forms require 2 unique identifiers.  
Identifiers that protect the identity of the individual are preferred
Transport Medium
Shipping Instructions which 
Include Specimen Handling 
Requirements
For best results, specimens should be shipped frozen on dry ice for overnight 
delivery to the HIV reference laboratory.
Methodology EIA
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HIV Molecular Surveillance Study (International Only)
CDC-10332
Test Order
Synonym(s) None
Performed on Specimens From Human
CDC Points of Contact Debrah Boeras (Primary POC)
(404) 639-3049
fhz2@cdc.gov
Chunfu Yang (Secondary)
(404) 639-4975
cxy0@cdc.gov
Pre-Approval Needed Boeras (Primary POC), Debrah, (404) 639-3049, fhz2@cdc.gov
Yang (Secondary), Chunfu, (404) 639-4975, cxy0@cdc.gov
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
To be determined
Minimum Volume Required To be determined
Turnaround Time  
Interferences & Limitations To be determined
Storage & Preservation of
Specimen Prior to Shipping
To be determined
Additional lnformation To be determined
Specimen Labeling All primary specimen containers must include 2 unique identifiers at the time of 
collection.  The identifiers must be clearly labeled on each specimen and 
correspond to information on the requisition form.
Surveillance studies and some protocols require 1 unique identifier (the ILB 
recommends 2 identifiers) de-linked from the patient. Do not include the 
patient’s name or any other personally identifiable information. Results are not 
reported back to patient.
Transport Medium To be determined
Shipping Instructions which 
Include Specimen Handling 
Requirements
To be determined
Methodology
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HIV Monitoring (CD4)
CDC-10277
Test Order
Synonym(s) CD4 Immunophenotype
Performed on Specimens From Human
CDC Points of Contact Rich Haaland (Primary)
(404) 639-4817
hyw9@cdc.gov
Clyde Hart (Secondary)
(404) 639-1032
ceh4@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Unclotted whole blood
Minimum Volume Required 1 mL
Turnaround Time 3 Days
Interferences & Limitations Clotted whole blood or blood specimen with high serum lipids will adversely 
affect test results.
Storage & Preservation of
Specimen Prior to Shipping
Blood should be properly stored in ethylenediaminetetraacetic acid (EDTA), 
heparin, or Acid Citrate Dextrose (ACD) tubes.  Stored and shipped at room 
temperature only.
Additional lnformation None
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship specimen Monday -Thursday overnight to avoid weekend deliveries
Keep specimen at room temperature
Methodology Fluorescence activated cell sorting (FACS), FLOW cytometry
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HIV Serology NHANES
CDC-10279
Test Order
Synonym(s) HIV ELISA, HIV antibody
Performed on Specimens From Human
CDC Points of Contact Tim Granade
(404) 639-3850
txg1@cdc.gov
Michele Owen
(404) 639-1046
smo2@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Serum and/or plasma.  The following anticoagulants are acceptable: EDTA, 
sodium citrate, CPD, CPDA-1, and ACD.  SST and PPT are also acceptable.
Minimum Volume Required 1 mL
Turnaround Time 21 Days
Interferences & Limitations None
Storage & Preservation of
Specimen Prior to Shipping
Specimens may be stored at 2-8°C for 7 days.  Long-term storage should be 
at -20°C or colder and specimens should not have incurred more than 5 freeze-
thaw cycles.
Additional lnformation None
Specimen Labeling Specimens and accompanying submission forms require 2 unique identifiers.  
Identifiers that protect the identity of the individual are preferred
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship specimen Monday -Thursday overnight to avoid weekend deliveries
Frozen specimen should be shipped on dry ice
Refrigerated specimen should be shipped on cold packs
Methodology Enzyme-linked Immunosorbent Assay (ELISA), Western Blot, Rapid Test
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HIV Serology Study (International Only)
CDC-10333
Test Order
Synonym(s) None
Performed on Specimens From Human
CDC Points of Contact Bharat Parekh
(404) 639-3647
bsp1@cdc.gov
Mireille Kalou
(404) 639-2794
chn7@cdc.gov
Pre-Approval Needed Parekh, Bharat, (404) 639-3647, bsp1@cdc.gov
Kalou, Mireille, (404) 639-2794, chn7@cdc.gov
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
To be determined
Minimum Volume Required To be determined
Turnaround Time  
Interferences & Limitations To be determined
Storage & Preservation of
Specimen Prior to Shipping
To be determined
Additional lnformation To be determined
Specimen Labeling All primary specimen containers must include 2 unique identifiers at the time of 
collection.  The identifiers must be clearly labeled on each specimen and 
correspond to information on the requisition form.
Surveillance studies and some protocols require 1 unique identifier (the ILB 
recommends 2 identifiers) de-linked from the patient. Do not include the 
patient’s name or any other personally identifiable information. Results are not 
reported back to patient.
Transport Medium To be determined
Shipping Instructions which 
Include Specimen Handling 
Requirements
To be determined
Methodology
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HIV Special Study
CDC-10278
Test Order
Synonym(s) None
Performed on Specimens From Human
CDC Points of Contact Michele Owen
(404) 639-1046
smo2@cdc.gov
Tim Granade
(404) 639-3850
txg1@cdc.gov
Pre-Approval Needed Owen, Michele, (404) 639-1046, smo2@cdc.gov
Granade, Tim, (404) 639-3850, txg1@cdc.gov
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
To be determined
Minimum Volume Required To be determined
Turnaround Time  
Interferences & Limitations To be determined
Storage & Preservation of
Specimen Prior to Shipping
To be determined
Additional lnformation To be determined
Specimen Labeling To be determined
Transport Medium To be determined
Shipping Instructions which 
Include Specimen Handling 
Requirements
To be determined
Methodology
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HIV-1 Drug Resistance Special Study (International Only)
CDC-10334
Test Order
Synonym(s) None
Performed on Specimens From Human
CDC Points of Contact Chunfu Yang
(404) 639-4975
cxy0@cdc.gov
Karidia Diallo
(404) 639-3568
edu9@cdc.gov
Pre-Approval Needed Yang, Chunfu, (404) 639-4975, cxy0@cdc.gov
Diallo, Karidia, (404) 639-3568, edu9@cdc.gov
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
To be determined
Minimum Volume Required To be determined
Turnaround Time  
Interferences & Limitations To be determined
Storage & Preservation of
Specimen Prior to Shipping
To be determined
Additional lnformation To be determined
Specimen Labeling All primary specimen containers must include 2 unique identifiers at the time of 
collection.  The identifiers must be clearly labeled on each specimen and 
correspond to information on the requisition form.
Surveillance studies and some protocols require 1 unique identifier (the ILB 
recommends 2 identifiers) de-linked from the patient. Do not include the 
patient’s name or any other personally identifiable information. Results are not 
reported back to patient.
Transport Medium To be determined
Shipping Instructions which 
Include Specimen Handling 
Requirements
To be determined
Methodology
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HIV-1 Genotype Drug Resistance (International Only)
CDC-10335
Test Order
Synonym(s) HIV DR, HIV, HIV Sequencing, HIV Susceptibility
Performed on Specimens From Human
Pre-Approval Needed Yang, Chunfu, (404) 639-4975, cxy0@cdc.gov
Diallo, Karidia, (404) 639-3568, edu9@cdc.gov
Supplemental Information
Required
Specimens must be accompanied with complete requisition form(s).
Plasma or Serum:
CDC Form 0.753: Application for Permit to Import or
Transport Etiological Agents, Hosts, or Vectors of Human Disease and 
Requisition Form
Dried Blood Spots:
Requisition Form
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Plasma, serum, and dried blood spots (DBS). Dried blood spots should be least 4 
saturated 13mm circles (preferably 5) containing 100 μL of whole blood.
Minimum Volume Required 1 mL (Plasma or Serum)
Turnaround Time 24 Weeks
Interferences & Limitations Do not use heparin as an anticoagulant. Plasma and serum should not be used 
Storage & Preservation of
Specimen Prior to Shipping
For plasma or serum keep frozen at -65°C to -80°C for 6 months. Use the 
appropriate anticoagulant (EDTA).
Dried blood spots should be kept at an ambient temperature (15°-35°C) for 
testing performed within 14 days and frozen at -70°C or colder if testing is not 
performed within 14 days.
Specimen Labeling All primary specimen containers must include 2 unique identifiers at the time of 
collection.  The identifiers must be clearly labeled on each specimen and 
correspond to information on the requisition form.
Surveillance studies and some protocols require 1 unique identifier (the ILB 
recommends 2 identifiers) de-linked from the patient. Do not include the 
patient’s name or any other personally identifiable information. Results are not 
reported back to patient.
Transport Medium Plasma or serum should be transported in a 1.5 - 2.0 mL polypropylene tube 
with screw cap and O-ring. Transport specimens in frozen conditions using dry 
ice or liquid nitrogen.  Dried blood spots should each be wrapped with a folded 
sheet of glassine paper. Stack 5-10 glassine paper-wrapped cards into a gas-
impermeable, sealable, plastic bag containing 5-10 desiccant packs to remove 
residual moisture along with one humidity indicator card. Ensure the specimen 
identification is clearly written on both the DBS card and on the plastic bag. 
Ensure the humidity indicator can be read without opening the bag. Gently apply 
pressure to the partially sealed bag to expel the air before sealing it completely. 
Place 5-10 of the above small bags into a large plastic bag.
Shipping Instructions which 
Include Specimen Handling 
Requirements
For shipments that are in transit for up to 14 days, maintain at ambient 
temperature (20°-30°C) and for greater than 14 days, maintain temperature 
at -20°C or colder with dry ice.
Methodology Identification of mutations within HIV-1 pol gene region, Sequencing
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HIV-1 Genotype Drug Resistance (International Only)
CDC-10335
Test Order
CDC Points of Contact Chunfu Yang
(404) 639-4975
cxy0@cdc.gov
Karidia Diallo
(404) 639-3568
edu9@cdc.gov
after more than 2 freeze-thaw cycles. Plasma or serum will be rejected if 
improperly labeled or unlabeled, or with discrepant documentation, insufficient 
volume, without documentation, unacceptable preservatives, and specimen that 
have leaked in transit or otherwise shown evidence of contamination.
Dried blood spots will be rejected if improperly labeled or unlabeled, without 
documentation or with discrepant documentation, without humidity indicators 
and desiccants, demonstrating any indication of humidity in the zip lock bags, 
insufficient volume for testing, improperly collected, containing blood clots or 
clumps, with a halo around the blood spot indicating contamination, if specimen 
are congruent or show evidence of commingling and collected onto 
inappropriate filter paper.
Additional lnformation The In-house assay may not detect minor viral species that constitute less than 
20% of the circulating virus population. Consultation with an expert in HIV drug 
resistance is encouraged to facilitate interpretation of genotype test results, and 
to evaluate which mutations and/or combinations of mutations are associated 
with drug resistance.
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HIV-1 Nucleic Acid Amplification (Qualitative)
CDC-10275
Test Order
Synonym(s) HIV NAAT
Performed on Specimens From Human
CDC Points of Contact Michele Owen
(404) 639-1046
smo2@cdc.gov
Tim Granade
(404) 639-3850
txg1@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Serum, plasma or whole blood.  Specimens may be collected EDTA, ACD sodium 
citrate, PPT, or serum tubes.  Follow sample tube manufacturer's instructions
Minimum Volume Required 1 mL
Turnaround Time 21 Days
Interferences & Limitations Collections in heparin coated tubes are unacceptable due to heparin interference 
with nucleic acid amplification
Storage & Preservation of
Specimen Prior to Shipping
Specimen stability is affected by elevated temperature.  Whole blood, plasma or 
serum may be stored for up to 72 hours from time of draw at <= 25°C; 
temperatures not to exceed 30°C are acceptable for no more than 24 hours.  
Specimens may be stored an additional five days at 2 to 8°C following 
centrifugation.  Plasma separated from the cells may be stored for longer periods 
of time at <= 20°C before testing.  Do not freeze whole blood. Long-term 
storage of serum has not been evaluated. 
Additional lnformation For RNA testing, separate the plasma by centrifugation and freeze (-70°C is 
optimal, -20°C acceptable) as soon as possible after separation (min volume of 
1mL of plasma is required, 5 mLs is optimal).  For DNA amplification, (required 
for HIV-2), freeze the cell pellet after plasma separation (-70°C is optimal, -20°C 
acceptable).  Indicate the original volume of blood used to generate the pellet on 
the shipping form.  If blood separation is not possible, tubes may be shipped 
overnight at ambient temperature.
Specimen Labeling Specimens and accompanying submission forms require 2 unique identifiers.  
Identifiers that protect the identity of the individual are preferred
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship specimen Monday -Thursday overnight to avoid weekend deliveries.
Keep specimen at room temperature. If frozen, specimen should be shipped on 
dry ice.
Methodology Nucleic acid amplification
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HIV-1 Nucleic Acid Amplification (Viral Load)
CDC-10276
Test Order
Synonym(s) HIV RNA-PCR, HIV RT-PCR, HIV Roche Viral load, HIV Cobas, HIV Abbot Viral 
load, HIV NAAT
Performed on Specimens From Human
CDC Points of Contact Tim Granade
(404) 639-3850
txg1@cdc.gov
Michele Owen
(404) 639-1046
smo2@cdc.gov
Pre-Approval Needed Granade, Tim, (404) 639-3850, txg1@cdc.gov
Owen, Michele, (404) 639-1046, smo2@cdc.gov
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Plasma collected in ACD or EDTA anticoagulants.  Follow manufacturer's 
instructions for proper collection.
Minimum Volume Required 1 mL
Turnaround Time 21 Days
Interferences & Limitations Collections in heparin coated tubes are unacceptable due to heparin interference 
with PCR amplification.
Storage & Preservation of
Specimen Prior to Shipping
Fresh whole blood may be held at 15-30°C for up to 6 hours or at 2-8°C for up 
to 24 hours.  After centrifugation, plasma may be stored at 15-30°C for up to 24 
hours and at 2-8°C for up to 5 days.  Plasma may be frozen at -20°C for up to 60 
days; longer storage should be at -70°C or colder.   Freeze-thaw cycles should 
be avoided and should not exceed 3 cycles.   
Additional lnformation For RNA testing, separate the plasma by centrifugation and freeze (-70°C is 
optimal, -20°C acceptable) as soon as possible after separation (min volume of 
1mL of plasma is required, 5 mL is optimal).
Specimen Labeling Specimens and accompanying submission forms require 2 unique identifiers.  
Identifiers that protect the identity of the individual are preferred
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship specimen Monday -Thursday overnight to avoid weekend deliveries.
Keep specimen at room temperature. If frozen, specimen should be shipped on 
dry ice.
Methodology Real time polymerase chain reaction (RT-PCR)
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HIV-1 PCR (International Only) Qualitative
CDC-10336
Test Order
Synonym(s) HIV, EID, PMTCT, Early infant diagnostic, DNA
Performed on Specimens From Human
Pre-Approval Needed Boeras(Primary), Debrah, (404) 639-3049, fhz2@cdc.gov
Yang (Secondary), Chunfu, (404) 639-4975, cxy0@cdc.gov
Supplemental Information
Required
Specimens must be accompanied with complete requisition form(s)
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Dried Blood Spots (DBS). At least 4 saturated 13mm circles (preferably 5) 
containing 50-100 μL of whole blood including capillary blood obtained by 
finger/toe/heel stick which is dropped directly onto the DBS card.
Minimum Volume Required Not Applicable
Turnaround Time 28 Days
Interferences & Limitations Do not use heparin as an anticoagulant. Specimen will be rejected if improperly 
labeled or unlabeled, without documentation or with discrepant documentation, 
without humidity indicators and desiccants, demonstrating any indication of 
humidity in the zip lock bags, insufficient volume for testing, improperly 
collected, containing blood clots or clumps, with a halo around the blood spot 
indicating contamination, if specimen are congruent or show evidence of 
commingling and collected onto inappropriate filter paper.
Storage & Preservation of
Specimen Prior to Shipping
The appropriate anticoagulant for DBS whole blood collection is EDTA.
Dried blood spots should be kept at an ambient temperature (15°-35°C) for 
testing performed within 14 days and frozen at -70°C if testing is not performed 
within 14 days.
Additional lnformation A test result of "HIV-1 Not Detected" or “Target not detected”, does not rule out 
necessarily HIV-1 DNA for the Amplicor test or HIV-1 RNA and DNA for the 
COBAS AmpliPrep platform. Either nucleic acid (HIV-1 DNA/RNA) concentrations 
below the limit of detection of the assays, the presence of PCR inhibitors in the 
patient specimen or improper specimen handling can lead to false negative 
results. PCR may not detect infection in the first weeks of infant’s life (< 6 
weeks) or within 6 weeks of weaning. HIV-1 may not be detected immediately 
after exposure. The diagnosis of HIV-1 infection is based on clinical presentation 
and results from additional diagnostic tests such as DNA PCR. Diagnosis should 
Specimen Labeling All primary specimen containers must include 2 unique identifiers at the time of 
collection.  The identifiers must be clearly labeled on each specimen and 
correspond to information on the requisition form.
Surveillance studies and some protocols require 1 unique identifier (the ILB 
recommends 2 identifiers) de-linked from the patient. Do not include the 
patient’s name or any other personally identifiable information. Results are not 
reported back to patient.
Transport Medium Transport specimen in a gas impermeable plastic bag with desiccant and 
humidity indicator card. Each DBS card needs to be packaged separately.
Shipping Instructions which 
Include Specimen Handling 
Requirements
For shipments that are in transit for up to 14 days, maintain at ambient 
temperature (15°-35°C) and shipments that are in transit for greater than 14 
days, maintain temperature at -20°C or colder with dry ice.
Methodology Qualitative PCR
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HIV-1 PCR (International Only) Qualitative
CDC-10336
Test Order
CDC Points of Contact Debrah Boeras (Primary)
(404) 639-3049
fhz2@cdc.gov
Chunfu Yang (Secondary)
(404) 639-4975
cxy0@cdc.gov
not be based solely on a single HIV-1 test. False positive test results may be 
caused by PCR contamination.
NOTE: If a specific testing platform is required, requests must be submitted and 
reviewed by the team lead.
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HIV-1 PCR (International Only) Quantitative Viral Load
CDC-10337
Test Order
Synonym(s) HIV, VL, RNA
Performed on Specimens From Human
Pre-Approval Needed Boeras (Primary), Debrah, (404) 639-3049, fhz2@cdc.gov
Yang (Secondary), Chunfu, (404) 639-4975, cxy0@cdc.gov
Supplemental Information
Required
Specimens must be accompanied with complete requisition form(s).
CDC Form 0.753:  Application for Permit to Import or
Transport Etiological Agents, Hosts, or Vectors of Human Disease and 
Requisition Form
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Plasma
Minimum Volume Required 0.2 mL
Turnaround Time 28 Days
Interferences & Limitations Do not use heparin as an anticoagulant. Do not use specimens after more than 5 
freeze-thaw cycles for the Roche assays and 3 freeze-thaw cycles for the Abbott 
m2000 assay. Specimen will be rejected if improperly labeled or unlabeled, or 
with discrepant documentation, insufficient volume, without documentation, 
unacceptable preservatives, and specimen that have leaked in transit or 
otherwise shown evidence of contamination.
Storage & Preservation of
Specimen Prior to Shipping
The appropriate anticoagulant for whole blood collection is EDTA.
Specimen should be kept at ambient temperature (20°-35°C) within 14 days after 
collection, but frozen at -70°C if testing is to be performed after 14 days.
Additional lnformation An interpretation of “Target Not Detected”, “HIV-1 RNA Not Detected ”, and “Not 
Detected" does not rule out the presence of PCR inhibitors or HIV-1 RNA 
concentrations below the level of detection of the assay. Care should be taken in 
the interpretation of any single viral load determination. The clinical significance 
of changes in HIV-1 RNA measurements has not been fully established; however, 
a change of 0.5 log copies/mL may be significant.
The linear range of each assay is as follows:
COBAS® AmpliPrep/COBAS® Taqman® v2.0 is 20-10,000,000 
copies/mL(1.30log-7.00log)
Specimen Labeling All primary specimen containers must include 2 unique identifiers at the time of 
collection.  The identifiers must be clearly labeled on each specimen and 
correspond to information on the requisition form.
Surveillance studies and some protocols require 1 unique identifier (the ILB 
recommends 2 identifiers) de-linked from the patient. Do not include the 
patient’s name or any other personally identifiable information. Results are not 
reported back to patient.
Transport Medium Transport specimen in a sterile 1.5-2.0 mL polypropylene tube, screw cap with 
O-ring
Shipping Instructions which 
Include Specimen Handling 
Requirements
For shipments that are in transit for up to 5 days, maintain at (2-8°C) and 
shipments in transit for greater than 5 days, maintain temperature at -20°C or 
colder with dry ice.
Methodology Quantitative PCR
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HIV-1 PCR (International Only) Quantitative Viral Load
CDC-10337
Test Order
CDC Points of Contact Debrah Boeras (Primary)
(404) 639-3049
fhz2@cdc.gov
Chunfu Yang (Secondary)
(404) 639-4975
cxy0@cdc.gov
Amplicor® HIV-1 Monitor v1.5 is 400-750,000 copies/mL(2.60log-5.88log)
Abbott Real Time HIV-1 assay is 40-10,000,000 copies/mL(1.60-7.00log)
The COBAS®AmpliPrep/COBAS® Taqman® HIV-1 v2.0 test exhibits a higher level 
of sensitivity when compared to the Amplicor® HIV-1 Monitor v1.5 test and the 
Abbott Real Time HIV-1 test for the m2000 system.
NOTE: If a specific testing platform is required, requests must be submitted and 
reviewed by the Team Lead.
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HIV-1/2 Antibody (International Only) EIA and Western Blot
CDC-10338
Test Order
Synonym(s) HIV, EIA, WB, ELISA
Performed on Specimens From Human
Pre-Approval Needed Parekh, Bharat, (404) 639-3647, bsp1@cdc.gov
Kalou, Mireille, (404) 639-2794, chn7@cdc.gov
Supplemental Information
Required
Specimens must be accompanied with complete requisition form(s).
Plasma or serum:
CDC Form 0.753: Application for Permit to Import or
Transport Etiological Agents, Hosts, or Vectors of Human Disease and 
Requisition Form
Dried Blood Spots:
Requisition Form
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Plasma, serum and dried blood spots. Dried Blood Spots should be at least 4 
saturated 13mm filter paper circles (preferably 5) containing 75 μL of whole 
blood.
Minimum Volume Required 0.5 mL (plasma and serum)
Storage & Preservation of
Specimen Prior to Shipping
Keep plasma and serum refrigerated at 2°-8°C if testing is performed within 7 
days. If testing is performed after 7 days of collection, the specimen should be 
kept frozen at -20°C or colder. 
Dried blood spots should be stored at an ambient temperature (20°-30°C) if 
testing is performed within 14 days. Specimen should be frozen at -20°C or 
colder if testing is not performed within 14 days.
Plasma: The appropriate anticoagulants for whole blood collection are either  
EDTA, Sodium heparin or Lithium heparin.
Dried Blood Spots: For DBS prepared from whole blood collected into tubes, the 
appropriate anticoagulant for DBS whole blood collection is EDTA. Finger pricks 
without anti-coagulant dropped directly onto filter paper is also acceptable.
Specimen Labeling All primary specimen containers must include 2 unique identifiers at the time of 
collection.  The identifiers must be clearly labeled on each specimen and 
correspond to information on the requisition form.
Surveillance studies and some protocols require 1 unique identifier (the ILB 
recommends 2 identifiers) de-linked from the patient. Do not include the 
patient’s name or any other personally identifiable information. Results are not 
reported back to patient.
Transport Medium Transport plasma and/or serum in plastic screw-cap vial with O-ring. Dried 
blood spots should be in gas impermeable plastic bag with desiccant and 
humidity indicator card and packaged separately.
Shipping Instructions which 
Include Specimen Handling 
Requirements
For shipments that are in transit for up to 7 days, maintain temperature at 2-8°C.
For shipments that are in transit for greater than 7 days, maintain temperature 
at -20°C or colder with dry ice.
For shipments that are in transit for up to 14 days, maintain at ambient 
temperature (20-30°C). For shipments that are in transit for greater than 14 
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HIV-1/2 Antibody (International Only) EIA and Western Blot
CDC-10338
Test Order
CDC Points of Contact Bharat Parekh
(404) 639-3647
bsp1@cdc.gov
Mireille Kalou
(404) 639-2794
chn7@cdc.gov
Turnaround Time 90 Days
Interferences & Limitations Do not use plasma and serum after more than 5 freeze-thaw cycles. Plasma or 
serum will be rejected if improperly labeled or unlabeled, without documentation 
or with discrepant documentation, insufficient volume, unacceptable 
preservatives, and specimen that have leaked in transit or otherwise shown 
evidence of contamination.
Dried blood spots will be rejected if improperly labeled or unlabeled, without 
documentation or with discrepant documentation, without humidity indicators 
and desiccants, demonstrating any indication of humidity in the zip lock bags, 
insufficient volume for testing, improperly collected, containing blood clots or 
clumps, with a halo around the blood spot indicating contamination, if specimen 
are congruent or show evidence of commingling and collected onto 
inappropriate filter paper.
Additional lnformation Positive results are confirmed by the highly specific method (i.e. Western Blot). 
Western Blot with an EIA-positivity has combined specificity of greater than 
99.9%.
Testing for EIA and Western Blot is perfumed in batches and the turnaround 
times are the following:
Batch with less than 200 specimens – within 50 days
Batch with 200-600 – within 70 days
Batch with greater than 600 specimens – within 90 days
days, maintain temperature at -20°C or colder with dry ice.
Methodology Enzyme Immunoassay, Enzyme-linked Immunosorbent Blot Technique (Western 
Blot)
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HIV-1/2 Antibody (International Only) Rapid Test
CDC-10339
Test Order
Synonym(s) HIV, RT
Performed on Specimens From Human
CDC Points of Contact Bharat Parekh
(404) 639-3647
bsp1@cdc.gov
Mireille Kalou
(404) 639-2794
Pre-Approval Needed Parekh, Bharat, (404) 639-3647, bsp1@cdc.gov
Kalou, Mireille, (404) 639-2794, chn7@cdc.gov
Supplemental Information
Required
Specimens must be accompanied with complete requisition form(s).
CDC Form 0.753: Application for Permit to Import or
Transport Etiological Agents, Hosts, or Vectors of Human Disease and 
Requisition Form
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Plasma and serum
Minimum Volume Required 0.5 mL
Turnaround Time 90 Days
Interferences & Limitations Do not use specimens after more than 5 freeze-thaw cycles. Specimen will be 
rejected if improperly labeled or unlabeled, without documentation or with 
discrepant documentation, insufficient volume, unacceptable preservatives, and 
specimen that have leaked in transit or otherwise shown evidence of 
contamination.
Storage & Preservation of
Specimen Prior to Shipping
The appropriate anticoagulants for whole blood collection are EDTA or Sodium 
heparin. Keep specimen at ambient temperature at 15°-35°C if testing will be 
performed within 48 hours of collection. If testing is to be performed within 7 
days keep specimen refrigerated at 2°-8°C. If testing is to be performed after 7 
days, keep specimen frozen at -20°C or colder.
Additional lnformation Turn around times are dependent on batch specimen: 
Batch with less than 200 specimens – within 50 days
Batch with 200-600 – within 70 days
Batch with greater than 600 specimens – within 90 days
Specimen Labeling All primary specimen containers must include 2 unique identifiers at the time of 
collection.  The identifiers must be clearly labeled on each specimen and 
correspond to information on the requisition form.
Surveillance studies and some protocols require 1 unique identifier (the ILB 
recommends 2 identifiers) de-linked from the patient. Do not include the 
patient’s name or any other personally identifiable information. Results are not 
reported back to patient.
Transport Medium Specimen should be transported in a plastic screw-cap vial
Shipping Instructions which 
Include Specimen Handling 
Requirements
For shipments that are in transit for up to 7 days, maintain temperature at 2-8°C 
and for shipments that are in transit for greater than 7 days, maintain 
temperature at -20°C or colder with dry ice.
Methodology Immuno-concentration
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HIV-1/2 Antibody (International Only) Rapid Test
CDC-10339
Test Order
chn7@cdc.gov
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HIV-1/2 Laboratory Algorithm 
CDC-10272
Test Order
Synonym(s) HIV ELISA, HIV antibody
Performed on Specimens From Human
CDC Points of Contact Tim Granade
(404) 639-3850
txg1@cdc.gov
Michele Owen
(404) 639-1046
smo2@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Serum and/or plasma.  The following anticoagulants are acceptable: EDTA, 
sodium citrate, CPD, CPDA-1, and ACD.  SST and PPT are also acceptable.
Minimum Volume Required 1 mL
Turnaround Time 21 Days
Interferences & Limitations None
Storage & Preservation of
Specimen Prior to Shipping
Specimens may be stored at 2-8°C for 7 days.  Long-term storage should be 
at -20°C or colder and specimens should not have incurred more than 5 freeze-
thaw cycles.
Additional lnformation None
Specimen Labeling Specimens and accompanying submission forms require 2 unique identifiers.  
Identifiers that protect the identity of the individual are preferred
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship specimen Monday -Thursday overnight to avoid weekend deliveries
Frozen specimen should be shipped on dry ice
Refrigerated specimen should be shipped on cold packs
Methodology HIV-1 Nucleic acid amplification (qualitative), HIV antigen/antibody combo ELISA 
or HIV antibody ELISA, HIV-1/2 differentiation assay, Rapid Test
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HIV-2 Nucleic Acid Amplification (Qualitative)
CDC-10429
Test Order
Synonym(s) HIV NAAT
Performed on Specimens From Human
CDC Points of Contact Michele Owen
(404) 639-1046
smo2@cdc.gov
Tim Granade
(404) 639-3850
txg1@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Serum and plasma
Minimum Volume Required 1 mL
Turnaround Time 21 Days
Interferences & Limitations Collections in heparin coated tubes are unacceptable due to heparin interference 
with PCR amplification.
Storage & Preservation of
Specimen Prior to Shipping
Specimen should be properly stored in ethylenediaminetetraacetic acid (EDTA) or 
Acid Citrate Dextrose (ACD) tubes. Serum and plasma can be stored at room 
temperature.  For plasma only collections, Plasma Preparation Tubes (PPT) are 
suitable.
Additional lnformation For RNA testing, separate the plasma by centrifugation and freeze (-70°C is 
optimal, -20°C acceptable) as soon as possible after separation (min volume of 
1mL of plasma is required, 5 mL is optimal). For DNA amplification, (required for 
HIV-2), freeze the cell pellet after plasma separation (-70°C is optimal, -20°C 
acceptable). Indicate the original volume of blood used to generate the pellet on 
the shipping form. If blood separation is not possible, tubes may be shipped 
overnight at ambient temperature.
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship specimen Monday -Thursday overnight to avoid weekend deliveries.
Keep specimen at room temperature. If frozen, specimen should be shipped on 
dry ice.
Methodology Polymerase Chain Reaction (PCR)
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HIV-2 Serology
CDC-10273
Test Order
Synonym(s) HIV ELISA, HIV antibody
Performed on Specimens From Human
CDC Points of Contact Tim Granade
(404) 639-3850
txg1@cdc.gov
Michele Owen
(404) 639-1046
smo2@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Serum and/or plasma.  The following anticoagulants are acceptable: EDTA, 
sodium citrate, CPD, CPDA-1, and ACD.  SST and PPT are also acceptable.
Minimum Volume Required 0.5 mL
Turnaround Time 21 Days
Interferences & Limitations None
Storage & Preservation of
Specimen Prior to Shipping
Keep specimen either refrigerated or frozen. Plasma should be properly stored in 
ethylenediaminetetraacetic acid (EDTA) or Acid Citrate Dextrose (ACD) tubes.
Additional lnformation None
Specimen Labeling Specimens and accompanying submission forms require 2 unique identifiers.  
Identifiers that protect the identity of the individual are preferred
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship specimen Monday -Thursday overnight to avoid weekend deliveries
Frozen specimen should be shipped on dry ice
Refrigerated specimen should be shipped on cold packs
Methodology HIV-1/2 Differentiation Assay, HIV-2 Western Blot
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HPV Special Study
CDC-10131
Test Order
Synonym(s) None
Performed on Specimens From Human
CDC Points of Contact Elizabeth Unger
(404) 639-3533
eru0@cdc.gov
Gitika Panicker
(404) 639-2269
dhv1@cdc.gov
Pre-Approval Needed Unger, Elizabeth, (404) 639-3533, eru0@cdc.gov
Panicker, Gitika, (404) 639-2269, dhv1@cdc.gov
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
To be determined
Minimum Volume Required To be determined
Turnaround Time  
Interferences & Limitations To be determined
Storage & Preservation of
Specimen Prior to Shipping
To be determined
Additional lnformation
Specimen Labeling To be determined
Transport Medium To be determined
Shipping Instructions which 
Include Specimen Handling 
Requirements
To be determined
Methodology Polymerase Chain Reaction (PCR), Serology
Martin Steinau
(404) 639-0561
azz9@cdc.gov
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Human Herpes Virus 6 (HHV6) Detection and Subtyping
CDC-10266
Test Order
Synonym(s) HHV6
Performed on Specimens From Human
CDC Points of Contact Scott Schmid
(404) 639-0066
dss1@cdc.gov
Kay Radford
(404) 639-2192
kjr7@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Saliva, cerebrospinal fluid (CSF) or blood
Minimum Volume Required 200 uL
Turnaround Time 2 Days
Interferences & Limitations None
Storage & Preservation of
Specimen Prior to Shipping
Keep specimen either refrigerated or frozen. Blood should be collected in EDTA 
or citrate tubes.
Additional lnformation None
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium None
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship overnight Monday–Thursday, with cold packs or dry ice as an etiologic 
agent.
Methodology Polymerase Chain Reaction (PCR)
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Human Herpes Virus 7 (HHV7) Detection
CDC-10267
Test Order
Synonym(s) HHV7
Performed on Specimens From Human
CDC Points of Contact Scott Schmid
(404) 639-0066
dss1@cdc.gov
Kay Radford
(404) 639-2192
kjr7@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Saliva, cerebrospinal fluid (CSF) or blood
Minimum Volume Required 200 uL
Turnaround Time 2 Days
Interferences & Limitations None
Storage & Preservation of
Specimen Prior to Shipping
Keep specimen either refrigerated or frozen. Blood should be collected in EDTA 
or citrate tubes.
Additional lnformation None
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Not applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship overnight Monday–Thursday, with cold packs or dry ice as an etiologic 
agent.
Methodology Polymerase Chain Reaction (PCR)
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Human Herpes Virus 8 (HHV8) Detection
CDC-10268
Test Order
Synonym(s) Kaposi's sarcoma-associated herpesvirus, KSHV, HHV8
Performed on Specimens From Human
CDC Points of Contact Sheila Dollard
(404) 639-2178
sgd5@cdc.gov
Scott Schmid
(404) 639-0066
dss1@cdc.gov
Pre-Approval Needed Dollard, Sheila, (404) 639-2178, sgd5@cdc.gov
Schmid, Scott, (404) 639-0066, dss1@cdc.gov
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Blood or saliva
Minimum Volume Required 200 uL
Turnaround Time 1 Week
Interferences & Limitations None
Storage & Preservation of
Specimen Prior to Shipping
Keep specimen either refrigerated or frozen. Blood should be collected in EDTA 
or citrate tubes.
Additional lnformation None
Specimen Labeling Provide a specimen ID. Do not send specimen labeled with patient’s name.
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship overnight Monday–Thursday, with cold packs or dry ice as an etiologic 
agent.
Methodology Polymerase Chain Reaction (PCR)
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Human Herpes Virus 8 (HHV8) Serology
CDC-10269
Test Order
Synonym(s) Kaposi's sarcoma-associated herpesvirus, KSHV, HHV8
Performed on Specimens From Human
CDC Points of Contact Sheila Dollard
(404) 639-2178
sgd5@cdc.gov
Scott Schmid
(404) 639-0066
dss1@cdc.gov
Pre-Approval Needed Dollard, Sheila, (404) 639-2178, sgd5@cdc.gov
Schmid, Scott, (404) 639-0066, dss1@cdc.gov
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Serum or plasma
Minimum Volume Required 200 uL
Turnaround Time 7 Days
Interferences & Limitations None
Storage & Preservation of
Specimen Prior to Shipping
Keep specimen either refrigerated or frozen.
Additional lnformation None
Specimen Labeling Provide a specimen ID. Do not send specimen labeled with patient’s name.
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship overnight Monday–Thursday, with cold packs or dry ice as an etiologic 
agent.
Methodology IgG antibody detected by IFA
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Influenza Antiviral Resistance Diagnosis
CDC-10423
Test Order
Synonym(s) Flu, Influenza Drug resistance, Neuraminidase inhibitor, Influenza Resistance 
testing
Performed on Specimens From Human
CDC Points of Contact Larisa Gubareva
(404) 639-3204
lqg3@cdc.gov
Marnie Levine
(404) 639-3353
itb4@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
Requires additional WHO submission form that can be obtained with your 
password
Supplemental Form http://www.nltn.org/IM-014Rev0D_2012_Specimen_Submission_Form.xls
Acceptable Sample/ Specimen 
Type for Testing
Must type/subtype prior to submission. Virus isolates, RNA, respiratory clinical 
specimens (nasopharyngeal swabs, nasal swabs, throat swabs, nasal aspirates, 
nasal washes, lower respiratory tract specimens), and others upon consultation 
with the laboratory.
Minimum Volume Required 0.5 mL
Turnaround Time 3 Days
Interferences & Limitations Low viral load (Ct values above 29 are not recommended for submission) or 
genetic variance can affect test results. 
Calcium alginate swabs are unacceptable and cotton swabs with wooden shafts 
are not recommended because it can cause a false-negative result.
Storage & Preservation of
Specimen Prior to Shipping
Swab specimens should be collected using only swabs with a synthetic tip, such 
as nylon or Dacron®, and an aluminum or plastic shaft. Ensure that, when 
transporting human respiratory specimens, all applicable regulations
for the transport of etiologic agents are met. Specimens received cold should be 
stored refrigerated (2–8°C) for up to 72 hours before processing. Store any 
residual specimens at ≤ -70°C. Although optimal performance is met when 
testing fresh specimens within 72 hours of collection, performance has been 
demonstrated with frozen specimens. If testing of a fresh specimen is not 
possible within 72 hours storage at 2°–8°C, the specimen may be frozen at 
≤ -70°C and tested at a later time. Specimens received frozen should be stored 
at ≤ -70°C until processing. Store any residual specimens at ≤ -70°C.
Additional lnformation Turn around time may be greater than 3 days during holidays. Testing is not 
performed on the weekends or on federal holidays.
Specimen Labeling Specimen ID must match the ID on the form
Transport Medium Swabs must be in viral transport medium
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday overnight to avoid weekend deliveries. Prior to shipping, 
notify CDC Influenza Division that you are sending specimens. Refer to the 
International Air Transport Association (IATA - www.iata.org) for requirements 
for shipment of human or potentially infectious biological specimens. 
Ship extracted RNA and frozen specimen on dry ice.
Refrigerated specimens should be shipped on cold packs.
Methodology Pyrosequencing
Julie Villanueva
(404) 639-3851
jfv3@cdc.gov
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Influenza Antiviral Resistance Diagnosis
CDC-10423
Test Order
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Influenza Molecular Diagnosis
CDC-10421
Test Order
Synonym(s) Influenza Real Time PCR, Influenza Diagnostics, Flu
Performed on Specimens From Human
CDC Points of Contact Stephen Lindstrom
(404) 639-1587
sql5@cdc.gov
LaShondra Berman
(404) 639-1686
zhj5@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
Requires additional WHO submission form that can be obtained with your 
password
Supplemental Form http://www.nltn.org/IM-014Rev0D_2012_Specimen_Submission_Form.xls
Acceptable Sample/ Specimen 
Type for Testing
Virus isolates, RNA, respiratory clinical specimens (i.e. Nasopharyngeal swabs, 
nasal swabs, throat swabs, nasal aspirates, nasal washes, lower respiratory tract 
specimens), and others upon consultation with the laboratory.
Minimum Volume Required 1 mL
Turnaround Time 3 Days
Interferences & Limitations Low virus numbers or co-infections can affect test results. Calcium alginate 
swabs are unacceptable and cotton swabs with wooden shafts are not 
recommended because it can cause a false-negative result.
Storage & Preservation of
Specimen Prior to Shipping
Swab specimens should be collected using only swabs with a synthetic tip, such 
as nylon or Dacron®, and an aluminum or plastic shaft. Ensure that, when 
transporting human respiratory specimens, all applicable regulations
for the transport of etiologic agents are met. Specimens received cold should be 
stored refrigerated (2°–8°C) for up to 72 hours before processing. Store any 
residual specimens at ≤ -70°C. Although optimal performance is met when 
testing fresh specimens within 72 hours of collection, performance has been 
demonstrated with frozen specimens. If testing of a fresh specimen is not 
possible within 72 hours storage at 2–8°C, the specimen may be frozen at ≤ -70°
C and tested at a later time. Specimens received frozen should be stored at 
≤ -70°C until processing. Store any residual specimens at ≤ -70°C.
Additional lnformation Specimens submitted for surveillance studies will take longer than three days for 
results
Specimen Labeling Specimen ID must match the ID on the form
Transport Medium Swabs must be in viral transport medium
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday, overnight to avoid weekend deliveries. Urgent specimen 
can be shipped any time with prior approval from the laboratory. Prior to 
shipping, notify CDC Influenza Division that you are sending specimen. Refer to 
the International Air Transport Association (IATA - www.iata.org) for 
requirements for shipment of human or potentially infectious biological 
specimens. 
Ship extracted RNA and frozen specimen on dry ice.
Refrigerated specimen should be shipped on cold packs.
Methodology Real Time PCR, Genetic Sequence Identification
Julie Villanueva
(404) 639-3851
jfv3@cdc.gov
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Influenza Serology
CDC-10424
Test Order
Synonym(s) Influenza Hemagglutination inhibition assay, Influenza microneutralization assay
Performed on Specimens From Human
CDC Points of Contact Min Levine
(404) 639-3504
mwl2@cdc.gov
Jackie Katz
(404) 639-4966
jmk9@cdc.gov
Pre-Approval Needed Levine, Min, (404) 639-3504, mwl2@cdc.gov
Katz, Jackie, (404) 639-4966, jmk9@cdc.gov
Supplemental Information
Required
Supplemental form will be supplied upon consultation with laboratory
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Paired Serum; Acute (less than 7 days post symptoms onset) and convalescent (at 
least 14 days after acute serum collection)
Minimum Volume Required .5 mL
Turnaround Time 6 Weeks
Interferences & Limitations Whole blood cannot be used for testing. Lipemic or hemolyzed sera will affect 
test results.
Storage & Preservation of
Specimen Prior to Shipping
Should be collected and immediately frozen. Specifics around storage and 
preservation are supplied on the supplemental form and upon consultation with 
laboratory.
Additional lnformation None
Specimen Labeling Please include patient identification number, patients age, date of collection and 
symptoms onset date. Do not include names.
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday, overnight to avoid weekend deliveries
Frozen specimen should be shipped on dry ice
Obtain approval prior to shipping
Methodology Hemagglutination inhibition assay, Microneutralization assay
Heather Tatum
gpg7@cdc.gov
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Influenza Special Study
CDC-10425
Test Order
Synonym(s) None
Performed on Specimens From Human
CDC Points of Contact Jullie Villanueva
(404) 639-3851
jfv3@cdc.gov
Stephen Lindstrom
(404) 639-1587
sql5@cdc.gov
Pre-Approval Needed Villanueva, Jullie, (404) 639-3851, jfv3@cdc.gov
Lindstrom, Stephen, (404) 639-1587, sql5@cdc.gov
Supplemental Information
Required
Requires additional WHO submission form that can be obtained with your 
password
Supplemental Form http://www.nltn.org/IM-014Rev0D_2012_Specimen_Submission_Form.xls
Acceptable Sample/ Specimen 
Type for Testing
To be determined
Minimum Volume Required To be determined
Turnaround Time  
Interferences & Limitations To be determined
Storage & Preservation of
Specimen Prior to Shipping
To be determined
Additional lnformation To be determined
Specimen Labeling To be determined
Transport Medium To be determined
Shipping Instructions which 
Include Specimen Handling 
Requirements
To be determined
Methodology
Xu Xiyan
(404) 639-1657
xxx1@cdc.gov
Larisa Gubareva
(404) 639-3204
lqg3@cdc.gov
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Influenza Surveillance
CDC-10422
Test Order
Synonym(s) Flu, Influenza Antigen Characterization
Performed on Specimens From Human
CDC Points of Contact Xiyan Xu
(404) 639-1657
xxx1@cdc.gov
Wendy Sessions
(404) 639-3211
gra6@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
Requires additional WHO submission form that can be obtained with your 
password
Supplemental Form http://www.nltn.org/IM-014Rev0D_2012_Specimen_Submission_Form.xls
Acceptable Sample/ Specimen 
Type for Testing
Respiratory specimens (nasopharyngeal swabs, nasal swabs, throat swabs, nasal 
aspirates, nasal washes, dual nasopharyngeal/throat swabs, bronchoalveolar 
lavage, sputum, tracheal aspirate, etc.), virus cultures, and others upon 
consultation with the laboratory.
Minimum Volume Required 1 mL
Turnaround Time 4 Weeks
Interferences & Limitations Low virus numbers or co-infections can affect test results. Calcium alginate 
swabs are unacceptable and cotton swabs with wooden shafts are not 
recommended because it can cause a false-negative result.
Storage & Preservation of
Specimen Prior to Shipping
Swab specimens should be collected using only swabs with a synthetic tip, such 
as nylon or Dacron®, and an aluminum or plastic shaft. Ensure that, when 
transporting human respiratory specimens, all applicable regulations
for the transport of etiologic agents are met. Specimens received cold should be 
stored refrigerated (2–8°C) for up to 72 hours before processing. Store any 
residual specimens at ≤ -70°C. Although optimal performance is met when 
testing fresh specimens within 72 hours of collection, performance has been 
demonstrated with frozen specimens. If testing of a fresh specimen is not 
possible within 72 hours storage at 2°–8°C, the specimen may be frozen at 
≤ -70°C and tested at a later time. Specimens received frozen should be stored 
at ≤ -70°C until processing. Store any residual specimens at ≤ -70°C.
Additional lnformation Turn around time may take up to a month if the virus needs to be cultured. Turn 
around time for isolates may be less than 1 month.
Specimen Labeling Specimen ID must match the ID on the form
Transport Medium Swabs must be in viral transport medium
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday, overnight to avoid weekend deliveries. Urgent specimen 
can be shipped at any time with prior approval from the laboratory. Refer to the 
International Air Transport Association (IATA - www.iata.org) for requirements 
for shipment of human or potentially infectious biological specimens. 
Ship extracted RNA and frozen specimen on dry ice.
Refrigerated specimen should be shipped on cold packs.
Methodology Hemagglutination Inhibition (HI) test, Virus Culture
Julie Villanueva
(404) 639-3851
jfv3@cdc.gov
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Junin Serology
CDC-10340
Test Order
Synonym(s) Argentine Hemorrhagic Fever, AHF, arenavirus
Performed on Specimens From Human and Animal
CDC Points of Contact Ute Stroeher
(404) 639-4704
ixy8@cdc.gov
Barbara Knust
(404) 639-1104
bkk0@cdc.gov
Pre-Approval Needed Stroeher, Ute, (404) 639-4704, ixy8@cdc.gov
Knust, Barbara, (404) 639-1104, bkk0@cdc.gov
Supplemental Information
Required
See Supplemental Form
Supplemental Form http://www.cdc.gov/ncezid/dhcpp/vspb/pdf/specimen-submission.pdf
Acceptable Sample/ Specimen 
Type for Testing
Blood and serum
Minimum Volume Required 1 mL
Turnaround Time 10 Days
Interferences & Limitations Specimen must remain frozen; warming or freeze thawing reduces sensitivity.
Storage & Preservation of
Specimen Prior to Shipping
Specimen must be kept cold (at or below 4°C). If possible place specimen in 
plastic screw capped vials. See link to supplemental submission form for specific 
information on various specimen types.
Additional lnformation Critical specimens will take less than 4 days to turn around. See link to 
supplemental submission forms for detailed information.
Specimen Labeling Patient name, patient ID #, specimen type, date collected
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday overnight to avoid weekend deliveries. Specimen should 
be shipped on cold packs or dry ice if frozen. See supplemental submission 
forms for further details. Do not ship specimen without prior consultation and 
approval.
Methodology ELISA
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Kyasanur Forest Disease Serology
CDC-10341
Test Order
Synonym(s) KFD
Performed on Specimens From Human and Animal
CDC Points of Contact Ute Stroeher
(404) 639-4704
ixy8@cdc.gov
Barbara Knust
(404) 639-1104
bkk0@cdc.gov
Pre-Approval Needed Stroeher, Ute, (404) 639-4704, ixy8@cdc.gov
Knust, Barbara, (404) 639-1104, bkk0@cdc.gov
Supplemental Information
Required
See Supplemental Form
Supplemental Form http://www.cdc.gov/ncezid/dhcpp/vspb/pdf/specimen-submission.pdf
Acceptable Sample/ Specimen 
Type for Testing
Blood and serum
Minimum Volume Required 1 mL
Turnaround Time 10 Days
Interferences & Limitations Specimen must remain frozen; warming or freeze thawing reduces sensitivity
Storage & Preservation of
Specimen Prior to Shipping
Specimen must be kept cold (at or below 4°C). If possible place specimen in 
plastic screw capped vials. See link to supplemental submission form for specific 
information on various specimen types.
Additional lnformation Critical specimens will take less than 4 days to turn around. See link to 
supplemental submission forms for detailed information.
Specimen Labeling Patient name, patient ID #, specimen type, date collected
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday overnight to avoid weekend deliveries. Specimen should 
be shipped on cold packs or dry ice if frozen. See supplemental submission 
forms for further details. Do not ship specimen without prior consultation and 
approval.
Methodology ELISA
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Laguna Negra Serology
CDC-10342
Test Order
Synonym(s) HPS, hanta
Performed on Specimens From Human and Animal
CDC Points of Contact Ute Stroeher
(404) 639-4704
ixy8@cdc.gov
Barbara Knust
(404) 639-1104
bkk0@cdc.gov
Pre-Approval Needed Stroeher, Ute, (404) 639-4704, ixy8@cdc.gov
Knust, Barbara, (404) 639-1104, bkk0@cdc.gov
Supplemental Information
Required
See Supplemental Form
Supplemental Form http://www.cdc.gov/ncezid/dhcpp/vspb/pdf/specimen-submission.pdf
Acceptable Sample/ Specimen 
Type for Testing
Blood and serum
Minimum Volume Required 1 mL
Turnaround Time 10 Days
Interferences & Limitations Specimen must remain frozen; warming or freeze thawing reduces sensitivity
Storage & Preservation of
Specimen Prior to Shipping
Specimen must be kept cold (at or below 4°C). If possible place specimen in 
plastic screw capped vials. See link to supplemental submission form for specific 
information on various specimen types.
Additional lnformation Critical specimens will take less than 4 days to turn around. See link to 
supplemental submission forms for detailed information.
Specimen Labeling Patient name, patient ID #, specimen type, date collected
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday overnight to avoid weekend deliveries. Specimen should 
be shipped on cold packs or dry ice if frozen. See supplemental submission 
forms for further details. Do not ship specimen without prior consultation and 
approval.
Methodology ELISA
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Lassa Fever Identification
CDC-10343
Test Order
Synonym(s) Arenavirus
Performed on Specimens From Human and Animal
CDC Points of Contact Ute Stroeher
(404) 639-4704
ixy8@cdc.gov
Barbara Knust
(404) 639-1104
bkk0@cdc.gov
Pre-Approval Needed Stroeher, Ute, (404) 639-4704, ixy8@cdc.gov
Knust, Barbara, (404) 639-1104, bkk0@cdc.gov
Supplemental Information
Required
See Supplemental Form
Supplemental Form http://www.cdc.gov/ncezid/dhcpp/vspb/pdf/specimen-submission.pdf
Acceptable Sample/ Specimen 
Type for Testing
Frozen tissue, blood, and serum
Minimum Volume Required 1 mL
Turnaround Time 10 Days
Interferences & Limitations Specimen must remain frozen; warming or freeze thawing reduces sensitivity. 
Heparin may cause interference with the molecular tests and should be avoided.
Storage & Preservation of
Specimen Prior to Shipping
Specimen must be placed in plastic screw capped vials, frozen to -70°C, and kept 
frozen until shipment. See link to supplemental submission form for specific 
information on various specimen types.
Additional lnformation Critical specimens will take less than 4 days to turn around. See link to 
supplemental submission forms for detailed information.
Specimen Labeling Patient name, patient ID #, specimen type, date collected
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday overnight to avoid weekend deliveries. Specimen should 
be shipped frozen on dry ice. See supplemental submission forms for further 
details. Do not ship specimen without prior consultation and approval.
Methodology Molecular Typing, Polymerase Chain Reaction (PCR)
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Lassa Fever Serology
CDC-10344
Test Order
Synonym(s) Arenavirus
Performed on Specimens From Human and Animal
CDC Points of Contact Ute Stroeher
(404) 639-4704
ixy8@cdc.gov
Barbara Knust
(404) 639-1104
bkk0@cdc.gov
Pre-Approval Needed Stroeher, Ute, (404) 639-4704, ixy8@cdc.gov
Knust, Barbara, (404) 639-1104, bkk0@cdc.gov
Supplemental Information
Required
See Supplemental Form
Supplemental Form http://www.cdc.gov/ncezid/dhcpp/vspb/pdf/specimen-submission.pdf
Acceptable Sample/ Specimen 
Type for Testing
Blood and serum
Minimum Volume Required 1 mL
Turnaround Time 10 Days
Interferences & Limitations Specimen must remain frozen; warming or freeze thawing reduces sensitivity
Storage & Preservation of
Specimen Prior to Shipping
Specimen must be kept cold (at or below 4°C). If possible place specimen in 
plastic screw capped vials. See link to supplemental submission form for specific 
information on various specimen types.
Additional lnformation Critical specimens will take less than 4 days to turn around. See link to 
supplemental submission forms for detailed information.
Specimen Labeling Patient name, patient ID #, specimen type, date collected
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday overnight to avoid weekend deliveries. Specimen should 
be shipped on cold packs or dry ice if frozen. See supplemental submission 
forms for further details. Do not ship specimen without prior consultation and 
approval.
Methodology ELISA
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Legionella species Identification and Typing
CDC-10159
Test Order
Synonym(s) Legionnaires' disease or LD, Legionellosis, Pontiac fever
Performed on Specimens From Human and Food/Environmental/Medical Devices/Biologics
CDC Points of Contact Jonas Winchell
(404) 639-4921
Jwinchell@cdc.gov
Natalia Kozak
(404) 639-2305
htv2@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Isolates or culture. For Human origin the acceptable specimen are sputum, 
bronchoalveolar lavage (BAL), lung tissue, and endotracheal tube (ETT). For 
specimen of environmental origin only isolates are accepted.
Minimum Volume Required Contingent upon specimen type. Please call for consultation
Turnaround Time 4 Weeks
Interferences & Limitations Specimen should be acquired prior to antibiotic treatment. Improper specimen 
storage and handling may result in inconclusive or inaccurate results.
Storage & Preservation of
Specimen Prior to Shipping
Clinical specimen should be frozen immediately. Isolates should be on 
appropriate slants (Buffered Charcoal Yeast Extract (BCYE)).
Additional lnformation If only PCR is needed then turn around time will be shorter than 4 weeks
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium BCYE or equivalent slants for isolates
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday overnight to avoid weekend deliveries
Frozen specimen should be sent on dry ice
Methodology Culture, Serogrouping, Sequencing, Real Time PCR
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Legionella species Molecular Detection
CDC-10160
Test Order
Synonym(s) Legionnaires' disease or LD, Legionellosis, Pontiac fever, Atypical pneumonia
Performed on Specimens From Human and Food/Environmental/Medical Devices/Biologics
CDC Points of Contact Jonas Winchell
(404) 639-4921
Jwinchell@cdc.gov
Natalia Kozak
(404) 639-2305
htv2@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Any lower respiratory tract specimen including bronchoalveolar lavage (BAL), 
endotracheal tube (ETT), lung biopsy or tissue, and sputum; isolates and purified 
nucleic acid.
Minimum Volume Required Contingent upon specimen type. Please call for consultation
Turnaround Time 7 Days
Interferences & Limitations Specimen should be acquired prior to antibiotic treatment. Improper specimen 
storage and handling may result in inconclusive or inaccurate results.
Storage & Preservation of
Specimen Prior to Shipping
Specimen should be kept frozen
Additional lnformation None
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday overnight to avoid weekend deliveries
Frozen specimen should be sent on dry ice
Methodology Real Time PCR, Sequencing
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Legionella species Study
CDC-10161
Test Order
Synonym(s) None
Performed on Specimens From Human and Food/Environmental/Medical Devices/Biologics
CDC Points of Contact Jonas Winchell
(404) 639-4921
Jwinchell@cdc.gov
Natalia Kozak
(404) 639-2305
htv2@cdc.gov
Pre-Approval Needed Winchell, Jonas, (404) 639-4921, Jwinchell@cdc.gov
Kozak, Natalia, (404) 639-2305, htv2@cdc.gov
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
To be determined
Minimum Volume Required To be determined
Turnaround Time  
Interferences & Limitations To be determined
Storage & Preservation of
Specimen Prior to Shipping
To be determined
Additional lnformation To be determined
Specimen Labeling To be determined
Transport Medium To be determined
Shipping Instructions which 
Include Specimen Handling 
Requirements
To be determined
Methodology
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Leishmania species Culture
CDC-10238
Test Order
Synonym(s) Parasite
Performed on Specimens From Human
CDC Points of Contact Frank Steurer
(404) 718-4175
fjs1@cdc.gov
Alex daSilva
(404) 718-4121
adasilva@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
Must contact laboratory at 770-488-4475, and CDC will provide the culture 
medium (typically Novy-MacNeal-Nicolle (NNN) medium).
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Blood or tissue
Minimum Volume Required Not Applicable
Turnaround Time 6 Weeks
Interferences & Limitations Formalin fixed specimens are not suitable for culture
Storage & Preservation of
Specimen Prior to Shipping
No Specific Requirements
Additional lnformation None
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Culture medium (typically Novy-MacNeal-Nicolle (NNN) medium).  Keep media 
refrigerated until it is used (stable for 2-4 weeks) and bring it to room 
temperature right before inoculation.  Once inoculated, keep the culture at room 
temperature and send to CDC as soon as possible by overnight mail.
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday – Thursday, overnight to avoid weekend deliveries. Culture should 
be kept at room temperature and mailed as soon as possible, as an etiologic 
agent.
Methodology Culture
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Leishmania spp Molecular Detection
CDC-10479
Test Order
Synonym(s) Visceral leishmaniasis, Cutaneous leishmaniasis, Kala azar, Leishmania 
donovoni, Leishmania major, Leishmania boliviensis, parasite 
Performed on Specimens From Human
CDC Points of Contact Alex daSilva
(404) 718-4121
adasilva@cdc.gov
Yvonne Qvarnstrom
(404) 718-4123
bvp2@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Tissue, Skin biopsy, blood
Minimum Volume Required 200 uL
Turnaround Time 21 Days
Interferences & Limitations Formalin fixed  specimens are not suitable for molecular studies
Storage & Preservation of
Specimen Prior to Shipping
Storage and preservation is specimen specific
Additional lnformation None
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday – Thursday, overnight to avoid weekend deliveries. Ship specimen 
at room temperature, not on dry ice, as an etiologic agent.
Methodology Conventional PCR, DNA Sequencing
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Leishmaniasis Indirect Fluorescent Antibody Test
CDC-10463
Test Order
Synonym(s) Visceral leishmaniasis, Kala azar; Leishmania donovoni, Leishmania major, 
Leishmania, parasite
Performed on Specimens From Human
CDC Points of Contact Frank Steurer
(404) 718-4101
fjs1@cdc.gov
Patricia Wilkins
(404) 718-4101
pma1@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
Exposure and travel history, include other relevant risk factors; clinical 
symptoms, treatment and relevant lab results.
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Serum and Plasma
Minimum Volume Required 0.5 mL
Turnaround Time 18 Days
Interferences & Limitations Substances known to interfere with immunoassays include: bilirubin, lipids, and 
hemoglobin 
Storage & Preservation of
Specimen Prior to Shipping
No specific requirements
Additional lnformation None
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday – Thursday, overnight to avoid weekend deliveries. Ship specimen 
at room temperature, not on dry ice, as an etiologic agent.
Methodology Indirect Fluorescent Antibody Assay, Antibody detection
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Leptospira species Identification and Genotyping
CDC-10199
Test Order
Synonym(s) Leptospirosis
Performed on Specimens From Human and Animal
CDC Points of Contact Renee Galloway
(404) 639-5461
zul0@cdc.gov
Robyn Stoddard
(404) 639-2053
frd8@cdc.gov
Pre-Approval Needed Galloway, Renee, (404) 639-5461, zul0@cdc.gov
Stoddard, Robyn, (40) 463-9205, frd8@cdc.gov
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Isolate and media inoculated with clinical specimens (blood, tissue and urine)
Minimum Volume Required Not Applicable
Turnaround Time 2 Weeks
Interferences & Limitations None
Storage & Preservation of
Specimen Prior to Shipping
Cultures should be stored at room temperature
Additional lnformation Turnaround time will vary depending on if an isolate is sent for identification or 
a specimen is sent for isolation. Primary isolation from clinical specimens takes 
up to 6 months.
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition
Transport Medium Isolates need to be shipped on Ellinghausen-McCullough-Johnson-Harris (EMJH) 
semisolid media
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship specimen Monday -Thursday overnight to avoid weekend deliveries
Isolates should be shipped at room temperature. All other specimens shipped at 
4°C.
Methodology Multilocus sequence typing (MLST), Pulsed field gel electrophoresis (PFGE), 
Microscopy, Polymerase Chain Reaction (PCR)
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Leptospira species Molecular Detection
CDC-10200
Test Order
Synonym(s) Leptospirosis
Performed on Specimens From Human and Animal
CDC Points of Contact Robyn Stoddard
(404) 639-2053
frd8@cdc.gov
Renee Galloway
(404) 639-5461
zul0@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Clinical specimens (blood and urine). Blood specimens should be collected in 
EDTA or Sodium Citrate tubes
Minimum Volume Required 250 uL
Turnaround Time 2 Days
Interferences & Limitations Blood specimens collected in heparin are not acceptable
Storage & Preservation of
Specimen Prior to Shipping
Keep frozen at -20⁰C
Additional lnformation None
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition
Transport Medium Blood specimens transported in EDTA or Sodium Citrate tubes
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship specimen Monday -Thursday overnight to avoid weekend deliveries
Specimens should be shipped frozen at -20⁰C
Methodology Polymerase Chain Reaction (PCR)
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Leptospira species Serology
CDC-10201
Test Order
Synonym(s) Leptospirosis
Performed on Specimens From Human and Animal
CDC Points of Contact Renee Galloway
(404) 639-5461
zul0@cdc.gov
Robyn Stoddard
(404) 639-2053
frd8@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Serum for MAT (acute and convalescent preferred for MAT). Serum or whole 
blood for ImmunoDOT (human only)
Minimum Volume Required 100 uL
Turnaround Time 1 Week
Interferences & Limitations Acute and convalescent preferred for MAT
MAT can be performed on human or animal sera but ImmunoDOT is for human 
sera only
Storage & Preservation of
Specimen Prior to Shipping
Store serum at 4°C before shipping
Additional lnformation ImmunoDOT (IgM detection) can be reported  within 1 week while MAT takes up 
to 2 weeks for confirmation
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship specimen Monday -Thursday overnight to avoid weekend deliveries
Serum should be shipped at 4°C
Methodology MAT-micro aggluination, ImmunoDOT
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Leptospira species Study
CDC-10202
Test Order
Synonym(s) None
Performed on Specimens From Human, Animal, and Food/Environmental/Medical Devices/Biologics
CDC Points of Contact Renee Galloway
(404) 639-5461
zul0@cdc.gov
Robyn Stoddard
(404) 639-2053
frd8@cdc.gov
Pre-Approval Needed Galloway, Renee, (404) 639-5461, zul0@cdc.gov
Stoddard, Robyn, (404) 639-2053, frd8@cdc.gov
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
To be determined
Minimum Volume Required To be determined
Turnaround Time  
Interferences & Limitations To be determined
Storage & Preservation of
Specimen Prior to Shipping
To be determined
Additional lnformation To be determined
Specimen Labeling To be determined
Transport Medium To be determined
Shipping Instructions which 
Include Specimen Handling 
Requirements
To be determined
Methodology
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Listeria Identification
CDC-10128
Test Order
Synonym(s) Listeria
Performed on Specimens From Human, Animal, and Food/Environmental/Medical Devices/Biologics
CDC Points of Contact Cheryl Tarr
(404) 639-2011
crt6@cdc.gov
Zuzana Kucerova
(404) 718-4143
zik0@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
Prior approval is not required for human specimens but is required for all other 
specimen types.
Provide any preliminary results that are available.
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Isolates
Minimum Volume Required Not Applicable
Turnaround Time 4 Weeks
Interferences & Limitations None
Storage & Preservation of
Specimen Prior to Shipping
No Specific Requirements
Additional lnformation Turnaround times for routine isolates may be extended during major foodborne 
outbreak activities or due to limited availability of resources.
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Ship growth on nonselective slant/stab such as TSA, HIA, etc.; screw cap tubes 
preferred.
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday, overnight to avoid weekend deliveries
Ship at ambient temperature in compliance with Federal and local guidelines
Methodology Phenotypic Idenification, Genetic Identification
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Listeria monocytogenes Identification and Subtyping
CDC-10129
Test Order
Synonym(s) Listeria Typing
Performed on Specimens From Human, Animal, and Food/Environmental/Medical Devices/Biologics
CDC Points of Contact Cheryl Tarr
(404) 639-2011
crt6@cdc.gov
Zuzana Kucerova
(404) 718-4143
zik0@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
Prior approval is not required for human specimens, but is required for all 
other specimen types.
Provide any preliminary results  available. Indicate subtyping method(s) 
requested on specimen submission form.
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Isolates
Minimum Volume Required Not Applicable
Turnaround Time 8 Weeks
Interferences & Limitations None
Storage & Preservation of
Specimen Prior to Shipping
No Specific Requirements
Additional lnformation Turnaround times for routine isolates may be extended during major foodborne 
outbreak activities due to limited availability of resources.
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Ship growth on nonselective slant/stab such as TSA, HIA, etc.; screw cap tubes 
preferred.
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday, overnight to avoid weekend deliveries
Ship at ambient temperature in compliance with Federal and local guidelines
Methodology Phenotypic Identification, Genetic Identification, PFGE, MLVA
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Listeria Study
CDC-10130
Test Order
Synonym(s) None
Performed on Specimens From Human, Animal, and Food/Environmental/Medical Devices/Biologics
CDC Points of Contact Cheryl Tarr
(404) 639-2011
crt6@cdc.gov
Zuzana Kucerova
(404) 718-4143
zik0@cdc.gov
Pre-Approval Needed Tarr, Cheryl, (404) 639-2011, crt6@cdc.gov
Kucerova, Zuzana, (404) 718-4143, zik0@cdc.gov
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
To be determined
Minimum Volume Required To be determined
Turnaround Time  
Interferences & Limitations To be determined
Storage & Preservation of
Specimen Prior to Shipping
To be determined
Additional lnformation To be determined
Specimen Labeling To be determined
Transport Medium To be determined
Shipping Instructions which 
Include Specimen Handling 
Requirements
To be determined
Methodology
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Lymphocytic Choriomeningitis (LCM) Identification
CDC-10345
Test Order
Synonym(s) LCM, Arenavirus
Performed on Specimens From Human and Animal
CDC Points of Contact Ute Stroeher
(404) 639-4704
ixy8@cdc.gov
Barbara Knust
(404) 639-1104
bkk0@cdc.gov
Pre-Approval Needed Stroeher, Ute, (404) 639-4704, ixy8@cdc.gov
Knust, Barbara, (404) 639-1104, bkk0@cdc.gov
Supplemental Information
Required
See Supplemental Form
Supplemental Form http://www.cdc.gov/ncezid/dhcpp/vspb/pdf/specimen-submission.pdf
Acceptable Sample/ Specimen 
Type for Testing
Frozen tissue, blood, serum, and CSF
Minimum Volume Required 1 mL
Turnaround Time 10 Days
Interferences & Limitations Specimen must remain frozen; warming or freeze thawing reduces sensitivity. 
Heparin may cause interference with the molecular tests and should be avoided.
Storage & Preservation of
Specimen Prior to Shipping
Specimen must be placed in plastic screw capped vials, frozen to -70°C, and kept 
frozen until shipment. See link to supplemental submission form for specific 
information on various specimen types.
Additional lnformation Critical specimens will take less than 4 days to turn around. See link to 
supplemental submission forms for detailed information.
Specimen Labeling Patient name, patient ID #, specimen type, date collected
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday overnight to avoid weekend deliveries. Specimen should 
be shipped frozen on dry ice. See supplemental submission forms for further 
details. Do not ship specimen without prior consultation and approval.
Methodology Molecular Typing, Polymerase Chain Reaction (PCR)
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Lymphocytic Choriomeningitis (LCM) Serology
CDC-10346
Test Order
Synonym(s) LCM, Arenavirus
Performed on Specimens From Human and Animal
CDC Points of Contact Ute Stroeher
(404) 639-4704
ixy8@cdc.gov
Barbara Knust
(404) 639-1104
bkk0@cdc.gov
Pre-Approval Needed Stroeher, Ute, (404) 639-4704, ixy8@cdc.gov
Knust, Barbara, (404) 639-1104, bkk0@cdc.gov
Supplemental Information
Required
See Supplemental Form
Supplemental Form http://www.cdc.gov/ncezid/dhcpp/vspb/pdf/specimen-submission.pdf
Acceptable Sample/ Specimen 
Type for Testing
CSF, blood and serum
Minimum Volume Required 1 mL
Turnaround Time 10 Days
Interferences & Limitations Specimen must remain frozen; warming or freeze thawing reduces sensitivity
Storage & Preservation of
Specimen Prior to Shipping
Specimen must be kept cold (at or below 4°C). If possible place specimen in 
plastic screw capped vials. See link to supplemental submission form for specific 
information on various specimen types.
Additional lnformation Critical specimens will take less than 4 days to turn around. See link to 
supplemental submission forms for detailed information.
Specimen Labeling Patient name, patient ID #, specimen type, date collected
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday overnight to avoid weekend deliveries. Specimen should 
be shipped on cold packs or dry ice if frozen. See supplemental submission 
forms for further details. Do not ship specimen without prior consultation and 
approval.
Methodology ELISA
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Machupo Identification
CDC-10347
Test Order
Synonym(s) Bolivian Hemorrhagic Fever, BHF, Arenavirus
Performed on Specimens From Human and Animal
CDC Points of Contact Ute Stroeher
(404) 639-4704
ixy8@cdc.gov
Barbara Knust
(404) 639-1104
bkk0@cdc.gov
Pre-Approval Needed Stroeher, Ute, (404) 639-4704, ixy8@cdc.gov
Knust, Barbara, (404) 639-1104, bkk0@cdc.gov
Supplemental Information
Required
See Supplemental Form
Supplemental Form http://www.cdc.gov/ncezid/dhcpp/vspb/pdf/specimen-submission.pdf
Acceptable Sample/ Specimen 
Type for Testing
Frozen tissue, blood and serum
Minimum Volume Required 1 mL
Turnaround Time 10 Days
Interferences & Limitations Specimen must remain frozen; warming or freeze thawing reduces sensitivity. 
Heparin may cause interference with the molecular tests and should be avoided.
Storage & Preservation of
Specimen Prior to Shipping
Specimen must be placed in plastic screw capped vials, frozen to -70°C, and kept 
frozen until shipment. See link to supplemental submission form for specific 
information on various specimen types.
Additional lnformation Critical specimens will take less than 4 days to turn around. See link to 
supplemental submission forms for detailed information.
Specimen Labeling Patient name, patient ID #, specimen type, date collected
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday overnight to avoid weekend deliveries. Specimen should 
be shipped frozen on dry ice. See supplemental submission forms for further 
details. Do not ship specimen without prior consultation and approval.
Methodology Molecular Typing, Polymerase Chain Reaction (PCR)
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Machupo Serology
CDC-10348
Test Order
Synonym(s) Bolivian Hemorrhagic Fever, BHF, Arenavirus
Performed on Specimens From Human and Animal
CDC Points of Contact Ute Stroeher
(404) 639-4704
ixy8@cdc.gov
Barbara Knust
(404) 639-1104
bkk0@cdc.gov
Pre-Approval Needed Stroeher, Ute, (404) 639-4704, ixy8@cdc.gov
Knust, Barbara, (404) 639-1104, bkk0@cdc.gov
Supplemental Information
Required
See Supplemental Form
Supplemental Form http://www.cdc.gov/ncezid/dhcpp/vspb/pdf/specimen-submission.pdf
Acceptable Sample/ Specimen 
Type for Testing
Blood and serum
Minimum Volume Required 1 mL
Turnaround Time 10 Days
Interferences & Limitations Specimen must remain frozen; warming or freeze thawing reduces sensitivity
Storage & Preservation of
Specimen Prior to Shipping
Specimen must be kept cold (at or below 4°C). If possible place specimen in 
plastic screw capped vials. See link to supplemental submission form for specific 
information on various specimen types.
Additional lnformation Critical specimens will take less than 4 days to turn around. See link to 
supplemental submission forms for detailed information.
Specimen Labeling Patient name, patient ID #, specimen type, date collected
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday overnight to avoid weekend deliveries. Specimen should 
be shipped on cold packs or dry ice if frozen. See supplemental submission 
forms for further details. Do not ship specimen without prior consultation and 
approval.
Methodology ELISA
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Malaria Indirect Fluorescent Antibody Test
CDC-10464
Test Order
Synonym(s) Plasmodium falciparum, Plasmodium vivax,  Plasmodium malariae, parasite
Performed on Specimens From Human
CDC Points of Contact Patricia Wilkins
(404) 718-4101
pma1@cdc.gov
Isabel McAuliffe
(404) 718-4100
ibm4@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
Travel history REQUIRED, include other relevant risk factors; clinical symptoms, 
treatment and relevant lab results.
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Serum and Plasma
Minimum Volume Required 0.5 mL
Turnaround Time 18 Days
Interferences & Limitations Substances known to interfere with immunoassays include: bilirubin, lipids, and 
hemoglobin 
Storage & Preservation of
Specimen Prior to Shipping
No specific requirements
Additional lnformation None
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday – Thursday, overnight to avoid weekend deliveries. Ship specimen 
at room temperature, not on dry ice, as an etiologic agent.
Methodology Indirect Fluorescent Antibody Assay, Antibody Detection
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Malaria Molecular Identification
CDC-10480
Test Order
Synonym(s) Plasmodium falciparum, Plasmodium vivax,  Plasmodium malariae, Plasmodium 
ovale, parasite
Performed on Specimens From Human
CDC Points of Contact Alex daSilva
(404) 718-4121
adasilva@cdc.gov
Yvonne Qvarnstrom
(404) 718-4123
bvp2@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Blood
Minimum Volume Required 200 uL
Turnaround Time 21 Days
Interferences & Limitations None
Storage & Preservation of
Specimen Prior to Shipping
Collect a 1-5 ml blood sample in Vacutainer® EDTA tubes prior to anti-parasitic 
therapy and ship at 4°C.  
Additional lnformation None
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday – Thursday, overnight to avoid weekend deliveries. Ship specimen 
at room temperature, not on dry ice, as an etiologic agent.
Methodology Conventional PCR, Real-Time PCR
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Malaria Surveillance
CDC-10235
Test Order
Synonym(s) Malaria Drug Resistance typing, parasite
Performed on Specimens From Human
CDC Points of Contact Alex daSilva
(404) 718-4121
adasilva@cdc.gov
John Barnwell
(404) 718-4420
wzb3@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
Supplemental form not needed
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Blood collected in EDTA tubes
Minimum Volume Required 1.0 mL
Turnaround Time  
Interferences & Limitations None
Storage & Preservation of
Specimen Prior to Shipping
Blood should be collected in EDTA tubes
Additional lnformation Turnaround time is determined by the surveillance project, no individual patient 
reports are issued
Please provide information on travel history and history of anti-malarial usage
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday – Thursday, overnight to avoid weekend deliveries. Do not ship 
specimen frozen.
Methodology Polymerase Chain Reaction (PCR), DNA Sequencing, In-vitro culture
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Marburg Identification
CDC-10349
Test Order
Synonym(s) None
Performed on Specimens From Human and Animal
CDC Points of Contact Ute Stroeher
(404) 639-4704
ixy8@cdc.gov
Barbara Knust
(404) 639-1104
bkk0@cdc.gov
Pre-Approval Needed Stroeher, Ute, (404) 639-4704, ixy8@cdc.gov
Knust, Barbara, (404) 639-1104, bkk0@cdc.gov
Supplemental Information
Required
See Supplemental Form
Supplemental Form http://www.cdc.gov/ncezid/dhcpp/vspb/pdf/specimen-submission.pdf
Acceptable Sample/ Specimen 
Type for Testing
Frozen tissue, blood and serum
Minimum Volume Required 1 mL
Turnaround Time 10 Days
Interferences & Limitations Specimen must remain frozen; warming or freeze thawing reduces sensitivity. 
Heparin may cause interference with the molecular tests and should be avoided.
Storage & Preservation of
Specimen Prior to Shipping
Specimen must be placed in plastic screw capped vials, frozen to -70°C, and kept 
frozen until shipment. See link to supplemental submission form for specific 
information on various specimen types.
Additional lnformation Critical specimens will take less than 4 days to turn around. See link to 
supplemental submission forms for detailed information.
Specimen Labeling Patient name, patient ID #, specimen type, date collected
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday overnight to avoid weekend deliveries. Specimen should 
be shipped frozen on dry ice. See supplemental submission forms for further 
details. Do not ship specimen without prior consultation and approval.
Methodology Molecular Typing, Polymerase Chain Reaction (PCR)
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Marburg Serology
CDC-10350
Test Order
Synonym(s) None
Performed on Specimens From Human and Animal
CDC Points of Contact Ute Stroeher
(404) 639-4704
ixy8@cdc.gov
Barbara Knust
(404) 639-1104
bkk0@cdc.gov
Pre-Approval Needed Stroeher, Ute, (404) 639-4704, ixy8@cdc.gov
Knust, Barbara, (404) 639-1104, bkk0@cdc.gov
Supplemental Information
Required
See Supplemental Form
Supplemental Form http://www.cdc.gov/ncezid/dhcpp/vspb/pdf/specimen-submission.pdf
Acceptable Sample/ Specimen 
Type for Testing
Blood and serum
Minimum Volume Required 1 mL
Turnaround Time 10 Days
Interferences & Limitations Specimen must remain frozen; warming or freeze thawing reduces sensitivity
Storage & Preservation of
Specimen Prior to Shipping
Specimen must be kept cold (at or below 4°C). If possible place specimen in 
plastic screw capped vials. See link to supplemental submission form for specific 
information on various specimen types.
Additional lnformation Critical specimens will take less than 4 days to turn around. See link to 
supplemental submission forms for detailed information.
Specimen Labeling Patient name, patient ID #, specimen type, date collected
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday overnight to avoid weekend deliveries. Specimen should 
be shipped on cold packs or dry ice if frozen. See supplemental submission 
forms for further details. Do not ship specimen without prior consultation and 
approval.
Methodology ELISA
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Measles and Rubella Detection and Genotyping
CDC-10243
Test Order
Synonym(s) Measles, Rubeola, Rubella, German measles; three day measles
Performed on Specimens From Human
CDC Points of Contact Paul Rota
(404) 639-4181
par1@cdc.gov
Joe Icenogle
(404) 639-4557
jci1@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Throat swab in viral medium, Nasopharyngeal aspirate or swab, urine, cataracts, 
lens aspirate, oral fluid, cerebrospinal fluid (CSF), dry blood spots, and tissue 
samples
Minimum Volume Required Not Applicable
Turnaround Time 7 Days
Interferences & Limitations Measles: http://www.cdc.gov/measles/lab-tools/
Rubella: http://www.cdc.gov/rubella/lab/lab-protocols.htm
Also see, http://www.cdc.gov/vaccines/pubs/surv-manual/index.html
http://www.cdc.gov/measles/lab-tools/index.html
Storage & Preservation of
Specimen Prior to Shipping
Measles: http://www.cdc.gov/measles/lab-tools/
Rubella: http://www.cdc.gov/rubella/lab/lab-protocols.htm
Also see: http://www.cdc.gov/vaccines/pubs/surv-manual/index.html
http://www.cdc.gov/measles/lab-tools/index.html
Additional lnformation Please include vaccination history, age, date of symptom onset and sample 
collection
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Clearly label specimen type.
Transport Medium Viral transport medium for swabs and appropriate culture medium. Make sure 
tubes are all in leak proof containers.
Shipping Instructions which 
Include Specimen Handling 
Requirements
The laboratory requests that the sender contacts the laboratory by email or 
phone before shipping.
For shipping address see: http://www.cdc.gov/measles/lab-tools/
Ship specimen Monday -Thursday overnight to avoid weekend deliveries
Frozen specimen should be shipped on dry ice
Refrigerated specimen should be shipped on cold packs
Methodology Real time RT-PCR, Genotyping by nucleic acid sequencing, Template production 
by RT-PCR, Viral culture
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Measles and Rubella Serology
CDC-10247
Test Order
Synonym(s) Measles, Rubeola, Rubella, German measles, three day measles
Performed on Specimens From Human
CDC Points of Contact Bill Bellini
(404) 639-4183
wjb2@cdc.gov
Joe Icenogle
(404) 639-4557
jci1@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Serum and others upon consultation with laboratory
Minimum Volume Required 200 uL
Turnaround Time 7 Days
Interferences & Limitations IgM positive may not occur until 5 days post-rash onset
Storage & Preservation of
Specimen Prior to Shipping
Serum should be kept refrigerated or frozen
Additional lnformation IgM and IgG assays are qualitative assays.
For outbreaks or immuno-compromised patients please contact laboratory prior 
to shipment.
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Clearly label specimen type.
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship specimen Monday -Thursday overnight to avoid weekend deliveries.
Refrigerated or frozen specimen should be shipped on cold packs.
laboratory will instruct on how to ship for other specimen types.
Methodology Commercial capture IgM, Commercial indirect IgG
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Measles Avidity
CDC-10248
Test Order
Synonym(s) None
Performed on Specimens From Human
CDC Points of Contact Bill Bellini
(404) 639-4183
wjb2@cdc.gov
Sara Mercader
(404) 639-4568
sjm7@cdc.gov
Pre-Approval Needed Bellini, Bill, (404) 639-4183, wjb2@cdc.gov
Mercader, Sara, (404) 639-4568, sjm7@cdc.gov
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Serum
Minimum Volume Required 300 uL
Turnaround Time 7 Days
Interferences & Limitations None
Storage & Preservation of
Specimen Prior to Shipping
Serum should be kept refrigerated, not frozen
Additional lnformation http://www.cdc.gov/vaccines/pubs/surv-manual/index.html
Specimen Labeling Provide a unique identifier on the specimen container and the test requisition
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship specimen Monday -Thursday overnight to avoid weekend deliveries
Refrigerated specimen should be shipped on cold packs
Methodology Measles avidity
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Measles Detection and Genotyping
CDC-10240
Test Order
Synonym(s) Rubeola
Performed on Specimens From Human
CDC Points of Contact Paul Rota
(404) 639-4181
par1@cdc.gov
Rebecca McNall
(404) 639-4541
dqo2@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Throat swab in viral transport medium, nasopharyngeal aspirate or swab, urine, 
oral fluid, cerebrospinal fluid (CSF), dry blood spots, and tissue samples
Minimum Volume Required Not Applicable
Turnaround Time 7 Days
Interferences & Limitations See: http://www.cdc.gov/measles/lab-tools/ for  information on the 
interferences and limitations of this test
Storage & Preservation of
Specimen Prior to Shipping
See: http://www.cdc.gov/measles/lab-tools/rt-pcr.html for detailed information 
on storage and preservation of specimen
Additional lnformation Please include vaccination history, age, date of rash onset and date of sample 
collection
For additional information, please see measles surveillance manual: 
http://www.cdc.gov/vaccines/pubs/surv-manual/chpt07-measles.html
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Clearly label specimen type.
Transport Medium Viral transport medium for swabs. Make sure tubes are all leak proof containers.
Shipping Instructions which 
Include Specimen Handling 
Requirements
The laboratory requests that the sender contacts the laboratory by email or 
phone before shipping
See instructions and shipping address: http://www.cdc.gov/measles/lab-tools/
Ship specimen Monday -Thursday overnight to avoid weekend deliveries
Frozen specimen should be shipped on dry ice
Refrigerated specimen should be shipped on cold packs
Methodology Viral culture, Genotyping by Nucleic acid sequencing, Real time RT-PCR, 
Template production by RT-PCR
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Measles Neutralization Antibody (Not for Immune Status)
CDC-10250
Test Order
Synonym(s) PRN test, Plaque-reduction neutralization
Performed on Specimens From Human
CDC Points of Contact Bill Bellini
(404) 639-4183
wjb2@cdc.gov
Sun Sowers
(404) 639-1360
sib9@cdc.gov
Pre-Approval Needed Bellini, Bill, (404) 639-4183, wjb2@cdc.gov
Sowers, Sun, (404) 639-1360, sib9@cdc.gov
Supplemental Information
Required
See Supplemental Form
Supplemental Form http://www.cdc.gov/vaccines/pubs/surv-manual/index.html
Acceptable Sample/ Specimen 
Type for Testing
Serum
Minimum Volume Required 300 uL
Turnaround Time 4 Weeks
Interferences & Limitations None
Storage & Preservation of
Specimen Prior to Shipping
Serum should be kept refrigerated, not frozen
Additional lnformation None
Specimen Labeling Provide a unique identifier on the specimen container and the test requisition
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship specimen Monday -Thursday overnight to avoid weekend deliveries
Refrigerated specimen should be shipped on cold packs
Methodology Neutralization assay - quantitative serological assay
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Measles Serology
CDC-10244
Test Order
Synonym(s) Rubeola
Performed on Specimens From Human
CDC Points of Contact Bill Bellini
(404) 639-4183
wjb2@cdc.gov
Nobia Williams
(404) 639-1049
new8@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Serum and others upon consultation
Minimum Volume Required 300 uL (50 uL)
Turnaround Time 7 Days
Interferences & Limitations IgM positive may not occur until 4 days post-rash onset
Storage & Preservation of
Specimen Prior to Shipping
Serum should be kept refrigerated, not frozen
Additional lnformation IgM and IgG assays are qualitative assays
For outbreaks or immuno-compromised patients please contact laboratory prior 
to shipment
Please include vaccination history, age, date of onset and sample collection
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship specimen Monday -Thursday overnight to avoid weekend deliveries
Refrigerated specimen should be shipped on cold packs
Laboratory will instruct on how to ship for other specimen types
Methodology CDC capture IgM, Commercial indirect IgG
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Measles Special Study
CDC-10251
Test Order
Synonym(s) Rubeola
Performed on Specimens From Human
CDC Points of Contact Bill Bellini
(404) 639-4183
wjb2@cdc.gov
Paul Rota
(404) 639-4181
par1@cdc.gov
Pre-Approval Needed Bellini, Bill, (404) 639-4183, wjb2@cdc.gov
Rota, Paul, (404) 639-4181, par1@cdc.gov
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
To be determined
Minimum Volume Required To be determined
Turnaround Time  
Interferences & Limitations To be determined
Storage & Preservation of
Specimen Prior to Shipping
To be determined
Additional lnformation To be determined
Specimen Labeling To be determined
Transport Medium To be determined
Shipping Instructions which 
Include Specimen Handling 
Requirements
To be determined
Methodology
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MERS-CoV PCR
CDC-10488
Test Order
Synonym(s) MERS-CoV PCR, Middle East Respiratory Syndrome Coronavirus PCR 
Performed on Specimens From Human
CDC Points of Contact Dean Erdman
Pre-Approval Needed Erdman, Dean, (404) 639-3727, dde1@cdc.gov
Supplemental Information
Required
See Supplemental Form
Supplemental Form http://www.cdc.gov/coronavirus/mers/downloads/MERS-investigation-short-form.pdf
Acceptable Sample/ Specimen 
Type for Testing
Nasopharyngeal wash/aspirates, nasopharyngeal swabs, oropharyngeal swabs, 
broncheoalveolar lavage, tracheal aspirate, pleural fluid tap, sputum, stool, 
serum, EDTA blood (plasma), and post-mortem tissue.  For more information go 
to: http://www.cdc.gov/coronavirus/mers/guidelines-clinical-specimens.html; 
http://www.cdc.gov/coronavirus/mers/downloads/Interim-MERS-Lab-
Biosafety-Guidelines.pdf
Minimum Volume Required 0.25 mL
Turnaround Time 2 Days
Interferences & Limitations Virus isolation in cell culture and initial characterization of viral agents 
recovered in cultures of MERS-CoV specimens are NOT recommended at this 
time. However, if done, these activities must be performed in a BSL-3 facility 
using BSL-3 work practices.   
Use only sterile Dacron or rayon swabs with plastic shafts or if available, flocked 
swabs. Do NOT use calcium alginate swabs or swabs with wooden sticks, as they 
may contain substances that inactivate some viruses and inhibit some molecular 
assays.
Storage & Preservation of
Specimen Prior to Shipping
Refrigerate or freeze tubes after specimens are placed in them. If specimens will 
be examined within 48 hours after collection, they can be refrigerated. If 
specimens must be held longer than 48 hours, freeze them as soon as possible 
after collection. Although storage in an ultra-low freezer (-70°C) is preferable, 
storage in a home-type freezer (if properly set at -20°C) is acceptable for short 
periods.  
http://www.cdc.gov/coronavirus/mers/guidelines-clinical-specimens.html
http://www.cdc.gov/coronavirus/mers/downloads/Interim-MERS-Lab-
Biosafety-Guidelines.pdf
Additional lnformation http://www.cdc.gov/coronavirus/mers/index.html,  
http://www.cdc.gov/coronavirus/mers/guidelines-clinical-specimens.html, 
http://www.cdc.gov/coronavirus/mers/downloads/Interim-MERS-Lab-
Biosafety-Guidelines.pdf
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Swabs may be shipped in commercial viral transport media
Shipping Instructions which 
Include Specimen Handling 
Requirements
Contact Dean Erdman (dde1@cdc.gov, 404-639-3727) for shipping address.
See the following link for additional shipping information:
http://www.cdc.gov/coronavirus/mers/guidelines-clinical-specimens.html
Methodology Polymerase Chain Reaction (PCR), Sequencing
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MERS-CoV PCR
CDC-10488
Test Order
(404) 639-3727
dde1@cdc.gov
Shifaq Kamili
(404) 639-2799
sgk5@cdc.gov
Monday, January 13, 2014 Page 228 of 380Version: 1.1
MERS-CoV Serology
CDC-10489
Test Order
Synonym(s) Middle East Respiratory Syndrome Coronavirus (MERS-CoV) ELISA, Middle East 
Respiratory Syndrome Coronavirus (MERS-CoV) EIA
Performed on Specimens From Human
CDC Points of Contact Lia Haynes
(404) 718-4639
loh5@cdc.gov
Pre-Approval Needed Haynes, Lia, (404) 718-4639, loh5@cdc.gov
Erdman, Dean, (404) 639-3727, dde1@cdc.gov
Supplemental Information
Required
See Supplemental Form
Supplemental Form http://www.cdc.gov/coronavirus/mers/downloads/MERS-investigation-short-form.pdf
Acceptable Sample/ Specimen 
Type for Testing
Serum (acute and convalescent preferred, but single specimen acceptable) and 
plasma. For more information go to 
http://www.cdc.gov/coronavirus/mers/guidelines-clinical-specimens.html
Minimum Volume Required 200µL
Turnaround Time 3 Days
Interferences & Limitations Virus isolation in cell culture and initial characterization of viral agents 
recovered in cultures of MERS-CoV specimens are NOT recommended at this 
time. However, if done, these activities must be performed in a BSL-3 facility 
using BSL-3 work practices.
Do not collect specimen in heparin tubes.
Storage & Preservation of
Specimen Prior to Shipping
Collect whole blood in a serum separator tube. Allow the blood to clot, 
centrifuge briefly, and collect all the resulting sera in vials with external caps and 
internal O-ring seals. If there is no O-ring seal, then seal tightly with the 
available cap and secure with Parafilm.  Collect whole blood in either EDTA tubes 
or in a clotting tube. For plasma, collect blood in EDTA tubes and place in vials 
with external caps and internal O-ring seals. Store plasma and serum at 4°C. 
Serum may be frozen. 
http://www.cdc.gov/coronavirus/mers/guidelines-clinical-specimens.html
http://www.cdc.gov/coronavirus/mers/downloads/Interim-MERS-Lab-
Biosafety-Guidelines.pdf
Additional lnformation http://www.cdc.gov/coronavirus/mers/index.html,  
http://www.cdc.gov/coronavirus/mers/guidelines-clinical-specimens.html, 
http://www.cdc.gov/coronavirus/mers/downloads/Interim-MERS-Lab-
Biosafety-Guidelines.pdf
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition. Also include date of collection.
Transport Medium None
Shipping Instructions which 
Include Specimen Handling 
Requirements
Contact Lia Haynes (404-718-4639, Loh5@cdc.gov) or Dean Erdman 
(404-639-3727, dde1@cdc.gov) for shipping address.
See the following link for additional shipping information: 
http://www.cdc.gov/coronavirus/mers/guidelines-clinical-specimens.html
Methodology ELISA
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MERS-CoV Serology
CDC-10489
Test Order
Dean Erdman
(404) 639-3727
dde1@cdc.gov
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Microsporidia Molecular Identification
CDC-10481
Test Order
Synonym(s) Anncaliia, Encephalitozoon cuniculi, Encephalitozoon hellem, Encephalitozoon 
intestinalis, Septata intestinalis, Tubulinosema, Enterocytozoon bieneusi, 
Nosema, Pleistophora, Trachipleistophora, Vittaforma corneae, Nosema 
corneum, parasite
Performed on Specimens From Human, Animal, and Food/Environmental/Medical Devices/Biologics
CDC Points of Contact Alex daSilva
(404) 718-4121
adasilva@cdc.gov
Yvonne Qvarnstrom
(404) 718-4123
bvp2@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Urine, Stool (unpreserved), Tissue
Minimum Volume Required 200 uL
Turnaround Time 21 Days
Interferences & Limitations Formalin and LC-PVA fixed stool specimens are not suitable for molecular 
studies
Storage & Preservation of
Specimen Prior to Shipping
Storage and preservation is specimen specific
Additional lnformation None
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday – Thursday, overnight to avoid weekend deliveries. Ship specimen 
at room temperature, not on dry ice, as an etiologic agent.
Methodology Conventional PCR
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Moraxella species ID
CDC-10140
Test Order
Synonym(s) Moraxella, GNDC
Performed on Specimens From Human and Food/Environmental/Medical Devices/Biologics
CDC Points of Contact John McQuiston
(404) 639-0270
zje8@cdc.gov
Anne Whitney
(404) 639-1374
amw0@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
Please notify laboratory prior to shipment if this is a critical care specimen
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Pure culture isolate on a suitable agar slant medium; consultation required for 
other sample/specimen types
Minimum Volume Required Not Applicable
Turnaround Time 3 Weeks
Interferences & Limitations The 3 week turnaround time applies to all tests unless biochemical and/or 
phenotypic analysis are required, which could take up to 2 months for test 
results.
Storage & Preservation of
Specimen Prior to Shipping
Keep specimen refrigerated if unable to ship immediately
Additional lnformation If available, please provide patient history including if the patient has used a 
catheter and/or if the patient is immunocompromised.
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship specimen Monday-Thursday, overnight to avoid weekend deliveries
Methodology Primary Culture based on specimen type, MALDI-TOF, 16S sequence based 
identification
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Mumps Detection and Genotyping
CDC-10241
Test Order
Synonym(s) None
Performed on Specimens From Human
CDC Points of Contact Paul Rota
(404) 639-4181
par1@cdc.gov
Rebecca McNall
(404) 639-4541
dqo2@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Buccal swab, nasal swab, throat swab, urine, oral fluid and cerebrospinal fluid 
(CSF)
Minimum Volume Required Not Applicable
Turnaround Time 7 Days
Interferences & Limitations See: http://www.cdc.gov/mumps/lab/ for information on the interferences and 
limitations of this test
Storage & Preservation of
Specimen Prior to Shipping
See: http://www.cdc.gov/mumps/lab/specimen-collect.html for detailed 
information on the storage and preservation of the specimen
Additional lnformation Please include vaccination history, age, date of symptom onset and date of 
sample collection
For additional information about mumps surveillance please see: 
http://www.cdc.gov/vaccines/pubs/surv-manual/chpt09-mumps.html
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Clearly label specimen type.
Transport Medium http://www.cdc.gov/mumps/lab/
Shipping Instructions which 
Include Specimen Handling 
Requirements
The laboratory requests that the sender contacts the laboratory by email or 
phone before shipping
See shipping instructions: http://www.cdc.gov/mumps/lab/
Ship specimen Monday -Thursday overnight to avoid weekend deliveries
Frozen specimen should be shipped on dry ice
Refrigerated specimen should be shipped on cold packs
Methodology Real time RT-PCR, Template production by RT-PCR, Viral culture, Genotyping by 
Nucleic acid sequencing
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Mumps Neutralization Antibody (Not for Immune Status)
CDC-10351
Test Order
Synonym(s) PRN test, Plaque-reduction neutralization
Performed on Specimens From Human
CDC Points of Contact Bill Bellini
(404) 639-4183
wjb2@cdc.gov
Carole Hickman
(404) 639-3339
cjh3@cdc.gov
Pre-Approval Needed Bellini, Bill, (404) 639-4183, wjb2@cdc.gov
Hickman, Carole, (404) 639-3339, cjh3@cdc.gov
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Paired serum
Minimum Volume Required 300 uL
Turnaround Time 4 Weeks
Interferences & Limitations None
Storage & Preservation of
Specimen Prior to Shipping
Serum should be kept refrigerated, not frozen.
Additional lnformation None
Specimen Labeling Provide a unique identifier on the specimen container and the test requisition.
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship specimen Monday -Thursday overnight to avoid weekend deliveries
Refrigerated specimen should be shipped on cold packs
Methodology Neutralization assay - quantitative serological assay
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Mumps Serology
CDC-10245
Test Order
Synonym(s) None
Performed on Specimens From Human
CDC Points of Contact Bill Bellini
(404) 639-4183
wjb2@cdc.gov
Carole Hickman
(404) 639-3339
cjh3@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Serum
Minimum Volume Required 300 uL
Turnaround Time 7 Days
Interferences & Limitations Rheumatoid factor, Parainfluenza viruses 1, 2, and 3, Epstein-Barr virus, 
adenovirus, and Human Herpes Virus 6 have all been noted to interfere with 
mumps serologic assays.
Storage & Preservation of
Specimen Prior to Shipping
Serum should be kept refrigerated, not frozen
Additional lnformation IgM and IgG assays are qualitative assays
Please include vaccination history, age, date of onset and sample collection
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship specimen Monday -Thursday overnight to avoid weekend deliveries
Refrigerated specimen should be shipped on cold packs
Methodology CDC IgM Capture, Commercial indirect IgG
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Mumps Special Study
CDC-10252
Test Order
Synonym(s) None
Performed on Specimens From Human
CDC Points of Contact Bill Bellini
(404) 639-4183
wjb2@cdc.gov
Carole Hickman
(404) 639-3339
cjh3@cdc.gov
Pre-Approval Needed Bellini, Bill, (404) 639-4183, wjb2@cdc.gov
Hickman, Carole, (404) 639-3339, cjh3@cdc.gov
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
To be determined
Minimum Volume Required To be determined
Turnaround Time  
Interferences & Limitations To be determined
Storage & Preservation of
Specimen Prior to Shipping
To be determined
Additional lnformation To be determined
Specimen Labeling To be determined
Transport Medium To be determined
Shipping Instructions which 
Include Specimen Handling 
Requirements
To be determined
Methodology
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Mycobacterium - Non-tuberculosis Mycobacteria Identification
CDC-10225
Test Order
Synonym(s) Non-TB Mycobacteria, Mycobacteria
Performed on Specimens From Human, Animal, and Food/Environmental/Medical Devices/Biologics
CDC Points of Contact David Lonsway
(404) 639-2825
Dlonsway@cdc.gov
Nadege Toney
(404) 639-1282
ngc6@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Isolates demonstrated to not be part of the Mycobacterium tuberculosis complex
Isolates from the following specimens will be accepted for testing: 
Sterile sites (e.g., blood, CSF, body fluids)
Abscess, exudate or skin lesion
Wounds or surgical sites (see Additional Information) 
BAL/ bronch wash
Sputum (see Additional Information)
Gastric lavage (pediatric)
Animal and environmental isolates with prior consultation
Minimum Volume Required Not Applicable
Turnaround Time 28 Days
Interferences & Limitations None
Storage & Preservation of
Specimen Prior to Shipping
Keep specimen at room temperature
Additional lnformation Isolates from wounds or surgical sites must have documentation that NTM was 
abundant on primary culture (3+ to 4+) or was the only organism isolated.  
Isolates from sputum must have  documentation that the NTM was from two or 
more sputum cultures (collected on different days), was the only mycobacterial 
species present, and have abundant growth on primary culture.
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Lowenstein-Jensen or Middlebrook 7H10/7H11 agar
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship specimen Monday -Thursday overnight to avoid weekend deliveries at room 
temperature as an etiologic agent.
Methodology 16S Sequencing, MALDI-TOF, Phenotypic Testing
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Mycobacterium TB Complex - Drug Susceptibility Testing
CDC-10185
Test Order
Synonym(s) MTB DST, TB, Tuberculosis
Performed on Specimens From Human
CDC Points of Contact Beverly Metchock
(404) 639-2455
TBLab@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Pure isolate on solid medium or in broth culture
Minimum Volume Required Not applicable
Turnaround Time 32 Days
Interferences & Limitations None
Storage & Preservation of
Specimen Prior to Shipping
No Specific Requirements
Additional lnformation None
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition
Transport Medium Mycobacterium tuberculosis (MTB) Growth Medium
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday – Thursday, overnight to avoid weekend deliveries. Broth should 
not be shipped frozen.
Methodology Agar proportion, Pyrazinamide (PZA) by MGIT 960
 
Monday, January 13, 2014 Page 238 of 380Version: 1.0
Mycobacterium TB Complex - Identification
CDC-10187
Test Order
Synonym(s) TB, Tuberculosis
Performed on Specimens From Human
CDC Points of Contact Beverly Metchock
(404) 639-2455
TBLab@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Pure culture isolate
Minimum Volume Required Not Applicable
Turnaround Time 14 Days
Interferences & Limitations None
Storage & Preservation of
Specimen Prior to Shipping
No Specific Requirements
Additional lnformation None
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition
Transport Medium Mycobacterium tuberculosis (MTB) Growth Medium
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday – Thursday, overnight to avoid weekend deliveries.
Methodology Genetic based testing
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Mycobacterium TB Complex - Identification and Drug 
Susceptibility Testing
CDC-10188
Test Order
Synonym(s) TB, Tuberculosis
Performed on Specimens From Human
CDC Points of Contact Beverly Metchock
(404) 639-2455
TBLab@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Pure isolate on solid medium or in broth culture
Minimum Volume Required Not Applicable
Turnaround Time 32 Days
Interferences & Limitations None
Storage & Preservation of
Specimen Prior to Shipping
No Specific Requirements
Additional lnformation None
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition
Transport Medium Mycobacterium tuberculosis (MTB) Growth Medium
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday – Thursday, overnight to avoid weekend deliveries. Broth should 
not be shipped frozen.
Methodology Genetic based testing, Pyrazinamide (PZA) by MGIT 960, Agar Proportion
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Mycobacterium TB Complex - Identification and Pyrazinamide 
Susceptibility Testing
CDC-10190
Test Order
Synonym(s) TB, Tuberculosis
Performed on Specimens From Human
CDC Points of Contact Beverly Metchock
(404) 639-2455
TBLab@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Pure isolate on solid medium or in broth culture
Minimum Volume Required Not Applicable
Turnaround Time 32 Days
Interferences & Limitations None
Storage & Preservation of
Specimen Prior to Shipping
No Specific Requirements
Additional lnformation None
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition
Transport Medium Mycobacterium tuberculosis (MTB) Growth Medium
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday – Thursday, overnight to avoid weekend deliveries. Broth should 
not be shipped frozen.
Methodology Pyrazinamide (PZA) by MGIT 960, Genetic based testing
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Mycobacterium TB Complex - Molecular Detection of Drug 
Resistance (MDDR)
CDC-10186
Test Order
Synonym(s) MDDR, TB, Tuberculosis
Performed on Specimens From Human
CDC Points of Contact Beverly Metchock
(404) 639-2455
TBLab@cdc.gov
Jeff Driscoll
(404) 639-2455
TBLab@cdc.gov
Pre-Approval Needed Metchock, Beverly, (404) 639-2455, TBLab@cdc.gov
Driscoll, Jeff, (404) 639-2455, TBLab@cdc.gov
Supplemental Information
Required
See Supplemental Form
Supplemental Form http://www.cdc.gov/tb/topic/laboratory/MDDRsubmissionform.pdf
Acceptable Sample/ Specimen 
Type for Testing
Nucleic Acid Amplification positive (NAA+) sputum sediment or pure culture 
isolate on solid medium or in broth culture
Minimum Volume Required 0.5 mL (sediment)
Turnaround Time 3 Days
Interferences & Limitations None
Storage & Preservation of
Specimen Prior to Shipping
No Specific Requirements
Additional lnformation None
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition
Transport Medium Mycobacterium tuberculosis (MTB) Growth Medium
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday – Thursday, overnight to avoid weekend deliveries. Sediments and 
broth cultures should not be shipped frozen.
Methodology Pyrosequencing, Sanger sequencing, Agar Proportion DST, MGIT 960 
Pyrazinamide (PZA)
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Mycobacterium TB Complex - Pyrazinamide Susceptibility 
Testing
CDC-10189
Test Order
Synonym(s) PZA DST, TB, Tuberculosis
Performed on Specimens From Human
CDC Points of Contact Beverly Metchock
(404) 639-2455
TBLab@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Pure isolate on solid medium or in broth culture
Minimum Volume Required Not applicable
Turnaround Time 14 Days
Interferences & Limitations None
Storage & Preservation of
Specimen Prior to Shipping
No Specific Requirements
Additional lnformation None
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition
Transport Medium Mycobacterium tuberculosis (MTB) Growth Medium
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday – Thursday, overnight to avoid weekend deliveries. Broth should 
not be shipped frozen.
Methodology Pyrazinamide (PZA) by MGIT 960
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Mycobacterium TB Complex - Special Study
CDC-10191
Test Order
Synonym(s) None
Performed on Specimens From Human
CDC Points of Contact Beverly Metchock
(404) 639-2455
TBLab@cdc.gov
Pre-Approval Needed Metchock, Beverly, (404) 639-2455, TBLab@cdc.gov
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
To be determined
Minimum Volume Required To be determined
Turnaround Time  
Interferences & Limitations To be determined
Storage & Preservation of
Specimen Prior to Shipping
To be determined
Additional lnformation To be determined
Specimen Labeling To be determined
Transport Medium To be determined
Shipping Instructions which 
Include Specimen Handling 
Requirements
To be determined
Methodology
 
Monday, January 13, 2014 Page 244 of 380Version: 1.0
Mycobacterium TB Complex (International Only) Identification 
and Drug Susceptibility Testing
CDC-10352
Test Order
Synonym(s) Culture, DST, AST, MTB, MTB complex, TB, MDR TB, ID, Tuberculosis
Performed on Specimens From Human
Pre-Approval Needed Alexander, Heather, (404) 639-5331, drz5@cdc.gov
DeGruy, Kyle, (404) 639-0875, gsz4@cdc.gov
Supplemental Information
Required
Supplemental form will be provided upon consultation
Fill out the ILB-100-F08C TB Requisition Form
CDC Form 0.753:
Application for Permit to Import or Transport Etiological Agents, Hosts, or 
Vectors of
Human Disease. It is a requirement to complete this form.
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Suspected Mycobacteria tuberculosis Complex isolates in Middlebrook 7H9 liquid 
media or MGIT (7H9) broth inoculated with culture isolate
Minimum Volume Required 0.3 mL
Turnaround Time 150 Days
Interferences & Limitations Nonviable isolates sent for phenotypic DST and contaminated or mixed isolates 
sent for phenotypic DST will interfere with the test. 
Specimen can be rejected if improperly labeled or unlabeled, insufficient volume 
for testing, without documentation or with discrepant documentation, and have 
leaked in transit or otherwise show evidence of contamination.
Storage & Preservation of
Specimen Prior to Shipping
Mycobacterium tuberculosis Complex in Sterile 2.0 mL screw cap cryovial with 
O-ring. Specimen should be kept frozen at -70°C indefinitely, but specimen may 
be stored at -20°C for three months.
Additional lnformation Turn around time is dependent on batch orders: 
Batches with less than 100 specimens within 150 days
Batches with greater than 100, contact Heather Alexander, drz5@cdc.gov.
Specimen Labeling All primary specimen containers must include 2 unique identifiers at the time of 
collection. The identifiers must be clearly labeled on each specimen and 
correspond to information on the requisition form.
Surveillance studies and some protocols require 1 unique identifier (the ILB 
recommends 2 identifiers) de-linked from the patient. Do not include the 
patient’s name or any other personally identifiable information. Results are not 
reported back to patient.
Transport Medium Middlebrook or MGIT (7H9) broth should be inoculated with a culture isolate of a 
suspected Mycobacterium tuberculosis Complex and  transported in a sterile 2.0 
mL screw cap cryovial with O-ring.
Shipping Instructions which 
Include Specimen Handling 
Requirements
Keep specimen frozen at -70°C or lower by using dry ice.
Refer to Mycobacterium tuberculosis Isolate Preparation & Shipments on page 7 
of International Laboratory Branch Test Directory or contact laboratory prior to 
submission.
Methodology Phenotypic and genotypic ID with reflex to drug susceptibility
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Mycobacterium TB Complex (International Only) Identification 
and Drug Susceptibility Testing
CDC-10352
Test Order
CDC Points of Contact Heather Alexander
(404) 639-5331
drz5@cdc.gov
Kyle DeGruy
(404) 639-0875
gsz4@cdc.gov
Drug Susceptibility Testing on Mycobacterium tuberculosis complex performed 
for first line drugs streptomycin, isoniazid, rifampicin, ethambutol, and 
pyrazinamide on the BD BACTEC™MGIT™ 960 system and for isoniazid and 
rifampicin on molecular line probe assay. Drug Susceptibility Testing on 
Mycobacterium tuberculosis complex performed for second line drugs with the 
modified method of proportion for streptomycin, isoniazid, rifampicin, 
ethambutol, rifabutin, PAS, ciprofloxacin, ofloxacin, kanamycin, ethionamide, 
capreomycin, and amikacin. Genotype MTBDRsl tests second line drugs are 
ofloxacin, ciprofloxacin, moxifloxacin, amikacin, kanamycin, capreomycin, 
viomycin and ethambutol.
Zilma Rey
(404) 639-2345
yzr0@cdc.gov
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Mycobacterium TB Complex (International Only) Special Study
CDC-10353
Test Order
Synonym(s) None
Performed on Specimens From Human
CDC Points of Contact Heather Alexander
(404) 639-5331
drz5@cdc.gov
Kyle DeGruy
(404) 639-0875
gsz4@cdc.gov
Pre-Approval Needed Alexander, Heather, (404) 639-5331, drz5@cdc.gov
DeGruy, Kyle, (404) 639-0875, gsz4@cdc.gov
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
To be determined
Minimum Volume Required To be determined
Turnaround Time  
Interferences & Limitations To be determined
Storage & Preservation of
Specimen Prior to Shipping
To be determined
Additional lnformation
Specimen Labeling All primary specimen containers must include 2 unique identifiers at the time of 
collection. The identifiers must be clearly labeled on each specimen and 
correspond to information on the requisition form.
Surveillance studies and some protocols require 1 unique identifier (the ILB 
recommends 2 identifiers) de-linked from the patient. Do not include the 
patient’s name or any other personally identifiable information. Results are not 
reported back to patient.
Transport Medium To be determined
Shipping Instructions which 
Include Specimen Handling 
Requirements
To be determined
Methodology
Zilma Rey
(404) 639-2345
yzr0@cdc.gov
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Mycoplasma pneumoniae Molecular Detection
CDC-10155
Test Order
Synonym(s) Walking pneumonia, Atypical pneumonia, Community Acquired Pneumoniae 
(CAP)
Performed on Specimens From Human
CDC Points of Contact Jonas Winchell
(404) 639-4921
Jwinchell@cdc.gov
Maureen Diaz
(404) 639-4534
mdiaz1@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Nasopharyngeal (NP) and/or Oropharyngeal (OP) swabs, and any lower 
respiratory tract specimen including bronchoalveolar lavage (BAL) and sputum; 
tissue, cerebral spinal fluid , isolates and purified nucleic acid; Others upon 
consultation with laboratory.
Minimum Volume Required Contingent upon specimen type. Please call for consultation
Turnaround Time 7 Days
Interferences & Limitations Do not use cotton swabs with wooden shafts. Specimen should be acquired prior 
to antibiotic treatment. Improper specimen storage and handling may result in 
inconclusive or inaccurate results.
Storage & Preservation of
Specimen Prior to Shipping
Specimens can be kept refrigerated if shipped in less than 72 hours of collection; 
otherwise specimen should be kept frozen. Store swabs in universal transport 
medium.
Additional lnformation None
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Universal transport medium
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday overnight to avoid weekend deliveries
Refrigerated specimen should be sent on ice packs
Frozen specimen should be sent on dry ice
Methodology Real Time PCR
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Mycoplasma species Study
CDC-10156
Test Order
Synonym(s) None
Performed on Specimens From Human
CDC Points of Contact Jonas Winchell
(404) 639-4921
Jwinchell@cdc.gov
Maureen Diaz
(404) 639-4534
mdiaz1@cdc.gov
Pre-Approval Needed Winchell, Jonas, (404) 639-4921, Jwinchell@cdc.gov
Diaz, Maureen, (404) 639-4534, mdiaz1@cdc.gov
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
To be determined
Minimum Volume Required To be determined
Turnaround Time  
Interferences & Limitations To be determined
Storage & Preservation of
Specimen Prior to Shipping
To be determined
Additional lnformation To be determined
Specimen Labeling To be determined
Transport Medium To be determined
Shipping Instructions which 
Include Specimen Handling 
Requirements
To be determined
Methodology
 
Monday, January 13, 2014 Page 249 of 380Version: 1.0
Naegleria Molecular Detection
CDC-10482
Test Order
Synonym(s) Free-living ameba, parasite
Performed on Specimens From Human
CDC Points of Contact Alex daSilva
(404) 718-4121
adasilva@cdc.gov
Jennifer Cope
(404) 718-4878
bjt9@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Cerebrospinal Fluid (CSF), Tissue
Minimum Volume Required 200 uL
Turnaround Time 21 Days
Interferences & Limitations Formalin fixed  specimens are not suitable for molecular studies
Storage & Preservation of
Specimen Prior to Shipping
Storage and preservation is specimen specific
Additional lnformation None
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday – Thursday, overnight to avoid weekend deliveries. Ship specimen 
at room temperature, not on dry ice, as an etiologic agent.
Methodology Conventional PCR, Real-Time PCR
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NARMS Susceptibility Testing
CDC-10107
Test Order
Synonym(s) National Antimicrobial Resistance Monitoring System, NARMS surveillance
Performed on Specimens From Human
CDC Points of Contact Kevin Joyce
(404) 639-1944
kdj7@cdc.gov
Patricia Jones
(404) 639-3334
entericbacteria@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
Submitter must be a NARMS participating laboratory. Specimens accepted 
according to current National Antimicrobial Resistance Monitoring System 
(NARMS) sampling scheme. NARMS log sheet or entry into NARMS web 
interface.
Supplemental Form https://wwwn.cdc.gov/NARMS/UserLogin.aspx
Acceptable Sample/ Specimen 
Type for Testing
Isolates. Specimens accepted according to NARMS guidelines
Minimum Volume Required Not Applicable
Turnaround Time 8 Weeks
Interferences & Limitations None
Storage & Preservation of
Specimen Prior to Shipping
No Specific Requirements
Additional lnformation The turn around time depends on the nature of subtyping performed; and, 
results are typically reported directly to the surveillance databases.
Specimen Labeling State or local public health laboratory number
Transport Medium Please refer to guidance for specific organism
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday, overnight to avoid weekend deliveries.
Please refer to guidance for specific organism.
Methodology Broth Microdilution Antimicrobial Susceptibility (AST), E-Test Susceptibility 
Testing
Regan Rickert
(404) 639-3479
gqv9@cdc.gov
Michael Korth
(404) 639-2099
mqk8@cdc.gov
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Neisseria (STD) Identification
CDC-10101
Test Order
Synonym(s) Neisseria, GC
Performed on Specimens From Human
CDC Points of Contact John Papp
(404) 639-3785
jwp6@cdc.gov
Kevin Pettus
(404) 639-4338
kbp9@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Genital, pharyngeal, and/or rectal swabs. In addition, bacterial culture or isolate 
on appropriate culture media
Minimum Volume Required Not Applicable
Turnaround Time 1 Week
Interferences & Limitations Anything that can affect viability of gonorrhea will adversely affect the test 
results
Storage & Preservation of
Specimen Prior to Shipping
Specimen needs to be stored in a manner that will maintain viability of 
gonorrhea
Additional lnformation Please provide information on any antibiotics the patient may have been treated 
with
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Any acceptable medium for gonorrhea transport
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday – Thursday, overnight to avoid weekend deliveries. Frozen 
specimen should be shipped on dry ice and refrigerated specimen should be 
shipped on cold packs, as an etiologic agent.
Methodology Phenotypic identification
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Neisseria gonorrhoeae Study
CDC-10103
Test Order
Synonym(s) None
Performed on Specimens From Human
CDC Points of Contact John Papp
(404) 639-3785
jwp6@cdc.gov
Kevin Pettus
(404) 639-4338
kbp9@cdc.gov
Pre-Approval Needed Papp, John, (404) 639-3785, jwp6@cdc.gov
Pettus, Kevin, (404) 639-4338, kbp9@cdc.gov
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
To be determined
Minimum Volume Required To be determined
Turnaround Time  
Interferences & Limitations To be determined
Storage & Preservation of
Specimen Prior to Shipping
To be determined
Additional lnformation To be determined
Specimen Labeling To be determined
Transport Medium To be determined
Shipping Instructions which 
Include Specimen Handling 
Requirements
To be determined
Methodology
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Neisseria gonorrhoeae Susceptibility Testing
CDC-10102
Test Order
Synonym(s) Neisseria AST, GC Susceptibility
Performed on Specimens From Human
CDC Points of Contact John Papp
(404) 639-3785
jwp6@cdc.gov
Kevin Pettus
(404) 639-4338
kbp9@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
Required: Patient demographics and recent travel history.
Supplemental Form http://www.cdc.gov/std/gisp/CDC73.60AGonococcal.pdf
Acceptable Sample/ Specimen 
Type for Testing
Genital, pharyngeal, and/or rectal swabs. In addition, bacterial culture or isolate 
on appropriate growth media
Minimum Volume Required Not Applicable
Turnaround Time 2 Weeks
Interferences & Limitations Anything that can affect viability of gonorrhea will adversely affect the test 
results
Storage & Preservation of
Specimen Prior to Shipping
Specimen needs to be stored in a manner that will maintain viability of 
gonorrhea
Additional lnformation Please provide information on any antibiotics the patient may have been treated 
with
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Any acceptable medium for gonorrhea transport
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday – Thursday, overnight to avoid weekend deliveries. Frozen 
specimen should be shipped on dry ice and refrigerated specimen should be 
shipped on cold packs, as an etiologic agent.
Methodology Agar Plate Dilution, E-test, Disk Diffusion
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Neisseria meningitidis Identification and Serogrouping
CDC-10219
Test Order
Synonym(s) N. meningitidis ID and SASG
Performed on Specimens From Human
CDC Points of Contact Xin Wang
(404) 639-5474
gqe8@cdc.gov
Jordan Theodore
(404) 639-0230
ale7@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Pure culture isolate, frozen stock, and primary specimen such as, CSF, whole 
blood, serum, and other sterile site specimen types upon consultation
Minimum Volume Required 0.25 mL
Turnaround Time 30 Days
Interferences & Limitations Improperly temperature controlled specimens can give a false negative PCR 
result
Storage & Preservation of
Specimen Prior to Shipping
Store slants at ambient temperature. Primary specimen and stocks should be 
frozen.
Additional lnformation None
Specimen Labeling Patient name, medical record, hospital or state ID or ABCs state ID or accession 
number
Transport Medium Chocolate agar slants preferred (plates not recommended) or frozen stock
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday overnight to avoid weekend deliveries. May ship Friday's 
with prior approval only. 
Frozen specimen should be shipped on dry ice
Methodology Growth, Morphology, Biochemical Testing, Slide Agglutination Serogrouping, 
Real-time PCR
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Neisseria meningitidis Study
CDC-10220
Test Order
Synonym(s) None
Performed on Specimens From Human
CDC Points of Contact Leonard Mayer
(404) 639-2841
lwm1@cdc.gov
Amanda Cohn
(404) 639-6039
anc0@cdc.gov
Pre-Approval Needed Mayer, Leonard, (404) 639-2841, lwm1@cdc.gov
Cohn, Amanda, (404) 639-6039, anc0@cdc.gov
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
To be determined
Minimum Volume Required To be determined
Turnaround Time  
Interferences & Limitations To be determined
Storage & Preservation of
Specimen Prior to Shipping
To be determined
Additional lnformation To be determined
Specimen Labeling To be determined
Transport Medium To be determined
Shipping Instructions which 
Include Specimen Handling 
Requirements
To be determined
Methodology
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Neisseria species (Not GC or meningococcus) ID
CDC-10139
Test Order
Synonym(s) Neisseria, GNDC
Performed on Specimens From Human and Food/Environmental/Medical Devices/Biologics
CDC Points of Contact John McQuiston
(404) 639-0270
zje8@cdc.gov
Anne Whitney
(404) 639-1374
amw0@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
Please notify laboratory prior to shipment if this is a critical care specimen
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Pure culture isolate on a suitable agar slant medium; Consultation required for 
other sample/specimen types
Minimum Volume Required Not Applicable
Turnaround Time 3 Weeks
Interferences & Limitations The 3 week turnaround time applies to all tests unless biochemical and/or 
phenotypic analysis are required, which could take up to 2 months for test 
results.
Storage & Preservation of
Specimen Prior to Shipping
Keep specimen refrigerated if unable to ship immediately
Additional lnformation If available, please provide patient history including if the patient has used a 
catheter and/or if the patient is immunocompromised.
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship specimen Monday-Thursday, overnight to avoid weekend deliveries
Methodology Primary Culture based on specimen type, MALDI-TOF, 16S sequence based 
identification
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Nipah Virus Identification
CDC-10354
Test Order
Synonym(s) None
Performed on Specimens From Human and Animal
CDC Points of Contact Ute Stroeher
(404) 639-4704
ixy8@cdc.gov
Barbara Knust
(404) 639-1104
bkk0@cdc.gov
Pre-Approval Needed Stroeher, Ute, (404) 639-4704, ixy8@cdc.gov
Knust, Barbara, (404) 639-1104, bkk0@cdc.gov
Supplemental Information
Required
See Supplemental Form
Supplemental Form http://www.cdc.gov/ncezid/dhcpp/vspb/pdf/specimen-submission.pdf
Acceptable Sample/ Specimen 
Type for Testing
Frozen tissue, blood and serum
Minimum Volume Required 1 mL
Turnaround Time 10 Days
Interferences & Limitations Specimen must remain frozen; warming or freeze thawing reduces sensitivity. 
Heparin may cause interference with the molecular tests and should be avoided.
Storage & Preservation of
Specimen Prior to Shipping
Specimen must be placed in plastic screw capped vials, frozen to -70°C, and kept 
frozen until shipment. See link to supplemental submission form for specific 
information on various specimen types.
Additional lnformation Critical specimens will take less than 4 days to turn around. See link to 
supplemental submission forms for detailed information.
Specimen Labeling Patient name, patient ID #, specimen type, date collected
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday overnight to avoid weekend deliveries. Specimen should 
be shipped frozen on dry ice. See supplemental submission forms for further 
details. Do not ship specimen without prior consultation and approval.
Methodology Molecular Typing, Polymerase Chain Reaction (PCR)
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Nipah Virus Serology
CDC-10355
Test Order
Synonym(s) None
Performed on Specimens From Human and Animal
CDC Points of Contact Ute Stroeher
(404) 639-4704
ixy8@cdc.gov
Barbara Knust
(404) 639-1104
bkk0@cdc.gov
Pre-Approval Needed Stroeher, Ute, (404) 639-4704, ixy8@cdc.gov
Knust, Barbara, (404) 639-1104, bkk0@cdc.gov
Supplemental Information
Required
See Supplemental Form
Supplemental Form http://www.cdc.gov/ncezid/dhcpp/vspb/pdf/specimen-submission.pdf
Acceptable Sample/ Specimen 
Type for Testing
Blood and serum
Minimum Volume Required 1 mL
Turnaround Time 10 Days
Interferences & Limitations Specimen must remain frozen; warming or freeze thawing reduces sensitivity
Storage & Preservation of
Specimen Prior to Shipping
Specimen must be kept cold (at or below 4°C). If possible place specimen in 
plastic screw capped vials. See link to supplemental submission form for specific 
information on various specimen types.
Additional lnformation Critical specimens will take less than 4 days to turn around. See link to 
supplemental submission forms for detailed information.
Specimen Labeling Patient name, patient ID #, specimen type, date collected
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday overnight to avoid weekend deliveries. Specimen should 
be shipped on cold packs or dry ice if frozen. See supplemental submission 
forms for further details. Do not ship specimen without prior consultation and 
approval.
Methodology ELISA
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Nocardia species ID
CDC-10150
Test Order
Synonym(s) None
Performed on Specimens From Human and Food/Environmental/Medical Devices/Biologics
CDC Points of Contact John McQuiston
(404) 639-0270
zje8@cdc.gov
Anne Whitney
(404) 639-1374
amw0@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
Please notify laboratory prior to shipment if this is a critical care specimen
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Pure culture isolate on a suitable agar slant medium; consultation required for 
other sample/specimen types
Minimum Volume Required Not Applicable
Turnaround Time 3 Weeks
Interferences & Limitations The 3 week turnaround time applies to all tests unless biochemical and/or 
phenotypic analysis are required, which could take up to 2 months for test 
results.
Storage & Preservation of
Specimen Prior to Shipping
Keep specimen refrigerated if unable to ship immediately
Additional lnformation If available, please provide patient history including if the patient has used a 
catheter and/or if the patient is immunocompromised.
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship specimen Monday-Thursday, overnight to avoid weekend deliveries
Methodology Primary Culture based on specimen type, MALDI-TOF, 16S sequence based 
identification
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Nocardia species ID and AST
CDC-10151
Test Order
Synonym(s) None
Performed on Specimens From Human and Food/Environmental/Medical Devices/Biologics
CDC Points of Contact John McQuiston
(404) 639-0270
zje8@cdc.gov
Anne Whitney
(404) 639-1374
amw0@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
Please notify laboratory prior to shipment if this is a critical care specimen
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Pure culture isolate on a suitable agar slant medium; consultation required for 
other sample/specimen types
Minimum Volume Required Not Applicable
Turnaround Time 3 Weeks
Interferences & Limitations The 3 week turnaround time applies to all tests unless biochemical and/or 
phenotypic analysis are required, which could take up to 2 months for test 
results.
Storage & Preservation of
Specimen Prior to Shipping
Keep specimen refrigerated if unable to ship immediately
Additional lnformation If available, please provide patient history including if the patient has used a 
catheter and/or if the patient is immunocompromised.
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition
Transport Medium Suitable agar slant medium
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship specimen Monday-Thursday, overnight to avoid weekend deliveries
Methodology Primary Culture based on specimen type, MALDI-TOF, 16S sequence based 
identification, AST by broth microdilution
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Norovirus Genotyping
CDC-10356
Test Order
Synonym(s) Norovirus
Performed on Specimens From Human and Food/Environmental/Medical Devices/Biologics
CDC Points of Contact Jan Vinje
(404) 639-3721
ahx8@cdc.gov
Nicole Gregoricus
(404) 639-1923
frv6@cdc.gov
Pre-Approval Needed Vinje, Jan, (404) 639-3721, ahx8@cdc.gov
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Stool, environmental swab
Minimum Volume Required 0.25 g or 0.25 mL
Turnaround Time 4 Weeks
Interferences & Limitations None
Storage & Preservation of
Specimen Prior to Shipping
Specimen must be stored at 2°-8°C
Additional lnformation None
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship specimen Monday -Thursday, overnight to avoid weekend deliveries
Refrigerated specimen should be shipped on cold packs
Methodology Polymerase Chain Reaction (PCR), Sequencing
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Norovirus Molecular Detection
CDC-10357
Test Order
Synonym(s) Norovirus
Performed on Specimens From Human and Food/Environmental/Medical Devices/Biologics
CDC Points of Contact Jan Vinje
(404) 639-3721
ahx8@cdc.gov
Nicole Gregoricus
(404) 639-1923
frv6@cdc.gov
Pre-Approval Needed Vinje, Jan, (404) 639-3721, ahx8@cdc.gov
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Stool, environmental swab
Minimum Volume Required 0.25 g or 0.25 mL
Turnaround Time 4 Weeks
Interferences & Limitations None
Storage & Preservation of
Specimen Prior to Shipping
Specimen should be stored at 2°-8°C
Additional lnformation None
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship specimen Monday -Thursday, overnight to avoid weekend deliveries
Refrigerated specimen should be shipped on cold packs
Methodology Polymerase Chain Reaction (PCR)
 
Monday, January 13, 2014 Page 263 of 380Version: 1.0
Norovirus Molecular Detection and Genotyping
CDC-10358
Test Order
Synonym(s) Norovirus
Performed on Specimens From Human and Food/Environmental/Medical Devices/Biologics
CDC Points of Contact Jan Vinje
(404) 639-3721
ahx8@cdc.gov
Nicole Gregoricus
(404) 639-1923
frv6@cdc.gov
Pre-Approval Needed Vinje, Jan, (404) 639-3721, ahx8@cdc.gov
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Stool, environmental swab
Minimum Volume Required 0.25 g or 0.25 mL
Turnaround Time 4 Weeks
Interferences & Limitations None
Storage & Preservation of
Specimen Prior to Shipping
Specimen must be stored at 2°-8°C
Additional lnformation None
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship specimen Monday -Thursday, overnight to avoid weekend deliveries
Refrigerated specimen should be shipped on cold packs
Methodology Polymerase Chain Reaction (PCR), Sequencing
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Orientia Molecular Detection
CDC-10359
Test Order
Synonym(s) Scrub Typhus
Performed on Specimens From Human
CDC Points of Contact Cecilia Kato
(404) 639-1075
ckato@cdc.gov
Jennifer McQuiston
(404) 639-1075
fzh7@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
Prior approval is required if the following information is not provided:
-Symptom onset date
-Sample collection date
-Type of infection
-Status of illness
Recommended:
-Travel history
-Exposure history
-Therapeutic agents
-Brief clinical history
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Acute samples only, anticoagulated whole blood collected in 
Ethylenediaminetetraacetic acid (EDTA) treated tubes preferred; serum; fresh 
tissue biopsy
Minimum Volume Required 1.0 mL
Turnaround Time 6 Weeks
Interferences & Limitations Hemolysis in whole blood specimen will interfere with results. Multiple freeze 
thaw cycles and sample storage above refrigerated temperatures will interfere 
with proper nucleic acid extraction. If a specimen is drawn at convalescence it 
will reduce the chance of the target organism being present in blood. Avoid 
collection of blood specimen in heparin tubes.
Storage & Preservation of
Specimen Prior to Shipping
Ideally keep specimen at a refrigerated temperature not frozen. If previously 
frozen, then keep specimen frozen.
Additional lnformation The Rickettsial Zoonoses Branch Reference Diagnostic Laboratory aids State 
Laboratories in diagnosis of difficult samples/cases or if specialized tests are 
needed. Routine diagnostic samples should be sent to your State Laboratory or a 
commercial laboratory.
Specimen Labeling Patient name and date of birth
Transport Medium Ethylenediaminetetraacetic acid (EDTA) blood tubes for blood; tissue in a sample 
collection tube
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday - Thursday, overnight to avoid weekend deliveries. Specimen 
should be shipped refrigerated on cold packs.
Methodology Real Time Polymerase Chain Reaction (PCR), Polymerase Chain Reaction (PCR), 
Sequencing
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Orientia Serology
CDC-10360
Test Order
Synonym(s) Scrub Typhus
Performed on Specimens From Human
CDC Points of Contact Cecilia Kato
(404) 639-1075
ckato@cdc.gov
Jennifer McQuiston
(404) 639-1075
fzh7@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
Prior approval is required if the following information is not provided:
-Symptom onset date
-Sample collection date
-Type of infection
-Status of illness
Recommended:
-Travel history
-Exposure history
-Therapeutic agents
-Brief clinical history
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Serum
-acute (during active stage of illness)
-convalescent (2-4 weeks after acute stage)
Minimum Volume Required 1.0 mL
Turnaround Time 6 Weeks
Interferences & Limitations Multiple freeze thaw cycles may interfere with antigen binding. Use sterile 
technique to avoid contamination of sample as this may compromise the sample 
and interfere with the ability to get accurate results. Acute and convalescent 
serum is needed for accurate diagnosis and if unable to collect both please 
contact laboratory prior to shipping.
Storage & Preservation of
Specimen Prior to Shipping
Ideally keep specimen at a refrigerated temperature not frozen. If previously 
frozen, then keep specimen frozen.
Additional lnformation The Rickettsial Zoonoses Branch Reference Diagnostic Laboratory aids State 
Laboratories in diagnosis of difficult samples/cases or if specialized tests are 
needed.  Routine diagnostic samples should be sent to your State Laboratory or a 
commercial lab.
Specimen Labeling Patient name and date of birth
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday - Thursday, overnight to avoid weekend deliveries. Specimen 
should be shipped refrigerated on cold packs.
Methodology Indirect Fluorescence Assay (IFA)
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Paragonimiasis Immunoblot
CDC-10465
Test Order
Synonym(s) Paragonimus westermani; Paragonimus kellicotti, parasite
Performed on Specimens From Human
CDC Points of Contact Patricia Wilkins
(404) 718-4101
pma1@cdc.gov
Isabel McAuliffe
(404) 718-4100
ibm4@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
Exposure and travel history, include other relevant risk factors; clinical 
symptoms, treatment and previous test results.
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Serum and Plasma
Minimum Volume Required 0.5 mL
Turnaround Time 15 Days
Interferences & Limitations Substances known to interfere with immunoassays include: bilirubin, lipids, and 
hemoglobin 
Storage & Preservation of
Specimen Prior to Shipping
No specific requirements
Additional lnformation None
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday – Thursday, overnight to avoid weekend deliveries. Ship specimen 
at room temperature, not on dry ice, as an etiologic agent.
Methodology Immunoblot, Western Blot, Antibody Detection
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Parasite - Morphologic Identification (O+P)
CDC-10234
Test Order
Synonym(s) Parasitology, Malaria parasite identification, Blood parasite, ova and parasite
Performed on Specimens From Human, Animal, and Food/Environmental/Medical Devices/Biologics
CDC Points of Contact Alex daSilva
(404) 718-4121
adasilva@cdc.gov
Blaine Mathison
(404) 718-4103
gqa4@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
Supplemental form not needed
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Stool specimens, blood, and tissue. Additional acceptable specimens are listed 
on the supplemental link.
Minimum Volume Required Not Applicable
Turnaround Time 7 Days
Interferences & Limitations None
Storage & Preservation of
Specimen Prior to Shipping
Storage and preservation is specimen specific, see supplemental link
Additional lnformation None
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday – Thursday, overnight to avoid weekend deliveries
Shipping is specimen specific see supplemental link
Methodology Microscopy
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Parasite - Special Study
CDC-10237
Test Order
Synonym(s) None
Performed on Specimens From Human, Animal, and Food/Environmental/Medical Devices/Biologics
CDC Points of Contact Patricia Wilkins
(404) 718-4104
pwilkins@cdc.gov
Alex daSilva
(404) 718-4121
adasilva@cdc.gov
Pre-Approval Needed Wilkins, Patricia, (404) 718-4104, pwilkins@cdc.gov
daSilva, Alex, (404) 718-4121, adasilva@cdc.gov
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
To be determined
Minimum Volume Required To be determined
Turnaround Time  
Interferences & Limitations To be determined
Storage & Preservation of
Specimen Prior to Shipping
To be determined
Additional lnformation To be determined
Specimen Labeling To be determined
Transport Medium To be determined
Shipping Instructions which 
Include Specimen Handling 
Requirements
To be determined
Methodology
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Parechovirus Detection and Identification
CDC-10362
Test Order
Synonym(s) Human parechovirus, HPEV, Echovirus 22, Echovirus 23, Ljungan virus, 
parechovirus
Performed on Specimens From Human, Animal, and Food/Environmental/Medical Devices/Biologics
Pre-Approval Needed None
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Specimens include stool, serum, throat or nasal swab, cerebrospinal fluid (CSF), 
vesicle fluid or lesion, rectal, or nasopharyngeal (NP)/oropharyngeal (OP) swabs. 
Fresh or frozen tissues are preferred to Formalin fixed tissues, but will accept 
both.
Minimum Volume Required Not Applicable
Turnaround Time 10 Days
Interferences & Limitations Collecting specimens during the first week of illness is ideal although the virus 
can be shed in stool for several weeks.  A specimen set collected in the second 
week of illness should include a rectal swab or stool sample.
Storage & Preservation of
Specimen Prior to Shipping
Vesicle fluid, rectal, or nasopharyngeal (NP)/oropharyngeal (OP) swabs: 
Use only sterile Dacron or rayon swabs with plastic shafts or if available, flocked 
swabs. Do NOT use calcium alginate swabs or swabs with wooden sticks, as they 
may contain substances that inactivate some viruses and inhibit some molecular 
assays.  Place the swab immediately into a sterile viral containing 2mL of viral 
transport media without antibiotics, if possible.
Stool:  Collect in a clean, dry, leak-proof container.
Serum:  For each serum specimen, collect whole blood into a serum separator 
tube (marble or tiger top SST). Allow to clot at room temperature for a minimum 
of 30 minutes and centrifuge.
Additional lnformation Minimum volume for cell culture is 0.5-1 mL, for CSF is 60 uL, and for fresh 
frozen tissues is 2 mm^2.
Stool:  Stool may be collected within 14 days of symptom onset.  Collect 10-20 g 
of stool in a clean, dry, leak-proof container.
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Viral transport medium. If you do not have viral transport media, place the swab 
into a sterile vial without viral transport media.  Aseptically, cut or break 
applicator sticks off near the tip to permit tightening of the cap.  For NP/OP 
swabs, both swabs can be placed in the same vial, if desired.
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday – Thursday, overnight to avoid weekend deliveries. Frozen 
specimen should be shipped on dry ice and refrigerated specimen should be 
shipped on cold packs, as an etiologic agent.
Include the full name, title, complete mailing address, email address, telephone, 
and fax number of the submitter.  This will be the person to whom the final 
report will be mailed to.
Methodology Molecular techniques
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Parechovirus Detection and Identification
CDC-10362
Test Order
CDC Points of Contact Alan Nix
(404) 639-1689
wbn0@cdc.gov
Steve Oberste
(404) 639-5497
mbo2@cdc.gov
Serum:  For each serum specimen, collect (adults and children >6kg: 5 mL, 
children <6 kg: 2 mL) of whole blood into a serum separator tube (marble or 
tiger top SST). A minimum of 1 mL of whole blood is needed for testing of 
pediatric patients. Allow to clot at room temperature for a minimum of 30 
minutes and centrifuge.
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Parvovirus B19 Molecular Detection
CDC-10363
Test Order
Synonym(s) Fifth Disease
Performed on Specimens From Human
CDC Points of Contact Dean Erdman
(404) 639-3727
dde1@cdc.gov
Shifaq Kamili
(404) 639-2799
sgk5@cdc.gov
Pre-Approval Needed Erdman, Dean, (404) 639-3727, dde1@cdc.gov
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Serum, blood, plasma, and amniotic fluid
Minimum Volume Required 0.25 mL
Turnaround Time 3 Weeks
Interferences & Limitations Do not use wooden-shafted swabs or calcium alginate swabs
Storage & Preservation of
Specimen Prior to Shipping
Refrigerate all specimens promptly after collection. If specimens can be shipped 
to CDC within 72 hours of collection, they should be kept refrigerated at 4°C and 
shipped on gel ice-packs.  If specimens must be held for >72 hours, they should 
be promptly frozen at -70°C and shipped on dry ice. Liquid specimens should be 
aliquoted into properly labeled, leak-proof, unbreakable screw cap vials. 
Samples should be collected and processed in a manner that prevents cross-
contamination between specimens, including changing gloves between 
specimens.
Additional lnformation None
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship specimen Monday -Thursday, overnight to avoid weekend deliveries
Refrigerated specimen should be shipped on cold packs
Frozen specimen should be shipped on dry ice
Methodology Polymerase Chain Reaction (PCR)
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Parvovirus B19 Serology
CDC-10364
Test Order
Synonym(s) Fifth Disease
Performed on Specimens From Human
CDC Points of Contact Dean Erdman
(404) 639-3727
dde1@cdc.gov
Shifaq Kamili
(404) 639-2799
sgk5@cdc.gov
Pre-Approval Needed Erdman, Dean, (404) 639-3727, dde1@cdc.gov
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Serum
Minimum Volume Required 0.25 mL
Turnaround Time 3 Weeks
Interferences & Limitations Do not collect in heparin tubes
Storage & Preservation of
Specimen Prior to Shipping
Refrigerate all specimens promptly after collection. If specimens can be shipped 
to CDC within 72 hours of collection, they should be kept refrigerated at 4°C and 
shipped on gel ice-packs. If specimens must be held for >72 hours, they should 
be promptly frozen at -70°C and shipped on dry ice. Liquid specimens should be 
aliquoted into properly labeled, leak-proof, unbreakable screw cap vials. 
Samples should be collected and processed in a manner that prevents cross-
contamination between specimens, including changing gloves between 
specimens.
Additional lnformation None
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship specimen Monday -Thursday, overnight to avoid weekend deliveries
Frozen specimen should be shipped on dry ice
Refrigerated specimen should be shipped on cold packs
Methodology IgG and IgM enzyme immunoassay
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Pathologic Evaluation of CNS Infections
CDC-10365
Test Order
Synonym(s) Central Nervous Tissue, autopsy, biopsy, formalin fixed tissues, fresh and frozen 
tissues, tissue culture, pathology, paraffin blocks, histopathology, electron 
microscopy, immunohistochemistry, PCR
Performed on Specimens From Human and Animal
Pre-Approval Needed Zaki, Sherif, (404) 639-3133, szaki@cdc.gov
Blau, Dianna, (404) 639-1495, Pathology@cdc.gov
Supplemental Information
Required
Please include a cover letter outlining a brief clinical history, including relevant 
demographic/epidemiologic information, a copy of (a) the autopsy report 
(preliminary or final) or (b) surgical pathology/report, copies of pertinent 
results (microbiology, hematology, serology, culture, and/or biochemical) and 
images (clinical and/or gross autopsy photos).
Please include a key to the identification of the blocks
Supplemental Form http://www.cdc.gov/ncezid/dhcpp/idpb/index.html
Acceptable Sample/ Specimen 
Type for Testing
The preferred specimens include paraffin blocks of involved CNS tissue, or 
representative tissues (See Additional Information section) in formalin. Fresh-
frozen tissue may also be submitted.
Minimum Volume Required Not Applicable
Turnaround Time 2 Weeks
Interferences & Limitations Prolonged fixation (>2 weeks) may interfere with some immunohistochemical 
and molecular diagnostic assays
Storage & Preservation of
Specimen Prior to Shipping
Specifics will be determined upon consultation. In general, paraffin-embedded 
tissue blocks should be submitted where tissues have been in formalin for a 
significant time, wet tissue should be in 10% neutral buffered formalin, 
unstained slides (not optimal) should be cut at 3-5 microns (10 slides per block), 
and Electron Microscopy specimen should be fixed in glutaraldehyde and held in 
phosphate buffer.
Additional lnformation Preliminary results are usually reported within 1 week, but may take up to 2 
weeks depending on the nature of the case.
Images are especially important in evaluation and guiding of testing.
Possible tissue sites include cerebralcortex (frontal, parietal, temporal, and 
Specimen Labeling Specimen (block) key, denoting tissue type is extremely helpful and will expedite 
results
Transport Medium Electron Microscopy specimen containers should be filled to the top with 
phosphate buffer and sent on wet ice. Do not freeze.
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday, overnight. If specimen is frozen, send separately on dry 
ice. If specimen is refrigerated, ship on frozen gel packs. For urgent cases, 
please contact laboratory immediately. During hot weather, to avoid melting of 
paraffin blocks, they should be packed on ice packs. Do not pack wet tissue and 
frozen tissue together, please package separately to avoid freezing and damage 
of wet tissue. Please include the full name, title, complete mailing address, e-
mail address, and telephone and fax numbers of the submitter. This will be to 
whom the final pathology report is addressed.
Methodology Histopathology, H&E's and Special Stains, Immunohistochemistry (IHC), 
Polymerase Chain Reaction (PCR) and Sequencing, Electron Microscopy (EM), 
Tissue Culture, Nucleic Acid Extraction
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Pathologic Evaluation of CNS Infections
CDC-10365
Test Order
CDC Points of Contact Sherif Zaki
(404) 639-3133
szaki@cdc.gov
Dianna Blau
(404) 639-1495
pathology@cdc.gov
occipital), brain stem (midbrain, pons, medulla) and spinal cord, cerebellum, 
basal ganglia, thalamus, hypothalamus, and hippocampus, and meninges.
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Pathologic Evaluation of Influenza and Other Viral Infections
CDC-10366
Test Order
Synonym(s) Autopsy, biopsy, formalin fixed tissues, fresh and frozen tissues, tissue culture, 
pathology, paraffin blocks, histopathology, electron microscopy, 
immunohistochemistry, PCR
Performed on Specimens From Human and Animal
Pre-Approval Needed Zaki, Sherif, (404) 639-3133, szaki@cdc.gov
Blau, Dianna, (404) 639-1495, Pathology@cdc.gov
Supplemental Information
Required
Please include a cover letter outlining a brief clinical history, including relevant 
demographic/epidemiologic information, a copy of (a) the autopsy report 
(preliminary or final) or (b) surgical pathology/report, copies of pertinent 
results (microbiology, hematology, serology, culture, and/or biochemical) and 
images (clinical and/or gross autopsy photos).
Please include a key to the identification of the blocks
Supplemental Form http://www.cdc.gov/ncezid/dhcpp/idpb/index.html
Acceptable Sample/ Specimen 
Type for Testing
Representative blocks or fixed tissue specimen of upper and lower respiratory 
and tissue showing pathology. Formalin-fixed paraffin embedded blocks made 
from BAL can also be submitted for IHC staining. Fresh-frozen tissue may also 
be submitted.
Minimum Volume Required Not Applicable
Turnaround Time 2 Weeks
Interferences & Limitations Prolonged fixation (>2 weeks) may interfere with some immunohistochemical 
and molecular diagnostic assays
Storage & Preservation of
Specimen Prior to Shipping
Specifics will be determined upon consultation. In general, paraffin-embedded 
tissue blocks should be submitted where tissues have been in formalin for a 
significant time, wet tissue should be in 10% neutral buffered formalin, 
unstained slides (not optimal), should be cut at 3-5 microns (10 slides per 
block), and Electron Microscopy specimen should be fixed in glutaraldehyde and 
held in phosphate buffer.
Additional lnformation Preliminary results are usually reported within 1 week, but may take up to 2 
weeks depending on the nature of the case.
Images are especially important in evaluation and guiding of testing.
Specimen Labeling Specimen (block) key, denoting tissue type is extremely helpful and will expedite 
results.
Transport Medium Electron Microscopy specimen containers should be filled to the top with 
phosphate buffer and sent on wet ice. Do not freeze.
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday, overnight. If specimen is frozen, send separately on dry 
ice. If specimen is refrigerated, ship on frozen gel packs. For urgent cases, 
please contact laboratory immediately. During hot weather, to avoid melting of 
paraffin blocks, they should be packed on ice packs. Do not pack wet tissue and 
frozen tissue together, please package separately to avoid freezing and damage 
of wet tissue. Please include the full name, title, complete mailing address, e-
mail address, and telephone and fax numbers of the submitter. This will be to 
whom the final pathology report is addressed.
Methodology Histopathology, H&E's and Special Stains, Immunohistochemistry (IHC), 
Polymerase Chain Reaction (PCR) and Sequencing, Electron Microscopy (EM), 
Tissue Culture, Nucleic Acid Extraction for transfer to SME
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Pathologic Evaluation of Influenza and Other Viral Infections
CDC-10366
Test Order
CDC Points of Contact Sherif Zaki
(404) 639-3133
szaki@cdc.gov
Dianna Blau
(404) 639-1495
pathology@cdc.gov
The recommended pulmonary sites include central (hilar) lung with segmental 
bronchi, right and left primary bronchi, trachea (proximal and distal), 
representative pulmonary parenchyma from right and left lung, for patients with 
suspected myocarditis, encephalitis, or rhabdomyolysis, specimens should 
include myocardium (right and left ventricle), CNS (cerebral cortex, basal ganglia, 
pons, medulla, and cerebellum, and skeletal muscle, respectively, and specimens 
should be included from any other organ showing significant gross or 
microscopic pathology.
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Pathologic Evaluation of Myocarditis
CDC-10367
Test Order
Synonym(s) Autopsy, biopsy, formalin fixed tissues, fresh and frozen tissues, tissue culture, 
pathology, paraffin blocks, histopathology, electron microscopy, 
immunohistochemistry, PCR
Performed on Specimens From Human and Animal
Pre-Approval Needed Zaki, Sherif, (404) 639-3133, szaki@cdc.gov
Blau, Dianna, (404) 639-1495, Pathology@cdc.gov
Supplemental Information
Required
Please include a cover letter outlining a brief clinical history, including relevant 
demographic/epidemiologic information, a copy of (a) the autopsy report 
(preliminary or final) or (b) surgical pathology/report, copies of pertinent 
results (microbiology, hematology, serology, culture, and/or biochemical) and 
images (clinical and/or gross autopsy photos).
Please include a key to the identification of the blocks
Supplemental Form http://www.cdc.gov/ncezid/dhcpp/idpb/index.html
Acceptable Sample/ Specimen 
Type for Testing
Minimum of 2 paraffin blocks of involved heart tissue, or representative tissues 
in formalin (i.e. wet tissue). Fresh-frozen tissue may also be submitted for 
culture and molecular-based assays.
Minimum Volume Required Not Applicable
Turnaround Time 2 Weeks
Interferences & Limitations Prolonged fixation (>2 weeks) may interfere with some immunohistochemical 
and molecular diagnostic assays
Storage & Preservation of
Specimen Prior to Shipping
Specifics will be determined upon consultation. In general, paraffin-embedded 
tissue blocks should be submitted where tissues have been in formalin for a 
significant time, wet tissue should be in 10% neutral buffered formalin, 
unstained slides (not optimal), should be cut at 3-5 microns (10 slides per 
block), and Electron Microscopy specimen should be fixed in glutaraldehyde and 
held in phosphate buffer.
Additional lnformation Preliminary results are usually reported within 1 week, but may take up to 2 
weeks depending on the nature of the case.
Images are especially important in evaluation and guiding of testing.
Specific guidelines for these samples include multiple fragments of cardiac 
Specimen Labeling Specimen (block) key, denoting tissue type is extremely helpful and will expedite 
results
Transport Medium Electron Microscopy specimen containers should be filled to the top with 
phosphate buffer and sent on wet ice. Do not freeze.
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday, overnight. If specimen is frozen, send separately on dry 
ice. If specimen is refrigerated, ship on frozen gel packs. For urgent cases, 
please contact laboratory immediately. During hot weather, to avoid melting of 
paraffin blocks, they should be packed on ice packs. Do not pack wet tissue and 
frozen tissue together, please package separately to avoid freezing and damage 
of wet tissue. Please include the full name, title, complete mailing address, e-
mail address, and telephone and fax numbers of the submitter. This will be to 
whom the final pathology report is addressed.
Methodology Histopathology, H&E's and Special Stains, Immunohistochemistry (IHC), 
Polymerase Chain Reaction (PCR) and Sequencing, Electron Microscopy (EM), 
Tissue Culture, Nucleic Acid Extraction for transfer to SME
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Pathologic Evaluation of Myocarditis
CDC-10367
Test Order
CDC Points of Contact Sherif Zaki
(404) 639-3133
szaki@cdc.gov
Dianna Blau
(404) 639-1495
pathology@cdc.gov
tissue representing each anatomic portion of the heart involved by inflammatory 
infiltrates (e.g., ventricles, epicardium, pericardium), and if myocarditis is 
identified in the context of a systemic illness, representative tissues should be 
included from ay other organ showing significant microscopic pathology.
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Pathologic Evaluation of Pneumonia and Other Respiratory 
Infections
CDC-10368
Test Order
Synonym(s) Autopsy, biopsy, formalin fixed tissues, fresh and frozen tissues, tissue culture, 
pathology, paraffin blocks, histopathology, electron microscopy, 
immunohistochemistry, PCR
Performed on Specimens From Human and Animal
Pre-Approval Needed Zaki, Sherif, (404) 639-3133, szaki@cdc.gov
Blau, Dianna, (404) 639-1495, Pathology@cdc.gov
Supplemental Information
Required
Please include a cover letter outlining a brief clinical history, including relevant 
demographic/epidemiologic information, a copy of (a) the autopsy report 
(preliminary or final) or (b) surgical pathology/report, copies of pertinent 
results (microbiology, hematology, serology, culture, and/or biochemical) and 
images (clinical and/or gross autopsy photos).
Please include a key to the identification of the blocks
Supplemental Form http://www.cdc.gov/ncezid/dhcpp/idpb/index.html
Acceptable Sample/ Specimen 
Type for Testing
Representative (minimum of 8) blocks and fixed tissue representing different 
pulmonary sites and other organs showing pathology. Formalin-fixed paraffin 
embedded blocks made from BAL can also be submitted. Fresh-frozen tissue 
may be submitted.
Minimum Volume Required Not Applicable
Turnaround Time 2 Weeks
Interferences & Limitations Prolonged fixation (>2 weeks) may interfere with some immunohistochemical 
and molecular diagnostic assays
Storage & Preservation of
Specimen Prior to Shipping
Specifics will be determined upon consultation. In general, paraffin-embedded 
tissue blocks should be submitted where tissues have been in formalin for a 
significant time, wet tissue should be in 10% neutral buffered formalin, 
unstained slides (not optimal), should be cut at 3-5 microns (10 slides per 
block), and Electron Microscopy specimen should be fixed in glutaraldehyde and 
held in phosphate buffer.
Additional lnformation Preliminary results are usually reported within 1 week, but may take up to 2 
weeks depending on the nature of the case.
Images are especially important in evaluation and guiding of testing.
Specimen Labeling Specimen (block) key, denoting tissue type is extremely helpful and will expedite 
results
Transport Medium Electron Microscopy specimen containers should be filled to the top with 
phosphate buffer and sent on wet ice. Do not freeze.
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday, overnight. If specimen is frozen, send separately on dry 
ice. If specimen is refrigerated, ship on frozen gel packs. For urgent cases, 
please contact laboratory immediately. During hot weather, to avoid melting of 
paraffin blocks, they should be packed on ice packs. Do not pack wet tissue and 
frozen tissue together, please package separately to avoid freezing and damage 
of wet tissue. Please include the full name, title, complete mailing address, e-
mail address, and telephone and fax numbers of the submitter. This will be to 
whom the final pathology report is addressed.
Methodology Histopathology, H&E's and Special Stains, Immunohistochemistry (IHC), 
Polymerase Chain Reaction (PCR) and Sequencing, Electron Microscopy (EM), 
Tissue Culture, Nucleic Acid Extraction for transfer to SME
Monday, January 13, 2014 Page 280 of 380Version: 1.0
Pathologic Evaluation of Pneumonia and Other Respiratory 
Infections
CDC-10368
Test Order
CDC Points of Contact Sherif Zaki
(404) 639-3133
szaki@cdc.gov
Dianna Blau
(404) 639-1495
pathology@cdc.gov
The preferred pulmonary sites include hilar lung with segmental bronchi, 
primary bronchi, and trachea, peripheral pulmonary parenchyma from both 
lungs and specimens should be included from any other organ showing 
significant gross or microscopic pathology.
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Pathologic Evaluation of Rash and Eschar-Associated Illness
CDC-10369
Test Order
Synonym(s) Autopsy, biopsy, formalin fixed tissues, fresh and frozen tissues, tissue culture, 
pathology, paraffin blocks, histopathology, electron microscopy, 
immunohistochemistry, PCR
Performed on Specimens From Human and Animal
Pre-Approval Needed Zaki, Sherif, (404) 639-3133, szaki@cdc.gov
Blau, Dianna, (404) 639-1495, Pathology@cdc.gov
Supplemental Information
Required
Please include a cover letter outlining a brief clinical history, including relevant 
demographic/epidemiologic information, a copy of (a) the autopsy report 
(preliminary or final) or (b) surgical pathology/report, copies of pertinent 
results (microbiology, hematology, serology, culture, and/or biochemical) and 
images (clinical and/or gross autopsy photos).
Please include a key to the identification of the blocks
Supplemental Form http://www.cdc.gov/ncezid/dhcpp/idpb/index.html
Acceptable Sample/ Specimen 
Type for Testing
Representative (minimum 1) paraffin block of the cutaneous lesion, or an 
appropriate biopsy specimen in formalin (i.e. wet tissue). Fresh-frozen tissue 
may also be submitted for culture and molecular based assays.
Minimum Volume Required Not Applicable
Turnaround Time 2 Weeks
Interferences & Limitations Prolonged fixation (>2 weeks) may interfere with some immunohistochemical 
and molecular diagnostic assays
Storage & Preservation of
Specimen Prior to Shipping
Specifics will be determined upon consultation. In general, paraffin-embedded 
tissue blocks should be submitted where tissues have been in formalin for a 
significant time, wet tissue should be in 10% neutral buffered formalin, 
unstained slides (not optimal), should be cut at 3-5 microns (10 slides per 
block), and Electron Microscopy specimen should be fixed in glutaraldehyde and 
held in phosphate buffer.
Additional lnformation Preliminary results are usually reported within 1 week, but may take up to 2 
weeks depending on the nature of the case.
Images are especially important in evaluation and guiding of testing.
Specific guidelines for the samples include minimally, a 3 mm punch, deep 
Specimen Labeling Specimen (block) key, denoting tissue type is extremely helpful and will expedite 
results
Transport Medium Electron Microscopy specimen containers should be filled to the top with 
phosphate buffer and sent on wet ice. Do not freeze.
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday, overnight. If specimen is frozen, send separately on dry 
ice. If specimen is refrigerated, ship on frozen gel packs. For urgent cases, 
please contact laboratory immediately. During hot weather, to avoid melting of 
paraffin blocks, they should be packed on ice packs. Do not pack wet tissue and 
frozen tissue together, please package separately to avoid freezing and damage 
of wet tissue. Please include the full name, title, complete mailing address, e-
mail address, and telephone and fax numbers of the submitter. This will be to 
whom the final pathology report is addressed.
Methodology Histopathology, H&E's and Special Stains, Immunohistochemistry (IHC), 
Polymerase Chain Reaction (PCR) and Sequencing, Electron Microscopy (EM), 
Tissue Culture, Nucleic Acid Extraction for transfer to SME
Monday, January 13, 2014 Page 282 of 380Version: 1.0
Pathologic Evaluation of Rash and Eschar-Associated Illness
CDC-10369
Test Order
CDC Points of Contact Sherif Zaki
(404) 639-3133
szaki@cdc.gov
Dianna Blau
(404) 639-1495
pathology@cdc.gov
shave, or excisional biopsy specimen from the eschar or a representative rash 
lesion. If multiple stages or forms of cutaneous lesions are identified, multiple 
biopsies should be submitted, and if a rash is identified in the context of a 
systemic fatal illness, representative tissues should be included from any other 
organ showing significant gross or microscopic pathology.
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Pathologic Evaluation of Select Hepatides
CDC-10370
Test Order
Synonym(s) pathologic evaluation of tissue, autopsy, biopsy, formalin fixed tissues, fresh and 
frozen tissues, tissue culture, pathology, paraffin blocks, histopathology, 
electron microscopy, immunohistochemistry, PCR
Performed on Specimens From Human and Animal
Pre-Approval Needed Zaki, Sherif, (404) 639-3133, szaki@cdc.gov
Blau, Dianna, (404) 639-1495, Pathology@cdc.gov
Supplemental Information
Required
Please include a cover letter outlining a brief clinical history, including relevant 
demographic/epidemiologic information, a copy of (a) the autopsy report 
(preliminary or final) or (b) surgical pathology/report, copies of pertinent 
results (microbiology, hematology, serology, culture, and/or biochemical) and 
images (clinical and/or gross autopsy photos).
Please include a key to the identification of the blocks
Supplemental Form http://www.cdc.gov/ncezid/dhcpp/idpb/index.html
Acceptable Sample/ Specimen 
Type for Testing
Representative (minimum of 2) paraffin blocks of involved hepatic tissue and 
representative tissues in formalin. Fresh-frozen tissue may also be submitted 
and epoxy-embedded tissues. Other major organs as applicable and others upon 
consultation.
Minimum Volume Required Not Applicable
Turnaround Time 2 Weeks
Interferences & Limitations Prolonged fixation (>2 weeks) may interfere with some immunohistochemical 
and molecular diagnostic assays
Storage & Preservation of
Specimen Prior to Shipping
Specifics will be determined upon consultation. In general, paraffin-embedded 
tissue blocks should be submitted where tissues have been in formalin for a 
significant time, wet tissue should be in 10% neutral buffered formalin, 
unstained slides (not optimal), should be cut at 3-5 microns (10 slides per 
block), and Electron Microscopy specimen should be fixed in glutaraldehyde and 
held in phosphate buffer.
Additional lnformation Preliminary results are usually reported within 1 week, but may take up to 2 
weeks depending on the nature of the case.
Images are especially important in evaluation and guiding of testing.
Specimen Labeling Specimen (block) key, denoting tissue type is extremely helpful and will expedite 
results
Transport Medium Electron Microscopy specimen containers should be filled to the top with 
phosphate buffer and sent on wet ice. Do not freeze.
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday, overnight. If specimen are frozen, send separately on 
dry ice. If specimen are refrigerated, ship on frozen gel packs. For urgent cases, 
please contact laboratory immediately. During hot weather, to avoid melting of 
paraffin blocks, they should be packed on ice packs. Do not pack wet tissue and 
frozen tissue together, please package separately to avoid freezing and damage 
of wet tissue. Please include the full name, title, complete mailing address, e-
mail address, and telephone and fax numbers of the submitter. This will be to 
whom the final pathology report is addressed.
Methodology Histopathology, H&E's and Special Stains, Immunohistochemistry (IHC), 
Polymerase Chain Reaction (PCR) and Sequencing, Electron Microscopy (EM), 
Tissue Culture, Nucleic Acid Extraction for transfer to SME
Monday, January 13, 2014 Page 284 of 380Version: 1.0
Pathologic Evaluation of Select Hepatides
CDC-10370
Test Order
CDC Points of Contact Sherif Zaki
(404) 639-3133
szaki@cdc.gov
Dianna Blau
(404) 639-1495
pathology@cdc.gov
Specific guidelines for these samples include multiple fragments of liver tissue 
involved by inflammatory infiltrates and if hepatitis is identified in the context of 
systemic illness, representative tissues should be included from any other organ 
showing significant microscopic pathology.
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Pathologic Evaluation of Sudden Unexplained Infant Death 
with Suspicion of Infection
CDC-10371
Test Order
Synonym(s) Autopsy, biopsy, formalin fixed tissues, fresh and frozen tissues, tissue culture, 
pathology, paraffin blocks, histopathology, electron microscopy, 
immunohistochemistry, PCR
Performed on Specimens From Human
Pre-Approval Needed Zaki, Sherif, (404) 639-3133, szaki@cdc.gov
Blau, Dianna, (404) 639-1495, Pathology@cdc.gov
Supplemental Information
Required
Please include a cover letter outlining a brief clinical history, including relevant 
demographic/epidemiologic information, a copy of (a) the autopsy report 
(preliminary or final) or (b) surgical pathology/report, copies of pertinent 
results (microbiology, hematology, serology, culture, and/or biochemical) and 
images (clinical and/or gross autopsy photos).
Please include a key to the identification of the blocks
Supplemental Form http://www.cdc.gov/ncezid/dhcpp/idpb/index.html
Acceptable Sample/ Specimen 
Type for Testing
Tissues should be collected in accordance with the National Association of 
Medical Examiners (NAME) protocol for a complete SUID autopsy. Tissue from the 
organ(s) demonstrating pathology and major organs without apparent 
histopathologic changes.
Minimum Volume Required Not Applicable
Turnaround Time 2 Weeks
Interferences & Limitations Prolonged fixation (>2 weeks) may interfere with some immunohistochemical 
and molecular diagnostic assays
Storage & Preservation of
Specimen Prior to Shipping
Specifics will be determined upon consultation. In general, paraffin-embedded 
tissue blocks should be submitted where tissues have been in formalin for a 
significant time, wet tissue should be in 10% neutral buffered formalin, 
unstained slides (not optimal), should be cut at 3-5 microns (10 slides per 
block), and Electron Microscopy specimen should be fixed in glutaraldehyde and 
held in phosphate buffer.
Additional lnformation Preliminary results are usually reported within 1 week, but may take up to 2 
weeks depending on the nature of the case.
Images are especially important in evaluation and guiding of testing.
Specimen Labeling Specimen (block) key, denoting tissue type is extremely helpful and will expedite 
results
Transport Medium Electron Microscopy specimen containers should be filled to the top with 
phosphate buffer and sent on wet ice. Do not freeze.
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday, overnight. If specimen is frozen, send separately on dry 
ice. If specimen is refrigerated, ship on frozen gel packs. For urgent cases, 
please contact laboratory immediately. During hot weather, to avoid melting of 
paraffin blocks, they should be packed on ice packs. Do not pack wet tissue and 
frozen tissue together, please package separately to avoid freezing and damage 
of wet tissue. Please include the full name, title, complete mailing address, e-
mail address, and telephone and fax numbers of the submitter. This will be to 
whom the final pathology report is addressed.
Methodology Histopathology, H&E's and Special Stains, Immunohistochemistry (IHC), 
Polymerase Chain Reaction (PCR) and Sequencing, Electron Microscopy (EM), 
Tissue Culture, Nucleic Acid Extraction for transfer to SME
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Pathologic Evaluation of Sudden Unexplained Infant Death 
with Suspicion of Infection
CDC-10371
Test Order
CDC Points of Contact Sherif Zaki
(404) 639-3133
szaki@cdc.gov
Dianna Blau
(404) 639-1495
pathology@cdc.gov
The NAME SUID white paper can be accessed online at 
http://thename.org/index2.php?option=com_docman&task=doc_view&gid=90
&Itemid=31
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Pathologic Evaluation of Unexplained Illness Due to Possible 
Infectious Etiology
CDC-10372
Test Order
Synonym(s) Autopsy, biopsy, formalin fixed tissues, fresh and frozen tissues, tissue culture, 
pathology, paraffin blocks, histopathology, electron microscopy, 
immunohistochemistry, PCR
Performed on Specimens From Human and Animal
Pre-Approval Needed Zaki, Sherif, (404) 639-3133, szaki@cdc.gov
Blau, Dianna, (404) 639-1495, Pathology@cdc.gov
Supplemental Information
Required
Please include a cover letter outlining a brief clinical history, including relevant 
demographic/epidemiologic information, a copy of (a) the autopsy report 
(preliminary or final) or (b) surgical pathology/report, copies of pertinent 
results (microbiology, hematology, serology, culture, and/or biochemical) and 
images (clinical and/or gross autopsy photos). 
Please include a key to the identification of the blocks
Supplemental Form http://www.cdc.gov/ncezid/dhcpp/idpb/index.html
Acceptable Sample/ Specimen 
Type for Testing
Representative tissues from all organs showing microscopic pathology. Preferred 
specimens include paraffin blocks of tissues showing gross or microscopic 
pathology and representative tissues in formalin. Fresh-frozen tissue may also 
be submitted.
Minimum Volume Required Not Applicable
Turnaround Time 2 Weeks
Interferences & Limitations Prolonged fixation (>2 weeks) may interfere with some immunohistochemical 
and molecular diagnostic assays
Storage & Preservation of
Specimen Prior to Shipping
Specifics will be determined upon consultation. In general, paraffin-embedded 
tissue blocks should be submitted where tissues have been in formalin for a 
significant time, wet tissue should be in 10% neutral buffered formalin, 
unstained slides (not optimal), should be cut at 3-5 microns (10 slides per 
block), and Electron Microscopy specimen should be fixed in glutaraldehyde and 
held in phosphate buffer.
Additional lnformation Preliminary results are usually reported within 1 week, but may take up to 2 
weeks depending on the nature of the case.
Images are especially important in evaluation and guiding of testing.
Specimen Labeling Specimen (block) key, denoting tissue type is extremely helpful and will expedite 
results
Transport Medium Electron Microscopy specimen containers should be filled to the top with 
phosphate buffer and sent on wet ice. Do not freeze.
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday, overnight. If specimens are frozen, send separately on 
dry ice. If specimens are refrigerated, ship on frozen gel packs. For urgent cases, 
please contact laboratory immediately. During hot weather, to avoid melting of 
paraffin blocks, they should be packed on ice packs. Do not pack wet tissue and 
frozen tissue together, please package separately to avoid freezing and damage 
of wet tissue. Please include the full name, title, complete mailing address, e-
mail address, and telephone and fax numbers of the submitter. This will be to 
whom the final pathology report is addressed.
Methodology Histopathology, H&E's and Special Stains, Immunohistochemistry (IHC), 
Polymerase Chain Reaction (PCR) and Sequencing, Electron Microscopy (EM), 
Tissue Culture, Nucleic Acid Extraction for transfer to SME
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Pathologic Evaluation of Unexplained Illness Due to Possible 
Infectious Etiology
CDC-10372
Test Order
CDC Points of Contact Sherif Zaki
(404) 639-3133
szaki@cdc.gov
Dianna Blau
(404) 639-1495
pathology@cdc.gov
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Pathology Special Study
CDC-10373
Test Order
Synonym(s) None
Performed on Specimens From Human and Animal
CDC Points of Contact Sherif Zaki
(404) 639-3133
szaki@cdc.gov
Dianna Blau
(404) 639-1495
pathology@cdc.gov
Pre-Approval Needed Zaki, Sherif, (404) 639-3133, szaki@cdc.gov
Blau, Dianna, (404) 639-1495, Pathology@cdc.gov
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
To be determined
Minimum Volume Required To be determined
Turnaround Time  
Interferences & Limitations To be determined
Storage & Preservation of
Specimen Prior to Shipping
To be determined
Additional lnformation To be determined
Specimen Labeling To be determined
Transport Medium To be determined
Shipping Instructions which 
Include Specimen Handling 
Requirements
To be determined
Methodology To be determined
 
Monday, January 13, 2014 Page 290 of 380Version: 1.1
Picornavirus Detection and Identification (not Hepatitis A, not 
Rhinovirus)
CDC-10374
Test Order
Synonym(s) Theier's murine encephalomyelitis virus (TMEV), Saffold virus (SAFV), Cosavirus 
(COSV) (Dekavirus), Salivirus (SALV) (Klassevirus), Kobuvirus, Aichi virus, 
Encephalomyocarditis virus (EMCV), Vilyuisk virus
Performed on Specimens From Human, Animal, and Food/Environmental/Medical Devices/Biologics
Pre-Approval Needed Nix, Alan, (404) 639-1689, wbn0@cdc.gov
Oberste, Steve, (404) 639-5497, mbo2@cdc.gov
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Specimens include stool, serum, throat or nasal swab, cerebrospinal fluid (CSF), 
vesicle fluid or lesion, rectal, or nasopharyngeal (NP)/oropharyngeal (OP) swabs. 
Fresh or frozen tissues are preferred to Formalin fixed tissues, but will accept 
both.
Minimum Volume Required Not Applicable
Turnaround Time 14 Days
Interferences & Limitations Collecting specimens during the first week of illness is ideal although the virus 
can be shed in stool for several weeks.  A specimen set collected in the second 
week of illness should include a rectal swab or stool sample.
Storage & Preservation of
Specimen Prior to Shipping
Vesicle fluid, rectal, or nasopharyngeal (NP)/oropharyngeal (OP) swabs: 
Use only sterile Dacron or rayon swabs with plastic shafts or if available, flocked 
swabs. DO NOT use calcium alginate swabs or swabs with wooden sticks, as they 
may contain substances that inactivate some viruses and inhibit some molecular 
assays.  Place the swab immediately into a sterile viral containing 2mL of viral 
transport media without antibiotics, if possible.  
Stool: Collect in a clean, dry, leak-proof container. 
Serum: For each serum specimen, collect whole blood into a serum separator 
tube (marble or tiger top SST). Allow to clot at room temperature for a minimum 
of 30 minutes and centrifuge.
Additional lnformation Minimum volume for cell culture is 0.5-1 mL, for CSF is 60 uL, and for fresh 
frozen tissues is 2 mm^2. 
Specimen Labeling Tests subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Viral transport medium. If you do not have viral transport media, place the swab 
into a sterile vial without viral transport media.  Aseptically, cut or break 
applicator sticks off near the tip to permit tightening of the cap.  For NP/OP 
swabs, both swabs can be placed in the same vial, if desired.
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday – Thursday, overnight to avoid weekend deliveries. Frozen 
specimen should be shipped on dry ice and refrigerated specimen should be 
shipped on cold packs, as an etiologic agent.
Include the full name, title, complete mailing address, email address, telephone, 
and fax number of the submitter.  This will be the person to whom the final 
report will be mailed to.
Methodology Molecular techniques
Monday, January 13, 2014 Page 291 of 380Version: 1.0
Picornavirus Detection and Identification (not Hepatitis A, not 
Rhinovirus)
CDC-10374
Test Order
CDC Points of Contact Alan Nix
(404) 639-1689
wbn0@cdc.gov
Steve Oberste
(404) 639-5497
mbo2@cdc.gov
Stool: Stool may be collected within 14 days of symptom onset.  Collect 10-20 g 
of stool in a clean, dry, leak-proof container.
Serum: For each serum specimen, collect (adults and children >6 kg: 5 mL, 
children <6 kg: 2 mL) of whole blood into a serum separator tube (marble or 
tiger top SST). A minimum of 1 mL of whole blood is needed for testing of 
pediatric patients. Allow to clot at room temperature for a minimum of 30 
minutes and centrifuge.
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Picornavirus Special Study
CDC-10375
Test Order
Synonym(s) None
Performed on Specimens From Human, Animal, and Food/Environmental/Medical Devices/Biologics
CDC Points of Contact Alan Nix
(404) 639-1689
wbn0@cdc.gov
Steve Oberste
(404) 639-5497
mbo2@cdc.gov
Pre-Approval Needed Nix, Alan, (404) 639-1689, wbn0@cdc.gov
Oberste, Steve, (404) 639-5497, mbo2@cdc.gov
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
To be determined
Minimum Volume Required To be determined
Turnaround Time  
Interferences & Limitations To be determined
Storage & Preservation of
Specimen Prior to Shipping
To be determined
Additional lnformation To be determined
Specimen Labeling To be determined
Transport Medium To be determined
Shipping Instructions which 
Include Specimen Handling 
Requirements
To be determined
Methodology
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Polio Isolation, Intratypic Differentiation, Genotyping
CDC-10376
Test Order
Synonym(s) PV polio virus, ITD, Polio sequencing, AFP acute flaccid paralysis
Performed on Specimens From Human, Animal, and Food/Environmental/Medical Devices/Biologics
CDC Points of Contact Cara Burns
(404) 639-5499
zqd1@cdc.gov
Steve Oberste
(404) 639-5497
mbo2@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Stool, tissue culture, isolate, Fast Technology for Analysis of nucleic acids (FTA) 
cards, less common clinical specimens include nasopharyngeal and rectal swabs 
and cerebrospinal fluid (CSF)
Minimum Volume Required 50 uL (tissue culture)
Turnaround Time 21 Days
Interferences & Limitations None
Storage & Preservation of
Specimen Prior to Shipping
Keep specimen refrigerated or frozen
Additional lnformation If case investigation form is readily available, please submit with specimen
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday – Thursday, overnight to avoid weekend deliveries. Frozen 
specimen should be shipped on dry ice and refrigerated specimen should be 
shipped on cold packs, as an etiologic agent.
Methodology Molecular techniques, Cell culture
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Polio Serology
CDC-10377
Test Order
Synonym(s) Neutralization assay, NT, MNT
Performed on Specimens From Human
CDC Points of Contact William Weldon
(404) 639-5485
wiw4@cdc.gov
Steve Oberste
(404) 639-5497
mbo2@cdc.gov
Pre-Approval Needed Weldon, William, (404) 639-5485, wiw4@cdc.gov
Oberste, Steve, (404) 639-5497, mbo2@cdc.gov
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Serum
Minimum Volume Required 200 uL
Turnaround Time 4 Weeks
Interferences & Limitations Red blood cell hemolysis will adversely affect test results
Storage & Preservation of
Specimen Prior to Shipping
Needs to be collected from clotted whole blood or through serum separated 
tubes (SST). Serum needs to be frozen.
Additional lnformation None
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday – Thursday, overnight to avoid weekend deliveries. Frozen 
specimen should be shipped on dry ice as an etiologic agent.
Methodology Neutralization assay
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Polio Special Study
CDC-10378
Test Order
Synonym(s) None
Performed on Specimens From Human, Animal, and Food/Environmental/Medical Devices/Biologics
CDC Points of Contact Cara Burns
(404) 639-5499
zqd1@cdc.gov
Steve Oberste
(404) 639-5497
mbo2@cdc.gov
Pre-Approval Needed Burns, Cara, (404) 639-5499, zqd1@cdc.gov
Oberste, Steve, (404) 639-5497, mbo2@cdc.gov
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
To be determined
Minimum Volume Required To be determined
Turnaround Time  
Interferences & Limitations To be determined
Storage & Preservation of
Specimen Prior to Shipping
To be determined
Additional lnformation To be determined
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition
Transport Medium To be determined
Shipping Instructions which 
Include Specimen Handling 
Requirements
To be determined
Methodology
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Poxvirus - Cowpox Specific Molecular Detection
CDC-10379
Test Order
Synonym(s) None
Performed on Specimens From Human and Animal
CDC Points of Contact  Help Desk
(404) 639-4129
Pre-Approval Needed Help Desk, , (404) 639-4129, 
Supplemental Information
Required
Clinical consultation with the Poxvirus Program is required prior to specimen 
shipment to determine testing urgency. A supplemental form will be supplied 
after initial consultation.
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Lesion fluid and/or material: vesicle/pustule skin or fluid, scab, crust, etc.
Collection method: fresh or frozen, swab, biopsy, touch prep slides, formalin 
fixed, paraffin block. Swabs should be made of nylon, polyester, or Dacron 
material
Minimum Volume Required Not Applicable
Turnaround Time 1 Day
Interferences & Limitations Swabs intended for the collection and transport of bacterial specimens should 
not be used. Cotton swabs may cause PCR inhibition and should not be used. 
The addition of viral transport media to swab specimens will dilute any viral DNA 
present.
Storage & Preservation of
Specimen Prior to Shipping
All specimens should be stored at 4⁰C until shipment. Swabs without individual 
holders may be stored in a sterile container. Dry swabs are preferred but a 
minimal amount of viral transport media may be added.
Additional lnformation Turnaround time:
Urgent cases
-Testing is completed and reported within 24 hours of specimen receipt when 
results directly impact patient care; 
Routine cases 
-Testing is completed and reported within 5 business days of specimen receipt.
Formalin fixed material is first tested by the Infectious Disease Pathology Branch 
(IDPB) and will only identify poxviruses to the genus level. DNA may be extracted 
from paraffin block embedded lesion material and tested by the Poxvirus 
Program. Fresh, non-frozen tissue is preferred by IDPB.
Specimen Labeling Specimens should be labeled with patient name, specimen type, date of 
collection, and body location
Transport Medium Prefer swabs dry but will accept specimen in a minimum viral transport medium
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday overnight to avoid weekend deliveries
Refrigerated specimen should be shipped on cold packs
Methodology Real Time-PCR
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Poxvirus - Encephalitis Work-Up (Post Vaccinia Encephalitis, 
Monkeypox, etc.)
CDC-10380
Test Order
Synonym(s) Monkeypox, Post-vaccinial encephalitis
Performed on Specimens From Human
CDC Points of Contact  Help Desk
(404) 639-4129
Pre-Approval Needed Help Desk, , (404) 639-4129, 
Supplemental Information
Required
Clinical consultation with the Poxvirus Program is required prior to specimen 
shipment to determine testing urgency. A supplemental form will be supplied 
after initial consultation.
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Cerebrospinal fluid (CSF) and serum must be submitted
Minimum Volume Required 1 mL
Turnaround Time 2 Days
Interferences & Limitations In order to accurately interpret test results generated from CSF specimens, 
paired serum must be submitted
Storage & Preservation of
Specimen Prior to Shipping
Keep specimen refrigerated. Serum should be collected in a venous blood tube 
containing a clot activator and/or gel. Blood tubes should be spun prior to 
shipment or an aliquot of the collected serum can be shipped.
Additional lnformation Turnaround time:
Urgent cases
- Testing is completed within 48 hours of specimen receipt when results directly 
impact patient care;
Routine cases
- Testing is completed within 5-7 days of specimen receipt.                                   
For serology testing, please notify the lab prior to shipment so reagents can be 
prepared
Specimen Labeling Specimens should be labeled with patient name, specimen type, and date of 
collection
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday overnight to avoid weekend deliveries
Refrigerated specimen should be shipped on cold packs
Methodology ELISA, Real Time PCR
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Poxvirus - Molluscum Contagiosum Specific Molecular 
Detection
CDC-10381
Test Order
Synonym(s) MCV
Performed on Specimens From Human
CDC Points of Contact  Help Desk
(404) 639-4129
Pre-Approval Needed Help Desk, , (404) 639-4129, 
Supplemental Information
Required
Clinical consultation with the Poxvirus Program is required prior to specimen 
shipment to determine testing urgency. A supplemental form will be supplied 
after initial consultation.
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Lesion fluid and/or material: vesicle/pustule skin or fluid, scab, crust, etc.
Collection method: fresh or frozen, swab, biopsy, touch prep slides, formalin 
fixed, paraffin block. Swabs should be made of nylon, polyester, or Dacron 
material
Minimum Volume Required Not Applicable
Turnaround Time 1 Day
Interferences & Limitations Swabs intended for the collection and transport of bacterial specimens should 
not be used. Cotton swabs may cause PCR inhibition and should not be used. 
The addition of viral transport media to swab specimens will dilute any viral DNA 
present.
Storage & Preservation of
Specimen Prior to Shipping
All specimens should be stored at 4⁰C until shipment. Swabs without individual 
holders may be stored in a sterile container. Dry swabs are preferred but a 
minimal amount of viral transport media may be added.
Additional lnformation Turnaround time:
Urgent cases
-Testing is completed and reported within 24 hours of specimen receipt when 
results directly impact patient care;
Routine cases
-Testing is completed and reported within 5 business days of specimen receipt.
Formalin fixed material is first tested by the Infectious Disease Pathology Branch 
(IDPB) and will only identify poxviruses to the genus level. DNA may be extracted 
from paraffin block embedded lesion material and tested by the Poxvirus 
Program. Fresh, non-frozen tissue is preferred by IDPB.
Specimen Labeling Specimens should be labeled with patient name, specimen type, date of 
collection, and body location
Transport Medium Prefer swabs dry but will accept specimen in a minimum viral transport medium
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday overnight to avoid weekend deliveries
Refrigerated specimen should be shipped on cold packs
Methodology Real Time-PCR
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Poxvirus - Monkeypox Specific Molecular Detection
CDC-10382
Test Order
Synonym(s) None
Performed on Specimens From Human and Animal
CDC Points of Contact  Help Desk
(404) 639-4129
Pre-Approval Needed Help Desk, , (404) 639-4129, 
Supplemental Information
Required
Clinical consultation with the Poxvirus Program is required prior to specimen 
shipment to determine testing urgency. A supplemental form will be supplied 
after initial consultation.
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Lesion fluid and/or material: vesicle/pustule skin or fluid, scab, crust, etc.
Collection method: fresh or frozen, swab, biopsy, touch prep slides, formalin 
fixed, paraffin block. Swabs should be made of nylon, polyester, or Dacron 
material.
Minimum Volume Required Not Applicable
Turnaround Time 1 Day
Interferences & Limitations Swabs intended for the collection and transport of bacterial specimens should 
not be used. Cotton swabs may cause PCR inhibition and should not be used. 
The addition of viral transport media to swab specimens will dilute any viral DNA 
present.
Storage & Preservation of
Specimen Prior to Shipping
All specimens should be stored at 4⁰C until shipment. Swabs without individual 
holders may be stored in a sterile container. Dry swabs are preferred but a 
minimal amount of viral transport media may be added.
Additional lnformation Turnaround time:
Urgent cases
-Testing is completed and reported within 24 hours of specimen receipt when 
results directly impact patient care;
Routine cases
-Testing is completed and reported within 5 business days of specimen receipt.
Formalin fixed material is first tested by the Infectious Disease Pathology Branch 
(IDPB) and will only identify poxviruses to the genus level. DNA may be extracted 
from paraffin block embedded lesion material and tested by the Poxvirus 
Program. Fresh, non-frozen tissue is preferred by IDPB.
Specimen Labeling Specimens should be labeled with patient name, specimen type, date of 
collection, and body location
Transport Medium Prefer swabs dry but will accept specimen in a minimum viral transport medium
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday overnight to avoid weekend deliveries
Refrigerated specimen should be shipped on cold packs
Methodology Real Time-PCR
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Poxvirus - Orthopoxvirus Serology (Includes Vaccinia virus)
CDC-10384
Test Order
Synonym(s) Orthopoxvirus, Vaccincia Antibody detection
Performed on Specimens From Human
CDC Points of Contact  Help Desk
(404) 639-4129
Pre-Approval Needed Help Desk, , (404) 639-4129, 
Supplemental Information
Required
Clinical consultation with the Poxvirus Program is required prior to specimen 
shipment to determine testing urgency. A supplemental form will be supplied 
after initial consultation.
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Paired sera
Minimum Volume Required 1 mL
Turnaround Time 2 Days
Interferences & Limitations Collection in either heparin and/or EDTA will interfere with results
Storage & Preservation of
Specimen Prior to Shipping
Keep specimen refrigerated. Serum should be collected in a venous blood tube 
containing a clot activator and/or gel. Blood tubes should be spun prior to 
shipment or an aliquot of the collected serum can be shipped.
Additional lnformation Turnaround time:
Urgent cases
-Testing is completed within 48 hours of specimen receipt when results directly 
impact patient care;
Routine cases
-Testing is completed within 5-7 days of specimen receipt.                                     
For serology testing, please notify the lab prior to shipment so reagents can be 
prepared
Specimen Labeling Specimens should be labeled with patient name, specimen type, and date of 
collection
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday overnight to avoid weekend deliveries
Refrigerated specimen should be shipped on cold packs
Methodology ELISA
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Poxvirus - Pan-Poxvirus Molecular Detection (Human 
Infections)
CDC-10385
Test Order
Synonym(s) None
Performed on Specimens From Human
CDC Points of Contact  Help Desk
(404) 639-4129
Pre-Approval Needed Help Desk, , (404) 639-4129, 
Supplemental Information
Required
Clinical consultation with the Poxvirus Program is required prior to specimen 
shipment to determine testing urgency. A supplemental form will be supplied 
after initial consultation.
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Lesion fluid and/or material: vesicle/pustule skin or fluid, scab, crust, etc.
Collection method: fresh or frozen, swab, biopsy, touch prep slides, formalin 
fixed, paraffin block. Swabs should be made of nylon, polyester, or Dacron 
material.
Minimum Volume Required Not Applicable
Turnaround Time 2 Days
Interferences & Limitations Swabs intended for the collection and transport of bacterial specimens should 
not be used. Cotton swabs may cause PCR inhibition and should not be used. 
The addition of viral transport media to swab specimens will dilute any viral DNA 
present.
Storage & Preservation of
Specimen Prior to Shipping
All specimens should be stored at 4⁰C until shipment. Swabs without individual 
holders may be stored in a sterile container. Dry swabs are preferred but a 
minimal amount of viral transport media may be added.
Additional lnformation Turnaround time:
Urgent cases
-Testing is completed and reported within 24 hours of specimen receipt when 
results directly impact patient care;
Routine cases
-Testing is completed and reported within 5 business days of specimen receipt.
Formalin fixed material is first tested by the Infectious Disease Pathology Branch 
(IDPB) and will only identify poxviruses to the genus level. DNA may be extracted 
from paraffin block embedded lesion material and tested by the Poxvirus 
Program. Fresh, non-frozen tissue is preferred by IDPB.
Specimen Labeling Specimens should be labeled with patient name, specimen type, date of 
collection, and body location
Transport Medium Prefer swabs dry but will accept specimen in a minimum viral transport medium
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday overnight to avoid weekend deliveries
Refrigerated specimen should be shipped on cold packs
Methodology Polymerase Chain Reaction (PCR)
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Poxvirus - Parapoxvirus Generic Molecular Detection
CDC-10383
Test Order
Synonym(s) Sore mouth, scabby mouth, contagious ecthyma
Performed on Specimens From Human
CDC Points of Contact  Help Desk
(404) 639-4129
Pre-Approval Needed Help Desk, , (404) 639-4129, 
Supplemental Information
Required
Clinical consultation with the Poxvirus Program is required prior to specimen 
shipment to determine testing urgency. A supplemental form will be supplied 
after initial consultation.
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Lesion fluid and/or material: vesicle/pustule skin or fluid, scab, crust, etc.
Collection method: fresh or frozen, swab, biopsy, touch prep slides, formalin 
fixed, paraffin block. Swabs should be made of nylon, polyester, or Dacron 
material
Minimum Volume Required Not Applicable
Turnaround Time 1 Day
Interferences & Limitations Swabs intended for the collection and transport of bacterial specimens should 
not be used. Cotton swabs may cause PCR inhibition and should not be used. 
The addition of viral transport media to swab specimens will dilute any viral DNA 
present.
Storage & Preservation of
Specimen Prior to Shipping
All specimens should be stored at 4⁰C until shipment. Swabs without individual 
holders may be stored in a sterile container. Dry swabs are preferred but a 
minimal amount of viral transport media may be added.
Additional lnformation Turnaround time:
Urgent cases
-Testing is completed and reported within 24 hours of specimen receipt when 
results directly impact patient care;
Routine cases
-Testing is completed and reported within 5 business days of specimen receipt.
Formalin fixed material is first tested by the Infectious Disease Pathology Branch 
(IDPB) and will only identify poxviruses to the genus level. DNA may be extracted 
from paraffin block embedded lesion material and tested by the Poxvirus 
Program. Fresh, non-frozen tissue is preferred by IDPB.
Specimen Labeling Specimens should be labeled with patient name, specimen type, date of 
collection, and body location
Transport Medium Prefer swabs dry but will accept specimen in a minimum viral transport medium
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday overnight to avoid weekend deliveries
Refrigerated specimen should be shipped on cold packs
Methodology Real Time-PCR
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Poxvirus - Parapoxvirus Molecular Detection
CDC-10386
Test Order
Synonym(s) None
Performed on Specimens From Human
CDC Points of Contact  Help Desk
(404) 639-4129
Pre-Approval Needed Help Desk, , (404) 639-4129, 
Supplemental Information
Required
Clinical consultation with the Poxvirus Program is required prior to specimen 
shipment to determine testing urgency. A supplemental form will be supplied 
after initial consultation.
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Lesion fluid and/or material: vesicle/pustule skin or fluid, scab, crust, etc.
Collection method: fresh or frozen, swab, biopsy, touch prep slides, formalin 
fixed, paraffin block. Swabs should be made of nylon, polyester, or Dacron 
material
Minimum Volume Required Not Applicable
Turnaround Time 1 Day
Interferences & Limitations Swabs intended for the collection and transport of bacterial specimens should 
not be used. Cotton swabs may cause PCR inhibition and should not be used. 
The addition of viral transport media to swab specimens will dilute any viral DNA 
present.
Storage & Preservation of
Specimen Prior to Shipping
All specimens should be stored at 4⁰C until shipment. Swabs without individual 
holders may be stored in a sterile container. Dry swabs are preferred but a 
minimal amount of viral transport media may be added.
Additional lnformation Turnaround time:
Urgent cases
-Testing is completed and reported within 24 hours of specimen receipt when 
results directly impact patient care;
Routine cases
-Testing is completed and reported within 5 business days of specimen receipt.
Formalin fixed material is first tested by the Infectious Disease Pathology Branch 
(IDPB) and will only identify poxviruses to the genus level. DNA may be extracted 
from paraffin block embedded lesion material and tested by the Poxvirus 
Program. Fresh, non-frozen tissue is preferred by IDPB.
Specimen Labeling Specimens should be labeled with patient name, specimen type, date of 
collection, and body location
Transport Medium Prefer swabs dry but will accept specimen in a minimum viral transport medium
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday overnight to avoid weekend deliveries
Refrigerated specimen should be shipped on cold packs
Methodology Real Time-PCR
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Poxvirus - Sealpox Specific Molecular Detection
CDC-10387
Test Order
Synonym(s) None
Performed on Specimens From Human and Animal
CDC Points of Contact  Help Desk
(404) 639-4129
Pre-Approval Needed Help Desk, , (404) 639-4129, 
Supplemental Information
Required
Clinical consultation with the Poxvirus Program is required prior to specimen 
shipment to determine testing urgency. A supplemental form will be supplied 
after initial consultation.
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Lesion fluid and/or material: vesicle/pustule skin or fluid, scab, crust, etc.
Collection method: fresh or frozen, swab, biopsy, touch prep slides, formalin 
fixed, paraffin block. Swabs should be made of nylon, polyester, or Dacron 
material
Minimum Volume Required Not Applicable
Turnaround Time 1 Day
Interferences & Limitations Swabs intended for the collection and transport of bacterial specimens should 
not be used. Cotton swabs may cause PCR inhibition and should not be used. 
The addition of viral transport media to swab specimens will dilute any viral DNA 
present.
Storage & Preservation of
Specimen Prior to Shipping
All specimens should be stored at 4⁰C until shipment. Swabs without individual 
holders may be stored in a sterile container. Dry swabs are preferred but a 
minimal amount of viral transport media may be added.
Additional lnformation Turnaround time:
Urgent cases
-Testing is completed and reported within 24 hours of specimen receipt when 
results directly impact patient care;
Routine cases
-Testing is completed and reported within 5 business days of specimen receipt.
Formalin fixed material is first tested by the Infectious Disease Pathology Branch 
(IDPB) and will only identify poxviruses to the genus level. DNA may be extracted 
from paraffin block embedded lesion material and tested by the Poxvirus 
Program. Fresh, non-frozen tissue is preferred by IDPB.
Specimen Labeling Specimens should be labeled with patient name, specimen type, date of 
collection, and body location
Transport Medium Prefer swabs dry but will accept specimen in a minimum viral transport medium
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday overnight to avoid weekend deliveries
Refrigerated specimen should be shipped on cold packs
Methodology Real Time-PCR
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Poxvirus - Smallpox (Variola Virus) Specific Molecular 
Detection
CDC-10388
Test Order
Synonym(s) None
Performed on Specimens From Human
CDC Points of Contact  DEOC
(770) 488-7100
Pre-Approval Needed DEOC, , (770) 488-7100, 
Supplemental Information
Required
Call CDC Emergency Operations Center prior to contacting laboratory 
770-488-7100
Supplemental Form http://www.bt.cdc.gov/agent/smallpox/
Acceptable Sample/ Specimen 
Type for Testing
Lesion fluid and/or material, serum, and blood must all be submitted. Lesion 
fluid and/or material: vesicle / pustule skin or fluid, scab, crust, etc.; collection 
method: touch prep slide, swab, biopsy
Minimum Volume Required 1 mL (blood and serum)
Turnaround Time 1 Day
Interferences & Limitations Cotton swabs may cause PCR inhibition and should not be used. Heparin may 
cause PCR inhibition and should not be used to collect whole blood.
Storage & Preservation of
Specimen Prior to Shipping
Serum should be collected in a venous blood tube containing a clot activator 
and/or gel. Blood tubes should be spun prior to shipment or an aliquot of the 
collected serum can be shipped. Whole blood should be collected in a blood tube 
containing ethylenediaminetetraacetic acid (EDTA). 
Keep specimen refrigerated. It is extremely important not to cross-contaminate 
specimens (i.e., one specimen per container). Viral transport media should not 
be added to specimens. All specimens should be stored at 4⁰C until shipment. 
Swabs without individual holders may be stored in a sterile container.
Additional lnformation A suspected case of smallpox must be immediately reported to appropriate local, 
state, or territorial health departments. After review, if smallpox is still 
suspected, the case should be immediately reported to CDC’s Emergency 
Operations Center.
Specimens should be collected as outlined in Guide D on the CDC website: 
Http://www.bt.cdc.gov/agent/smallpox/response-plan/files/guide-d.pdf
Specimen Labeling Specimens should be labeled with patient name, specimen type, date of 
collection, and body location
Transport Medium Prefer swabs dry but will accept specimen in a minimum viral transport medium
Shipping Instructions which 
Include Specimen Handling 
Requirements
Approval must be obtained prior to the shipment of potential smallpox patient 
clinical specimens to CDC
Methodology Real Time-PCR
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Poxvirus - Tanapox Specific Molecular Detection
CDC-10389
Test Order
Synonym(s) None
Performed on Specimens From Human
CDC Points of Contact  Help Desk
(404) 639-4129
Pre-Approval Needed Help Desk, , (404) 639-4129, 
Supplemental Information
Required
Clinical consultation with the Poxvirus Program is required prior to specimen 
shipment to determine testing urgency. A supplemental form will be supplied 
after initial consultation.
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Lesion fluid and/or material: vesicle/pustule skin or fluid, scab, crust, etc.
Collection method: fresh or frozen, swab, biopsy, touch prep slides, formalin 
fixed, paraffin block. Swabs should be made of nylon, polyester, or Dacron 
material
Minimum Volume Required Not Applicable
Turnaround Time 1 Day
Interferences & Limitations Swabs intended for the collection and transport of bacterial specimens should 
not be used. Cotton swabs may cause PCR inhibition and should not be used. 
The addition of viral transport media to swab specimens will dilute any viral DNA 
present.
Storage & Preservation of
Specimen Prior to Shipping
All specimens should be stored at 4⁰C until shipment. Swabs without individual 
holders may be stored in a sterile container. Dry swabs are preferred but a 
minimal amount of viral transport media may be added.
Additional lnformation Turnaround time:
Urgent cases
-Testing is completed and reported within 24 hours of specimen receipt when 
results directly impact patient care;
Routine cases
-Testing is completed and reported within 5 business days of specimen receipt.
Formalin fixed material is first tested by the Infectious Disease Pathology Branch 
(IDPB) and will only identify poxviruses to the genus level. DNA may be extracted 
from paraffin block embedded lesion material and tested by the Poxvirus 
Program. Fresh, non-frozen tissue is preferred by IDPB.
Specimen Labeling Specimens should be labeled with patient name, specimen type, date of 
collection, and body location
Transport Medium Prefer swabs dry but will accept specimen in a minimum viral transport medium
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday overnight to avoid weekend deliveries
Refrigerated specimen should be shipped on cold packs
Methodology Real Time-PCR
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Poxvirus - Vaccinia Specific Molecular Detection
CDC-10390
Test Order
Synonym(s) Smallpox Vaccine
Performed on Specimens From Human
CDC Points of Contact  Help Desk
(404) 639-4129
Pre-Approval Needed Help Desk, , (404) 639-4129, 
Supplemental Information
Required
Clinical consultation with the Poxvirus Program is required prior to specimen 
shipment to determine testing urgency. A supplemental form will be supplied 
after initial consultation.
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Lesion fluid and/or material: vesicle/pustule skin or fluid, scab, crust, etc.
Collection method: fresh or frozen, swab, biopsy, touch prep slides, formalin 
fixed, paraffin block. Swabs should be made of nylon, polyester, or Dacron 
material.
Minimum Volume Required Not Applicable
Turnaround Time 1 Day
Interferences & Limitations Swabs intended for the collection and transport of bacterial specimens should 
not be used. Cotton swabs may cause PCR inhibition and should not be used. 
The addition of viral transport media to swab specimens will dilute any viral DNA 
present.
Storage & Preservation of
Specimen Prior to Shipping
All specimens should be stored at 4⁰C until shipment. Swabs without individual 
holders may be stored in a sterile container. Dry swabs are preferred but a 
minimal amount of viral transport media may be added.
Additional lnformation Turnaround time:
Urgent cases
-Testing is completed and reported within 24 hours of specimen receipt when 
results directly impact patient care;
Routine cases
-Testing is completed and reported within 5 business days of specimen receipt.
Formalin fixed material is first tested by the Infectious Disease Pathology Branch 
(IDPB) and will only identify poxviruses to the genus level. DNA may be extracted 
from paraffin block embedded lesion material and tested by the Poxvirus 
Program. Fresh, non-frozen tissue is preferred by IDPB.
Specimen Labeling Specimens should be labeled with patient name, specimen type, date of 
collection, and body location
Transport Medium Prefer swabs dry but will accept specimen in a minimum viral transport medium
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday overnight to avoid weekend deliveries
Refrigerated specimen should be shipped on cold packs
Methodology Real Time-PCR
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Puumala Serology
CDC-10391
Test Order
Synonym(s) Hanta, HFRS, Nephropathia epidemica
Performed on Specimens From Human and Animal
CDC Points of Contact Ute Stroeher
(404) 639-4704
ixy8@cdc.gov
Barbara Knust
(404) 639-1104
bkk0@cdc.gov
Pre-Approval Needed Stroeher, Ute, (404) 639-4704, ixy8@cdc.gov
Knust, Barbara, (404) 639-1104, bkk0@cdc.gov
Supplemental Information
Required
See Supplemental Form
Supplemental Form http://www.cdc.gov/ncezid/dhcpp/vspb/pdf/specimen-submission.pdf
Acceptable Sample/ Specimen 
Type for Testing
Blood and serum
Minimum Volume Required 1 mL
Turnaround Time 10 Days
Interferences & Limitations Specimen must remain frozen; warming or freeze thawing reduces sensitivity
Storage & Preservation of
Specimen Prior to Shipping
Specimen must be kept cold (at or below 4°C). If possible place specimen in 
plastic screw capped vials. See link to supplemental submission form for specific 
information on various specimen types.
Additional lnformation Critical specimens will take less than 4 days to turn around. See link to 
supplemental submission forms for detailed information.
Specimen Labeling Patient name, patient ID #, specimen type, date collected
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday overnight to avoid weekend deliveries. Specimen should 
be shipped on cold packs or dry ice if frozen. See supplemental submission 
forms for further details. Do not ship specimen without prior consultation and 
approval.
Methodology ELISA
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Rabies Antemortem Human Testing
CDC-10392
Test Order
Synonym(s) None
Performed on Specimens From Human
CDC Points of Contact  Rabies Duty Officer
(404) 639-1050
Pre-Approval Needed Rabies Duty Officer, , (404) 639-1050, 
Supplemental Information
Required
See Supplemental Form
Supplemental Form www.cdc.gov/rabies/specific_groups/laboratories/index.html
Acceptable Sample/ Specimen 
Type for Testing
All four of the following are required for testing: serum, CSF, nuchal (skin) 
biopsy, and saliva
Minimum Volume Required 500 uL (serum, CSF, saliva)
Turnaround Time 3 Days
Interferences & Limitations Saliva and CSF specimen should be free of blood because blood may interfere 
with test results due to the inhibitors present in blood
Storage & Preservation of
Specimen Prior to Shipping
Keep all samples stored at -80⁰C and ship on dry ice. Serum and CSF can be 
refrigerated before shipping. Please see the supplemental link for specific 
specimen storage and preservation.
Additional lnformation Sequencing will only be performed if the RT-PCR test is positive. Nuchal (skin) 
biopsy has to be a full punch (5-6 millimeters). If testing needs to be repeated 
results may take up to 7 days.
Specimen Labeling Two patient identifiers on the specimen container and the test requisition, 
sample type and date of collection
Transport Medium Saliva and Nuchal (skin) biopsy should not be put in a transport medium
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship all specimens overnight, first AM delivery and provide the CDC Point of 
Contact with the tracking number of package.
Frozen specimen should be shipped on dry ice
Refrigerated specimen should be shipped on cold packs
Methodology IgG by IFA (Serum and CSF), IgM by IFA (Serum and CSF), Viral Neutralizing 
Antibodies by RFFIT (Serum and CSF), DFA (Nuchal (skin) biopsy), RT-PCR 
(Nuchal (skin) biopsy), RT-PCR (Saliva), Sequencing
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Rabies Antibody - Pre/Post-exposure Prophylaxis
CDC-10393
Test Order
Synonym(s) Serology, Immunization status, Rabies titer
Performed on Specimens From Human
CDC Points of Contact  Rabies Duty Officer
(404) 639-1050
Pre-Approval Needed Rabies Duty Officer, , (404) 639-1050, 
Supplemental Information
Required
See Supplemental Form
Supplemental Form http://www.cdc.gov/rabies/specific_groups/laboratories/index.html
Acceptable Sample/ Specimen 
Type for Testing
Serum
Minimum Volume Required 500 uL
Turnaround Time 3 Days
Interferences & Limitations Hemolyzed samples interfere with test results
Storage & Preservation of
Specimen Prior to Shipping
Specimen can be kept refrigerated but prefer frozen
Additional lnformation If testing needs to be repeated results may take up to 7 days
Specimen Labeling Two patient identifiers on the specimen container and the test requisition, 
sample type and date of collection
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship all specimens overnight, first AM delivery and provide the CDC Point of 
Contact with the tracking number of package.
Frozen specimen should be shipped on dry ice
Refrigerated specimen should be shipped on cold packs
Methodology Viral Neutralizing Antibodies RFFIT
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Rabies Confirmatory Testing (Animal)
CDC-10394
Test Order
Synonym(s) Rabies DFA
Performed on Specimens From Animal
CDC Points of Contact  Rabies Duty Officer
(404) 639-1050
Pre-Approval Needed Rabies Duty Officer, , (404) 639-1050, 
Supplemental Information
Required
See Supplemental Form
Supplemental Form http://www.cdc.gov/rabies/specific_groups/laboratories/index.html
Acceptable Sample/ Specimen 
Type for Testing
Fresh-frozen brain tissues: full cross section of brain stem and cerebellum 
(vermis, right and left lateral lobes). Other specimens may be submitted upon 
consultation with Rabies Duty Officer.
Minimum Volume Required Not Applicable
Turnaround Time 2 Days
Interferences & Limitations Test is limited by decomposed tissues due to denaturation of viral proteins
Storage & Preservation of
Specimen Prior to Shipping
Stored at -80⁰C and should be kept on dry ice
Additional lnformation May take up longer if repeat testing and additional procedures are required to 
rule-out rabies
Specimen Labeling One patient identifier on the specimen container and the test requisition, 
sample type and date of collection
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship all specimens overnight, first AM delivery and provide the CDC Point of 
Contact with the tracking number of package
Frozen specimen should be shipped on dry ice
Methodology DFA for rabies virus antigen, Direct Rapid Immunohistochemistry test (DRIT), RT-
PCR, Virus Isolation, Antigenic Typing, Sequence Analysis
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Rabies Confirmatory Testing (Human)
CDC-10395
Test Order
Synonym(s) None
Performed on Specimens From Human
CDC Points of Contact  Rabies Duty Officer
(404) 639-1050
Pre-Approval Needed Rabies Duty Officer, , (404) 639-1050, 
Supplemental Information
Required
See Supplemental Form
Supplemental Form http://www.cdc.gov/rabies/specific_groups/laboratories/index.html
Acceptable Sample/ Specimen 
Type for Testing
All four of the following are required for antemortem testing: serum, CSF, Nuchal 
(skin) biopsy, and saliva. Fresh-frozen brain tissues for postmortem testing: full 
cross section of brain stem and cerebellum (vermis right and left lateral lobes).
Minimum Volume Required 500 uL (serum, CSF, saliva)
Turnaround Time 3 Days
Interferences & Limitations Saliva and CSF specimen should be free of blood because blood may interfere 
with test results due to the inhibitors present in blood. Test is limited by 
decomposed tissues due to denaturation of viral proteins.
Storage & Preservation of
Specimen Prior to Shipping
Keep all samples stored at -80⁰C and ship on dry ice. Serum and CSF can be 
refrigerated before shipping. Please see the supplemental link for specific 
specimen storage and preservation.
Additional lnformation Sequencing will only be performed if the RT-PCR test is positive. Nuchal (skin) 
biopsy has to be a full punch (5-6 millimeters). If testing needs to be repeated 
results may take up to 7 days.
Specimen Labeling Two patient identifiers on the specimen container and the test requisition, 
sample type and date of collection
Transport Medium Saliva and nuchal (skin) biopsy should not be put in a transport medium
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship all specimens overnight, first AM delivery and provide the CDC Point of 
Contact with the tracking number of package.
Frozen specimen should be shipped on dry ice
Refrigerated specimen should be shipped on cold packs
Methodology IgG by IFA (Serum and CSF), DFA (Nuchal (skin) biopsy and for rabies virus 
antigen), Antigenic Typing (brain), RT-PCR, Sequence Analysis, Isolation, Direct 
Rapid Immunohistochemistry test (DRIT), IHC, Viral Neutralizing Antibodies by 
RFFIT (Serum and CSF)
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Rabies Postmortem Human Testing
CDC-10396
Test Order
Synonym(s) Rabies DFA
Performed on Specimens From Human
CDC Points of Contact  Rabies Duty Officer
(404) 639-1050
Pre-Approval Needed Rabies Duty Officer, , (404) 639-1050, 
Supplemental Information
Required
See Supplemental Form
Supplemental Form http://www.cdc.gov/rabies/specific_groups/laboratories/index.html
Acceptable Sample/ Specimen 
Type for Testing
Fresh-frozen brain tissues: full cross section of brain stem and cerebellum 
(vermis, right and left lateral lobes). Other specimens may be submitted upon 
consultation with Rabies Duty Officer.
Minimum Volume Required Not Applicable
Turnaround Time 2 Days
Interferences & Limitations Tests are limited by decomposed tissues due to denaturation of viral proteins
Storage & Preservation of
Specimen Prior to Shipping
Stored at -80⁰C and should be kept on dry ice
Additional lnformation If testing needs to be repeated results may take up to 7 days
Specimen Labeling Two patient identifiers on the specimen container and the test requisition, 
sample type and date of collection
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship all specimens overnight, first AM delivery and provide the CDC Point of 
Contact with the tracking number of package
Frozen specimen should be shipped on dry ice
Methodology DFA for rabies virus antigen, RT-PCR, Direct Rapid Immunohistochemistry test 
(DRIT), Virus Isolation, Sequence Analysis, Antigenic Typing
 
Monday, January 13, 2014 Page 314 of 380Version: 1.0
Rabies Virus Genetic Typing
CDC-10397
Test Order
Synonym(s) Rabies Antigenic Typing, Rabies Monoclonal Antibody Typing, Rabies MAB 
Typing, Rabies  RT-PCR, Rabies Sequence Analysis, Rabies Variant Typing
Performed on Specimens From Human and Animal
CDC Points of Contact  Rabies Duty Officer
(404) 639-1050
Pre-Approval Needed Rabies Duty Officer, , (404) 639-1050, 
Supplemental Information
Required
See Supplemental Form
Supplemental Form http://www.cdc.gov/rabies/specific_groups/laboratories/index.html
Acceptable Sample/ Specimen 
Type for Testing
Fresh-frozen brain tissues: full cross section of brain stem and cerebellum 
(vermis, right and left lateral lobes) preferred, or a viral isolate. Other specimens 
may be submitted upon consultation with Rabies Duty Officer.
Minimum Volume Required Not Applicable
Turnaround Time 7 Days
Interferences & Limitations Tests are limited by decomposed tissues due to denaturation of viral proteins
Storage & Preservation of
Specimen Prior to Shipping
Stored at -80⁰C and should be kept on dry ice
Additional lnformation Non-urgent specimen may take longer than 7 days
Specimen Labeling Two unique identifiers for human specimen and one unique identifier for animal 
specimen, date of collection and specimen type
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday overnight to avoid weekend deliveries and provide the 
CDC Point of Contact with the tracking number of package
Frozen specimen should be shipped on dry ice
Methodology RT-PCR, Sequence Analysis, Isolation
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Rabies Virus Typing - CNS Tissues
CDC-10398
Test Order
Synonym(s) Rabies Antigenic typing
Performed on Specimens From Human and Animal
CDC Points of Contact  Rabies Duty Officer
(404) 639-1050
Pre-Approval Needed None
Supplemental Information
Required
See Supplemental Form
Supplemental Form http://www.cdc.gov/rabies/specific_groups/laboratories/index.html
Acceptable Sample/ Specimen 
Type for Testing
Fresh-frozen brain tissues: full cross section of brain stem and cerebellum 
(vermis, right and left lateral lobes). Other specimens may be submitted upon 
consultation with Rabies Duty Officer.
Minimum Volume Required Not Applicable
Turnaround Time 7 Days
Interferences & Limitations Test is limited by decomposed tissues due to denaturation of viral proteins
Storage & Preservation of
Specimen Prior to Shipping
Stored at -80⁰C and should be kept on dry ice
Additional lnformation Urgent specimens will be reported within 24 hours if the test does not need to 
be repeated. Non-urgent specimen may take longer than 7 days.
Specimen Labeling Two unique identifiers for human specimen and one unique identifier for animal 
specimen, date of collection and specimen type
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday overnight to avoid weekend deliveries and provide the 
CDC Point of Contact with the tracking number of package
Frozen specimen should be shipped on dry ice
Methodology DFA, IFA, Isolation, Sequencing Analysis
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Respiratory Agents (Chlamydia, Legionella, Mycoplasma) 
Molecular Detection
CDC-10157
Test Order
Synonym(s) Atypical pneumonia, CAP, Chlamydia pneumoniae, Legionnaires' disease or LD, 
Legionellosis, Pontiac fever, Walking pneumonia
Performed on Specimens From Human
CDC Points of Contact Jonas Winchell
(404) 639-4921
Jwinchell@cdc.gov
Maureen Diaz
(404) 639-4534
mdiaz1@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Nasopharyngeal (NP) and/or Oropharyngeal (OP) swabs, and any lower 
respiratory tract specimen including bronchoalveolar lavage (BAL) and sputum. 
Others upon consultation with laboratory.
Minimum Volume Required 1 mL
Turnaround Time 3 Days
Interferences & Limitations Do not use cotton swabs with wooden shafts. Specimen should be acquired prior 
to antibiotic treatment. Improper specimen storage and handling may result in 
inconclusive or inaccurate results.
Storage & Preservation of
Specimen Prior to Shipping
Specimens can be kept refrigerated if shipped in less than 72 hours of collection; 
otherwise specimen should be kept frozen. Store swabs in universal transport 
medium.
Additional lnformation None
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Universal transport medium
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday overnight to avoid weekend deliveries
Refrigerated specimen should be sent on ice packs
Frozen specimen should be sent on dry ice
Methodology Real Time PCR
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Respiratory Virus (Not Influenza) Special Study
CDC-10400
Test Order
Synonym(s) None
Performed on Specimens From Human and Animal
CDC Points of Contact Dean Erdman
(404) 639-3727
dde1@cdc.gov
Shifaq Kamili
(404) 639-2799
sgk5@cdc.gov
Pre-Approval Needed Erdman, Dean, (404) 639-3727, dde1@cdc.gov
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
To be determined
Minimum Volume Required To be determined
Turnaround Time  
Interferences & Limitations To be determined
Storage & Preservation of
Specimen Prior to Shipping
To be determined
Additional lnformation To be determined
Specimen Labeling To be determined
Transport Medium To be determined
Shipping Instructions which 
Include Specimen Handling 
Requirements
To be determined
Methodology
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Respiratory Virus Molecular Detection (Not Influenza)
CDC-10401
Test Order
Synonym(s) Non-influenza Respiratory Virus
Performed on Specimens From Human and Animal
CDC Points of Contact Dean Erdman
(404) 639-3727
dde1@cdc.gov
Shifaq Kamili
(404) 639-2799
sgk5@cdc.gov
Pre-Approval Needed Erdman, Dean, (404) 639-3727, dde1@cdc.gov
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Upper or lower respiratory tract specimens; pure culture isolate
Minimum Volume Required 0.25 mL
Turnaround Time 3 Weeks
Interferences & Limitations Use only sterile Dacron or rayon swabs with plastic shafts or if available, flocked 
swabs. Do NOT use calcium alginate swabs or swabs with wooden sticks, as they 
may contain substances that inactivate some viruses and inhibit some molecular 
assays.
Storage & Preservation of
Specimen Prior to Shipping
Refrigerate all specimens promptly after collection. If specimens can be shipped 
to CDC within 72 hours of collection, they should be kept refrigerated at 4°C and 
shipped on gel ice-packs. Freezing should be avoided if possible, as this will 
reduce virus infectivity. Specimens for virus culture should not be frozen at -20°
C. If specimens must be held for >72 hours, they should be promptly frozen 
at -70°C and shipped on dry ice. Liquid specimens should be aliquoted into 
properly labeled, leak-proof, unbreakable screw cap vials. Samples should be 
collected and processed in a manner that prevents cross-contamination between 
specimens, including changing gloves between specimens.
Additional lnformation None
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Swabs may be shipped in commercial viral transport media
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship specimen Monday -Thursday, overnight to avoid weekend deliveries
Frozen specimen should be shipped on dry ice
Refrigerated specimen should be shipped on cold packs
Methodology Polymerase Chain Reaction (PCR)
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Rickettsia Molecular Detection
CDC-10402
Test Order
Synonym(s) Rickettsiosis, Rocky Mountain Spotted Fever (RMSF), Spotted fever group
Rickettsia (SFG), Typhus group Rickettsia (TG)
Performed on Specimens From Human
CDC Points of Contact Cecilia Kato
(404) 639-1075
ckato@cdc.gov
Jennifer McQuiston
(404) 639-1075
fzh7@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
Prior approval is required if the following information is not provided:
-Symptom onset date
-Sample collection date
-Type of infection
-Status of illness
Recommended:
-Travel history
-Exposure history
-Therapeutic agents
-Brief clinical history
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Acute samples only, anticoagulated whole blood collected in 
Ethylenediaminetetraacetic acid (EDTA) treated tubes preferred; serum; fresh 
tissue biopsy
Minimum Volume Required 1.0 mL
Turnaround Time 6 Weeks
Interferences & Limitations Hemolysis in whole blood specimen will interfere with results. Multiple freeze 
thaw cycles and sample storage above refrigerated temperatures will interfere 
with proper nucleic acid extraction. If a specimen is drawn at convalescence it 
will reduce the chance of the target organism being present in blood. Avoid 
collection of blood specimen in heparin tubes.
Storage & Preservation of
Specimen Prior to Shipping
Ideally keep specimen at a refrigerated temperature not frozen. If previously 
frozen, then keep specimen frozen.
Additional lnformation The Rickettsial Zoonoses Branch Reference Diagnostic Laboratory aids State 
Laboratories in diagnosis of difficult samples/cases or if specialized tests are 
needed. Routine diagnostic samples should be sent to your State Laboratory or a 
commercial laboratory.
Specimen Labeling Patient name and date of birth
Transport Medium Ethylenediaminetetraacetic acid (EDTA) blood tubes for blood; tissue in a sample 
collection tube
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday - Thursday, overnight to avoid weekend deliveries. Specimen 
should be shipped refrigerated on cold packs.
Methodology Real Time Polymerase chain Reaction (PCR), Polymerase Chain Reaction (PCR), 
Sequencing
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Rickettsia Serology Spotted Fever Group (RMSF) Serology
CDC-10403
Test Order
Synonym(s) Spotted fever group Rickettsiosis, Rocky Mountain Spotted Fever (RMSF)
Performed on Specimens From Human
CDC Points of Contact Cecilia Kato
(404) 639-1075
ckato@cdc.gov
Jennifer McQuiston
(404) 639-1075
fzh7@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
Prior approval is required if the following information is not provided:
-Symptom onset date
-Sample collection date
-Type of infection
-Status of illness
Recommended:
-Travel history
-Exposure history
-Therapeutic agents
-Brief clinical history
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Serum
-acute (during active stage of illness)
-convalescent (2-4 weeks after acute stage)
Minimum Volume Required 1.0 mL
Turnaround Time 6 Weeks
Interferences & Limitations Multiple freeze thaw cycles may interfere with antigen binding. Use sterile 
technique to avoid contamination of sample as this may compromise the sample 
and interfere with the ability to get accurate results. Acute and convalescent 
serum is needed for accurate diagnosis and if unable to collect both please 
contact lab prior to shipping.
Storage & Preservation of
Specimen Prior to Shipping
Ideally keep specimen at a refrigerated temperature not frozen. If previously 
frozen, then keep specimen frozen.
Additional lnformation The Rickettsial Zoonoses Branch Reference Diagnostic Laboratory aids State 
Laboratories in diagnosis of difficult samples/cases or if specialized tests are 
needed. Routine diagnostic samples should be sent to your State Laboratory or a 
commercial laboratory.
Specimen Labeling Patient name and date of birth
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday - Thursday, overnight to avoid weekend deliveries. Specimen 
should be shipped refrigerated on cold packs.
Methodology IFA (Immunofluorescence Assay)
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Rickettsia Serology Typhus Group Serology
CDC-10404
Test Order
Synonym(s) Typhus Group Rickettsiosis, Including epidemic Typhus and murine Typhus
Performed on Specimens From Human
CDC Points of Contact Cecilia Kato
(404) 639-1075
ckato@cdc.gov
Jennifer McQuiston
(404) 639-1075
fzh7@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
Prior approval is required if the following information is not provided:
-Symptom onset date
-Sample collection date
-Type of infection
-Status of illness
Recommended:
-Travel history
-Exposure history
-Therapeutic agents
-Brief clinical history
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Serum
-acute (during active stage of illness)
-convalescent (2-4 weeks after acute stage)
Minimum Volume Required 1.0 mL
Turnaround Time 6 Weeks
Interferences & Limitations Multiple freeze thaw cycles may interfere with antigen binding. Use sterile 
technique to avoid contamination of sample as this may compromise the sample 
and interfere with the ability to get accurate results. Acute and convalescent 
serum is needed for accurate diagnosis and if unable to collect both please 
contact laboratory prior to shipping.
Storage & Preservation of
Specimen Prior to Shipping
Ideally keep specimen at a refrigerated temperature not frozen. If previously 
frozen, then keep specimen frozen.
Additional lnformation The Rickettsial Zoonoses Branch Reference Diagnostic Laboratory aids State 
Laboratories in diagnosis of difficult samples/cases or if specialized tests are 
needed. Routine diagnostic samples should be sent to your State Laboratory or a 
commercial laboratory.
Specimen Labeling Patient name and date of birth
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday - Thursday, overnight to avoid weekend deliveries. Specimen 
should be shipped refrigerated on cold packs.
Methodology Indirect Fluorescence Assay (IFA)
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Ricksettsia Special Study
CDC-10405
Test Order
Synonym(s) Rickettsiosis, Rocky Mountain Spotted Fever (RMSF), Spotted fever group 
Rickettsia (SFG), Typhus group Rickettsia (TG)
Performed on Specimens From Human, Animal, and Food/Environmental/Medical Devices/Biologics
CDC Points of Contact Cecilia Kato
(404) 639-1075
ckato@cdc.gov
Jennifer McQuiston
(404) 639-1075
fzh7@cdc.gov
Pre-Approval Needed Kato, Cecilia, (404) 639-1075, ckato@cdc.gov
McQuiston, Jennifer, (404) 639-1075, fzh7@cdc.gov
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
To be determined
Minimum Volume Required To be determined
Turnaround Time  
Interferences & Limitations To be determined
Storage & Preservation of
Specimen Prior to Shipping
To be determined
Additional lnformation To be determined
Specimen Labeling To be determined
Transport Medium To be determined
Shipping Instructions which 
Include Specimen Handling 
Requirements
To be determined
Methodology Molecular detection, Serology, Culture, Immunohistochemistry (IHC), Other
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Rift Valley Fever (RVF) Identification
CDC-10406
Test Order
Synonym(s) RVF
Performed on Specimens From Human and Animal
CDC Points of Contact Ute Stroeher
(404) 639-4704
ixy8@cdc.gov
Barbara Knust
(404) 639-1104
bkk0@cdc.gov
Pre-Approval Needed Stroeher, Ute, (404) 639-4704, ixy8@cdc.gov
Knust, Barbara, (404) 639-1104, bkk0@cdc.gov
Supplemental Information
Required
See Supplemental Form
Supplemental Form http://www.cdc.gov/ncezid/dhcpp/vspb/pdf/specimen-submission.pdf
Acceptable Sample/ Specimen 
Type for Testing
Frozen tissue, blood and serum
Minimum Volume Required 1 mL
Turnaround Time 10 Days
Interferences & Limitations Specimen must remain frozen; warming or freeze thawing reduces sensitivity. 
Heparin may cause interference with the molecular tests and should be avoided.
Storage & Preservation of
Specimen Prior to Shipping
Specimen must be placed in plastic screw capped vials, frozen to -70°C, and kept 
frozen until shipment. See link to supplemental submission form for specific 
information on various specimen types.
Additional lnformation Critical specimens will take less than 4 days to turn around. See link to 
supplemental submission forms for detailed information.
Specimen Labeling Patient name, patient ID #, specimen type, date collected
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday overnight to avoid weekend deliveries. Specimen should 
be shipped frozen on dry ice. See supplemental submission forms for further 
details. Do not ship specimen without prior consultation and approval.
Methodology Molecular Typing, Polymerase Chain Reaction (PCR)
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Rift Valley Fever (RVF) Serology
CDC-10407
Test Order
Synonym(s) RVF
Performed on Specimens From Human and Animal
CDC Points of Contact Ute Stroeher
(404) 639-4704
ixy8@cdc.gov
Barbara Knust
(404) 639-1104
bkk0@cdc.gov
Pre-Approval Needed Stroeher, Ute, (404) 639-4704, ixy8@cdc.gov
Knust, Barbara, (404) 639-1104, bkk0@cdc.gov
Supplemental Information
Required
See Supplemental Form
Supplemental Form http://www.cdc.gov/ncezid/dhcpp/vspb/pdf/specimen-submission.pdf
Acceptable Sample/ Specimen 
Type for Testing
Blood and serum
Minimum Volume Required 1 mL
Turnaround Time 10 Days
Interferences & Limitations Specimen must remain frozen; warming or freeze thawing reduces sensitivity
Storage & Preservation of
Specimen Prior to Shipping
Specimen must be kept cold (at or below 4°C). If possible place specimen in 
plastic screw capped vials. See link to supplemental submission form for specific 
information on various specimen types.
Additional lnformation Critical specimens will take less than 4 days to turn around. See link to 
supplemental submission forms for detailed information.
Specimen Labeling Patient name, patient ID #, specimen type, date collected
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday overnight to avoid weekend deliveries. Specimen should 
be shipped on cold packs or dry ice if frozen. See supplemental submission 
forms for further details. Do not ship specimen without prior consultation and 
approval.
Methodology ELISA
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Rotavirus Antigen Detection
CDC-10408
Test Order
Synonym(s) Rotavirus Antigen EIA, Rotavirus Antigen ELISA
Performed on Specimens From Human
CDC Points of Contact Mike Bowen
(404) 639-4922
mkb6@cdc.gov
Jamie Lewis
(404) 639-4054
erw9@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
Contact laboratory for supplemental forms
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Human stool
Minimum Volume Required 0.25 g or 0.25 mL
Turnaround Time 15 Days
Interferences & Limitations None
Storage & Preservation of
Specimen Prior to Shipping
Specimen should be kept either frozen at -20°C or colder or refrigerated at 4°C. 
Specimen tubes or cups must be packed inside of a leak proof secondary 
container. The secondary container needs to be packed inside an approved class 
B specimen shipping container (i.e. Fisher scientific cat# 22-130-431).
Additional lnformation Contact laboratory for instructions to recover a limited sample from diaper 
material
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Do not send specimen in bacterial or viral transport medium or a fixative
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship specimen Monday -Wednesday, overnight to avoid weekend deliveries
Frozen specimen should be shipped on dry ice
Refrigerated specimen should be shipped on cold packs
Include a hardcopy list of specimens with your shipment. Please notify Mike 
Bowen (mkb6@cdc.gov) and Jamie Lewis (erw9@cdc.gov) when you are going to 
send specimens, and include the shipment tracking number if possible.
Methodology Enzyme immunoassay (EIA)
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Rotavirus Genotyping
CDC-10409
Test Order
Synonym(s) Rotavirus typing
Performed on Specimens From Human
CDC Points of Contact Mike Bowen
(404) 639-4922
mkb6@cdc.gov
Jamie Lewis
(404) 639-4054
erw9@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
Contact laboratory for supplemental forms.
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Human stool
Minimum Volume Required 0.25 g or 0.25 mL
Turnaround Time 4 Weeks
Interferences & Limitations None
Storage & Preservation of
Specimen Prior to Shipping
Specimen should be kept either frozen at -20°C or colder or refrigerated at 4°C. 
Specimen tubes or cups must be packed inside of a leak proof secondary 
container. The secondary container needs to be packed inside an approved class 
B specimen shipping container (i.e. Fisher scientific cat# 22-130-431).
Additional lnformation Contact laboratory for instructions to recover a limited sample from diaper 
material
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Do not send specimen in bacterial or viral transport medium or a fixative
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship specimen Monday -Wednesday, overnight to avoid weekend deliveries
Frozen specimen should be shipped on dry ice
Refrigerated specimen should be shipped on cold packs
Include a hardcopy list of specimens with your shipment. Please notify Mike 
Bowen (mkb6@cdc.gov) and Jamie Lewis (erw9@cdc.gov) when you are going to 
send specimens, and include the shipment tracking number if possible.
Methodology RT-PCR, Sequencing
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Rotavirus Molecular Detection and Genotyping
CDC-10410
Test Order
Synonym(s) Rotavirus Real Time RT-PCR
Performed on Specimens From Human
CDC Points of Contact Mike Bowen
(404) 639-4922
mkb6@cdc.gov
Jamie Lewis
(404) 639-4054
erw9@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
Contact laboratory for supplemental forms
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Human stool
Minimum Volume Required 0.25 g or 0.25 mL
Turnaround Time 15 Days
Interferences & Limitations None
Storage & Preservation of
Specimen Prior to Shipping
Specimen should be kept either frozen at -20°C or colder or refrigerated at 4°C. 
Specimen tubes or cups must be packed inside of a leak proof secondary 
container. The secondary container needs to be packed inside an approved class 
B specimen shipping container (i.e. Fisher scientific cat# 22-130-431).
Additional lnformation Contact laboratory for instructions to recover a limited sample from diaper 
material
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Do not send specimen in bacterial or viral transport medium or a fixative
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship specimen Monday-Wednesday, overnight to avoid weekend deliveries
Frozen specimen should be shipped on dry ice
Refrigerated specimen should be shipped on cold packs
Include a hardcopy list of specimens with your shipment. Please notify Mike 
Bowen (mkb6@cdc.gov) and Jamie Lewis (erw9@cdc.gov) when you are going to 
send specimens, and include the shipment tracking number if possible.
Methodology Real Time RT-PCR, RT-PCR, Sequencing
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Rubella Detection and Genotyping
CDC-10242
Test Order
Synonym(s) German measles, three day measles
Performed on Specimens From Human
CDC Points of Contact Joe Icenogle
(404) 639-4557
jci1@cdc.gov
Emily Abernathy
(404) 639-1249
efa9@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Throat swab in viral medium, nasopharyngeal aspirate or swab, Urine, cataracts, 
lens aspirate, oral fluid, cerebrospinal fluid (CSF), dry blood spots, and tissue 
samples
Minimum Volume Required Not Applicable
Turnaround Time 7 Days
Interferences & Limitations See: http://www.cdc.gov/rubella/lab/lab-protocols.htm for information on the 
interferences and limitations
Storage & Preservation of
Specimen Prior to Shipping
See: http://www.cdc.gov/rubella/lab/lab-protocols.htm for collection and 
storage protocol
Additional lnformation Please include vaccination history, age, date of onset and sample collection.
For additional information please refer to: 
http://www.cdc.gov/vaccines/pubs/surv-manual/index.html and 
http://www.cdc.gov/measles/lab-tools/index.html
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Clearly label specimen type.
Transport Medium Viral transport medium for swabs and appropriate culture medium. Make sure 
tubes are all in leak proof containers.
Shipping Instructions which 
Include Specimen Handling 
Requirements
The laboratory requests that the sender contacts the laboratory by email or 
phone before shipping
Ship specimen Monday -Thursday overnight to avoid weekend deliveries
Frozen specimen should be shipped on dry ice
Refrigerated specimen should be shipped on cold packs
Methodology Template production by RT-PCR, Real time RT-PCR, Viral culture, Genotyping by 
Nucleic acid sequencing
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Rubella Serology
CDC-10246
Test Order
Synonym(s) German measles, three day measles
Performed on Specimens From Human
CDC Points of Contact Joe Icenogle
(404) 639-4557
jci1@cdc.gov
Emily Abernathy
(404) 639-1249
efa9@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Serum and others upon consultation
Minimum Volume Required 200 uL
Turnaround Time 7 Days
Interferences & Limitations IgM positive may not occur until 5 days post-rash onset
Storage & Preservation of
Specimen Prior to Shipping
Serum should be kept refrigerated or frozen
Additional lnformation IgM and IgG assays are qualitative assays
For outbreaks or immuno-compromised patients please contact laboratory prior 
to shipment
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Clearly label specimen type.
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship specimen Monday -Thursday overnight to avoid weekend deliveries
Refrigerated or frozen specimen should be shipped on cold packs
Laboratory will instruct on how to ship for other specimen types
Methodology Commercial capture IgM, Commercial indirect IgG
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Rubella Serology (IgM and IgG) and Avidity
CDC-10249
Test Order
Synonym(s) German measles, three day measles
Performed on Specimens From Human
CDC Points of Contact Joe Icenogle
(404) 639-4557
jci1@cdc.gov
Emily Abernathy
(404) 639-1249
efa9@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Serum
Minimum Volume Required 200 uL
Turnaround Time 7 Days
Interferences & Limitations Date of onset is necessary for accurate interpretation
Storage & Preservation of
Specimen Prior to Shipping
Serum should be kept refrigerated or frozen
Additional lnformation Date of onset, vaccination status, age, date of collection and pregnancy status if 
applicable.
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Clearly label specimen type.
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
The laboratory requests that the sender contacts the laboratory by email or 
phone before shipping
Ship specimen Monday -Thursday overnight to avoid weekend deliveries
Frozen specimen should be shipped on dry ice
Refrigerated specimen should be shipped on cold packs
Methodology CDC IgG avidity assay
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Rubella Special Study
CDC-10253
Test Order
Synonym(s) German measles, three day measles
Performed on Specimens From Human
CDC Points of Contact Joe Icenogle
(404) 639-4557
jci1@cdc.gov
Emily Abernathy
(404) 639-1249
efa9@cdc.gov
Pre-Approval Needed Icenogle, Joe, (404) 639-4557, jci1@cdc.gov
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
To be determined
Minimum Volume Required To be determined
Turnaround Time  
Interferences & Limitations To be determined
Storage & Preservation of
Specimen Prior to Shipping
To be determined
Additional lnformation To be determined
Specimen Labeling To be determined
Transport Medium To be determined
Shipping Instructions which 
Include Specimen Handling 
Requirements
To be determined
Methodology
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Salmonella Identification and Serotyping
CDC-10110
Test Order
Synonym(s) Salmonella Typing
Performed on Specimens From Human, Animal, and Food/Environmental/Medical Devices/Biologics
CDC Points of Contact Matthew Mikoleit
(404) 639-2946
euh1@cdc.gov
Patricia Jones
(404) 639-3334
entericbacteria@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
Prior approval is not required for human specimens; Please call for approval 
prior to sending, other specimen types. Provide any preliminary results 
available.
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Isolates
Minimum Volume Required Not Applicable
Turnaround Time 4 Weeks
Interferences & Limitations None
Storage & Preservation of
Specimen Prior to Shipping
No Specific Requirements
Additional lnformation Turnaround times for routine isolates may be extended during major foodborne 
outbreak activities or due to limited availability of resources.
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Ship cultures on nonselective nutrient or similar agar (TSA, HIA, etc.) in tubes 
with leak-proof screw cap closures.  Agar plates are not acceptable.
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday, overnight to avoid weekend deliveries
Ship at ambient temperature in compliance with Federal and local guidelines
Methodology Phenotypic identification, Phenotypic serotyping, Genetic identification, Genetic 
serotyping
Michael Korth
(404) 639-2099
mqk8@cdc.gov
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Salmonella serovar Typhi (only) serology
CDC-10453
Test Order
Synonym(s) Enteric Pathogen
Performed on Specimens From Human
CDC Points of Contact Deborah Talkington
(404) 639-3918
dft1@cdc.gov
Jim Pruckler
(404) 639-3816
jmp3@cdc.gov
Pre-Approval Needed Talkington, Deborah, (404) 639-3918, dft1@cdc.gov
Pruckler, Jim, (404) 639-3816, jmp3@cdc.gov
Supplemental Information
Required
Date of illness onset, date of serum collection, clinical diagnosis. Indicate if 
patient is currently on antibiotics. Indicate if patient is suspect chronic carrier.
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Serum, paired serum preferred. Do not pool specimens. 
Minimum Volume Required 200 uL (More preferred)
Turnaround Time 3 Months
Interferences & Limitations Plasma is not acceptable for typhoid testing
Storage & Preservation of
Specimen Prior to Shipping
Maintain serum at 4°C (preferred); frozen specimens acceptable
Additional lnformation Paired serum specimens always preferred. 
Please send one tube per specimen submission form. Submit multiple forms if 
needed. 
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Separate serum from the clot and ship in a sterile labeled tube with the top 
tightly closed
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday, overnight to avoid weekend deliveries. Please notify 
Deborah Talkington (dft1@cdc.gov) and Jim Pruckler (jmp3@cdc.gov) once  
specimens have been shipped to provide the tracking number.
Ship with cold packs in compliance with federal and local guidelines
Methodology Various methods utilized; Consultation required
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Salmonella Study
CDC-10109
Test Order
Synonym(s) None
Performed on Specimens From Human, Animal, and Food/Environmental/Medical Devices/Biologics
CDC Points of Contact Matthew Mikoleit
(404) 639-2946
euh1@cdc.gov
Patricia Jones
(404) 639-3334
entericbacteria@cdc.gov
Pre-Approval Needed Mikoleit, Matthew, (404) 639-2946, euh1@cdc.gov
Jones, Patricia, (404) 639-3334, entericbacteria@cdc.gov
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
To be determined
Minimum Volume Required To be determined
Turnaround Time  
Interferences & Limitations To be determined
Storage & Preservation of
Specimen Prior to Shipping
To be determined
Additional lnformation To be determined
Specimen Labeling To be determined
Transport Medium To be determined
Shipping Instructions which 
Include Specimen Handling 
Requirements
To be determined
Methodology
Michael Korth
(404) 639-2099
mqk8@cdc.gov
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Salmonella Subtyping
CDC-10108
Test Order
Synonym(s) Salmonella Typing
Performed on Specimens From Human, Animal, and Food/Environmental/Medical Devices/Biologics
CDC Points of Contact Matthew Mikoleit
(404) 639-2946
euh1@cdc.gov
Patricia Jones
(404) 639-3334
entericbacteria@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
Prior approval is not required for human specimen, but is required for all other 
types of specimen.
Indicate subtyping method(s) requested; provide PulseNet cluster code and 
PFGE pattern numbers if appropriate.
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Isolates
Minimum Volume Required Not Applicable
Turnaround Time 8 Weeks
Interferences & Limitations None
Storage & Preservation of
Specimen Prior to Shipping
No Specific Requirements
Additional lnformation Specify type of subtyping requested in 'Previous Laboratory Results' on back of 
form. Epidemiologic metadata, PulseNet cluster code, and PFGE pattern 
designation requested if available.
Turn around time depends on the nature of subtyping performed; and, results 
are typically not reported directly back to the submitter, but deposited in 
surveillance databases. If the surveillance database is not accessible to 
submitters, results are posted on the PulseNet and OutbreakNet discussion 
board. Specific turn around time and a report are available upon request.
Specimen Labeling Not Applicable
Transport Medium Ship cultures on nonselective nutrient or similar agar (TSA, HIA, etc.) in tubes 
with leak-proof screw cap closures.  Agar plates are not acceptable.
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday, overnight to avoid weekend deliveries
Ship at ambient temperature in compliance with Federal and local guidelines
Methodology Serotyping, PFGE, MLVA, AST
Michael Korth
(404) 639-2099
mqk8@cdc.gov
Monday, January 13, 2014 Page 336 of 380Version: 1.0
SARS Molecular Detection
CDC-10412
Test Order
Synonym(s) SARS coronavirus
Performed on Specimens From Human
CDC Points of Contact Dean Erdman
(404) 639-3727
dde1@cdc.gov
Shifaq Kamili
(404) 639-2799
sgk5@cdc.gov
Pre-Approval Needed Erdman, Dean, (404) 639-3727, dde1@cdc.gov
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Nasopharyngeal wash/aspirates, nasopharyngeal swabs, oropharyngeal swabs, 
broncheoalveolar lavage, tracheal aspirate, pleural fluid tap, sputum, and post-
mortem tissue.
For more information go to http://www.cdc.gov/sars/guidance/F-lab/app4.html
Minimum Volume Required 0.25 mL
Turnaround Time 3 Days
Interferences & Limitations Use only sterile Dacron or rayon swabs with plastic shafts or if available, flocked 
swabs. Do NOT use calcium alginate swabs or swabs with wooden sticks, as they 
may contain substances that inactivate some viruses and inhibit some molecular 
assays.
Storage & Preservation of
Specimen Prior to Shipping
Refrigerate or freeze tubes after specimens are placed in them. If specimens will 
be examined within 48 hours after collection, they can be refrigerated. If 
specimens must be held longer than 48 hours, freeze them as soon as possible 
after collection. Although storage in an ultra-low freezer (-70°C) is preferable, 
storage in a home-type freezer (if properly set at -20°C) is acceptable for short 
periods.
For more information go to http://www.cdc.gov/sars/guidance/F-lab/app4.html
Additional lnformation http://www.cdc.gov/sars/about/index.html
http://www.cdc.gov/sars/guidance/F-lab/app5.html
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Swabs may be shipped in commercial viral transport media
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday, overnight to avoid weekend deliveries
http://www.cdc.gov/sars/lab/specimen.html
Methodology Polymerase Chain Reaction (PCR), Sequencing
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SARS Serology
CDC-10413
Test Order
Synonym(s) SARS-CoV, SARS-CoV EIA, SARS-CoV ELISA, SARS ELISA, SARS EIA
Performed on Specimens From Human
CDC Points of Contact Lia Haynes
(404) 639-4004
loh5@cdc.gov
Dean Erdman
(404) 639-3727
dde1@cdc.gov
Pre-Approval Needed Haynes, Lia, (404) 639-4004, loh5@cdc.gov
Erdman, Dean, (404) 639-3727, dde1@cdc.gov
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Serum (acute and convalescent) and plasma  
For more information go to http://www.cdc.gov/sars/guidance/F-lab/app4.html
Minimum Volume Required 200 uL
Turnaround Time 3 Days
Interferences & Limitations Do not collect in heparin tubes
Storage & Preservation of
Specimen Prior to Shipping
Collect whole blood in a serum separator tube. Allow the blood to clot, 
centrifuge briefly, and collect all the resulting sera in vials with external caps and 
internal O-ring seals. If there is no O-ring seal, then seal tightly with the 
available cap and secure with Parafilm.  Collect whole blood in either EDTA tubes 
or in a clotting tube. For plasma, collect blood in EDTA tubes and place in vials 
with external caps and internal O-ring seals. Store plasma and serum at 4°C. 
Serum may be frozen.
Additional lnformation None
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition. Also, date of collection.
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday, overnight to avoid weekend deliveries
Refrigerated specimen should be shipped on cold packs
Frozen specimen should be shipped on dry ice
http://www.cdc.gov/sars/lab/specimen.html
Methodology ELISA
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Schistosomiasis Serology
CDC-10466
Test Order
Synonym(s) Schistosoma mansoni, Schistosoma haematobium, Schistosoma japonicum; 
Bilharzia, parasite
Performed on Specimens From Human
CDC Points of Contact Patricia Wilkins
(404) 718-4101
pma1@cdc.gov
Isabel McAuliffe
(404) 718-4100
ibm4@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
Travel history REQUIRED, include other relevant risk factors; clinical symptoms, 
treatment and relevant lab results.
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Serum and Plasma
Minimum Volume Required 0.5 mL
Turnaround Time 21 Days
Interferences & Limitations Substances known to interfere with immunoassays include: bilirubin, lipids, and 
hemoglobin 
Storage & Preservation of
Specimen Prior to Shipping
No specific requirements
Additional lnformation None
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday – Thursday, overnight to avoid weekend deliveries. Ship specimen 
at room temperature, not on dry ice, as an etiologic agent.
Methodology FAST-ELISA, Immunoblot, Western Blot, MAMA, HAMA, JAMA, Antibody Detection
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Seoul Virus Serology
CDC-10414
Test Order
Synonym(s) Hanta, HFRS, HPS
Performed on Specimens From Human and Animal
CDC Points of Contact Ute Stroeher
(404) 639-4704
ixy8@cdc.gov
Barbara Knust
(404) 639-1104
bkk0@cdc.gov
Pre-Approval Needed Stroeher, Ute, (404) 639-4704, ixy8@cdc.gov
Knust, Barbara, (404) 639-1104, bkk0@cdc.gov
Supplemental Information
Required
See Supplemental Form
Supplemental Form http://www.cdc.gov/ncezid/dhcpp/vspb/pdf/specimen-submission.pdf
Acceptable Sample/ Specimen 
Type for Testing
Blood and serum
Minimum Volume Required 1 mL
Turnaround Time 10 Days
Interferences & Limitations Specimen must remain frozen; warming or freeze thawing reduces sensitivity
Storage & Preservation of
Specimen Prior to Shipping
Specimen must be kept cold (at or below 4°C). If possible place specimen in 
plastic screw capped vials. See link to supplemental submission form for specific 
information on various specimen types.
Additional lnformation Critical specimens will take less than 4 days to turn around. See link to 
supplemental submission forms for detailed information.
Specimen Labeling Patient name, patient ID #, specimen type, date collected
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday overnight to avoid weekend deliveries. Specimen should 
be shipped on cold packs or dry ice if frozen. See supplemental submission 
forms for further details. Do not ship specimen without prior consultation and 
approval.
Methodology ELISA
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Shiga Toxin-producing E. coli Isolation from Enrichment Broth
CDC-10105
Test Order
Synonym(s) STEC,  E. coli O157
Performed on Specimens From Human
CDC Points of Contact Cheryl Bopp
(404) 639-1798
cab4@cdc.gov
Michele Parsons
(404) 639-1965
zcp9@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
Only Stx+ broths that produce growth on subculture should be submitted. 
Consult with EDLB contact before sending other specimens. Provide any 
preliminary results available.
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Submit broths only positive by Shiga toxin-testing (Stx+) that produce growth of 
STEC on subculture. Consult with Dr. Bopp before sending other specimen types 
or fecal specimens in enrichment broth that are Stx+ but no growth of STEC on 
subculture.
Minimum Volume Required 5 mL (broth)
Turnaround Time 8 Weeks
Interferences & Limitations None
Storage & Preservation of
Specimen Prior to Shipping
Maintain specimen at 4°C
Additional lnformation None
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday, overnight to avoid weekend deliveries
Ship with cold packs in compliance with federal and local guidelines
Methodology Isolation, Phenotypic Identification Including Serotyping, PCR Testing for 
Virulence Markers
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Special Bacterial Pathogen Study
CDC-10147
Test Order
Synonym(s) None
Performed on Specimens From Human and Food/Environmental/Medical Devices/Biologics
CDC Points of Contact John McQuiston
(404) 639-0270
zje8@cdc.gov
Anne Whitney
(404) 639-1374
amw0@cdc.gov
Pre-Approval Needed McQuiston, John, (404) 639-0270, zje8@cdc.gov
Whitney, Anne, (404) 639-1374, amw0@cdc.gov
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
To be determined
Minimum Volume Required To be determined
Turnaround Time  
Interferences & Limitations To be determined
Storage & Preservation of
Specimen Prior to Shipping
To be determined
Additional lnformation To be determined
Specimen Labeling To be determined
Transport Medium To be determined
Shipping Instructions which 
Include Specimen Handling 
Requirements
To be determined
Methodology
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Staphylococcal Toxic Shock Syndrome Toxin (TSST-1)
CDC-10426
Test Order
Synonym(s) Staph Toxin, Toxic Shock Syndrome
Performed on Specimens From Human, Animal, and Food/Environmental/Medical Devices/Biologics
CDC Points of Contact David Lonsway
(404) 639-2825
Dlonsway@cdc.gov
Kamile Rasheed
(404) 639-3247
jkr1@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Pure culture isolate on suitable agar medium
Minimum Volume Required Not Applicable
Turnaround Time 28 Days
Interferences & Limitations None
Storage & Preservation of
Specimen Prior to Shipping
Isolate should be stored at room temperature
Additional lnformation SEA-SHE and PVL testing performed only with prior approval
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Pure culture isolate on suitable agar medium
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship specimen Monday -Thursday overnight to avoid weekend deliveries at room 
temperature as an etiologic agent.
Methodology 16S sequencing, MALDI-TOF, Phenotypic Testing, SEA - SHE, PVL
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Staphylococcus - Micrococcus Identification
CDC-10226
Test Order
Synonym(s) Staph, Micrococcus, Kocuria Identification
Performed on Specimens From Human, Animal, and Food/Environmental/Medical Devices/Biologics
CDC Points of Contact David Lonsway
(404) 639-2825
Dlonsway@cdc.gov
Valerie Albrecht
(404) 639-4552
gpy8@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Pure culture isolate on suitable agar medium
Minimum Volume Required Not Applicable
Turnaround Time 28 Days
Interferences & Limitations None
Storage & Preservation of
Specimen Prior to Shipping
Isolate should be stored at room temperature
Additional lnformation None
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Pure culture isolate on suitable agar medium
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship specimen Monday -Thursday overnight to avoid weekend deliveries at room 
temperature as an etiologic agent.
Methodology 16S Sequencing, MALDI-TOF, Phenotypic Testing
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Staphylococcus and MRSA Outbreak Strain Typing
CDC-10230
Test Order
Synonym(s) Staph Typing, MRSA Typing, Staphylococcal Typing
Performed on Specimens From Human, Animal, and Food/Environmental/Medical Devices/Biologics
CDC Points of Contact Kamile Rasheed
(404) 639-3247
JRasheed@cdc.gov
Valerie Albrecht
(404) 639-1282
gpy8@cdc.gov
Pre-Approval Needed Rasheed, Kamile, (404) 639-3247, JRasheed@cdc.gov
Albrecht, Valerie, (404) 639-1282, gpy8@cdc.gov
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Pure culture isolate on suitable agar medium. Additional specimen types upon 
consultation with laboratory.
Minimum Volume Required Not Applicable
Turnaround Time 28 Days
Interferences & Limitations None
Storage & Preservation of
Specimen Prior to Shipping
Isolate should be stored at room temperature
Additional lnformation Not CLIA compliant testing; for epidemiologic purposes only
Specimen Labeling Include date of isolation and unique specimen identifier
Transport Medium Pure culture isolate on suitable agar medium or frozen in TSB plus glycerol
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship specimen Monday -Thursday overnight to avoid weekend deliveries at room 
temperature as an etiologic agent.
Methodology 16S Sequencing, MALDI-TOF, Phenotypic Testing, Molecular Strain Typing
 
Monday, January 13, 2014 Page 345 of 380Version: 1.1
Staphylococcus aureus Detection - Foodborne Outbreak
CDC-10113
Test Order
Synonym(s) None
Performed on Specimens From Human and Food/Environmental/Medical Devices/Biologics
CDC Points of Contact Deborah Talkington
(404) 639-3918
dft1@cdc.gov
Gerardo Gomez
(404) 639-0537
goe4@cdc.gov
Pre-Approval Needed Talkington, Deborah, (404) 639-3918, dft1@cdc.gov
Gomez, Gerardo, (404) 639-0537, goe4@cdc.gov
Supplemental Information
Required
Only specimens from foodborne outbreaks accepted. Consult with EDLB 
contact before sending specimens. Provide any preliminary results if available.
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Isolates, vomitus, stool, food. Only specimens from foodborne outbreaks 
accepted. Consult with  Dr. Talkington before sending specimens.
Minimum Volume Required 25 g (food), 10 g (vomitus, stool)
Turnaround Time 2 Months
Interferences & Limitations None
Storage & Preservation of
Specimen Prior to Shipping
Maintain food, vomitus and stool at 4°C
Additional lnformation Direct toxin detection requires food samples
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday, overnight to avoid weekend deliveries. Please notify 
Deborah Talkington (dft1@cdc.gov) and Gerardo Gomez (goe4@cdc.gov) once  
specimens have been shipped to provide the tracking number.
Ship with cold packs  in compliance with federal and local guidelines
Methodology Toxin Detection in Food, Culture, PCR
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STD Bacterial Molecular Diagnostic Evaluation
CDC-10178
Test Order
Synonym(s) Sexually Transmitted Disease
Performed on Specimens From Human
CDC Points of Contact David Trees
(404) 639-2134
dlt1@cdc.gov
Steve Johnson
(404) 639-2879
sbj1@cdc.gov
Pre-Approval Needed Trees, David, (404) 639-2134, dlt1@cdc.gov
Johnson, Steve, (404) 639-2879, sbj1@cdc.gov
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Gonococcal bacterial culture
Minimum Volume Required Not Applicable
Turnaround Time 12 Weeks
Interferences & Limitations None
Storage & Preservation of
Specimen Prior to Shipping
Store culture at -70°C in TSA with 20% glycerol medium
Additional lnformation Please provide information on any antibiotics the patient may have been treated 
with
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium TSA with 20% glycerol
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday – Thursday, overnight to avoid weekend deliveries. Specimen 
should be shipped on dry ice, as an etiologic agent.
Methodology Molecular cloning, PCR, Whole genome sequencing
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STD International QA - N. gonorrhoeae, C. trachomatis, M. 
genitalium, T. vaginalis
CDC-10175
Test Order
Synonym(s) Sexually Transmitted Disease
Performed on Specimens From Human
CDC Points of Contact Cheng Chen
(404) 639-3154
cyc1@cdc.gov
Kai Chi
(404) 639-0694
krc2@cdc.gov
Pre-Approval Needed Cheng, Cheng, (404) 639-3154, cyc1@cdc.gov
Chi, Kai, (404) 639-0694, krc2@cdc.gov
Supplemental Information
Required
Determined upon consultation
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Urine, oral pharynx swabs, cervical swabs, vaginal swabs, and rectal swabs 
collected on any commercially available product, and other specimen types upon 
consultation with laboratory
Minimum Volume Required Not Applicable
Turnaround Time 12 Weeks
Interferences & Limitations None
Storage & Preservation of
Specimen Prior to Shipping
Swabs must be kept frozen
Additional lnformation None
Specimen Labeling Please include country of origin, de-linked identifier and date of collection
Transport Medium Should be transported on commercial Nucleic Acid Amplification Test (NAAT)  
medium
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday – Thursday, overnight to avoid weekend deliveries. Specimen 
should be shipped on dry ice, as an etiologic agent.
Methodology PCR
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Strep ABCs Surveillance Study
CDC-10218
Test Order
Synonym(s) None
Performed on Specimens From Human, Animal, and Food/Environmental/Medical Devices/Biologics
CDC Points of Contact Lesley McGee
(404) 639-0455
afi4@cdc.gov
Bernard Beall
(404) 639-1237
bbeall@cdc.gov
Pre-Approval Needed McGee, Lesley, (404) 639-0455, afi4@cdc.gov
Beall, Bernard, (404) 639-1237, bbeall@cdc.gov
Supplemental Information
Required
See Supplemental Form
Supplemental Form http://www.cdc.gov/abcs/downloads/ABCs_case_rpt_form_2010.pdf
Acceptable Sample/ Specimen 
Type for Testing
Sterile site Isolates of GAS, GBS and S.pneumoniae that meet the ABCs inclusion 
criteria
Minimum Volume Required Not applicable
Turnaround Time 8 Weeks
Interferences & Limitations Based on consultation
Storage & Preservation of
Specimen Prior to Shipping
For isolates, store on blood or chocolate agar, in transport media or as a frozen 
glycerol stock; additional details and directions will be provided upon 
consultation.
Additional lnformation None
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Note: surveillance studies may label specimens according to protocol
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship specimen Monday -Thursday, overnight to avoid weekend deliveries
Frozen specimen should be shipped on dry ice
Refrigerated specimen should be shipped on cold packs
Methodology Phenotypic Testing, Molecular Testing
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Streptococcus (Beta Hemolytic Strep) Typing
CDC-10216
Test Order
Synonym(s) GAS typing, GBS typing, other beta hemolytic strep, Group A Strep, Group B Strep
Performed on Specimens From Human, Animal, and Food/Environmental/Medical Devices/Biologics
CDC Points of Contact Bernard Beall
(404) 639-1237
bbeall@cdc.gov
Patricia Shewmaker
(404) 639-4826
paw3@cdc.gov
Pre-Approval Needed Beall, Bernard, (404) 639-1237, bbeall@cdc.gov
Supplemental Information
Required
See Supplemental Form
Supplemental Form http://www.cdc.gov/ncidod/biotech/strep/other-streptococci-qa.htm
Acceptable Sample/ Specimen 
Type for Testing
Isolates and clinical/environmental specimens and others as approved upon 
consultation
Minimum Volume Required Not Applicable
Turnaround Time 2 Weeks
Interferences & Limitations Based on consultation
Storage & Preservation of
Specimen Prior to Shipping
For isolates, store on blood or chocolate agar, in transport media or as a frozen 
glycerol stock; additional details and directions will be provided upon 
consultation.
Additional lnformation Please complete questionnaire on website
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Dependent on specimen type to be determined upon consultation
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship specimen Monday -Thursday, overnight to avoid weekend deliveries
Frozen specimen should be shipped on dry ice
Refrigerated specimen should be shipped on cold packs
Methodology Phenotypic Testing, Molecular Testing
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Streptococcus (Catalase negative, Gram Positive Coccus) 
Identification
CDC-10213
Test Order
Synonym(s) Streptococci, enterococci, viridans streptococci
Performed on Specimens From Human, Animal, and Food/Environmental/Medical Devices/Biologics
CDC Points of Contact Bernard Beall
(404) 639-1237
bbeall@cdc.gov
Patricia Shewmaker
(404) 639-4826
paw3@cdc.gov
Pre-Approval Needed Beall, Bernard, (404) 639-1237, bbeall@cdc.gov
Shewmaker, Patricia, (404) 639-4826, paw3@cdc.gov
Supplemental Information
Required
See Supplemental Form
Supplemental Form http://www.cdc.gov/ncidod/biotech/strep/other-streptococci-qa.htm
Acceptable Sample/ Specimen 
Type for Testing
Isolates and clinical/environmental specimens and others as approved upon 
consultation
Minimum Volume Required Not Applicable
Turnaround Time 8 Weeks
Interferences & Limitations Based on consultation
Storage & Preservation of
Specimen Prior to Shipping
For isolates, store on blood or chocolate agar, in transport media or as a frozen 
glycerol stock; additional details and directions will be provided upon 
consultation.
Additional lnformation Please complete questionnaire on website
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Dependent on specimen type to be determined upon consultation
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship specimen Monday -Thursday, overnight to avoid weekend deliveries
Frozen specimen should be shipped on dry ice
Refrigerated specimen should be shipped on cold packs
Methodology Phenotypic Testing, Molecular Testing
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Streptococcus (Catalase negative, Gram Positive Coccus) 
Identification and AST
CDC-10214
Test Order
Synonym(s) Streptococci, enterococci, viridans streptococci
Performed on Specimens From Human, Animal, and Food/Environmental/Medical Devices/Biologics
CDC Points of Contact Bernard Beall
(404) 639-1237
BBEALL@cdc.gov
Patricia Shewmaker
(404) 639-2825
paw3@cdc.gov
Pre-Approval Needed Beall, Bernard, (404) 639-1237, BBEALL@cdc.gov
Shewmaker, Patricia, (404) 639-4826, paw3@cdc.gov
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Pure culture isolate on a suitable agar slant medium; Prior consultation required 
for other sample/specimen types
Minimum Volume Required Not applicable
Turnaround Time 8 Weeks
Interferences & Limitations None
Storage & Preservation of
Specimen Prior to Shipping
Keep refrigerated if cannot ship immediately
Additional lnformation Preliminary susceptibility results may be available within 28 days or less.
If susceptibility has been performed, indicate the method and results.  
Date of specimen collection and original submitter.
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Note: surveillance studies may label specimens according to protocol
Transport Medium Suitable agar slant medium (example: blood or chocolate); Frozen glycerol stock 
is also acceptable.
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship specimen Monday -Thursday, overnight to avoid weekend deliveries
Frozen specimen should be shipped on dry ice
Refrigerated specimen should be shipped on cold packs
At room temperature for any etiologic agents
Methodology Phenotypic Testing, Molecular Testing, Broth microdilution MIC
David Lonsway
(404) 639- 2825
dul7@cdc.gov
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Streptococcus pneumoniae Typing
CDC-10215
Test Order
Synonym(s) Pneumococcus Serotyping 
Performed on Specimens From Human, Animal, and Food/Environmental/Medical Devices/Biologics
CDC Points of Contact Bernard Beall
(404) 639-1237
bbeall@cdc.gov
Lesley McGee
(404) 639-0455
afi4@cdc.gov
Pre-Approval Needed Beall, Bernard, (404) 639-1237, bbeall@cdc.gov
Supplemental Information
Required
See Supplemental Form
Supplemental Form http://www.cdc.gov/ncidod/biotech/strep/s-pneumoniae-qa.htm
Acceptable Sample/ Specimen 
Type for Testing
Isolates and clinical/environmental specimens and others as approved upon 
consultation
Minimum Volume Required Not Applicable
Turnaround Time 2 Weeks
Interferences & Limitations Based on consultation
Storage & Preservation of
Specimen Prior to Shipping
For isolates, store on blood or chocolate agar, in transport media or as a frozen 
glycerol stock; additional details and directions will be provided upon 
consultation.
Additional lnformation Please complete questionnaire on website
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Dependent on specimen type to be determined upon consultation
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship specimen Monday -Thursday, overnight to avoid weekend deliveries
Frozen specimen should be shipped on dry ice
Refrigerated specimen should be shipped on cold packs
Methodology Phenotypic Testing, Molecular Testing
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Streptococcus Study
CDC-10217
Test Order
Synonym(s) None
Performed on Specimens From Human, Animal, and Food/Environmental/Medical Devices/Biologics
CDC Points of Contact Bernard Beall
(404) 639-1237
bbeall@cdc.gov
Lesley McGee
(404) 639-0455
afi4@cdc.gov
Pre-Approval Needed Beall, Bernard, (404) 639-1237, bbeall@cdc.gov
McGee, Lesley, (404) 639-0455, afi4@cdc.gov
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Isolates and clinical/environmental specimens and others as approved upon 
consultation
Minimum Volume Required To be determined
Turnaround Time 8 Weeks
Interferences & Limitations To be determined
Storage & Preservation of
Specimen Prior to Shipping
For isolates blood or chocolate agar; transport media or frozen glycerol stock; 
additional details and directions will be provided upon consultation.
Additional lnformation To be determined
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Note: surveillance studies may label specimens according to protocol
Transport Medium To be determined
Shipping Instructions which 
Include Specimen Handling 
Requirements
To be determined
Methodology Phenotypic Testing, Molecular Testing
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Strongyloidiasis Enzyme Immunoassay
CDC-10467
Test Order
Synonym(s) Strongyloidiasis, Strongyloides stercoralis, parasite
Performed on Specimens From Human
CDC Points of Contact Patricia  Wilkins
(404) 718-4101
pma1@cdc.gov
Isabel McAuliffe
(404) 718-4100
ibm4@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
Exposure and travel history, include other relevant risk factors; clinical 
symptoms, treatment and relevant lab results.
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Serum or Plasma
Minimum Volume Required 0.5 mL
Turnaround Time 18 Days
Interferences & Limitations Substances known to interfere with immunoassays include: bilirubin, lipids, and 
hemoglobin 
Storage & Preservation of
Specimen Prior to Shipping
No specific requirements
Additional lnformation None
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday – Thursday, overnight to avoid weekend deliveries. Ship specimen 
at room temperature, not on dry ice, as an etiologic agent.
Methodology EIA, ELISA, Antibody Detection
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Syphilis Serology
CDC-10173
Test Order
Synonym(s) Treponemal and non-treponemal
Performed on Specimens From Human
CDC Points of Contact Yetunde Fakile
(404) 639-3784
yfakile@cdc.gov
Susan Kikkert
(404) 639-2871
sjk4@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
Need to supply date of birth
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Serum (preferred), CSF, and/or plasma (possible to preform test but not 
preferred)
Minimum Volume Required 1 mL (for serum or plasma)
Turnaround Time 2 Weeks
Interferences & Limitations Avoid freeze-thaw cycles as this can affect test results
Storage & Preservation of
Specimen Prior to Shipping
Serum and Plasma can be stored at 4°C unless for more than 4-5 days it should 
be frozen. CSF should be stored frozen at -70°C.
Additional lnformation None
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition. Also, include date collected.
Transport Medium None
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday – Thursday, overnight to avoid weekend deliveries. Frozen 
specimen should be shipped on dry ice and refrigerated specimen should be 
shipped on cold packs, as an etiologic agent.
Methodology RPR, TPPA, TrepSURE, CSF-VDRL
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Tick Borne Encephalitis (TBE) Identification
CDC-10415
Test Order
Synonym(s) None
Performed on Specimens From Human and Animal
CDC Points of Contact Ute Stroeher
(404) 639-4704
ixy8@cdc.gov
Barbara Knust
(404) 639-1104
bkk0@cdc.gov
Pre-Approval Needed Stroeher, Ute, (404) 639-4704, ixy8@cdc.gov
Knust, Barbara, (404) 639-1104, bkk0@cdc.gov
Supplemental Information
Required
See Supplemental Form
Supplemental Form http://www.cdc.gov/ncezid/dhcpp/vspb/pdf/specimen-submission.pdf
Acceptable Sample/ Specimen 
Type for Testing
Frozen tissue, blood and serum
Minimum Volume Required 1 mL
Turnaround Time 10 Days
Interferences & Limitations Specimen must remain frozen; warming or freeze thawing reduces sensitivity. 
Heparin may cause interference with the molecular tests and should be avoided.
Storage & Preservation of
Specimen Prior to Shipping
Specimen must be placed in plastic screw capped vials, frozen to -70°C, and kept 
frozen until shipment. See link to supplemental submission form for specific 
information on various specimen types.
Additional lnformation Critical specimens will take less than 4 days to turn around. See link to 
supplemental submission forms for detailed information.
Specimen Labeling Patient name, patient ID #, specimen type, date collected
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday overnight to avoid weekend deliveries. Specimen should 
be shipped frozen on dry ice. See supplemental submission forms for further 
details. Do not ship specimen without prior consultation and approval.
Methodology Molecular Typing, Polymerase Chain Reaction (PCR)
 
Monday, January 13, 2014 Page 357 of 380Version: 1.2
Tick Borne Encephalitis (TBE) Serology
CDC-10416
Test Order
Synonym(s) None
Performed on Specimens From Human and Animal
CDC Points of Contact Ute Stroeher
(404) 639-4704
ixy8@cdc.gov
Barbara Knust
(404) 639-1104
bkk0@cdc.gov
Pre-Approval Needed Stroeher, Ute, (404) 639-4704, ixy8@cdc.gov
Knust, Barbara, (404) 639-1104, bkk0@cdc.gov
Supplemental Information
Required
See Supplemental Form
Supplemental Form http://www.cdc.gov/ncezid/dhcpp/vspb/pdf/specimen-submission.pdf
Acceptable Sample/ Specimen 
Type for Testing
CSF, blood and serum
Minimum Volume Required 1 mL
Turnaround Time 10 Days
Interferences & Limitations Specimen must remain frozen; warming or freeze thawing reduces sensitivity
Storage & Preservation of
Specimen Prior to Shipping
Specimen must be kept cold (at or below 4°C). If possible place specimen in 
plastic screw capped vials. See link to supplemental submission form for specific 
information on various specimen types.
Additional lnformation Critical specimens will take less than 4 days to turn around. See link to 
supplemental submission forms for detailed information.
Specimen Labeling Patient name, patient ID #, specimen type, date collected
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday overnight to avoid weekend deliveries. Specimen should 
be shipped on cold packs or dry ice if frozen. See supplemental submission 
forms for further details. Do not ship specimen without prior consultation and 
approval.
Methodology ELISA
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Toxocariasis Enzyme Immunoassay
CDC-10468
Test Order
Synonym(s) Larva migrans, Toxocariasis, Toxocara canis, Toxocara cati, parasite
Performed on Specimens From None
CDC Points of Contact Patricia Wilkins
(404) 718-4101
pma1@cdc.gov
Isabel McAuliffe
(404) 718-4100
ibm4@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
Exposure and travel history, include other relevant risk factors; clinical 
symptoms, treatment and relevant lab results.
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Serum, plasma, or vitreous fluid
Minimum Volume Required 0.5
Turnaround Time 18 Days
Interferences & Limitations Substances known to interfere with immunoassays include: bilirubin, lipids, and 
hemoglobin 
Storage & Preservation of
Specimen Prior to Shipping
No specific requirements
Additional lnformation None
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday – Thursday, overnight to avoid weekend deliveries. Ship specimen 
at room temperature, not on dry ice, as an etiologic agent.
Methodology EIA, ELISA, Antibody Detection
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Toxoplasmosis Special Study
CDC-10492
Test Order
Synonym(s) None
Performed on Specimens From None
CDC Points of Contact Patricia Wilkins
(404) 718-4101
pma1@cdc.gov
Alex daSilva
(404) 718-4121
abs8@cdc.gov
Pre-Approval Needed Wilkins, Patricia, (404) 718-4101, pma1@cdc.gov
daSilva, Alex, (404) 718-4121, abs8@cdc.gov
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
To be determined
Minimum Volume Required To be determined
Turnaround Time  
Interferences & Limitations To be determined
Storage & Preservation of
Specimen Prior to Shipping
To be determined
Additional lnformation To be determined
Specimen Labeling To be determined
Transport Medium To be determined
Shipping Instructions which 
Include Specimen Handling 
Requirements
To be determined
Methodology
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Treponema pallidum Molecular Detection
CDC-10176
Test Order
Synonym(s) Syphilis
Performed on Specimens From Human
CDC Points of Contact Allan Pillay
(404) 639-2140
apillay@cdc.gov
Kai Chi
(404) 639-0694
krc2@cdc.gov
Pre-Approval Needed Pillay, Allan, (404) 639-2140, apillay@cdc.gov
Chi, Kai, (404) 639-0694, krc2@cdc.gov
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Swab of an ulcer or skin lesion, blood collected in an EDTA tube, body fluids, 
frozen tissue and/or Formalin-Fixed, Paraffin-Embedded (FFPE) tissue
Minimum Volume Required Not Applicable
Turnaround Time 2 Weeks
Interferences & Limitations None
Storage & Preservation of
Specimen Prior to Shipping
Specimens should be frozen unless FFPE tissue which can be stored at room 
temperature
Additional lnformation None
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition. Also, include date collected.
Transport Medium Should be transported on commercial Nucleic Acid Amplification Test (NAAT) 
medium
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday – Thursday, overnight to avoid weekend deliveries. Frozen 
specimen should be shipped on dry ice, refrigerated specimen should be shipped 
on cold packs and FFPE can be shipped at room temperature, as an etiologic 
agent.
Methodology PCR
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Treponema pallidum Molecular Typing
CDC-10177
Test Order
Synonym(s) Treponema pallidum Genotyping, Treponema pallidum Strain Typing, Syphilis 
Typing
Performed on Specimens From Human
CDC Points of Contact Allan Pillay
(404) 639-2140
apillay@cdc.gov
Cheng Chen
(404) 639-3154
cyc1@cdc.gov
Pre-Approval Needed Pillay, Allan, (404) 639-2140, apillay@cdc.gov
Chen, Cheng, (404) 639-3154, cyc1@cdc.gov
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Swab of an ulcer or skin lesion, blood collected in an EDTA tube, body fluids, 
frozen tissue and/or Formalin-Fixed, Paraffin-Embedded (FFPE) tissue
Minimum Volume Required Not Applicable
Turnaround Time 4 Weeks
Interferences & Limitations None
Storage & Preservation of
Specimen Prior to Shipping
Specimens should be frozen except for FFPE tissue, which can be stored at room 
temperature
Additional lnformation None
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition. Also, include date collected.
Transport Medium Should be transported on commercial Nucleic Acid Amplification Test (NAAT) 
medium
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday – Thursday, overnight to avoid weekend deliveries. Frozen 
specimen should be shipped on dry ice, refrigerated specimen should be shipped 
on cold packs and FFPE can be shipped at room temperature, as an etiologic 
agent.
Methodology PCR, Sequencing, RFLP
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Trichinellosis Enzyme Immunoassay
CDC-10470
Test Order
Synonym(s) Trichinosis,Trichinella spiralis, parasite
Performed on Specimens From Human
CDC Points of Contact Patricia Wilkins
(404) 719-4101
pma1@cdc.gov
Isabel McAuliffe
(404) 718-4100
ibm4@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
Exposure and travel history, include other relevant risk factors (consumption of 
raw or undercooked pork or game meat); clinical symptoms, treatment and 
relevant lab  results.
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Serum or Plasma
Minimum Volume Required 0.5 mL
Turnaround Time 18 Days
Interferences & Limitations Substances known to interfere with immunoassays include: bilirubin, lipids, and 
hemoglobin 
Storage & Preservation of
Specimen Prior to Shipping
No specific requirements
Additional lnformation None
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday – Thursday, overnight to avoid weekend deliveries. Ship specimen 
at room temperature, not on dry ice, as an etiologic agent.
Methodology EIA, ELISA, Antibody Detection
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Trichomonas Susceptibility
CDC-10239
Test Order
Synonym(s) Trichomonas, trich, parasite
Performed on Specimens From Human
CDC Points of Contact Evan Secor
(404) 718-4141
Pre-Approval Needed None
Supplemental Information
Required
Supplemental form not needed
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Vaginal swabs or scrapings. Must be a live culture.
Minimum Volume Required Not Applicable
Turnaround Time 4 Weeks
Interferences & Limitations None
Storage & Preservation of
Specimen Prior to Shipping
Do not freeze specimen. If the specimen cannot be examined immediately, it 
should be preserved in polyvinyl alcohol (PVA) and stained after smears in order 
to be examined later.
Additional lnformation None
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium InPouch TV (Commercial product) or Diamond’s TYM
Shipping Instructions which 
Include Specimen Handling 
Requirements
The isolate should be sent to CDC by overnight courier (not USPS) on the same 
day it is obtained from the patient.
Insure the InPouch is properly closed and place it in the mailing container that 
they arrived in and mail by OVERNIGHT delivery service (recommended: Federal 
Express or AirBorne Express) to:
  
Pete Augostini
CDC/Parasitic Disease Branch
1600 Clifton Rd. NE, MS D65
Bldg. 23, 10th Floor, Rm. 108
Atlanta, GA 30329-4081
NOTE:
a) Delivery to the reference laboratory within 24 hours is essential to ensure 
organism survival.
B) The laboratory can only accept sample delivery  Monday through Friday. Please 
plan to ship your samples Monday, Tuesday, Wednesday, or Thursday in order 
for the laboratory to receive the overnight delivery the next day.
C) While we provide the testing as a no-cost service, we do not have the funds to 
pay for shipment of the organism. Therefore, please do not mark “recipient” as 
the party responsible for payment of shipment costs. If this occurs, we will refer 
the shipping company back to you for payment of costs.
Please include the metronidazole treatment history and request forms with your 
sample.
Methodology Antimicrobial susceptibility
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Trichomonas Susceptibility
CDC-10239
Test Order
was4@cdc.gov
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Trypanosoma cruzi Culture
CDC-10361
Test Order
Synonym(s) Chagas' disease, parasite
Performed on Specimens From Human
CDC Points of Contact Frank Steurer
(404) 718-4175
fjs1@cdc.gov
Alex daSilva
(404) 718-4121
adasilva@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
Must contact laboratory at 770-488-4475, and CDC will provide the culture 
medium (typically Novy-MacNeal-Nicolle (NNN) medium).
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Blood or tissue
Minimum Volume Required Not Applicable
Turnaround Time 6 Weeks
Interferences & Limitations Formalin fixed specimens are not suitable for culture
Storage & Preservation of
Specimen Prior to Shipping
No Specific Requirements
Additional lnformation None
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Culture medium (typically Novy-MacNeal-Nicolle (NNN) medium). Keep media 
refrigerated until it is used (stable for 2-4 weeks) and bring it to room 
temperature right before inoculation. Once inoculated, keep the culture at room 
temperature and send to CDC as soon as possible by overnight mail.
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday – Thursday, overnight to avoid weekend deliveries. Culture should 
be kept at room temperature and mailed as soon as possible, as an etiologic 
agent.
Methodology Culture
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Varicella Zoster Virus (VZV) Avidity
CDC-10256
Test Order
Synonym(s) Chicken pox, shingles
Performed on Specimens From Human
CDC Points of Contact Scott Schmid
(404) 639-0066
dss1@cdc.gov
Kay Radford
(404) 639-2192
(404) 639-2192
Pre-Approval Needed Schmid, Scott, (404) 639-0066, dss1@cdc.gov
Radford, Kay, (404) 639-2192, (404) 639-2192
Supplemental Information
Required
See Supplemental Form
Supplemental Form http://www.cdc.gov/vaccines/pubs/surv-manual/index.html
Acceptable Sample/ Specimen 
Type for Testing
Serum or plasma
Minimum Volume Required 200 uL
Turnaround Time 1 Week
Interferences & Limitations None
Storage & Preservation of
Specimen Prior to Shipping
Keep specimen either refrigerated or frozen
Additional lnformation None
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship overnight Monday – Thursday, with cold packs or dry ice as an etiologic 
agent.
Methodology IgG avidity
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Varicella Zoster Virus (VZV) Detection
CDC-10254
Test Order
Synonym(s) Chicken pox, shingles
Performed on Specimens From Human
CDC Points of Contact Scott Schmid
(404) 639-0066
dss1@cdc.gov
Kay Radford
(404) 639-2192
kjr7@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Skin lesions, scab, saliva, cerebrospinal fluid (CSF), urine, and whole blood
Minimum Volume Required 200 uL
Turnaround Time 7 Days
Interferences & Limitations None
Storage & Preservation of
Specimen Prior to Shipping
Frozen or refrigerated for saliva, cerebrospinal fluid (CSF), urine or whole blood. 
Room temperature, dry skin lesions and scabs. Blood should be collected in 
EDTA or citrate tubes.
Additional lnformation None
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship specimen Monday-Thursday, overnight. Cold packs or dry ice for liquid 
specimen. Ambient temperature for scabs and lesions. Ship as an etiologic 
agent.
Methodology Polymerase Chain Reaction (PCR)
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Varicella Zoster Virus (VZV) Genotyping
CDC-10257
Test Order
Synonym(s) Chicken pox, shingles
Performed on Specimens From Human
CDC Points of Contact Scott Schmid
(404) 639-0066
dss1@cdc.gov
Jennifer Folster
(404) 639-3668
apz5@cdc.gov
Pre-Approval Needed Schmid, Scott, (404) 639-0066, dss1@cdc.gov
Folster, Jennifer, (404) 639-3668, apz5@cdc.gov
Supplemental Information
Required
See Supplemental Form
Supplemental Form http://www.cdc.gov/vaccines/pubs/surv-manual/index.html
Acceptable Sample/ Specimen 
Type for Testing
Skin lesions, scab, saliva, cerebrospinal fluid (CSF), urine, and whole blood
Minimum Volume Required 200 uL
Turnaround Time 1 Week
Interferences & Limitations None
Storage & Preservation of
Specimen Prior to Shipping
Frozen or refrigerated for saliva, cerebrospinal fluid (CSF), urine or whole blood. 
Room temperature, dry skin lesions and scabs. Blood should be collected in 
EDTA or citrate tubes.
Additional lnformation None
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship specimen Monday-Thursday, overnight. Cold packs or dry ice for liquid 
specimen. Ambient temperature for scabs and lesions. Ship as an etiologic 
agent.
Methodology Polymerase Chain Reaction (PCR), DNA sequencing
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Varicella Zoster Virus (VZV) Serology
CDC-10255
Test Order
Synonym(s) Chicken pox, shingles
Performed on Specimens From Human
CDC Points of Contact Scott Schmid
(404) 639-0066
dss1@cdc.gov
Kay Radford
(404) 639-2192
kjr7@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Serum, plasma or cerebrospinal fluid (CSF)
Minimum Volume Required 200 uL
Turnaround Time 2 Days
Interferences & Limitations None
Storage & Preservation of
Specimen Prior to Shipping
Keep specimen either refrigerated or frozen
Additional lnformation None
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium None
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship overnight Monday – Thursday, with cold packs or dry ice as an etiologic 
agent.
Methodology IgG antibody detected by EIA, IgM antibody detected by EIA
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Vibrio cholerae Identification
CDC-10119
Test Order
Synonym(s) Cholera
Performed on Specimens From Human, Animal, and Food/Environmental/Medical Devices/Biologics
CDC Points of Contact Cheryl Bopp
(404) 639-1798
cab4@cdc.gov
Michele Parsons
(404) 639-1965
zcp9@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
Prior approval is not required for human specimens; Please call for approval 
prior to sending, other specimen types. 
Provide any preliminary results available.
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Isolates
Minimum Volume Required Not Applicable
Turnaround Time 4 Weeks
Interferences & Limitations None
Storage & Preservation of
Specimen Prior to Shipping
No Specific Requirements
Additional lnformation Every suspect Vibrio cholerae isolate should be sent to EDLB as soon as possible
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Ship cultures on nonselective nutrient or similar agar (TSA, HIA, etc.) in tubes 
with leak-proof screw cap closures.  Agar plates are not acceptable.
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday, overnight to avoid weekend deliveries
Every suspect Vibrio cholerae isolate should be sent to EDLB as soon as possible. 
Ship at ambient temperature in compliance with Federal and local guidelines.
Methodology Phenotypic Characterization (Serogrouping for O1, O139, O75, and O141), PCR 
for Virulence Markers (Toxin and tcpA biotype)
 
Monday, January 13, 2014 Page 371 of 380Version: 1.0
Vibrio cholerae serology 
CDC-10454
Test Order
Synonym(s) Enteric Pathogen
Performed on Specimens From Human
CDC Points of Contact Deborah Talkington
(404) 639-3918
Dft1@cdc.gov
Jim Pruckler
(404) 639-3816
jmp3@cdc.gov
Pre-Approval Needed Talkington, Deborah, (404) 639-3918, Dft1@cdc.gov
Pruckler, Jim, (404) 639-3816, jmp3@cdc.gov
Supplemental Information
Required
Date of illness onset, date of serum collection, clinical diagnosis. Indicate if 
patient is currently on antibiotics.
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Paired serum is preferred. Serum is always preferred but plasma is acceptable. 
Do not pool specimens. 
Minimum Volume Required 100 uL (more preferred)
Turnaround Time 3 Months
Interferences & Limitations None
Storage & Preservation of
Specimen Prior to Shipping
Maintain serum at 4°C (preferred); frozen specimens acceptable
Additional lnformation Paired serum specimens always preferred.
Please send one tube per specimen submission form. Submit multiple forms if 
needed. 
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Separate serum from the clot and ship in a sterile labeled tube with the top 
tightly closed.
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday, overnight to avoid weekend deliveries. Please notify 
Deborah Talkington (dft1@cdc.gov) and Jim Pruckler (jmp3@cdc.gov) once  
specimens have been shipped to provide the tracking number.
Ship with cold packs in compliance with federal and local guidelines
Methodology Various methods utilized; Consultation required
 
Monday, January 13, 2014 Page 372 of 380Version: 1.0
Vibrio Subtyping
CDC-10122
Test Order
Synonym(s) None
Performed on Specimens From Human, Animal, and Food/Environmental/Medical Devices/Biologics
CDC Points of Contact Cheryl Tarr
(404) 639-2011
crt6@cdc.gov
Maryann Turnsek
(404) 639-5178
hud4@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
Prior approval is not required for human specimens, but is required for all 
other specimen types.
Specify type of subtyping requested in 'Previous Laboratory Results' on back of 
form.
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Isolates
Minimum Volume Required Not Applicable
Turnaround Time 8 Weeks
Interferences & Limitations None
Storage & Preservation of
Specimen Prior to Shipping
No Specific Requirements
Additional lnformation Turn around time depends on the nature of subtyping performed; and, results 
are typically not reported directly back to the submitter, but deposited in 
surveillance databases. If the surveillance database is not accessible to 
submitters, results are posted on the PulseNet and OutbreakNet discussion 
board.
Specimen Labeling Not Applicable
Transport Medium Ship cultures on nonselective nutrient or similar agar (TSA, HIA, etc.) in tubes 
with leak-proof screw cap closures.  Agar plates are not acceptable.
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday, overnight to avoid weekend deliveries
Ship at ambient temperature in compliance with Federal and local guidelines
Methodology PFGE, MLST, MLVA, AST
 
Monday, January 13, 2014 Page 373 of 380Version: 1.0
Vibrio, Aeromonas, and Related Organisms Identification
CDC-10120
Test Order
Synonym(s) Grimontia species,  Photobacterium species, Salinivibrio species
Performed on Specimens From Human, Animal, and Food/Environmental/Medical Devices/Biologics
CDC Points of Contact Cheryl Tarr
(404) 639-2011
crt6@cdc.gov
Maryann Turnsek
(404) 639-5178
hud4@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
Prior approval is not required for human specimens, but is required for all 
other specimen types.
Provide any preliminary results that are available.
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Isolates
Minimum Volume Required Not Applicable
Turnaround Time 8 Weeks
Interferences & Limitations None
Storage & Preservation of
Specimen Prior to Shipping
No Specific Requirements
Additional lnformation Turnaround times for routine isolates may be extended during major foodborne 
outbreak activities or due to limited availability of resources.
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Ship cultures on nonselective nutrient or similar agar (TSA, HIA, etc.) in tubes 
with leak-proof screw cap closures.  Agar plates are not acceptable.
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday, overnight to avoid weekend deliveries
Ship at ambient temperature in compliance with Federal and local guidelines
Methodology Phenotypic Identification, Genetic Identification
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Vibrio, Aeromonas, and Related Organisms Study
CDC-10121
Test Order
Synonym(s) None
Performed on Specimens From Human, Animal, and Food/Environmental/Medical Devices/Biologics
CDC Points of Contact Cheryl Tarr
(404) 639-2011
crt6@cdc.gov
Maryann Turnsek
(404) 639-5178
hud4@cdc.gov
Pre-Approval Needed Tarr, Cheryl, (404) 639-2011, crt6@cdc.gov
Turnsek, Maryann, (404) 639-5178, hud4@cdc.gov
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
To be determined
Minimum Volume Required To be determined
Turnaround Time  
Interferences & Limitations To be determined
Storage & Preservation of
Specimen Prior to Shipping
To be determined
Additional lnformation To be determined
Specimen Labeling To be determined
Transport Medium To be determined
Shipping Instructions which 
Include Specimen Handling 
Requirements
To be determined
Methodology
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Yersinia (non-Y. pestis) and Other Enterobacteriaceae
Identification
CDC-10123
Test Order
Synonym(s) Arsenophonus, Biostraticola, Brenneria, Buchnera, Budvicia, Buttiauxella, 
Calymmatobacterium, Cedecea, Citrobacter, Cosenzaea, Cronobacter, Dickeya, 
Edwardsiella, Enterobacter, Erwinia, Ewingella, Gibbsiella, Hafnia,  Klebsiella, 
Kluyvera, Leclercia, Leminorella, Levinea, Lonsdalea, Mangrovibacter, Moellerella, 
Morganella, Obesumbacterium, Pantoea, Pectobacterium, Phaseolibacter, 
Photorhabdus, Plesiomonas, Pragia, Proteus, Providencia, Rahnella, Raoultella, 
Saccharobacter, Samsonia, Serratia, Shimwellia, Sodalis, Tatumella, Thorsellia, 
Trabulsiella,  Wigglesworthia, Xenorhabdus, Yersinia, Yokenella
Performed on Specimens From Human, Animal, and Food/Environmental/Medical Devices/Biologics
CDC Points of Contact Cheryl Tarr
(404) 639-2011
crt6@cdc.gov
Lori Gladney
(404) 639-1219
hze1@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
Prior approval is not required for human specimens, but is required for all 
other specimen types.
Provide any preliminary results that are available.
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Isolates
Minimum Volume Required Not Applicable
Turnaround Time 8 Weeks
Interferences & Limitations None
Storage & Preservation of
Specimen Prior to Shipping
No Specific Requirements
Additional lnformation Turnaround times for routine isolates may be extended during major foodborne 
outbreak activities or due to limited availability of resources.
Specimen Labeling Test subject to CLIA regulations require two patient identifiers on the specimen 
container and the test requisition.
Transport Medium Ship cultures on nonselective nutrient or similar agar (TSA, HIA, etc.) in tubes 
with leak-proof screw cap closures.  Agar plates are not acceptable.
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday, overnight to avoid weekend deliveries
Ship at ambient temperature in compliance with Federal and local guidelines
Methodology Phenotypic Identification, Genetic Identification
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Yersinia (non-Y. pestis) Subtyping
CDC-10124
Test Order
Synonym(s) None
Performed on Specimens From Human, Animal, and Food/Environmental/Medical Devices/Biologics
CDC Points of Contact Cheryl Tarr
(404) 639-2011
crt6@cdc.gov
Lori Gladney
(404) 639-1219
hze1@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
Prior approval is not required for human specimens, but is required for all 
other specimen types.
Indicate subtyping method(s) requested on specimen submission form
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Isolates
Minimum Volume Required Not Applicable
Turnaround Time 8 Weeks
Interferences & Limitations None
Storage & Preservation of
Specimen Prior to Shipping
No Specific Requirements
Additional lnformation Specify type of subtyping requested in 'Previous Laboratory Results' on back of 
form.
Turn around time depends on the nature of subtyping performed; and, results 
are typically not reported directly back to the submitter, but deposited in 
surveillance databases. If the surveillance database is not accessible to 
submitters, results are posted on the PulseNet and OutbreakNet discussion 
board.
Specimen Labeling Not Applicable
Transport Medium Ship cultures on nonselective nutrient or similar agar (TSA, HIA, etc.) in tubes 
with leak-proof screw cap closures.  Agar plates are not acceptable.
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday, overnight to avoid weekend deliveries
Ship at ambient temperature in compliance with Federal and local guidelines
Methodology Serotyping, PFGE, MLST
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Yersinia pestis Culture and Identification
CDC-10418
Test Order
Synonym(s) Plague
Performed on Specimens From Human, Animal, and Food/Environmental/Medical Devices/Biologics
CDC Points of Contact Marty Schriefer
(970) 221-6479
mms7@cdc.gov
Jeannine Petersen
(970) 266-3524
nzp0@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
Please include submitting agency, contact name, address, phone number, 
specimen identifier, patient name, specimen source and type, sex and date of 
birth, symptoms of onset, sample collection date, and clinical information 
including type and date of treatment patient has received.
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Human: lymph node aspirate, sputum, bronchial/tracheal wash, pleural fluid, 
blood, ulcer swab, biopsy/autopsy specimens (sections of lymph node, lung, 
liver, spleen); Animal: necropsy specimen (lymph node, lung, liver or spleen); 
Environmental: fleas
Minimum Volume Required Not Applicable
Turnaround Time 3 Weeks
Interferences & Limitations Samples for testing by culture should be taken prior to antibiotic treatment
Storage & Preservation of
Specimen Prior to Shipping
Store specimens containing suspected live bacteria at 2°-8°C to maintain 
viability. If processing is delayed, tissue samples can be directly frozen at -70°C. 
Store samples for culture of live bacteria without preservatives (formaldehyde, 
alcohol), at 2°-8°C (not frozen). Anticoagulants such as heparin, citrate and EDTA 
are acceptable because they do not inhibit the viability of bacteria.
Additional lnformation None
Specimen Labeling Specimen identifier and patient name
Transport Medium Respiratory specimens, lymph node aspirates, blood, 
tissue/biopsy/autopsy/necropsy specimens should all be transported at 4°C. 
Swabs must be in a Cary-Blair or Amies medium, not frozen. If tissue 
biopsy/autopsy/necropsy transport is delayed, tissue samples can be directly 
frozen at -70°C.
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday, overnight to avoid weekend deliveries. All packages 
must be addressed to:
Centers for Disease Control and Prevention
Bacterial Diseases Branch
Attn: John Young
3156 Rampart Road
Fort Collins, CO 80521
Frozen specimen should be shipped on dry ice
Refrigerated specimen should be shipped on ice packs
Methodology Culture, Direct Fluorescent Antibody (DFA), Bacteriophage Lysis
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Yersinia pestis Serology
CDC-10419
Test Order
Synonym(s) Plague
Performed on Specimens From Human and Animal
CDC Points of Contact Marty Schriefer
(970) 221-6479
mms7@cdc.gov
Jeannine Petersen
(970) 266-3524
nzp0@cdc.gov
Pre-Approval Needed None
Supplemental Information
Required
Please include submitting agency, contact name, address, phone number, 
specimen identifier, patient name, specimen source and type, sex and date of 
birth, symptoms of onset, sample collection date, and clinical information 
including type and date of treatment patient has received.
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
Serum
Minimum Volume Required 500 uL
Turnaround Time 2 Weeks
Interferences & Limitations Hemolyzed samples may interfere with test results
Storage & Preservation of
Specimen Prior to Shipping
Sera may be stored at 2°-8°C for up to 14 days. If testing is delayed for a longer 
period, serum samples may be frozen.
Additional lnformation None
Specimen Labeling Specimen identifier and patient name
Transport Medium Not Applicable
Shipping Instructions which 
Include Specimen Handling 
Requirements
Ship Monday-Thursday, overnight to avoid weekend deliveries. All packages 
must be addressed to:
Centers for Disease Control and Prevention
Bacterial Diseases Branch
Attn: John Young
3156 Rampart Road
Fort Collins, CO 80521
Frozen specimen should be shipped on dry ice
Refrigerated specimen should be shipped on ice packs
Methodology Passive Hemagglutination, Passive Hemagglutination Inhibition
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Yersinia pestis Special Study
CDC-10420
Test Order
Synonym(s) None
Performed on Specimens From Human and Animal
CDC Points of Contact Marty Schriefer
(970) 221-6479
mms7@cdc.gov
Jeannine Petersen
(970) 266-3524
nzp0@cdc.gov
Pre-Approval Needed Schriefer, Marty, (970) 221-6479, mms7@cdc.gov
Petersen, Jeannine, (970) 266-3524, nzp0@cdc.gov
Supplemental Information
Required
None
Supplemental Form None
Acceptable Sample/ Specimen 
Type for Testing
To be determined
Minimum Volume Required To be determined
Turnaround Time  
Interferences & Limitations To be determined
Storage & Preservation of
Specimen Prior to Shipping
To be determined
Additional lnformation To be determined
Specimen Labeling To be determined
Transport Medium To be determined
Shipping Instructions which 
Include Specimen Handling 
Requirements
To be determined
Methodology
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